Publications

Journals

• Jones BJ; Tan T; Bloom SR. (31 Jan 2012). Glucagon in Stress and Energy Homeostasis. Endocrinology. DOI.
• Greenwood HC; Bloom SR; Murphy KG. (2011). Peptides and their potential role in the treatment of diabetes and obesity. Rev Diabet Stud. 8:355-368. DOI.
• Simpson K; Parker J; Plumer J; Bloom S. (2012). CCK, PYY and PP: The Control of Energy Balance. Handb Exp Pharmacol. 209:209-230. DOI.
• Dixon AF; le Roux CW; Ghatei MA; Bloom SR; McGee TL; Dixon JB. (Dec 2011). Pancreatic polypeptide meal response may predict gastric band-induced weight loss. Obes Surg. 21:1906-1913. DOI.
• Ramachandran R; Bech P; Murphy K; Dhillo W; Meeran K; Chapman R; Caplin M; Ghatei M; et alBloom S; Martin N. (16 Dec 2011). Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assays. Clin Endocrinol (Oxf). DOI.
• Salem V; Bloom SR. (Jan 2010). Approaches to the pharmacological treatment of obesity. Expert Rev Clin Pharmacol. 3:73-88. DOI.
• Ghourab S; Beale KE; Semjonous NM; Simpson KA; Martin NM; Ghatei MA; Bloom SR; Smith KL. (10 Dec 2011). Intracerebroventricular administration of vasoactive intestinal peptide inhibits food intake. Regul Pept. 172:8-15. DOI.
• Addison ML; Minnion JS; Shillito JC; Suzuki K; Tan TM; Field BC; Germain-Zito N; Becker-Pauly C; et alGhatei MA; Bloom SR; Murphy KG. (Dec 2011). A role for metalloendopeptidases in the breakdown of the gut hormone, PYY 3-36. Endocrinology. 152:4630-4640. DOI.
• De Silva A; Salem V; Long CJ; Makwana A; Newbould RD; Rabiner EA; Ghatei MA; Bloom SR; et alMatthews PM; Beaver JD; Dhillo WS. (2 Nov 2011). The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab. 14:700-706. DOI.
• Zac-Varghese S; De Silva A; Bloom SR. (Dec 2011). Translational studies on PYY as a novel target in obesity. Curr Opin Pharmacol. 11:582-585. DOI.
• Jayasena CN; Nijher GM; Comninos AN; Abbara A; Januszewki A; Vaal ML; Sriskandarajah L; Murphy KG; et alFarzad Z; Ghatei MA; Bloom SR; Dhillo WS. (Dec 2011). The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans. J Clin Endocrinol Metab. 96:E1963-E1972. DOI.
• Suzuki K; Jayasena CN; Bloom SR. (2011). The gut hormones in appetite regulation. J Obes. 2011:528401. DOI.
• Hankir MK; Parkinson JR; Bloom SR; Bell JD. (16 Jan 2012). The effects of glutamate receptor agonists and antagonists on mouse hypothalamic and hippocampal neuronal activity shown through manganese enhanced MRI. Neuroimage. 59:968-978. DOI.
• Li JV; Ashrafian H; Bueter M; Kinross J; Sands C; le Roux CW; Bloom SR; Darzi A; et alAthanasiou T; Marchesi JR; Nicholson JK; Holmes E. (Sep 2011). Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. GUT. 60:1214-1223. DOI.
• Patterson M; Bloom SR; Gardiner JV. (Nov 2011). Ghrelin and appetite control in humans--potential application in the treatment of obesity. Peptides. 32:2290-2294. DOI.
• Tan TM; Field BC; Minnion JS; Cuenco-Shillito J; Chambers ES; Zac-Varghese S; Brindley CJ; Mt-Isa S; et alFiorentino F; Ashby D; Ward I; Ghatei MA; Bloom SR. (Feb 2012). Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420. Br J Clin Pharmacol. 73:232-239. DOI.
• Bueter M; Miras AD; Chichger H; Fenske W; Ghatei MA; Bloom SR; Unwin RJ; Lutz TA; et alSpector AC; le Roux CW. (24 Oct 2011). Alterations of sucrose preference after Roux-en-Y gastric bypass. Physiol Behav. 104:709-721. DOI.
• le Roux CW; Bueter M; Theis N; Werling M; Ashrafian H; Löwenstein C; Athanasiou T; Bloom SR; et alSpector AC; Olbers T; Lutz TA. (Oct 2011). Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol. 301:R1057-R1066. DOI.
• Fenske WK; Bueter M; Miras AD; Ghatei MA; Bloom SR; le Roux CW. (21 Jun 2011). Exogenous peptide YY3-36 and Exendin-4 further decrease food intake, whereas octreotide increases food intake in rats after Roux-en-Y gastric bypass. Int J Obes (Lond). DOI.
• Huda MS; Dovey TM; Wong SP; English PJ; Halford JC; McCulloch P; Cleator J; Martin B; et alCashen J; Hayden K; Ghatei MA; Bloom SR; Wilding JP; Pinkney JH. (Jul 2011). Ghrelin does not orchestrate the metabolic changes seen in fasting but has significant effects on lipid mobilisation and substrate utilisation. Eur J Endocrinol. 165:45-55. DOI.
• Li JV; Ashrafian H; Bueter M; Kinross J; Sands C; le Roux CW; Bloom SR; Darzi A; et alAthanasiou T; Marchesi JR; Nicholson JK; Holmes E. (Sep 2011). Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut. 60:1214-1223. DOI.
• Beckman LM; Beckman TR; Sibley SD; Thomas W; Ikramuddin S; Kellogg TA; Ghatei MA; Bloom SR; et alle Roux CW; Earthman CP. (Mar 2011). Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. JPEN J Parenter Enteral Nutr. 35:169-180. DOI.
• Hussain SS; Bloom SR. (Jan 2011). The pharmacological treatment and management of obesity. Postgrad Med. 123:34-44. DOI.
• Hankir MK; Parkinson JR; Minnion JS; Addison ML; Bloom SR; Bell JD. (Apr 2011). Peptide YY 3-36 and pancreatic polypeptide differentially regulate hypothalamic neuronal activity in mice in vivo as measured by manganese-enhanced magnetic resonance imaging. J Neuroendocrinol. 23:371-380. DOI.
• Ford HE; Peters V; Martin NM; Sleeth ML; Ghatei MA; Frost GS; Bloom SR. (Apr 2011). Effects of oral ingestion of sucralose on gut hormone response and appetite in healthy normal-weight subjects. Eur J Clin Nutr. 65:508-513. DOI.
• Beale KE; Murphy KG; Harrison EK; Kerton AJ; Ghatei MA; Bloom SR; Smith KL. (Aug 2011). Accurate measurement of body weight and food intake in environmentally enriched male Wistar rats. Obesity (Silver Spring). 19:1715-1721. DOI.
• Zac-Varghese S; Tan T; Bloom SR. (Dec 2010). Hormonal interactions between gut and brain. Discov Med. 10:543-552.
• Tharakan G; Tan T; Bloom S. (Jan 2011). Emerging therapies in the treatment of 'diabesity': beyond GLP-1. Trends Pharmacol Sci. 32:8-15. DOI.
• Simpson KA; Bloom SR. (Dec 2010). Appetite and hedonism: gut hormones and the brain. Endocrinol Metab Clin North Am. 39:729-743. DOI.
• Pournaras DJ; Osborne A; Hawkins SC; Vincent RP; Mahon D; Ewings P; Ghatei MA; Bloom SR; et alWelbourn R; le Roux CW. (Dec 2010). Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg. 252:966-971. DOI.
• McGowan BM; Minnion JS; Murphy KG; White NE; Roy D; Stanley SA; Dhillo WS; Gardiner JV; et alGhatei MA; Bloom SR. (Dec 2010). Central and peripheral administration of human relaxin-2 to adult male rats inhibits food intake. Diabetes Obes Metab. 12:1090-1096. DOI.
• Nijher GM; Chaudhri OB; Ramachandran R; Murphy KG; Zac-Varghese SE; Fowler A; Chinthapalli K; Patterson M; et alThompson EL; Williamson C; Kumar S; Ghatei MA; Bloom SR; Dhillo WS. (Nov 2010). The effects of kisspeptin-54 on blood pressure in humans and plasma kisspeptin concentrations in hypertensive diseases of pregnancy. Br J Clin Pharmacol. 70:674-681. DOI.
• Jayasena CN; Nijher GM; Abbara A; Murphy KG; Lim A; Patel D; Mehta A; Todd C; et alDonaldson M; Trew GH; Ghatei MA; Bloom SR; Dhillo WS. (Dec 2010). Twice-weekly administration of kisspeptin-54 for 8 weeks stimulates release of reproductive hormones in women with hypothalamic amenorrhea. Clin Pharmacol Ther. 88:840-847. DOI.
• Bloom SR. (Mar 2010). Bowels control brain - gut hormones and obesity. ENDOCR J. 57:S192-S192.
• Tadross JA; Patterson M; Wynne KJ; Patel S; Suzuki K; Ghatei MA; Bloom SR. (Mar 2010). Nesfatin suppresses feeding and stimulates the hypothalamo-pituitary-gonadal axis. ENDOCR J. 57:S442-S442.
• Tadross JA; Patterson M; Suzuki K; Ghatei MA; Bloom SR. (Mar 2010). Augurin is a novel hypothalamic neuropeptide which stimulates the hypothalamo-pituitary-adrenal axis. ENDOCR J. 57:S344-S344.
• Wynne K; Field BC; Bloom SR. (Oct 2010). The mechanism of action for oxyntomodulin in the regulation of obesity. Curr Opin Investig Drugs. 11:1151-1157.
• Ashrafian H; Athanasiou T; Li JV; Bueter M; Ahmed K; Nagpal K; Holmes E; Darzi A; et alBloom SR. (May 2011). Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass. Obes Rev. 12:e257-e272. DOI.
• Gardiner JV; Beale KE; Roy D; Boughton CK; Bataveljic A; Campbell DC; Bewick GA; Patel NA; et alPatterson M; Leavy EM; Ghatei MA; Bloom SR; Dhillo WS. (Oct 2010). Cerebellin1 is a novel orexigenic peptide. DIABETES OBES METAB. 12:883-890. DOI.
• Boughton CK; Patterson M; Bewick GA; Tadross JA; Gardiner JV; Beale KEL; Chaudery F; Hunter G; et alBusbridge M; Leavy EM; Ghatei MA; Bloom SR; Murphy KG. (Oct 2010). Alarin stimulates food intake and gonadotrophin release in male rats. BRIT J PHARMACOL. 161:601-613. DOI.
• Curtis AE; Cooke JH; Baxter JE; Parkinson JR; Bataveljic A; Ghatei MA; Bloom SR; Murphy KG. (Feb 2010). A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10. Am J Physiol Endocrinol Metab. 298:E296-E303. DOI.
• Hrabovszky E; Ciofi P; Vida B; Horvath MC; Keller E; Caraty A; Bloom SR; Ghatei MA; et alDhillo WS; Liposits Z; Kallo I. (Jun 2010). The kisspeptin system of the human hypothalamus: sexual dimorphism and relationship with gonadotropin-releasing hormone and neurokinin B neurons. Eur J Neurosci. 31:1984-1998. DOI.
• le Roux CW; Borg C; Wallis K; Vincent RP; Bueter M; Goodlad R; Ghatei MA; Patel A; et alBloom SR; Aylwin SJ. (Jul 2010). Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg. 252:50-56. DOI.
• Field BC; Chaudhri OB; Bloom SR. (Aug 2010). Bowels control brain: gut hormones and obesity. Nat Rev Endocrinol. 6:444-453. DOI.
• Cegla J; Tan TM; Bloom SR. (Sep 2010). Gut-brain cross-talk in appetite regulation. Curr Opin Clin Nutr Metab Care. 13:588-593. DOI.
• Liu YL; Ford HE; Druce MR; Minnion JS; Field BC; Shillito JC; Baxter J; Murphy KG; et alGhatei MA; Bloom SR. (Dec 2010). Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents. Int J Obes (Lond). 34:1715-1725. DOI.
• Suzuki K; Simpson KA; Minnion JS; Shillito JC; Bloom SR. (2010). The role of gut hormones and the hypothalamus in appetite regulation. Endocr J. 57:359-372.
• Curtis AE; Murphy KG; Chaudhri OB; Ramachandran R; Young AM; Waxman J; Nijher GM; Bewick GA; et alGhatei MA; Bloom SR; Dhillo WS. (Jun 2010). Kisspeptin is released from human prostate cancer cell lines but plasma kisspeptin is not elevated in patients with prostate cancer. Oncol Rep. 23:1729-1734.
• Field BC; Wren AM; Peters V; Baynes KC; Martin NM; Patterson M; Alsaraf S; Amber V; et alWynne K; Ghatei MA; Bloom SR. (Jul 2010). PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans. Diabetes. 59:1635-1639. DOI.
• Nijher GM; Baxter JE; Chaudhri OB; Murphy KG; Ramachandran R; Fowler A; Chinthapalli K; Patterson M; et alJayasena CN; Williamson C; Kumar S; Ghatei MA; Bloom SR; Dhillo WS. (Jun 2010). Identification of the hormone kisspeptin in amniotic fluid. Clin Chem. 56:1029-1031. DOI.
• Tadross JA; Patterson M; Suzuki K; Beale KE; Boughton CK; Smith KL; Moore S; Ghatei MA; et alBloom SR. (Apr 2010). Augurin stimulates the hypothalamo-pituitary-adrenal axis via the release of corticotrophin-releasing factor in rats. Br J Pharmacol. 159:1663-1671. DOI.
• Gardiner JV; Campbell D; Patterson M; Kent A; Ghatei MA; Bloom SR; Bewick GA. (Jun 2010). The hyperphagic effect of ghrelin is inhibited in mice by a diet high in fat. Gastroenterology. 138:2468-2476.e1. DOI.
• Nijher GK; Dhillo WS; Bloom SR. (Dec 2009). Kisspeptin: a novel role in the regulation of reproductive function. Drug News Perspect. 22:573-578. DOI.
• Bueter M; Löwenstein C; Ashrafian H; Hillebrand J; Bloom SR; Olbers T; Lutz T; le Roux CW. (May 2010). Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg. 20:616-622. DOI.
• Pournaras DJ; Osborne A; Hawkins SC; Mahon D; Ghatei MA; Bloom SR; Welbourn R; le Roux CW. (Jan 2010). The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study. Obes Surg. 20:56-60. DOI.
• Curtis AE; Cooke JH; Baxter JE; Parkinson JR; Bataveljic A; Ghatei MA; Bloom SR; Murphy KG. (Feb 2010). A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10. Am J Physiol Endocrinol Metab. 298:E296-E303. DOI.
• Taylor VJ; Patterson M; Ghatei MA; Bloom SR; Wilson CA. (Dec 2009). Ghrelin and peptide YY (PYY) profiles in gastrointestinal tissues and the circulation of the rat during pregnancy and lactation. PEPTIDES. 30:2213-2220. DOI.
• Ashrafian H; Bueter M; Ahmed K; Suliman A; Bloom SR; Darzi A; Athanasiou T. (Dec 2010). Metabolic surgery: an evolution through bariatric animal models. Obes Rev. 11:907-920. DOI.
• Field BCT; Chaudhri OB; Bloom SR. (Dec 2009). Obesity treatment: novel peripheral targets. BRIT J CLIN PHARMACO. 68:830-843. DOI.
• Bueter M; Löwenstein C; Olbers T; Wang M; Cluny NL; Bloom SR; Sharkey KA; Lutz TA; et alle Roux CW. (May 2010). Gastric bypass increases energy expenditure in rats. Gastroenterology. 138:1845-1853. DOI.
• Gardiner JV; Bataveljic A; Patel NA; Bewick GA; Roy D; Campbell D; Greenwood HC; Murphy KG; et alHameed S; Jethwa PH; Ebling FJ; Vickers SP; Cheetham S; Ghatei MA; Bloom SR; Dhillo WS. (Feb 2010). Prokineticin 2 is a hypothalamic neuropeptide that potently inhibits food intake. Diabetes. 59:397-406. DOI.
• Keun HC; Sidhu J; Pchejetski D; Lewis JS; Marconell H; Patterson M; Bloom SR; Amber V; et alCoombes RC; Stebbing J. (1 Nov 2009). Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy. CLIN CANCER RES. 15:6716-6723. DOI.
• Bloom S. (10 Oct 2009). It's not fair. NEW SCI. 204:65-65.
• Kokkinos A; le Roux CW; Alexiadou K; Tentolouris N; Vincent RP; Kyriaki D; Perrea D; Ghatei MA; et alBloom SR; Katsilambros N. (Jan 2010). Eating slowly increases the postprandial response of the anorexigenic gut hormones, peptide YY and glucagon-like peptide-1. J Clin Endocrinol Metab. 95:333-337. DOI.
• Ashby DR; Gale DP; Busbridge M; Murphy KG; Duncan ND; Cairns TD; Taube DH; Bloom SR; et alTam FW; Chapman R; Maxwell PH; Choi P. (Mar 2010). Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica. 95:505-508. DOI.
• Jayasena CN; Nijher GM; Chaudhri OB; Murphy KG; Ranger A; Lim A; Patel D; Mehta A; et alTodd C; Ramachandran R; Salem V; Stamp GW; Donaldson M; Ghatei MA; Bloom SR; Dhillo WS. (Nov 2009). Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocrinol Metab. 94:4315-4323. DOI.
• Violante IR; Anastasovska J; Sanchez-Canon GJ; Rodrigues TB; Righi V; Nieto-Charques L; Parkinson JRC; Bloom SR; et alBell JD; Cerdan S. (Aug 2009). Cerebral Activation by Fasting Induces Lactate Accumulation in the Hypothalamus. MAGN RESON MED. 62:279-283. DOI.
• Patterson M; Murphy KG; Patel SR; Patel NA; Greenwood HC; Cooke JH; Campbell D; Bewick GA; et alGhatei MA; Bloom SR. (Aug 2009). Hypothalamic Injection of Oxyntomodulin Suppresses Circulating Ghrelin-Like Immunoreactivity. ENDOCRINOLOGY. 150:3513-3520. DOI.
• Struthers AD; Anderson JV; Causon RC; Christofides ND; Bloom SR. (Dec 1985). The effect of human atrial natriuretic peptide on urinary sodium and urinary dopamine excretion in man. J Hypertens Suppl. 3:S315-S317.
• Carvalho TL; Hodson NP; Blank MA; Watson PF; Mulderry PK; Bishop AE; Gu J; Bloom SR; et alPolak JM. (Dec 1986). Occurrence, distribution and origin of peptide-containing nerves of guinea-pig and rat male genitalia and the effects of denervation on sperm characteristics. J Anat. 149:121-141.
• Fuessl HS; Domin J; Anderson JV; Bloom SR. (Feb 1987). Chronic administration of the somatostatin analogue SMS 201-995 does not lead to endogenous antibody formation. Aliment Pharmacol Ther. 1:45-50.
• Williams G; Ball JA; Lawson RA; Joplin GF; Bloom SR; Maskill MR. (25 Jul 1987). Analgesic effect of somatostatin analogue (octreotide) in headache associated with pituitary tumours. Br Med J (Clin Res Ed). 295:247-248.
• Fuessl HS; Burrin JM; Williams G; Adrian TE; Bloom SR. (Aug 1987). The effect of a long-acting somatostatin analogue (SMS 201-995) on intermediary metabolism and gut hormones after a test meal in normal subjects. Aliment Pharmacol Ther. 1:321-330.
• Fuessl HS; Williams G; Adrian TE; Bloom SR. (Sep 1987). Guar sprinkled on food: effect on glycaemic control, plasma lipids and gut hormones in non-insulin dependent diabetic patients. Diabet Med. 4:463-468.
• Inyama CO; Wharton J; Davis CJ; Jackson RH; Bloom SR; Polak JM. (16 Oct 1987). Distribution of vasoactive intestinal polypeptide binding sites in guinea pig genital tissues. Neurosci Lett. 81:111-116.
• Power RF; Bishop AE; Wharton J; Inyama CO; Jackson RH; Bloom SR; Polak JM. (1988). Anatomical distribution of vasoactive intestinal peptide binding sites in peripheral tissues investigated by in vitro autoradiography. Ann N Y Acad Sci. 527:314-325.
• Steel JH; Hamid Q; Van Noorden S; Jones P; Denny P; Burrin J; Legon S; Bloom SR; et alPolak JM. (1988). Combined use of in situ hybridisation and immunocytochemistry for the investigation of prolactin gene expression in immature, pubertal, pregnant, lactating and ovariectomised rats. Histochemistry. 89:75-80.
• Anand P; Llewelyn JG; Thomas PK; Gillon KR; Lisk R; Bloom SR. (Feb 1988). Water content, vasoactive intestinal polypeptide and substance P in intact and crushed sciatic nerves of normal and streptozotocin-diabetic rats. J Neurol Sci. 83:167-177.
• Williams G; Füessl HS; Burrin JM; Chilvers E; Bloom SR. (Mar 1988). Postprandial glycaemic effects of a long-acting somatostatin analogue (octreotide) in non-insulin dependent diabetes mellitus. Horm Metab Res. 20:168-170. DOI.
• Williams G; Steel JH; Cardoso H; Ghatei MA; Lee YC; Gill JS; Burrin JM; Polak JM; et alBloom SR. (Jun 1988). Increased hypothalamic neuropeptide Y concentrations in diabetic rat. Diabetes. 37:763-772.
• Williams G; Ghatei MA; Diani AR; Gerritsen GC; Bloom SR. (Nov 1988). Reduced hypothalamic somatostatin and neuropeptide Y concentrations in the spontaneously-diabetic Chinese hamster. Horm Metab Res. 20:668-670. DOI.
• Winter RJ; Meleagros L; Pervez S; Jamal H; Krausz T; Polak JM; Bloom SR. (Jan 1989). Atrial natriuretic peptide levels in plasma and in cardiac tissues after chronic hypoxia in rats. Clin Sci (Lond). 76:95-101.
• Power RF; Wharton J; Salas SP; Kanse S; Ghatei M; Bloom SR; Polak JM. (24 Jan 1989). Autoradiographic localisation of endothelin binding sites in human and porcine coronary arteries. Eur J Pharmacol. 160:199-200.
• Williams G; Gill JS; Lee YC; Cardoso HM; Okpere BE; Bloom SR. (Mar 1989). Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozocin-induced diabetic rats. Diabetes. 38:321-327.
• Kanse SM; Ghatei MA; Bloom SR. (1 Jun 1989). Endothelin binding sites in porcine aortic and rat lung membranes. Eur J Biochem. 182:175-179.
• Goodlad RA; Ratcliffe B; Fordham JP; Ghatei MA; Domin J; Bloom SR; Wright NA. (Jul 1989). Plasma enteroglucagon, gastrin and peptide YY in conventional and germ-free rats refed with a fibre-free or fibre-supplemented diet. Q J Exp Physiol. 74:437-442.
• Datta HK; Zaidi M; Wimalawansa SJ; Ghatei MA; Beacham JL; Bloom SR; MacIntyre I. (31 Jul 1989). In vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbit. Biochem Biophys Res Commun. 162:876-881.
• Williams G; Lee YC; Ghatei MA; Cardoso HM; Ball JA; Bone AJ; Baird JD; Bloom SR. (Sep 1989). Elevated neuropeptide Y concentrations in the central hypothalamus of the spontaneously diabetic BB/E Wistar rat. Diabet Med. 6:601-607.
• Black PN; Ghatei MA; Takahashi K; Bretherton-Watt D; Krausz T; Dollery CT; Bloom SR. (11 Sep 1989). Formation of endothelin by cultured airway epithelial cells. FEBS Lett. 255:129-132.
• Giaid A; Gibson SJ; Ibrahim BN; Legon S; Bloom SR; Yanagisawa M; Masaki T; Varndell IM; et alPolak JM. (Oct 1989). Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc Natl Acad Sci U S A. 86:7634-7638.
• Kar S; Bretherton-Watt D; Gibson SJ; Steel JH; Gentleman SM; Roberts GW; Valentino K; Tatemoto K; et alGhatei MA; Bloom SR. (22 Oct 1989). Novel peptide pancreastatin: its occurrence and codistribution with chromogranin A in the central nervous system of the pig. J Comp Neurol. 288:627-639. DOI.
• Desborough JP; Edlin SA; Burrin JM; Bloom SR; Morgan M; Hall GM. (Nov 1989). Hormonal and metabolic responses to cholecystectomy: comparison of extradural somatostatin and diamorphine. Br J Anaesth. 63:508-515.
• Allen JM; Rodrigo J; Kerle DJ; Darcy K; Williams G; Polak JM; Bloom SR. (Jan 1990). Neuropeptide Y (NPY)-containing nerves in mammalian ureter. Urology. 35:81-86.
• Ghatei MA; Datta HK; Zaidi M; Bretherton-Watt D; Wimalawansa SJ; MacIntyre I; Bloom SR. (Feb 1990). Amylin and amylin-amide lack an acute effect on blood glucose and insulin. J Endocrinol. 124:R9-11.
• Bretherton-Watt D; Gilbey SG; Ghatei MA; Beacham J; Bloom SR. (Feb 1990). Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in man. Diabetologia. 33:115-117.
• Bretherton-Watt D; Kenny MJ; Ghatei MA; Bloom SR. (5 Mar 1990). The distribution of galanin message-associated peptide-like immunoreactivity in the pig. Regul Pept. 27:307-315.
• Wynick D; Ratcliffe WA; Heath DA; Ball S; Barnard M; Bloom SR. (19 May 1990). Treatment of a malignant pancreatic endocrine tumour secreting parathyroid hormone related protein. BMJ. 300:1314-1315.
• Williams G; Cardoso HM; Domin J; Ghatei MA; Russell JC; Bloom SR. (Sep 1990). Hypothalamic regulatory peptide disturbances in the spontaneously obese JCR: LA-corpulent rat. Diabetes Res. 15:1-7.
• Jamal H; Bretherton-Watt D; Suda K; Ghatei MA; Bloom SR. (Sep 1990). Islet amyloid polypeptide-like immunoreactivity (amylin) in rats treated with dexamethasone and streptozotocin. J Endocrinol. 126:425-429.
• Füessl HS; Yiangou Y; Ghatei MA; Goebel FD; Bloom SR. (Oct 1990). Effect of synthetic human glucose-dependent insulinotropic polypeptide (hGIP) on the release of insulin in man. Eur J Clin Invest. 20:525-529.
• Steel JH; O'Halloran DJ; Jones PM; Van Noorden S; Chin WW; Bloom SR; Polak JM. (Oct 1990). Combined use of immunocytochemistry and in situ hybridization to study beta thyroid-stimulating hormone gene expression in pituitaries of hypothyroid rats. Mol Cell Probes. 4:385-396.
• Wynick D; Bloom SR. (Dec 1990). Magnetic bead separation of anterior pituitary cells. Neuroendocrinology. 52:560-565.
• Kanse SM; Takahashi K; Warren JB; Perera T; Porta M; Ghatei M; Bloom SR. (1991). Production of endothelin by vascular smooth muscle cells. J Cardiovasc Pharmacol. 17 Suppl 7:S113-S116.
• Kanse SM; Takahashi K; Lam HC; Rees A; Warren JB; Porta M; Molinatti P; Ghatei M; et alBloom SR. (1991). Cytokine stimulated endothelin release from endothelial cells. Life Sci. 48:1379-1384.
• Bretherton-Watt D; Ghatei MA; Legon S; Jamal H; Suda K; Bloom SR. (Feb 1991). Depletion of islet amyloid polypeptide in the spontaneously diabetic (BB) Wistar rat. J Mol Endocrinol. 6:3-7.
• Williams G; Cardoso HM; Lee YC; Ball JM; Ghatei MA; Stock MJ; Bloom SR. (May 1991). Hypothalamic regulatory peptides in obese and lean Zucker rats. Clin Sci (Lond). 80:419-426.
• Warren JB; Donnelly LE; Cullen S; Robertson BE; Ghatei MA; Bloom SR; MacDermot J. (17 May 1991). Pituitary adenylate cyclase-activating polypeptide: a novel, long-lasting, endothelium-independent vasorelaxant. Eur J Pharmacol. 197:131-134.
• Kanse SM; Takahashi K; Warren JB; Ghatei M; Bloom SR. (18 Jun 1991). Glucocorticoids induce endothelin release from vascular smooth muscle cells but not endothelial cells. Eur J Pharmacol. 199:99-101.
• Bennet WM; Hill SF; Ghatei MA; Bloom SR. (Sep 1991). Galanin in the normal human pituitary and brain and in pituitary adenomas. J Endocrinol. 130:463-467.
• Williams G; Cardoso H; Lee YC; Ghatei MA; Flatt PR; Bailey CJ; Bloom SR. (Oct 1991). Reduced hypothalamic neurotensin concentrations in the genetically obese diabetic (ob/ob) mouse: possible relationship to obesity. Metabolism. 40:1112-1116.
• Propato-Mussafiri R; Kanse SM; Ghatei MA; Bloom SR. (Jan 1992). Pituitary adenylate cyclase-activating polypeptide releases 7B2, adrenocorticotrophin, growth hormone and prolactin from the mouse and rat clonal pituitary cell lines AtT-20 and GH3. J Endocrinol. 132:107-113.
• Bretherton-Watt D; Gilbey SG; Ghatei MA; Beacham J; Macrae AD; Bloom SR. (May 1992). Very high concentrations of islet amyloid polypeptide are necessary to alter the insulin response to intravenous glucose in man. J Clin Endocrinol Metab. 74:1032-1035.
• Steel JH; O'Halloran DJ; Emson MA; Van Noorden S; Bloom SR; Polak JM. (May 1992). Identification of bombesin-immunoreactive cells in rat, human, and other mammalian pituitaries, their ontogeny and the effect of endocrine manipulations in the rat. Endocrinology. 130:2587-2596.
• Bretherton-Watt D; Ghatei MA; Jamal H; Gilbey SG; Jones PM; Bloom SR. (30 Jun 1992). The physiology of calcitonin gene-related peptide in the islet compared with that of islet amyloid polypeptide (amylin). Ann N Y Acad Sci. 657:299-312.
• Macrae AD; Bloom SR. (Jul 1992). Endothelin an endocrine role. Trends Endocrinol Metab. 3:153-157.
• Playford RJ; Benito-Orfila MA; Nihoyannopoulos P; Nandha KA; Cockcroft J; Todd S; Ghatei MA; Domin J; et alBloom SR; Calam J. (Oct 1992). Effects of peptide YY on the human cardiovascular system: reversal of responses to vasoactive intestinal peptide. Am J Physiol. 263:E740-E747.
• Hearn SC; Jones PM; Ghatei MA; Byrne J; Hill SF; Bloom SR. (Nov 1992). The presence, characterisation and synthesis of neuromedin B in the human pituitary gland. Neuroendocrinology. 56:729-734.
• Jamal H; Suda K; Bretherton-Watt D; Ghatei MA; Bloom SR. (Mar 1993). Molecular form of islet amyloid polypeptide (amylin) released from isolated rat islets of Langerhans. Pancreas. 8:261-266.
• Wilding JP; Gilbey SG; Lambert PD; Ghatei MA; Bloom SR. (Apr 1993). Increases in neuropeptide Y content and gene expression in the hypothalamus of rats treated with dexamethasone are prevented by insulin. Neuroendocrinology. 57:581-587.
• Bretherton-Watt D; Ghatei MA; Bloom SE; Williams S; Bloom SR. (Apr 1993). Islet amyloid polypeptide-like immunoreactivity in human tissue and endocrine tumors. J Clin Endocrinol Metab. 76:1072-1074.
• Wilding JP; Gilbey SG; Bailey CJ; Batt RA; Williams G; Ghatei MA; Bloom SR. (May 1993). Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology. 132:1939-1944.
• Hammond PJ; Talbot K; Chapman R; Ghatei MA; Bloom SR. (Jun 1993). Vasoactive intestinal peptide, but not pituitary adenylate cyclase-activating peptide, modulates the responsiveness of the gonadotroph to LHRH in man. J Endocrinol. 137:529-532.
• Hammond PJ; Bloom SR. (1994). Gut neuroendocrine tumors. Curr Ther Endocrinol Metab. 5:570-575.
• Wilding JP; Khandan-Nia N; Bennet WM; Gilbey SG; Beacham J; Ghatei MA; Bloom SR. (Feb 1994). Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans. Diabetologia. 37:166-169.
• Bennet WM; Beis CS; Ghatei MA; Byfield PG; Bloom SR. (Apr 1994). Amylin tonally regulates arginine-stimulated insulin secretion in rats. Diabetologia. 37:436-438.
• Bennet WM; Smith DM; Bloom SR. (Nov 1994). Islet amyloid polypeptide: does it play a pathophysiological role in the development of diabetes?. Diabet Med. 11:825-829.
• Hurley JD; Gardiner JV; Jones PM; Bloom SR. (Feb 1995). Cloning and molecular characterization of complementary deoxyribonucleic acid corresponding to a novel form of pituitary adenylate cyclase-activating polypeptide messenger ribonucleic acid in the rat testis. Endocrinology. 136:550-557.
• Akinsanya KO; Ghatei MA; Bloom SR. (Feb 1995). Gonadal steroids regulate rat anterior pituitary levels of TSH-releasing hormone- and pyroglutamyl-glutamyl-proline amide-like immunoreactivity. Endocrinology. 136:734-740.
• O'Shea D; Gunn I; Chen X; Bloom S; Herbert J. (29 Feb 1996). A role for central glucagon-like peptide-1 in temperature regulation. Neuroreport. 7:830-832.
• Hammond PJ; Smith DM; Akinsanya KO; Mufti WA; Wynick D; Bloom SR. (Jun 1996). Signalling pathways mediating secretory and mitogenic responses to galanin and pituitary adenylate cyclase-activating polypeptide in the 235-1 clonal rat lactotroph cell line. J Neuroendocrinol. 8:457-464.
• Hammond PJ; Khandan-Nia N; Withers DJ; Jones PM; Ghatei MA; Bloom SR. (Feb 1997). Regulation of anterior pituitary galanin and vasoactive intestinal peptide by oestrogen and prolactin status. J Endocrinol. 152:211-219.
• Janmohamed S; Bloom SR. (Apr 1997). Carcinoid tumours. Postgrad Med J. 73:207-214.
• Gunn I; O'Shea D; Bloom SR. (Nov 1997). Control of appetite--the role of glucagon-like peptide-1 (7-36) amide. J Endocrinol. 155:197-200.
• Cooke JH; Patterson M; Patel SR; Smith KL; Ghatei MA; Bloom SR; Murphy KG. (Jun 2009). Peripheral and Central Administration of Xenin and Neurotensin Suppress Food Intake in Rodents. OBESITY. 17:1135-1143. DOI.
• Semjonous NM; Smith KL; Parkinson JR; Gunner DJ; Liu YL; Murphy KG; Ghatei MA; Bloom SR; et alSmall CJ. (Jul 2009). Coordinated changes in energy intake and expenditure following hypothalamic administration of neuropeptides involved in energy balance. Int J Obes (Lond). 33:775-785. DOI.
• Simpson KA; Martin NM; Bloom SR. (Mar 2009). Hypothalamic regulation of food intake and clinical therapeutic applications. Arq Bras Endocrinol Metabol. 53:120-128.
• McGowan BM; Stanley SA; Ghatei MA; Bloom SR. (Apr 2009). Relaxin-3 and its role in neuroendocrine function. Ann N Y Acad Sci. 1160:250-255. DOI.
• Ashby DR; Gale DP; Busbridge M; Murphy KG; Duncan ND; Cairns TD; Taube DH; Bloom SR; et alTam FWK; Chapman RS; Maxwell PH; Choi P. (May 2009). Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. KIDNEY INT. 75:976-981. DOI.
• Ashby DR; Ford HE; Wynne KJ; Wren AM; Murphy KG; Busbridge M; Brown EA; Taube DH; et alGhatei MA; Tam FW; Bloom SR; Choi P. (Jul 2009). Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int. 76:199-206. DOI.
• Bewick GA; Kent A; Campbell D; Patterson M; Ghatei MA; Bloom SR; Gardiner JV. (Apr 2009). Mice With Hyperghrelinemia Are Hyperphagic and Glucose Intolerant and Have Reduced Leptin Sensitivity. DIABETES. 58:840-846. DOI.
• Druce MR; Minnion JS; Field BCT; Patel SR; Shillito JC; Tilby M; Beale KEL; Murphy KG; et alGhatei MA; Bloom SR. (Apr 2009). Investigation of Structure-Activity Relationships of Oxyntomodulin (Oxm) Using Oxm Analogs. ENDOCRINOLOGY. 150:1712-1721. DOI.
• Thompson EL; Amber V; Stamp GW; Patterson M; Curtis AE; Cooke JH; Appleby GF; Dhillo WS; et alGhatei MA; Bloom SR; Murphy KG. (Feb 2009). Kisspeptin-54 at high doses acutely induces testicular degeneration in adult male rats via central mechanisms. Br J Pharmacol. 156:609-625. DOI.
• Dhillo WS; Bewick GA; White NE; Gardiner JV; Thompson EL; Bataveljic A; Murphy KG; Roy D; et alPatel NA; Scutt JN; Armstrong A; Ghatei MA; Bloom SR. (Mar 2009). The thyroid hormone derivative 3-iodothyronamine increases food intake in rodents. DIABETES OBES METAB. 11:251-260. DOI.
• Jayasena CN; Dhillo WS; Bloom SR. (Jan 2009). Kisspeptins and the control of gonadotropin secretion in humans. PEPTIDES. 30:76-82. DOI.
• Chaudhri OB; Field BC; Bloom SR. (Dec 2008). Gastrointestinal satiety signals. Int J Obes (Lond). 32 Suppl 7:S28-S31. DOI.
• Liu YL; Semjonous NM; Murphy KG; Ghatei MA; Bloom SR. (Nov 2008). The effects of pancreatic polypeptide on locomotor activity and food intake in mice. INT J OBESITY. 32:1712-1715. DOI.
• Beck AL; Cabrera L; Pan WKY; Cama V; Friedland JS; Ghatei MA; Bloom SR; Lews J; et alGilman RH. (Nov 2008). Peptide YY: A Gut Hormone Associated with Anorexia during Infectious Diarrhea in Children. J PEDIATR. 153:677-682. DOI.
• De Waele K; Ishkanian SL; Bogarin R; Miranda CA; Ghatei MA; Bloom SR; Pacaud D; Chanoine JP. (Oct 2008). Long-acting octreotide treatment causes a sustained decrease in ghrelin concentrations but does not affect weight, behaviour and appetite in subjects with Prader-Willi syndrome. EUR J ENDOCRINOL. 159:381-388. DOI.
• Jayasena CN; Bloom SR. (Sep 2008). Role of Gut Hormones in Obesity. ENDOCRIN METAB CLIN. 37:769-+. DOI.
• Parkinson JR; Chaudhri OB; Kuo YT; Field BC; Herlihy AH; Dhillo WS; Ghatei MA; Bloom SR; et alBell JD. (1 Feb 2009). Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese-enhanced magnetic resonance imaging (MEMRI). Neuroimage. 44:1022-1031. DOI.
• Smith KL; Gardiner JV; Ward HL; Kong WM; Murphy KG; Martin NM; Ghatei MA; Bloom SR. (Oct 2008). Overexpression of CART in the PVN increases food intake and weight gain in rats. OBESITY. 16:2239-2244. DOI.
• Hameed S; Dhillo WS; Bloom SR. (Jan 2009). Gut hormones and appetite control. Oral Dis. 15:18-26. DOI.
• Ashby D; Choi P; Bloom S. (Aug 2008). Gut hormones and the treatment of disease cachexia. PROCEEDINGS OF THE NUTRITION SOCIETY. 67:263-269. DOI.
• le Roux CW; Shurey S; Vincent RP; Ghatei MA; Bloom SR. (2004). Role of PYY in appetite regulation during obesity. POULTRY SCI. 83:80-81.
• le Roux CW; Shurey S; Vincent RP; Ghatei MA; Bloom SR. (2004). Role of PYY in appetite regulation during obesity. J DAIRY SCI. 87:80-81.
• le Roux CW; Shurey S; Vincent RP; Ghatei MA; Bloom SR. (2004). Role of PYY in appetite regulation during obesity. J ANIM SCI. 82:80-81.
• Patel SR; Murphy KG; Thompson EL; Patterson M; Curtis AE; Ghatei MA; Bloom SR. (Sep 2008). Pyroglutamylated RFamide peptide 43 stimulates the hypothalamic-pituitary-gonadal axis via gonadotropin-releasing hormone in rats. ENDOCRINOLOGY. 149:4747-4754. DOI.
• McGowan BM; Stanley SA; Donovan J; Thompson EL; Patterson M; Semjonous NM; Gardiner JV; Murphy KG; et alGhatei MA; Bloom SR. (Aug 2008). Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis. AM J PHYSIOL-ENDOC M. 295:E278-E286. DOI.
• Keen KL; Wegner FH; Bloom SR; Ghatei MA; Terasawa E. (Aug 2008). An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo. ENDOCRINOLOGY. 149:4151-4157. DOI.
• Gardiner JV; Jayasena CN; Bloom SR. (Jun 2008). Gut hormones: a weight off your mind. J Neuroendocrinol. 20:834-841. DOI.
• Neary NM; McGowan BM; Monteiro MP; Jesudason DR; Ghatei MA; Bloom SR. (Sep 2008). No evidence of an additive inhibitory feeding effect following PP and PYY 3-36 administration. Int J Obes (Lond). 32:1438-1440. DOI.
• Bloom SR; Kuhajda FP; Ismail L; Pi-Sunyer X; Ronnett GV; Tan TMM; Weigle DS. (1 Apr 2008). The obesity epidemic: Pharmacological challenges. MOLECULAR INTERVENTIONS. 8:82-98. DOI.
• Murphy KG; Dhillo WS; Bloom SR. (Dec 2006). Gut peptides in the regulation of food intake and energy homeostasis. ENDOCR REV. 27:719-727. DOI.
• Manuchehri AM; Sathyapalan T; Jayagopal V; Kilpatrick ES; Ghatei MA; Bloom SR; Atkin SL. (May 2008). Alterations in thyroid status do not affect plasma peptide YY (PYY) and ghrelin concentrations. CLIN ENDOCRINOL. 68:836-838. DOI.
• Bretherton-Watt D; Bloom SR. (Nov 1991). Islet amyloid polypeptide: the cause of type-2 diabetes?. Trends Endocrinol Metab. 2:203-206.
• Parkinson JRC; Dhillo WS; Small CJ; Chaudhri OB; Bewick GA; Pritchard I; Moore S; Ghatei MA; et alBloom SR. (Apr 2008). PYY3-36 injection in mice produces an acute anorexigenic effect followed by a delayed orexigenic effect not observed with other anorexigenic gut hormones. AM J PHYSIOL-ENDOC M. 294:E698-E708. DOI.
• Chaudhri OB; Salem V; Murphy KG; Bloom SR. (2008). Gastrointestinal satiety signals. ANNU REV PHYSIOL. 70:239-255. DOI.
• Ramachandran R; Patterson M; Murphy KG; Dhillo WS; Patel S; Kazarian A; Ghatei MA; Bloom SR. (Mar 2008). Preanalytical factors affecting RIA measurement of plasma kisspeptin. CLIN CHEM. 54:615-617. DOI.
• Field BCT; Wren AM; Cooke D; Bloom SR. (2008). Gut hormones as potential new targets for appetite regulation and the treatment of obesity. DRUGS. 68:147-163.
• Gardiner J; Bloom S. (Mar 2008). Ghrelin gets its GOAT. Cell Metab. 7:193-194. DOI.
• le Roux CW; Borg CM; Murphy KG; Vincent RP; Ghatei MA; Bloom SR. (Jan 2008). Supraphysiological doses of intravenous PYY3-36 cause nausea, but no additional reduction in food intake. Ann Clin Biochem. 45:93-95. DOI.
• Chaudhri OB; Wynne K; Bloom SR. (Feb 2008). Can gut hormones control appetite and prevent obesity?. Diabetes Care. 31 Suppl 2:S284-S289. DOI.
• Nematy M; Brynes AE; Hornick PI; Patterson M; Ghatei MA; Bloom SR; Brett SJ; Frost GS. (8 Oct 2007). Postprandial ghrelin suppression is exaggerated following major surgery; implications for nutritional recovery. NUTR METAB. 4. DOI.
• White NE; Dhillo WS; Liu YL; Small CJ; Kennett GA; Gardiner JV; Ghatei MA; Bloom SR. (Feb 2008). Co-administration of SR141716 with peptide YY3-36 or oxyntomodulin has additive effects on food intake in mice. DIABETES OBES METAB. 10:167-170. DOI.
• Bech P; Winstanley V; Murphy KG; Sam AH; Meeran K; Ghatei MA; Bloom SR. (Apr 2008). Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancy. J Clin Endocrinol Metab. 93:1246-1253. DOI.
• Moran LJ; Noakes M; Clifton PM; Wittert GA; Le Roux CW; Ghatei MA; Bloom SR; Norman RJ. (Dec 2007). Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome. AM J CLIN NUTR. 86:1603-1610.
• Dhillo WS; Chaudhri OB; Thompson EL; Murphy KG; Patterson M; Ramachandran R; Nijher GK; Amber V; et alKokkinos A; Donaldson M; Ghatei MA; Bloom SR. (Oct 2007). Kisspeptin-54 stimulates gonadotropin release most potently during the Preovulatory phase of the menstrual cycle in women. J CLIN ENDOCR METAB. 92:3958-3966. DOI.
• Kuo YT; Parkinson JR; Chaudhri OB; Herlihy AH; So PW; Dhillo WS; Small CJ; Bloom SR; et alBell JD. (7 Nov 2007). The temporal sequence of gut peptide CNS interactions tracked in vivo by magnetic resonance imaging. J Neurosci. 27:12341-12348. DOI.
• le Roux CW; Welbourn R; Werling M; Osborne A; Kokkinos A; Laurenius A; Lönroth H; Fändriks L; et alGhatei MA; Bloom SR; Olbers T. (Nov 2007). Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 246:780-785. DOI.
• Borg CM; Le Roux CW; Ghatei MA; Bloom SR; Patel AG. (Sep 2007). Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. OBESITY SURGERY. 17:1193-1198.
• Hanusch-Enserer U; Ghatei MA; Cauza E; Bloom SR; Prager R; Roden M. (Jun 2007). Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery. WIEN KLIN WOCHENSCHR. 119:291-296. DOI.
• Neganova I; Al-Qassab H; Heffron H; Selman C; Choudhury AI; Lingard SJ; Diakonov I; Patterson M; et alGhatei M; Bloom SR; Franks S; Huhtaniemi I; Hardy K; Withers DJ. (Jun 2007). Role of central nervous system and ovarian insulin receptor substrate 2 signaling in female reproductive function in the mouse. BIOL REPROD. 76:1045-1053. DOI.
• English PJ; Ashcroft A; Patterson M; Dovey TM; Halford JCG; Harrison J; Eccleston D; Bloom SR; et alGhatei MA; Wilding JPH. (May 2007). Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes. DIABETES-METAB RES. 23:299-303. DOI.
• Martins C; Morgan LM; Bloom SR; Robertson MD. (May 2007). Effects of exercise on gut peptides, energy intake and appetite. J ENDOCRINOL. 193:251-258. DOI.
• Wren AM; Bloom SR. (May 2007). Gut hormones and appetite control. Gastroenterology. 132:2116-2130. DOI.
• Martin NM; Small CJ; Lee JL; Ellis S; Dhillo WS; Smith KL; Kong WM; Frost GS; et alBloom SR. (May 2007). Low-dose oral tri-iodothyronine does not directly increase food intake in man. Diabetes Obes Metab. 9:435-437. DOI.
• Germain N; Galusca B; Le Roux CW; Bossu C; Ghatei MA; Lang F; Bloom SR; Estour B. (Apr 2007). Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. Am J Clin Nutr. 85:967-971.
• Bloom S. (Mar 2007). Hormonal regulation of appetite. OBES REV. 8:63-65.
• McGowan BM; Stanley SA; White NE; Spangeus A; Patterson M; Thompson EL; Smith KL; Donovan J; et alGardiner JV; Ghatei MA; Bloom SR. (Mar 2007). Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar rats. Am J Physiol Endocrinol Metab. 292:E913-E919. DOI.
• Todd JF; Bloom SR. (Mar 2007). Incretins and other peptides in the treatment of diabetes. Diabet Med. 24:223-232. DOI.
• Jesudason DR; Monteiro MP; McGowan BM; Neary NM; Park AJ; Philippou E; Small CJ; Frost GS; et alGhatei MA; Bloom SR. (Mar 2007). Low-dose pancreatic polypeptide inhibits food intake in man. Br J Nutr. 97:426-429. DOI.
• Dhillo WS; Murphy KG; Bloom SR. (Mar 2007). The neuroendocrine physiology of kisspeptin in the human. Rev Endocr Metab Disord. 8:41-46. DOI.
• Milton JE; Sananthanan CS; Patterson M; Ghatei MA; Bloom SR; Frost GS. (Dec 2007). Glucagon-like peptide-1 (7-36) amide response to low versus high glycaemic index preloads in overweight subjects with and without type II diabetes mellitus. Eur J Clin Nutr. 61:1364-1372. DOI.
• Ashby D; Bloom SR. (Feb 2007). Recent progress in PYY research--an update report for 8th NPY meeting. Peptides. 28:198-202.
• Murphy KG; Bloom SR. (16 Jan 2007). Nonpeptidic glucagon-like peptide 1 receptor agonists: a magic bullet for diabetes?. Proc Natl Acad Sci U S A. 104:689-690. DOI.
• Murphy KG; Bloom SR. (14 Dec 2006). Gut hormones and the regulation of energy homeostasis. Nature. 444:854-859. DOI.
• Wynne K; Park AJ; Small CJ; Meeran K; Ghatei MA; Frost GS; Bloom SR. (Dec 2006). Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial. Int J Obes (Lond). 30:1729-1736. DOI.
• Chaudhri OB; Parkinson JR; Kuo YT; Druce MR; Herlihy AH; Bell JD; Dhillo WS; Stanley SA; et alGhatei MA; Bloom SR. (17 Nov 2006). Differential hypothalamic neuronal activation following peripheral injection of GLP-1 and oxyntomodulin in mice detected by manganese-enhanced magnetic resonance imaging. Biochem Biophys Res Commun. 350:298-306. DOI.
• Thompson EL; Murphy KG; Patterson M; Bewick GA; Stamp GW; Curtis AE; Cooke JH; Jethwa PH; et alTodd JF; Ghatei MA; Bloom SR. (Nov 2006). Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats. Am J Physiol Endocrinol Metab. 291:E1074-E1082. DOI.
• Wren AM; Bloom SR. (Nov 2006). Peptide hormones: Therapeutic targets in appetite regulation. LETT DRUG DES DISCOV. 3:593-597.
• Nematy M; Powell CA; Brynes AE; Pearse M; Patterson M; Ghatei MA; Bloom SR; Frost GS. (Nov 2006). Peptide YY (PYY) is increased in elderly patients with femoral neck fractures: a prospective cohort study. JPEN J Parenter Enteral Nutr. 30:530-531.
• Dhillo WS; Savage P; Murphy KG; Chaudhri OB; Patterson M; Nijher GM; Foggo VM; Dancey GS; et alMitchell H; Seckl MJ; Ghatei MA; Bloom SR. (Nov 2006). Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment. Am J Physiol Endocrinol Metab. 291:E878-E884. DOI.
• Baynes KC; Dhillo WS; Bloom SR. (Nov 2006). Regulation of food intake by gastrointestinal hormones. Curr Opin Gastroenterol. 22:626-631. DOI.
• Cooke D; Bloom S. (Nov 2006). The obesity pipeline: current strategies in the development of anti-obesity drugs. Nat Rev Drug Discov. 5:919-931. DOI.
• Wynne K; Bloom SR. (Nov 2006). The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control. Nat Clin Pract Endocrinol Metab. 2:612-620. DOI.
• Patterson M; Murphy KG; Thompson EL; Smith KL; Meeran K; Ghatei MA; Bloom SR. (Oct 2006). Microinjection of galanin-like peptide into the medial preoptic area stimulates food intake in adult male rats. J Neuroendocrinol. 18:742-747. DOI.
• McGowan BM; Stanley SA; Smith KL; Minnion JS; Donovan J; Thompson EL; Patterson M; Connolly MM; et alAbbott CR; Small CJ; Gardiner JV; Ghatei MA; Bloom SR. (11 Sep 2006). Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regul Pept. 136:72-77. DOI Open Access copy.
• English PJ; Ashcroft A; Patterson M; Dovey TM; Halford JCG; Harrison J; Eccleston D; Bloom SR; et alGhatei MA; Wilding JPH. (Sep 2006). Fasting plasma peptide-YY concentrations are elevated but do not rise postprandially in type 2 diabetes. DIABETOLOGIA. 49:2219-2221. DOI.
• Murray CD; le Roux CW; Gouveia C; Bassett P; Ghatei MA; Bloom SR; Emmanuel AV; Gabe SM. (Aug 2006). The effect of different macronutrient infusions on appetite, ghrelin and peptide YY in parenterally fed patients. Clin Nutr. 25:626-633. DOI.
• Chaudhri O; Small C; Bloom S. (29 Jul 2006). Gastrointestinal hormones regulating appetite. Philos Trans R Soc Lond B Biol Sci. 361:1187-1209. DOI.
• Feltrin KL; Patterson M; Ghatei MA; Bloom SR; Meyer JH; Horowitz M; Feinle-Bisset C. (Jul 2006). Effect of fatty acid chain length on suppression of ghrelin and stimulation of PYY, GLP-2 and PP secretion in healthy men. PEPTIDES. 27:1638-1643. DOI.
• Dhillo WS; Murphy KG; Bloom S. (Jul 2006). Endocrinology: the next 60 years. J Endocrinol. 190:7-10. DOI.
• Smith KL; Patterson M; Dhillo WS; Patel SR; Semjonous NM; Gardiner JV; Ghatei MA; Bloom SR. (Jul 2006). Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology. 147:3510-3518. DOI Open Access copy.
• Jethwa PH; Smith KL; Small CJ; Abbott CR; Darch SJ; Murphy KG; Seth A; Semjonous NM; et alPatel SR; Todd JF; Ghatei MA; Bloom SR. (Jun 2006). Neuromedin U partially mediates leptin-induced hypothalamo-pituitary adrenal (HPA) stimulation and has a physiological role in the regulation of the HPA axis in the rat. Endocrinology. 147:2886-2892. DOI Open Access copy.
• Patterson M; Murphy KG; Thompson EL; Patel S; Ghatei MA; Bloom SR. (May 2006). Administration of kisspeptin-54 into discrete regions of the hypothalamus potently increases plasma luteinising hormone and testosterone in male adult rats. J NEUROENDOCRINOL. 18:349-354. DOI.
• Patel AD; Stanley SA; Murphy KG; Frost GS; Gardiner JV; Kent AS; White NE; Ghatei MA; et alBloom SR. (15 Mar 2006). Ghrelin stimulates insulin-induced glucose uptake in adipocytes. Regul Pept. 134:17-22. DOI.
• Martin NM; Houston PA; Patterson M; Sajedi A; Carmignac DF; Ghatei MA; Bloom SR; Small CJ. (Mar 2006). Abnormalities of the somatotrophic axis in the obese agouti mouse. Int J Obes (Lond). 30:430-438. DOI.
• Chaudhri OB; Field BC; Bloom SR. (Mar 2006). Editorial: from gut to mind--hormonal satiety signals and anorexia nervosa. J Clin Endocrinol Metab. 91:797-798. DOI.
• Murray JF; Hahn JD; Kennedy AR; Small CJ; Bloom SR; Haskell-Luevano C; Coen CW; Wilson CA. (Mar 2006). Evidence for a stimulatory action of melanin-concentrating hormone on luteinising hormone release involving MCH1 and melanocortin-5 receptors. J NEUROENDOCRINOL. 18:157-167. DOI.
• Nematy M; O'Flynn JE; Wandrag L; Brynes AE; Brett SJ; Patterson M; Ghatei MA; Bloom SR; et alFrost GS. (Feb 2006). Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study. Crit Care. 10:R10. DOI.
• Martin NM; Smith KL; Bloom SR; Small CJ. (Feb 2006). Interactions between the melanocortin system and the hypothalamo-pituitary-thyroid axis. Peptides. 27:333-339. DOI Open Access copy.
• Borg CM; le Roux CW; Ghatei MA; Bloom SR; Patel AG; Aylwin SJ. (Feb 2006). Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg. 93:210-215. DOI.
• Druce MR; Neary NM; Small CJ; Milton J; Monteiro M; Patterson M; Ghatei MA; Bloom SR. (Feb 2006). Subcutaneous administration of ghrelin stimulates energy intake in healthy lean human volunteers. Int J Obes (Lond). 30:293-296. DOI.
• Abbott CR; Small CJ; Sajedi A; Smith KL; Parkinson JR; Broadhead LL; Ghatei MA; Bloom SR. (Feb 2006). The importance of acclimatisation and habituation to experimental conditions when investigating the anorectic effects of gastrointestinal hormones in the rat. Int J Obes (Lond). 30:288-292. DOI.
• Druce M; Bloom SR. (Feb 2006). The regulation of appetite. Arch Dis Child. 91:183-187. DOI.
• Neary NM; Druce MR; Small CJ; Bloom SR. (Jan 2006). Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut. 55:135.
• Murphy KG; Bloom SR. (Jan 2006). Are all fats created equal?. Nat Med. 12:32-33. DOI.
• le Roux CW; Batterham RL; Aylwin SJ; Patterson M; Borg CM; Wynne KJ; Kent A; Vincent RP; et alGardiner J; Ghatei MA; Bloom SR. (Jan 2006). Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology. 147:3-8. DOI.
• le Roux CW; Aylwin SJ; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghatei MA; et alPatel AG; Bloom SR. (Jan 2006). Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 243:108-114.
• Taheri S; Ghatei M; Bloom S. (2006). Measurement of gut hormones in plasma. Methods Mol Biol. 324:213-233. DOI.
• Druce MR; Bloom SR. (2006). Oxyntomodulin : a novel potential treatment for obesity. Treat Endocrinol. 5:265-272.
• Mahmoodi M; Gardiner JV; Karam GRA; Khaksari M; Murphy KG; Ghatei MA; Bloom SR. (15 Dec 2005). Implantation of fibre encapsulated RIN 1056a cells transfected with NPY cDNA into the lateral ventricle of rats alters body weight. REGUL PEPTIDES. 132:80-84. DOI.
• Dhillo WS; Gardiner JV; Castle L; Bewick GA; Smith KL; Meeran K; Todd JF; Ghatei MA; et alBloom SR. (Dec 2005). Agouti related protein (AgRP) is upregulated in Cushing's syndrome. Exp Clin Endocrinol Diabetes. 113:602-606. DOI Open Access copy.
• Feinle-Bisset C; Patterson M; Ghatei MA; Bloom SR; Horowitz M. (Dec 2005). Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid. AM J PHYSIOL-ENDOC M. 289:E948-E953. DOI.
• Murray CDR; Martin NM; Patterson M; Taylor SA; Ghatei MA; Kamm MA; Johnston C; Bloom SR; et alEmmanuel AV. (Dec 2005). Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study. GUT. 54:1693-1698. DOI.
• Dhillo WS; Chaudhri OB; Patterson M; Thompson EL; Murphy KG; Badman MK; McGowan BM; Amber V; et alPatel S; Ghatei MA; Bloom SR. (Dec 2005). Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab. 90:6609-6615. DOI.
• Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; et alWang F; Kent AS; Frost GS; Ghatei MA; Bloom SR. (Dec 2005). Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology. 146:5120-5127. DOI.
• Stanley S; Wynne K; McGowan B; Bloom S. (Oct 2005). Hormonal regulation of food intake. Physiol Rev. 85:1131-1158. DOI.
• Murphy KG; Bloom SR. (Oct 2005). Peripheral influences on central melanocortin neurons. Peptides. 26:1744-1752. DOI.
• Druce MR; Wren AM; Park AJ; Milton JE; Patterson M; Frost G; Ghatei MA; Small C; et alBloom SR. (Sep 2005). Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond). 29:1130-1136. DOI.
• McGowan BM; Stanley SA; Smith KL; White NE; Connolly MM; Thompson EL; Gardiner JV; Murphy KG; et alGhatei MA; Bloom SR. (Aug 2005). Central relaxin-3 administration causes hyperphagia in male Wistar rats. Endocrinology. 146:3295-3300. DOI Open Access copy.
• le Roux CW; Neary NM; Halsey TJ; Small CJ; Martinez-Isla AM; Ghatei MA; Theodorou NA; Bloom SR. (Aug 2005). Ghrelin does not stimulate food intake in patients with surgical procedures involving vagotomy. J Clin Endocrinol Metab. 90:4521-4524. DOI.
• Bewick GA; Dhillo WS; Darch SJ; Murphy KG; Gardiner JV; Jethwa PH; Kong WM; Ghatei MA; et alBloom SR. (Aug 2005). Hypothalamic cocaine- and amphetamine-regulated transcript (CART) and agouti-related protein (AgRP) neurons coexpress the NOP1 receptor and nociceptin alters CART and AgRP release. Endocrinology. 146:3526-3534. DOI.
• Jethwa PH; Small CJ; Smith KL; Seth A; Darch SJ; Abbott CR; Murphy KG; Todd JF; et alGhatei MA; Bloom SR. (Aug 2005). Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin. Am J Physiol Endocrinol Metab. 289:E301-E305. DOI.
• Bewick GA; Gardiner JV; Dhillo WS; Kent AS; White NE; Webster Z; Ghatei MA; Bloom SR. (Aug 2005). Postembryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J. 19:1680-+. DOI.
• Wynne K; Park AJ; Small CJ; Patterson M; Ellis SM; Murphy KG; Wren AM; Frost GS; et alMeeran K; Ghatei MA; Bloom SR. (Aug 2005). Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes. 54:2390-2395.
• Kitchen PA; Goodlad RA; FitzGerald AJ; Mandir N; Ghatei MA; Bloom SR; Berlanga-Acosta J; Playford RJ; et alForbes A; Walters JR. (Jul 2005). Intestinal growth in parenterally-fed rats induced by the combined effects of glucagon-like peptide 2 and epidermal growth factor. JPEN J Parenter Enteral Nutr. 29:248-254.
• Wynne K; Giannitsopoulou K; Small CJ; Patterson M; Frost G; Ghatei MA; Brown EA; Bloom SR; et alChoi P. (Jul 2005). Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol. 16:2111-2118. DOI.
• Abbott CR; Monteiro M; Small CJ; Sajedi A; Smith KL; Parkinson JR; Ghatei MA; Bloom SR. (17 May 2005). The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 1044:127-131. DOI.
• Abbott CR; Small CJ; Kennedy AR; Neary NM; Sajedi A; Ghatei MA; Bloom SR. (10 May 2005). Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res. 1043:139-144. DOI.
• Goldstone AP; Patterson M; Kalingag N; Ghatei MA; Brynes AE; Bloom SR; Grossman AB; Korbonits M. (May 2005). Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. J CLIN ENDOCR METAB. 90:2681-2690. DOI.
• le Roux CW; Bloom SR. (May 2005). Peptide YY, appetite and food intake. Proc Nutr Soc. 64:213-216.
• Small CJ; Bloom SR. (May 2005). The therapeutic potential of gut hormone peptide YY3-36 in the treatment of obesity. Expert Opin Investig Drugs. 14:647-653. DOI.
• Patterson M; Murphy KG; le Roux CW; Ghatei MA; Bloom SR. (Apr 2005). Characterization of ghrelin-like immunoreactivity in human plasma. J Clin Endocrinol Metab. 90:2205-2211. DOI.
• Stock S; Leichner P; Wong ACK; Ghatei MA; Kieffer TJ; Bloom SR; Chanoine JP. (Apr 2005). Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J CLIN ENDOCR METAB. 90:2161-2168. DOI.
• Dhillo WS; Jayasena CN; Jackson JE; Lynn JA; Bloom SR; Meeran K; Todd JF. (Apr 2005). Localization of gastrinomas by selective intra-arterial calcium injection in patients on proton pump inhibitor or H2 receptor antagonist therapy. Eur J Gastroenterol Hepatol. 17:429-433.
• Small CJ; Parkinson JR; Bloom SR. (Apr 2005). Novel therapeutic targets for appetite regulation. Curr Opin Investig Drugs. 6:369-372.
• Bloom S; Wynne K; Chaudhri O. (Mar 2005). Gut feeling--the secret of satiety?. Clin Med. 5:147-152.
• Park AJ; Bloom SR. (Mar 2005). Neuroendocrine control of food intake. Curr Opin Gastroenterol. 21:228-233.
• Gardiner JV; Kong WM; Ward H; Murphy KG; Dhillo WS; Bloom SR. (25 Feb 2005). AAV mediated expression of anti-sense neuropeptide Y cRNA in the arcuate nucleus of rats results in decreased weight gain and food intake. Biochem Biophys Res Commun. 327:1088-1093. DOI.
• Wynne K; Stanley S; McGowan B; Bloom S. (Feb 2005). Appetite control. J Endocrinol. 184:291-318. DOI.
• le Roux CW; Patterson M; Vincent RP; Hunt C; Ghatei MA; Bloom SR. (Feb 2005). Postprandial plasma ghrelin is suppressed proportional to meal calorie content in normal-weight but not obese subjects. J Clin Endocrinol Metab. 90:1068-1071. DOI.
• le Roux CW; Ghatei MA; Gibbs JSR; Bloom SR. (Feb 2005). The putative satiety hormone PYY is raised in cardiac cachexia associated with primary pulmonary hypertension. HEART. 91:241-242. DOI.
• le Roux CW; Bloom SR. (Jan 2005). Editorial: Why do patients lose weight after Roux-en-Y gastric bypass?. J CLIN ENDOCR METAB. 90:591-592. DOI.
• Forbes S; Moonan M; Robinson S; Anyaoku V; Patterson M; Murphy KG; Ghatei MA; Bloom SR; et alJohnston DG. (Jan 2005). Impaired circulating glucagon-like peptide-1 response to oral glucose in women with previous gestational diabetes. Clin Endocrinol (Oxf). 62:51-55. DOI.
• McGowan BM; Bloom SR. (Dec 2004). Peptide YY and appetite control. Curr Opin Pharmacol. 4:583-588. DOI.
• Martin NM; Small CJ; Sajedi A; Liao XH; Weiss RE; Gardiner JV; Ghatei MA; Bloom SR. (15 Nov 2004). Abnormalities of the hypothalamo-pituitary-thyroid axis in the pro-opiomelanocortin deficient mouse. Regul Pept. 122:169-172. DOI.
• Dhillo WS; Bloom SR. (Nov 2004). Gastrointestinal hormones and regulation of food intake. Horm Metab Res. 36:846-851. DOI.
• Kong WM; Martin NM; Smith KL; Gardiner JV; Connoley IP; Stephens DA; Dhillo WS; Ghatei MA; et alSmall CJ; Bloom SR. (Nov 2004). Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditure. Endocrinology. 145:5252-5258. DOI Open Access copy.
• Thompson EL; Murphy KG; Todd JF; Martin NM; Small CJ; Ghatei MA; Bloom SR. (8 Oct 2004). Chronic administration of NMU into the paraventricular nucleus stimulates the HPA axis but does not influence food intake or body weight. Biochem Biophys Res Commun. 323:65-71. DOI.
• Thompson EL; Patterson M; Murphy KG; Smith KL; Dhillo WS; Todd JF; Ghatei MA; Bloom SR. (Oct 2004). Central and peripheral administration of kisspeptin-10 stimulates the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol. 16:850-858. DOI Open Access copy.
• Small CJ; Bloom SR. (Oct 2004). Gut hormones as peripheral anti obesity targets. Curr Drug Targets CNS Neurol Disord. 3:379-388.
• Murphy KG; Bloom SR. (Sep 2004). Gut hormones in the control of appetite. Exp Physiol. 89:507-516. DOI.
• Stanley SA; Murphy KG; Bewick GA; Kong WM; Opacka-Juffry J; Gardiner JV; Ghatei M; Small CJ; et alBloom SR. (Sep 2004). Regulation of rat pituitary cocaine- and amphetamine-regulated transcript (CART) by CRH and glucocorticoids. Am J Physiol Endocrinol Metab. 287:E583-E590. DOI.
• Small CJ; Bloom SR. (Aug 2004). Gut hormones and the control of appetite. Trends Endocrinol Metab. 15:259-263. DOI.
• Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; et alLow MJ; Ghatei MA; Cone RD; Bloom SR. (8 Jul 2004). Does gut hormone PYY3-36 decrease food intake in rodents? Reply. NATURE. 430. DOI.
• Small CJ; Carling D; Bloom SR. (Jul 2004). Cellular energy sensor balances the scales. NAT MED. 10:681-682. DOI.
• Martin NM; Small CJ; Sajedi A; Patterson M; Ghatei MA; Bloom SR. (Jul 2004). Pre-obese and obese agouti mice are sensitive to the anorectic effects of peptide YY(3-36) but resistant to ghrelin. Int J Obes Relat Metab Disord. 28:886-893. DOI.
• Park A; Bloom SR. (15 Jun 2004). Peptides and obesity: the PYY3-36 story. Regul Pept. 119:1-2. DOI.
• Neary NM; Small CJ; Wren AM; Lee JL; Druce MR; Palmieri C; Frost GS; Ghatei MA; et alCoombes RC; Bloom SR. (Jun 2004). Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 89:2832-2836. DOI.
• Druce MR; Small CJ; Bloom SR. (Jun 2004). Minireview: Gut peptides regulating satiety. Endocrinology. 145:2660-2665. DOI.
• Dakin CL; Small CJ; Batterham RL; Neary NM; Cohen MA; Patterson M; Ghatei MA; Bloom SR. (Jun 2004). Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology. 145:2687-2695. DOI.
• Wynne K; Stanley S; Bloom S. (Jun 2004). The gut and regulation of body weight. J Clin Endocrinol Metab. 89:2576-2582. DOI.
• Stanley S; Wynne K; Bloom S. (May 2004). Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide. Am J Physiol Gastrointest Liver Physiol. 286:G693-G697. DOI.
• Goldstone AP; Thomas EL; Brynes AE; Castroman G; Edwards R; Ghatei MA; Frost G; Holland AJ; et alGrossman AB; Korbonits M; Bloom SR; Bell JD. (Apr 2004). Elevated fasting plasma ghrelin in Prader-Willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance. J CLIN ENDOCR METAB. 89:1718-1726. DOI.
• Andersson U; Filipsson K; Abbott CR; Woods A; Smith K; Bloom SR; Carling D; Small CJ. (26 Mar 2004). AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem. 279:12005-12008. DOI Open Access copy.
• Mahmoodi M; Gardiner JV; Ghatei MA; Asadikaram G; Bloom SR. (Mar 2004). Investigation of the chronic effects of NPY by subcutaneous implantation of 6-23 cells producing NPY in WAG rats. CLIN BIOCHEM. 37:217-223. DOI.
• Barakat MT; Meeran K; Bloom SR. (Mar 2004). Neuroendocrine tumours. Endocr Relat Cancer. 11:1-18.
• Neary NM; Goldstone AP; Bloom SR. (Feb 2004). Appetite regulation: from the gut to the hypothalamus. Clin Endocrinol (Oxf). 60:153-160.
• Seth A; Stanley S; Jethwa P; Gardiner J; Ghatei M; Bloom S. (Feb 2004). Galanin-like peptide stimulates the release of gonadotropin-releasing hormone in vitro and may mediate the effects of leptin on the hypothalamo-pituitary-gonadal axis. Endocrinology. 145:743-750. DOI.
• Malik IA; English PJ; Ghatei MA; Bloom SR; MacFarlane IA; Wilding JPH. (Jan 2004). The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency. CLIN ENDOCRINOL. 60:137-141. DOI.
• Murray CDR; Kamm MA; Bloom SR; Emmanuel AV. (Nov 2003). Ghrelin for the gastroenterologist: History and potential. GASTROENTEROLOGY. 125:1492-1502. DOI.
• Cohen MA; Ellis SM; Le Roux CW; Batterham RL; Park A; Patterson M; Frost GS; Ghatei MA; et alBloom SR. (Oct 2003). Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab. 88:4696-4701.
• Batterham RL; Cohen MA; Ellis SM; Le Roux CW; Withers DJ; Frost GS; Ghatei MA; Bloom SR. (4 Sep 2003). Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 349:941-948. DOI.
• Abbott CR; Kennedy AR; Wren AM; Rossi M; Murphy KG; Seal LJ; Todd JF; Ghatei MA; et alSmall CJ; Bloom SR. (Sep 2003). Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology. 144:3943-3949.
• Bloom S. (9 Aug 2003). The fat controller. NEW SCI. 179:38-41.
• Batterham RL; Le Roux CW; Cohen MA; Park AJ; Ellis SM; Patterson M; Frost GS; Ghatei MA; et alBloom SR. (Aug 2003). Pancreatic polypeptide reduces appetite and food intake in humans. J Clin Endocrinol Metab. 88:3989-3992.
• Kong WM; Stanley S; Gardiner J; Abbott C; Murphy K; Seth A; Connoley I; Ghatei M; et alStephens D; Bloom S. (Jul 2003). A role for arcuate cocaine and amphetamine regulated transcript in hyperphagia, thermogenesis, and cold adaptation. FASEB J. 17:1688-+. DOI.
• Small CJ; Goubillon ML; Murray JF; Siddiqui A; Grimshaw SE; Young H; Sivanesan V; Kalamatianos T; et alKennedy AR; Coen CW; Bloom SR; Wilson CA. (Jul 2003). Central orexin A has site-specific effects on luteinizing hormone release in female rats. ENDOCRINOLOGY. 144:3225-3236. DOI.
• Druce M; Bloom SR. (Jul 2003). Central regulators of food intake. Curr Opin Clin Nutr Metab Care. 6:361-367. DOI.
• Neary NM; Small CJ; Bloom SR. (Jul 2003). Gut and mind. Gut. 52:918-921.
• Batterham RL; Bloom SR. (Jun 2003). The gut hormone peptide YY regulates appetite. Ann N Y Acad Sci. 994:162-168.
• Stanley SA; Davies S; Small CJ; Gardiner JV; Ghatei MA; Smith DM; Bloom SR. (22 May 2003). gamma-MSH increases intracellular cAMP accumulation and GnRH release in vitro and LH release in vivo. FEBS Lett. 543:66-70.
• Small CJ; Liu YL; Stanley SA; Connoley IP; Kennedy A; Stock MJ; Bloom SR. (Apr 2003). Chronic CNS administration of Agouti-related protein (Agrp) reduces energy expenditure. Int J Obes Relat Metab Disord. 27:530-533. DOI.
• Dhillo WS; Small CJ; Jethwa PH; Russell SH; Gardiner JV; Bewick GA; Seth A; Murphy KG; et alGhatei MA; Bloom SR. (Apr 2003). Paraventricular nucleus administration of calcitonin gene-related peptide inhibits food intake and stimulates the hypothalamo-pituitary-adrenal axis. Endocrinology. 144:1420-1425.
• le Roux CW; Bloom SR. (Mar 2003). Clinical authorization: what is best for the patient?. Ann Clin Biochem. 40:113-114. DOI.
• Kennedy AR; Todd JF; Dhillo WS; Seal LJ; Ghatei MA; O'Toole CP; Jones M; Witty D; et alWinborne K; Riley G; Hervieu G; Wilson S; Bloom SR. (Mar 2003). Effect of direct injection of melanin-concentrating hormone into the paraventricular nucleus: further evidence for a stimulatory role in the adrenal axis via SLC-1. J Neuroendocrinol. 15:268-272.
• Brynes AE; Mark Edwards C; Ghatei MA; Dornhorst A; Morgan LM; Bloom SR; Frost GS. (Feb 2003). A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men. Br J Nutr. 89:207-218. DOI.
• Ward H; Gardiner J; Kong WM; Murphy K; Bloom S. (Feb 2003). Distribution of fluorescence following injection of recombinant adeno-associated virus encoding green fluorescent protein into the paraventricular nucleus. Neuroendocrinology. 77:100-104. DOI.
• Seth A; Stanley S; Dhillo W; Murphy K; Ghatei M; Bloom S. (Feb 2003). Effects of galanin-like peptide on food intake and the hypothalamo-pituitary-thyroid axis. Neuroendocrinology. 77:125-131. DOI.
• Frost GS; Brynes AE; Dhillo WS; Bloom SR; McBurney MI. (Feb 2003). The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal. Eur J Clin Nutr. 57:293-298. DOI.
• Dhillo WS; Small CJ; Gardiner JV; Bewick GA; Whitworth EJ; Jethwa PH; Seal LJ; Ghatei MA; et alHinson JP; Bloom SR. (31 Jan 2003). Agouti-related protein has an inhibitory paracrine role in the rat adrenal gland. Biochem Biophys Res Commun. 301:102-107.
• Todd JF; Stanley SA; Roufosse CA; Bishop AE; Khoo B; Bloom SR; Meeran K. (18 Jan 2003). A tumour that secretes glucagon-like peptide-1 and somatostatin in a patient with reactive hypoglycaemia and diabetes. Lancet. 361:228-230.
• Dakin CL; Small CJ; Park AJ; Seth A; Ghatei MA; Bloom SR. (Dec 2002). Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats. Am J Physiol Endocrinol Metab. 283:E1173-E1177. DOI.
• Bacon A; Holmes FE; Small CJ; Ghatei M; Mahoney S; Bloom S; Wynick D. (15 Nov 2002). Transgenic over-expression of galanin in injured primary sensory neurons. Neuroreport. 13:2129-2132.
• Small CJ; Stanley SA; Bloom SR. (Nov 2002). Appetite control and reproduction: leptin and beyond. Semin Reprod Med. 20:389-398. DOI.
• Wren AM; Small CJ; Abbott CR; Jethwa PH; Kennedy AR; Murphy KG; Stanley SA; Zollner AN; et alGhatei MA; Bloom SR. (Nov 2002). Hypothalamic actions of neuromedin U. Endocrinology. 143:4227-4234. Open Access copy.
• Wren AM; Small CJ; Fribbens CV; Neary NM; Ward HL; Seal LJ; Ghatei MA; Bloom SR. (Nov 2002). The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology. 76:316-324.
• Bloom S. (21 Sep 2002). Who's to say that the risk is worth taking? Faced with the fear that their science might be misused, what should a researcher do?. NEW SCI. 175:25-25.
• Dhillo WS; Small CJ; Stanley SA; Jethwa PH; Seal LJ; Murphy KG; Ghatei MA; Bloom SR. (Sep 2002). Hypothalamic interactions between neuropeptide Y, agouti-related protein, cocaine- and amphetamine-regulated transcript and alpha-melanocyte-stimulating hormone in vitro in male rats. J Neuroendocrinol. 14:725-730.
• Batterham RL; Cowley MA; Small CJ; Herzog H; Cohen MA; Dakin CL; Wren AM; Brynes AE; et alLow MJ; Ghatei MA; Cone RD; Bloom SR. (8 Aug 2002). Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 418:650-654. DOI.
• Lord GM; Matarese G; Howard JK; Bloom SR; Lechler RI. (Aug 2002). Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol. 72:330-338.
• Seal LJ; Small CJ; Dhillo WS; Kennedy AR; Ghatei MA; Bloom SR. (Aug 2002). Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus. Neuroendocrinology. 76:70-78.
• Goldstone AP; Howard JK; Lord GM; Ghatei MA; Gardiner JV; Wang ZL; Wang RM; Girgis SI; et alBailey CJ; Bloom SR. (12 Jul 2002). Leptin prevents the fall in plasma osteocalcin during starvation in male mice. Biochem Biophys Res Commun. 295:475-481.
• Choksi T; Hay DL; Legon S; Poyner DR; Hagner S; Bloom SR; Smith DM. (Jul 2002). Comparison of the expression of calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) with CGRP and adrenomedullin binding in cell lines. Br J Pharmacol. 136:784-792. DOI.
• English PJ; Ghatei MA; Malik IA; Bloom SR; Wilding JPH. (Jun 2002). Food fails to suppress ghrelin levels in obese humans. J CLIN ENDOCR METAB. 87:2984-2987.
• English PJ; Ghatei MA; Malik IA; Bloom SR; Wilding JP. (Jun 2002). Food fails to suppress ghrelin levels in obese humans. J Clin Endocrinol Metab. 87:2984.
• Kim MS; Rossi M; Abbott CR; AlAhmed SH; Smith DM; Bloom SR. (Jun 2002). Sustained orexigenic effect of Agouti related protein may be not mediated by the melanocortin 4 receptor. Peptides. 23:1069-1076.
• Kim MS; Small CJ; Russell SH; Morgan DG; Abbott CR; alAhmed SH; Hay DL; Ghatei MA; et alSmith DM; Bloom SR. (Apr 2002). Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptors. J Neuroendocrinol. 14:276-282.
• Dhillo WS; Small CJ; Seal LJ; Kim MS; Stanley SA; Murphy KG; Ghatei MA; Bloom SR. (Apr 2002). The hypothalamic melanocortin system stimulates the hypothalamo-pituitary-adrenal axis in vitro and in vivo in male rats. Neuroendocrinology. 75:209-216.
• Russell SH; Small CJ; Sunter D; Morgan I; Dakin CL; Cohen MA; Bloom SR. (15 Mar 2002). Chronic intraparaventricular nuclear administration of orexin A in male rats does not alter thyroid axis or uncoupling protein-1 in brown adipose tissue. Regul Pept. 104:61-68.
• Taheri S; Murphy K; Cohen M; Sujkovic E; Kennedy A; Dhillo W; Dakin C; Sajedi A; et alGhatei M; Bloom S. (15 Mar 2002). The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochem Biophys Res Commun. 291:1208-1212. DOI.
• Bates SH; Gardiner JV; Jones RB; Bloom SR; Bailey CJ. (Mar 2002). Acute stimulation of glucose uptake by leptin in l6 muscle cells. Horm Metab Res. 34:111-115. DOI.
• Owji AA; Khoshdel Z; Sanea F; Panjehshahin MR; Shojaee Fard M; Smith DM; Coppock HA; Ghatei MA; et alBloom SR. (1 Mar 2002). Effects of intracerebroventricular injection of glucagon like peptide-1 and its related peptides on serotonin metabolism and on levels of amino acids in the rat hypothalamus. Brain Res. 929:70-75.
• Goldstone AP; Brynes AE; Thomas EL; Bell JD; Frost G; Holland A; Ghatei MA; Bloom SR. (Mar 2002). Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. Am J Clin Nutr. 75:468-475.
• Goldstone AP; Unmehopa UA; Bloom SR; Swaab DF. (Feb 2002). Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects. J Clin Endocrinol Metab. 87:927-937.
• Brynes AE; Edwards CM; Ghatei MA; Bloom SR; Frost GS. (Feb 2002). Men at increased risk of coronary heart disease are not different from age- and weight-matched healthy controls in their postprandial triglyceride, nonesterified fatty acid, or incretin responses to sucrose. Metabolism. 51:195-200.
• FitzGerald AJ; Ghatei MA; Mandir N; Bloom SR; Iversen L; Goodlad RA. (2002). Effects of amidated gastrin and glycine-extended gastrin on cell proliferation and crypt fission in parenterally and orally fed rats. Digestion. 66:58-66.
• Wren AM; Seal LJ; Cohen MA; Brynes AE; Frost GS; Murphy KG; Dhillo WS; Ghatei MA; et alBloom SR. (Dec 2001). Ghrelin enhances appetite and increases food intake in humans. J CLIN ENDOCR METAB. 86:5992-5995.
• Wren AM; Seal LJ; Cohen MA; Brynes AE; Frost GS; Murphy KG; Dhillo WS; Ghatei MA; et alBloom SR. (Dec 2001). Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 86:5992. Open Access copy.
• Dhillo WS; Bloom SR. (Dec 2001). Hypothalamic peptides as drug targets for obesity. Curr Opin Pharmacol. 1:651-655.
• Russell SH; Small CJ; Kennedy AR; Stanley SA; Seth A; Murphy KG; Taheri S; Ghatei MA; et alBloom SR. (Dec 2001). Orexin A interactions in the hypothalamo-pituitary gonadal axis. Endocrinology. 142:5294-5302.
• Wren AM; Small CJ; Abbott CR; Dhillo WS; Seal LJ; Cohen MA; Batterham RL; Taheri S; et alStanley SA; Ghatei MA; Bloom SR. (Nov 2001). Ghrelin causes hyperphagia and obesity in rats. Diabetes. 50:2540-2547. Open Access copy.
• Dakin CL; Gunn I; Small CJ; Edwards CM; Hay DL; Smith DM; Ghatei MA; Bloom SR. (Oct 2001). Oxyntomodulin inhibits food intake in the rat. Endocrinology. 142:4244-4250.
• Seal LJ; Small CJ; Dhillo WS; Stanley SA; Abbott CR; Ghatei MA; Bloom SR. (Oct 2001). PRL-releasing peptide inhibits food intake in male rats via the dorsomedial hypothalamic nucleus and not the paraventricular hypothalamic nucleus. Endocrinology. 142:4236-4243.
• Goldstone AP; Thomas EL; Brynes AE; Bell JD; Frost G; Saeed N; Hajnal JV; Howard JK; et alHolland A; Bloom SR. (Sep 2001). Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. J Clin Endocrinol Metab. 86:4330-4338.
• Abbott CR; Rossi M; Wren AM; Murphy KG; Kennedy AR; Stanley SA; Zollner AN; Morgan DG; et alMorgan I; Ghatei MA; Small CJ; Bloom SR. (Aug 2001). Evidence of an orexigenic role for cocaine- and amphetamine-regulated transcript after administration into discrete hypothalamic nuclei. Endocrinology. 142:3457-3463.
• Saxty BA; Yadollahi-Farsani M; Upton PD; Johnstone SR; MacDermot J. (Aug 2001). Inactivation of platelet-derived growth factor-BB following modification by ADP-ribosyltransferase. Br J Pharmacol. 133:1219-1226. DOI.
• Ward HL; Small CJ; Murphy KG; Kennedy AR; Ghatei MA; Bloom SR. (Aug 2001). The actions of tuberoinfundibular peptide on the hypothalamo-pituitary axes. Endocrinology. 142:3451-3456.
• Sunter D; Morgan I; Edwards CM; Dakin CL; Murphy KG; Gardiner J; Taheri S; Rayes E; et alBloom SR. (13 Jul 2001). Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem. Brain Res. 907:27-34.
• Edwards CM; Stanley SA; Davis R; Brynes AE; Frost GS; Seal LJ; Ghatei MA; Bloom SR. (Jul 2001). Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers. Am J Physiol Endocrinol Metab. 281:E155-E161.
• Kennedy AR; Todd JF; Stanley SA; Abbott CR; Small CJ; Ghatei MA; Bloom SR. (Jul 2001). Melanin-concentrating hormone (MCH) suppresses thyroid stimulating hormone (TSH) release, in vivo and in vitro, via the hypothalamus and the pituitary. Endocrinology. 142:3265-3268.
• Ghatei MA; Goodlad RA; Taheri S; Mandir N; Brynes AE; Jordinson M; Bloom SR. (Jun 2001). Proglucagon-derived peptides in intestinal epithelial proliferation: glucagon-like peptide-2 is a major mediator of intestinal epithelial proliferation in rats. Dig Dis Sci. 46:1255-1263.
• Russell SH; Small CJ; Dakin CL; Abbott CR; Morgan DG; Ghatei MA; Bloom SR. (Jun 2001). The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats. J Neuroendocrinol. 13:561-566.
• Matarese G; Di Giacomo A; Sanna V; Lord GM; Howard JK; Di Tuoro A; Bloom SR; Lechler RI; et alZappacosta S; Fontana S. (15 May 2001). Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J Immunol. 166:5909-5916.
• Matarese G; Sanna V; Di Giacomo A; Lord GM; Howard JK; Bloom SR; Lechler RI; Fontana S; et alZappacosta S. (May 2001). Leptin potentiates experimental autoimmune encephalomyelitis in SJL female mice and confers susceptibility to males. Eur J Immunol. 31:1324-1332. DOI.
• Taheri S; Bloom S. (Apr 2001). Orexins/hypocretins: waking up the scientific world. Clin Endocrinol (Oxf). 54:421-429.
• Taheri S; Gardiner J; Hafizi S; Murphy K; Dakin C; Seal L; Small C; Ghatei M; et alBloom S. (5 Mar 2001). Orexin A immunoreactivity and preproorexin mRNA in the brain of Zucker and WKY rats. Neuroreport. 12:459-464.
• Stanley SA; Small CJ; Murphy KG; Rayes E; Abbott CR; Seal LJ; Morgan DG; Sunter D; et alDakin CL; Kim MS; Hunter R; Kuhar M; Ghatei MA; Bloom SR. (2 Mar 2001). Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats. Brain Res. 893:186-194.
• Fitzgerald AJ; Ghatei MA; Mandir N; Bloom SR; Iverson L; Goodlad RA. (Mar 2001). Intestinal cell proliferation and crypt branching in parenterally and orally fed rats, effects of gastrin and glycine extended gastrin. GUT. 48:A80-A80.
• Kitchen P; FitzGerald A; Mandir N; Ghatei M; Bloom S; Walters J; Forbes A; Goodlad R. (Mar 2001). The effect of glucagon-like peptide-2, epidermal growth factor and glutamine on intestinal growth. GUT. 48:A19-A19.
• Russell SH; Small CJ; Stanley SA; Franks S; Ghatei MA; Bloom SR. (Mar 2001). The in vitro role of tumour necrosis factor-alpha and interleukin-6 in the hypothalamic-pituitary gonadal axis. J Neuroendocrinol. 13:296-301.
• Upton PD; Wharton J; Coppock H; Davie N; Yang X; Yacoub MH; Ghatei MA; Polak JM; et alBloom SR; Smith DM; Morrell NW. (Feb 2001). Adrenomedullin expression and growth inhibitory effects in distinct pulmonary artery smooth muscle cell subpopulations. Am J Respir Cell Mol Biol. 24:170-178.
• Small CJ; Kim MS; Stanley SA; Mitchell JR; Murphy K; Morgan DG; Ghatei MA; Bloom SR. (Feb 2001). Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals. Diabetes. 50:248-254.
• Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; et alGhatei MA; Bloom SR. (Dec 2000). Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin. J Neuroendocrinol. 12:1213-1218.
• Brynes AE; Edwards CM; Jadhav A; Ghatei MA; Bloom SR; Frost GS. (Nov 2000). Diet-induced change in fatty acid composition of plasma triacylglycerols is not associated with change in glucagon-like peptide 1 or insulin sensitivity in people with type 2 diabetes. Am J Clin Nutr. 72:1111-1118.
• Wren AM; Small CJ; Ward HL; Murphy KG; Dakin CL; Taheri S; Kennedy AR; Roberts GH; et alMorgan DG; Ghatei MA; Bloom SR. (Nov 2000). The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 141:4325-4328.
• Stanley SA; Todd JF; Small CJ; Kim MS; Heath MM; Anand P; Ghatei MA; Bloom SR. (Oct 2000). The effects of ciliary neurotrophic factor on the hypothalamo-pituitary gonadal axis in vitro in female rats. J Neuroendocrinol. 12:1009-1013.
• Park A; Le Roux C; Frost P; Bloom S. (16 Sep 2000). Chemical pathology. BMJ. 321:S2-S7262.
• Murphy KG; Abbott CR; Mahmoudi M; Hunter R; Gardiner JV; Rossi M; Stanley SA; Ghatei MA; et alKuhar MJ; Bloom SR. (Sep 2000). Quantification and synthesis of cocaine- and amphetamine-regulated transcript peptide (79-102)-like immunoreactivity and mRNA in rat tissues. J Endocrinol. 166:659-668.
• Matarese G; Alviggi C; Sanna V; Howard JK; Lord GM; Carravetta C; Fontana S; Lechler RI; et alBloom SR; De Placido G. (Jul 2000). Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J CLIN ENDOCR METAB. 85:2483-2487.
• Abbott CR; Rossi M; Kim M; AlAhmed SH; Taylor GM; Ghatei MA; Smith DM; Bloom SR. (30 Jun 2000). Investigation of the melanocyte stimulating hormones on food intake. Lack Of evidence to support a role for the melanocortin-3-receptor. Brain Res. 869:203-210.
• Edwards CM; Abbott CR; Sunter D; Kim M; Dakin CL; Murphy KG; Abusnana S; Taheri S; et alRossi M; Bloom SR. (2 Jun 2000). Cocaine- and amphetamine-regulated transcript, glucagon-like peptide-1 and corticotrophin releasing factor inhibit feeding via agouti-related protein independent pathways in the rat. Brain Res. 866:128-134.
• Todd JF; Edwards CM; Ghatei MA; Bloom SR. (Jun 2000). The differential effects of galanin-(1-30) and -(3-30) on anterior pituitary hormone secretion in vivo in humans. Am J Physiol Endocrinol Metab. 278:E1060-E1066.
• Chakravarty P; Suthar TP; Coppock HA; Nicholl CG; Bloom SR; Legon S; Smith DM. (May 2000). CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues. Br J Pharmacol. 130:189-195. DOI.
• Kulkarni RN; Wang ZL; Wang RM; Smith DM; Ghatei MA; Bloom SR. (May 2000). Glibenclamide but not other sulphonylureas stimulates release of neuropeptide Y from perifused rat islets and hamster insulinoma cells. J Endocrinol. 165:509-518.
• Seal LJ; Small CJ; Kim MS; Stanley SA; Taheri S; Ghatei MA; Bloom SR. (May 2000). Prolactin releasing peptide (PrRP) stimulates luteinizing hormone (LH) and follicle stimulating hormone (FSH) via a hypothalamic mechanism in male rats. Endocrinology. 141:1909-1912.
• Satoh F; Smith DM; Gardiner JV; Mahmoodi M; Murphy KG; Ghatei MA; Bloom SR. (Apr 2000). Characterization and distribution of prolactin releasing peptide (PrRP) binding sites in the rat--evidence for a novel binding site subtype in cardiac and skeletal muscle. Br J Pharmacol. 129:1787-1793. DOI.
• Satoh F; Beak SA; Small CJ; Falzon M; Ghatei MA; Bloom SR; Smith DM. (Apr 2000). Characterization of human and rat glucagon-like peptide-1 receptors in the neurointermediate lobe: lack of coupling to either stimulation or inhibition of adenylyl cyclase. Endocrinology. 141:1301-1309.
• Kitchen PA; Barley NF; FitzGerald AF; Mandir N; Ghatei M; Bloom S; Goodlad RA; Forbes A; et alWalters JR. (Apr 2000). Effect of glucagon-like peptide 2 on functional and transcription factor gene expression in the small intestine. GASTROENTEROLOGY. 118:A559-A559.
• Kitchen PA; FitzGerald AF; Mandir N; Ghatei M; Bloom S; Walters JR; Forbes A; Goodlad RA. (Apr 2000). Glucagon-like peptide 2 and epidermal growth factor, but not glutamine, have additive effects on intestinal growth. GASTROENTEROLOGY. 118:A1104-A1104.
• Kitchen PA; FitzGerald AJ; Barley N; Ghatei MA; Bloom SR; Walters JRF; Goodlad RA; Forbes A. (Apr 2000). Glucagon-like peptide 2 stimulates proliferation, differentiation and gene expression in the small intestine of TPN rats. GUT. 46:A65-A65.
• Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J. (Apr 2000). Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study. DIABETES OBES METAB. 2:105-112.
• Kim MS; Small CJ; Stanley SA; Morgan DG; Seal LJ; Kong WM; Edwards CM; Abusnana S; et alSunter D; Ghatei MA; Bloom SR. (Apr 2000). The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J Clin Invest. 105:1005-1011. DOI.
• Kitchen PA; Barley N; Mandir N; FitzGerald AF; Goodlad RA; Ghatei M; Bloom S; Walters JRF; et alForbes A. (Apr 2000). The effects of glutamine and glucagon-like peptide 2 on the intestine. GUT. 46:A65-A65.
• Kitchen PA; Barley N; FitzGerald AF; Mandir N; Goodlad RA; Ghatei M; Bloom S; Walters JRF; et alForbes A. (Apr 2000). The trophic effects on the small intestine of glucagon-like peptide 2 and epidermal growth factor are additive. GUT. 46:A33-A33.
• Goldstone AP; Morgan I; Mercer JG; Morgan DG; Moar KM; Ghatei MA; Bloom SR. (16 Mar 2000). Effect of leptin on hypothalamic GLP-1 peptide and brain-stem pre-proglucagon mRNA. Biochem Biophys Res Commun. 269:331-335. DOI.
• Taheri S; Ward H; Ghatei M; Bloom S. (4 Mar 2000). Role of orexins in sleep and arousal mechanisms. LANCET. 355:847-847.
• Kitchen PA; Fitzgerald AJ; Goodlad RA; Barley NF; Ghatei MA; Legon S; Bloom SR; Price A; et alWalters JRF; Forbes A. (Mar 2000). Glucagon-like peptide-2 increases sucrase-isomaltase but not caudal-related homeobox protein-2 gene expression. AM J PHYSIOL-GASTR L. 278:G425-G428.
• Sunter D; O'Shea D; Bloom SR. (Mar 2000). Leptin: Your brain, appetite and obesity. J NEUROENDOCRINOL. 12:189-190.
• Goodlad RA; Mandir N; Meeran K; Ghatei MA; Bloom SR; Playford RJ. (8 Feb 2000). Does the response of the intestinal epithelium to keratinocyte growth factor vary according to the method of administration?. REGUL PEPTIDES. 87:83-90.
• Kim MS; Rossi M; Abusnana S; Sunter D; Morgan DG; Small CJ; Edwards CM; Heath MM; et alStanley SA; Seal LJ; Bhatti JR; Smith DM; Ghatei MA; Bloom SR. (Feb 2000). Hypothalamic localization of the feeding effect of agouti-related peptide and alpha-melanocyte-stimulating hormone. Diabetes. 49:177-182.
• Taheri S; Sunter D; Dakin C; Moyes S; Seal L; Gardiner J; Rossi M; Ghatei M; et alBloom S. (28 Jan 2000). Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. Neurosci Lett. 279:109-112.
• Chaudhary M; Mandir N; FitzGerald AJ; Howard JK; Lord GM; Ghatei MA; Bloom SR; Goodlad RA. (2000). Starvation, leptin and epithelial cell proliferation in the gastrointestinal tract of the mouse. Digestion. 61:223-229.
• Upton PD; Wharton J; Coppock HA; Smith DM; Ghatei MA; Bloom SR; Morrell NW. (Mar 1999). Adrenomedullin (AM), a vasodilator peptide secreted by human pulmonary artery-derived cells, increases intracellular cAMP and inhibits DNA synthesis. BRIT J PHARMACOL. 126:U75-U75.
• Wharton J; Chang SE; Upton PD; Guirez AR; Ghatei MA; Bloom SR; Polak JM; Tetley TD; et alMorrell NW. (Mar 1999). Autocrine role of endothelin in human small airway epithelial cells and modulation by cytokines. AM J RESP CRIT CARE. 159:A178-A178.
• Edwards CM; Todd JF; Mahmoudi M; Wang Z; Wang RM; Ghatei MA; Bloom SR. (Jan 1999). Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes. 48:86-93.
• Upton PD; Wharton J; Coppock H; Smith DM; Ghatel MA; Bloom SR; Morrell NW. (27 Oct 1998). Adrenomedullin inhibits PDGF-stimulated DNA synthesis and ET-1 release in human pulmonary artery smooth muscle cells. CIRCULATION. 98:341-341.
• Morgan DG; Small CJ; Abusnana S; Turton M; Gunn I; Heath M; Rossi M; Goldstone AP; et alO'Shea D; Meeran K; Ghatei M; Smith DM; Bloom S. (25 Sep 1998). The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism. Regul Pept. 75-76:377-382.
• Lord GM; Matarese G; Howard JK; Baker RJ; Bloom SR; Lechler RI. (27 Aug 1998). Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature. 394:897-901. DOI.
• Leyva F; Godsland IF; Ghatei M; Proudler AJ; Aldis S; Walton C; Bloom S; Stevenson JC. (Jun 1998). Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol. 18:928-933.
• Duncan H; Cole S; Bowling T; Ghatei M; Bloom S; Silk D. (15 Apr 1998). Is diarrhea complicating bolus nasogastric tube feeding caused by an abnormal PYY response?. GASTROENTEROLOGY. 114:A877-A877.
• Playford RJ; Marchbank T; Mandir N; Higham A; Meeran K; Ghatei MA; Bloom SR; Goodlad RA. (Mar 1998). Effects of keratinocyte growth factor (KGF) on gut growth and repair. J PATHOL. 184:316-322.
• Duncan H; Cole S; Bowling T; Ghatei M; Bloom S; Silk D. (Mar 1998). Is diarrhoea complicating bolus nasogastric tube feeding caused by an abnormal PYY response. GUT. 42:A12-A12.
• Leyva F; Godsland IF; Gathei M; Bloom S; Stevenson JC. (Feb 1998). Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. J AM COLL CARDIOL. 31:197A-197A.
• Wang ZL; Kulkarni RN; Wang RM; Smith DM; Ghatei MA; Byfield PG; Bennet WM; Bloom SR. (1 Jul 1997). Possible evidence for endogenous production of a novel galanin-like peptide. J Clin Invest. 100:189-196. DOI.
• Playford RJ; Boulton R; Ghatei MA; Bloom SR; Wright NA; Goodlad RA. (Sep 1996). Comparison of the effects of transforming growth factor alpha and epidermal growth factor on gastrointestinal proliferation and hormone release. DIGESTION. 57:362-367.
• Gunn I; O'Shea D; Turton MD; Beak SA; Bloom SR. (May 1996). Central glucagon-like peptide-I in the control of feeding. Biochem Soc Trans. 24:581-584.
• SABROE I; BLOOM S; HUGHES JMB; SHAUNAK S; ROBERTSON I; LYNN WA. (26 Aug 1995). GRAND ROUNDS - HAMMERSMITH-HOSPITAL - THROMBOEMBOLIC OCCLUSION OF A PULMONARY ARTERIOVENOUS MALFORMATION - A VERY UNUSUAL PULMONARY-EMBOLISM. BRIT MED J. 311:553-555.
• Bhogal R; Smith DM; Owji AA; Bloom SR. (Jul 1995). Binding sites for islet amyloid polypeptide in mammalian lung: species variation and effects on adenylyl cyclase. Can J Physiol Pharmacol. 73:1030-1036.
• Smith DM; Bloom SR. (May 1995). Paracrine/autocrine control of the islet and the amylin family. Biochem Soc Trans. 23:336-340.
• Playford RJ; Mehta S; Upton P; Rentch R; Moss S; Calam J; Bloom S; Payne N; et alGhatei M; Edwards R. (Apr 1995). Effect of peptide YY on human renal function. Am J Physiol. 268:F754-F759.
• TILLER J; MACRAE A; SCHMIDT U; BLOOM S; TREASURE J. (Aug 1994). THE PREVALENCE OF EATING DISORDERS IN THYROID-DISEASE - A PILOT-STUDY. J PSYCHOSOM RES. 38:609-616.
• ROBINSON L; JACKSON J; BLOOM S; PRIDE N; HUGHES J. (25 Jun 1994). GRAND ROUNDS - HAMMERSMITH-HOSPITAL - NEW APPROACH TO SUPERIOR VENA-CAVAL OBSTRUCTION. BRIT MED J. 308:1697-1699.
• PERRAUDEAU M; WALPORT M; OAKLEY C; BLOOM S; BROOKS D. (19 Feb 1994). GRAND ROUNDS - HAMMERSMITH-HOSPITAL - LATE PRESENTATION OF KARTAGENERS-SYNDROME. BRIT MED J. 308:519-521.
• Perraudeau M; Scott J; Walport M; Oakley C; Bloom S; Brooks D. (19 Feb 1994). Late presentation of Kartagener's syndrome. Consequences of ciliary dysfunction. BMJ. 308:519-521.
• GOODLAD RA; LEE CY; GHATEI MA; BLOOM SR; WRIGHT NA. (23 Jul 1992). DIFFERENTIAL-EFFECTS OF EGF AND TGF-A ON GASTROINTESTINAL EPITHELIAL-CELL PROLIFERATION. REGUL PEPTIDES. 40:157-157.
• Goodlad RA; Ghatei MA; Bloom SR; Wright NA. (Nov 1991). Glucagon 1-21 reduces intestinal epithelial cell proliferation in parenterally fed rats. Exp Physiol. 76:943-949.
• CHARD MD; GHATEI MA; BLOOM S; CRISP AJ. (Dec 1990). VASOACTIVE INTESTINAL POLYPEPTIDE IN ALGODYSTROPHY. BRIT J RHEUMATOL. 29:489-490.
• GILBEY SG; GOODLAD R; DOMIN J; JONES PM; LEE CY; GHATEI MA; WRIGHT NA; BLOOM SR. (Apr 1990). HYPOTHALAMIC NPY AND APPETITE - NPY CONCENTRATIONS RESPOND TO THE REGULATION OF NUTRIENT INTAKE DURING PARENTERAL-NUTRITION IN RATS. CLIN SCI. 78:P2-P2.
• Goodlad RA; Ghatei MA; Domin J; Bloom SR; Wright NA. (1990). Is peptide YY trophic to the intestinal epithelium of parenterally fed rats?. Digestion. 46 Suppl 2:177-181.
• GOODLAD RA; GHATEI MA; DOMIN J; BLOOM SR; GREGORY H; WRIGHT NA. (May 1989). PEPTIDE-YY IN RATS AFTER UROGASTRONE-EGF ADMINISTRATION - A PROLIFERATIVE ROLE FOR PYY IN THE INTESTINAL EPITHELIUM. GUT. 30:A705-A705.
• DOBNER PR; TISCHLER AS; LEE YC; BLOOM SR; DONAHUE SR. (5 Oct 1988). LITHIUM DRAMATICALLY POTENTIATES NEUROTENSIN NEUROMEDIN-N GENE-EXPRESSION. J BIOL CHEM. 263:13983-13986.
• SPOKES RA; LEE YC; YIANGOU Y; BLOOM SR. (Sep 1988). A COMPARISON OF THE ABILITY OF NEUROTENSIN AND PEPTIDE HISTIDINE METHIONINE TO STIMULATE NET FLUID SECRETION INTO THE SMALL-INTESTINE OF THE ANESTHETIZED RAT. REGUL PEPTIDES. 22:433-433.
• NATORI S; IGUCHI H; KUROSE SN; BLOOM SR; NAWATA H. (Sep 1988). AGE-RELATED CHANGE IN 7B2 (A NOVEL PITUITARY POLYPEPTIDE) CONCENTRATIONS IN HUMAN CEREBROSPINAL-FLUID. REGUL PEPTIDES. 22:371-376.
• KANSE SM; GHATEI MA; POLAK JM; BLOOM SR. (Sep 1988). BINDING AND DEGRADATION OF ENDOTHELIN BY PORCINE AORTIC MEMBRANES. REGUL PEPTIDES. 22:412-412.
• CALAM J; GUPTA S; TAIT C; GHATEI MA; ADRIAN TE; DOMIN J; BLOOM SR. (Sep 1988). DIMINISHED CONCENTRATIONS OF REGULATORY PEPTIDES IN COLONIC POLYPS. REGUL PEPTIDES. 22:394-394.
• SALAHUDDIN MJ; SEKIYA K; GHATEI MA; BLOOM SR. (Sep 1988). DISTRIBUTION OF GAWK-LIKE IMMUNOREACTIVITY IN MAMMALIAN CNS. REGUL PEPTIDES. 22:429-429.
• GHATEI MA; SEKIYA K; SALAHUDDIN MJ; BISHOP AE; HAMID QA; IBAYASHI H; POLAK JM; BLOOM SR. (Sep 1988). GAWK (CHROMOGRANIN-B 420-493) IN ENDOCRINE TUMORS. REGUL PEPTIDES. 22:405-405.
• KREYMANN B; KANSE S; GHATEI MA; WILLIAMS G; BLOOM SR. (Sep 1988). GLUCAGON-LIKE PEPTIDE-1 7-36, A NEW BRAIN-GUT HORMONE. REGUL PEPTIDES. 22:414-414.
• NIKOU G; YIANGOU Y; CHRSYANTHOU BJ; DOMIN J; BLOOM SR. (Sep 1988). PHV-42 A NOVEL GASTRIC PEPTIDE, STIMULATES GASTRIC-ACID SECRETION IN MAN. REGUL PEPTIDES. 22:424-424.
• CONLON JM; DOMIN J; THIM L; DIMARZO V; MORRIS HR; BLOOM SR. (Sep 1988). PRIMARY STRUCTURE OF NEUROMEDIN-U FROM THE RAT. J NEUROCHEM. 51:988-991.
• WYNICK D; WILLIAMS SJ; BLOOM SR. (Sep 1988). RESISTANCE TO LONG-TERM TREATMENT OF PANCREATIC ENDOCRINE TUMORS WITH THE SOMATOSTATIN ANALOG OCTREOTIDE (SMS-201-995). REGUL PEPTIDES. 22:439-439.
• SPOKES RA; GHATEI MA; BLOOM SR. (Sep 1988). THE EFFECT OF ENDOTHELIN ON ARTERIAL BLOOD-PRESSURE AND HEART-RATE IN THE ANESTHETIZED RAT. REGUL PEPTIDES. 22:432-432.
• DOMIN J; CONLON JM; DIMARZO V; THIM L; MORRIS HR; BLOOM SR. (Sep 1988). THE PURIFICATION AND SEQUENCE-ANALYSIS OF RAT NEUROMEDIN-U. REGUL PEPTIDES. 22:400-400.
• RUPPIN H; HAGEL J; FEUERBACH W; SCHUTT H; PICHL J; HILLEBRAND I; BLOOM S; DOMSCHKE W. (Jul 1988). FATE AND EFFECTS OF THE ALPHA-GLUCOSIDASE INHIBITOR ACARBOSE IN HUMANS - AN INTESTINAL SLOW-MARKER PERFUSION STUDY. GASTROENTEROLOGY. 95:93-99.
• GILMAN RH; PARTANEN R; BROWN KH; SPIRA WM; KHANAM S; GREENBERG B; BLOOM SR; ALI A. (Jun 1988). DECREASED GASTRIC-ACID SECRETION AND BACTERIAL-COLONIZATION OF THE STOMACH IN SEVERELY MALNOURISHED BANGLADESHI CHILDREN. GASTROENTEROLOGY. 94:1308-1314.
• FERRI GL; ADRIAN TE; ALLEN JM; SOIMERO L; CANCELLIERI A; YEATS JC; BLANK M; POLAK JM; et alBLOOM SR. (Jun 1988). INTRAMURAL DISTRIBUTION OF REGULATORY PEPTIDES IN THE SIGMOID-RECTO-ANAL REGION OF THE HUMAN GUT. GUT. 29:762-768.
• IGUCHI H; NATORI S; OU Y; NAWATA H; KATO K; IBAYASHI H; BLOOM SR. (Jun 1988). PLASMA-LEVELS OF 7B2 (A NOVEL PITUITARY POLYPEPTIDE) AND ITS MOLECULAR-FORMS IN PLASMA AND URINE IN PATIENTS WITH CHRONIC RENAL-FAILURE - POSSIBLE DEGRADATION BY THE KIDNEY. REGUL PEPTIDES. 21:263-270.
• BLOOM SR. (21 May 1988). FIBER AND PATIENTS WITH DIABETES. BRIT MED J. 296:1471-1471.
• BAUER FE; ZINTEL A; KENNY MJ; CALDER D; GHATEI MA; BLOOM SR. (May 1988). INHIBITORY EFFECT OF GALANIN ON POSTPRANDIAL GASTROINTESTINAL (GI) MOTILITY AND GUT HORMONE-RELEASE IN MAN. GASTROENTEROLOGY. 94:A28-A28.
• CALAM J; MEHTA A; PAUL G; YIANGOU Y; BLOOM SR. (May 1988). PEPTIDE HISTIDINE METHIONINE (PHM) INCREASES ILEOSTOMY OUTPUT. GUT. 29:A716-A716.
• SPOKES RA; LEE YC; YIANGOU Y; BLOOM SR. (May 1988). SECRETORY ACTIVITY OF PEPTIDE HISTIDINE METHIONINE AND NEUROTENSIN IN RAT SMALL-INTESTINE CLOSELY MATCH THEIR DISTRIBUTION. GUT. 29:A739-A739.
• MULDERRY PK; GHATEI MA; SPOKES RA; JONES PM; PIERSON AM; HAMID QA; KANSE S; AMARA SG; et alBURRIN JM; LEGON S; POLAK JM; BLOOM SR. (Apr 1988). DIFFERENTIAL EXPRESSION OF ALPHA-CGRP AND BETA-CGRP BY PRIMARY SENSORY NEURONS AND ENTERIC AUTONOMIC NEURONS OF THE RAT. NEUROSCIENCE. 25:195-205.
• SUZUKI H; KOBORI H; OHTAKE R; HASHIGAMI Y; SUZUKI Y; SHIMODA SI; BLOOM SR. (Feb 1988). CIRCULATING CONCENTRATIONS OF IMMUNOREACTIVE PEPTIDE 7B2 IN CERTAIN PATHOPHYSIOLOGICAL CONDITIONS, AND RESPONSE TO ORAL GLUCOSE-LOAD. CLIN CHEM. 34:410-413.
• BORGES F; ANDERSON JV; VOLTA C; PERRY L; DRURY PL; BLOOM SR; BESSER GM; GROSSMAN A. (Feb 1988). OPIOID-PEPTIDES DO NOT MODULATE ATRIAL NATRIURETIC PEPTIDE OR ALDOSTERONE RELEASE UNDER BASAL CONDITIONS IN MAN. J ENDOCRINOL. 116:313-317.
• BANNISTER R; BLOOM SR; CORTELLI P; KOONER JS; MATHIAS CJ; RAIMBACH SJ. (Feb 1988). THE SOMATOSTATIN ANALOG SMS 201-995 REDUCES ORAL GLUCOSE-INDUCED HYPOTENSION IN HUMAN AUTONOMIC FAILURE. J PHYSIOL-LONDON. 396:P90-P90.
• GIBSON SJ; GIAID A; HAMID QA; KAR S; DESPERBACSQUES M; JONES PM; DENNY P; LEGON S; et alAMARA SG; CRAIG R; BLOOM SR; POLAK JM. (Jan 1988). ALPHA-CALCITONIN GENE-RELATED PEPTIDE (CGRP) MESSENGER-RNA IS EXPRESSED IN SENSORY AND MOTOR NEURONS IN THE NERVOUS-SYSTEM OF MAN AND RAT. J PATHOL. 154:A78-A79.
• WYNICK D; BLOOM SR. (21 Nov 1987). EFFECT OF CALCITONIN IN PATIENTS WITH MALIGNANT METASTATIC ISLET CELL TUMORS. BRIT MED J. 295:1346-1346.
• BLOOM SR. (Nov 1987). GUT HORMONES. CURR OPIN GASTROEN. 3:938-943.
• MELEAGROS L; GILL JS; MULDERRY PK; DOMIN J; GHATEI MA; BLOOM SR. (Oct 1987). ACUTE INTESTINAL ISCHEMIA - DIFFERENTIAL RESPONSE OF GUT NEUROPEPTIDES. GUT. 28:A1334-A1335.
• DOMIN J; GHATEI MA; ADOLPHUS N; BLOOM SR. (Oct 1987). DISTRIBUTION AND MOLECULAR CHARACTERIZATION OF NEUROMEDIN-U-LIKE, NEUROMEDIN-B-LIKE AND BOMBESIN-LIKE IMMUNOREACTIVITY IN THE AMPHIBIAN RANA-TEMPORARIA. REGUL PEPTIDES. 19:106-106.
• BISHOP AE; GREEN DM; RINDI G; LEE FI; ISAACS PJ; DALY MJ; DOMIN J; BLOOM SR; et alPOLAK JM. (Oct 1987). ENTEROCHROMAFFIN LIKE (ECL) CELL-POPULATIONS ARE DEPENDENT ON AGE AND SEX. GUT. 28:A1410-A1410.
• ADDIS BJ; HAMID Q; IBRAHIMS NBN; FAHEY M; BLOOM SR; POLAK JM. (Oct 1987). IMMUNOHISTOCHEMICAL MARKERS OF SMALL CELL-CARCINOMA AND RELATED NEUROENDOCRINE TUMORS OF THE LUNG. J PATHOL. 153:137-150.
• POLAK JM; BLOOM SR. (Oct 1987). LOCALIZATION OF BOMBESIN-LIKE PEPTIDES IN TUMORS. REGUL PEPTIDES. 19:132-132.
• MELEAGROS L; KREYMANN B; GHATEI MA; BLOOM SR. (Oct 1987). MOUTH-TO-CECUM TRANSIT-TIME IN MAN IS REDUCED BY A NOVEL SEROTONIN M-RECEPTOR ANTAGONIST. GUT. 28:A1373-A1373.
• GIBSON SJ; GIAID A; HAMID QA; KAR S; JONES PM; DENNY P; LEGON S; AMARA SG; et alCRAIG R; BLOOM SR; POLAK JM. (Sep 1987). ALPHA-CALCITONIN GENE-RELATED PEPTIDE (CGRP) GENE TRANSCRIPTS ARE EXPRESSED IN AREAS ASSOCIATED WITH SENSORY AND MOTOR FUNCTIONS IN MAN AND RAT. REGUL PEPTIDES. 18:357-357.
• ANDERSSON PO; BLOOM SR; MATTIASSON A; UVELIUS B. (Sep 1987). BLADDER VASODILATATION AND RELEASE OF VASOACTIVE INTESTINAL POLYPEPTIDE FROM THE URINARY-BLADDER OF THE CAT IN RESPONSE TO PELVIC NERVE-STIMULATION. J UROLOGY. 138:671-673.
• VENETIKOU MS; LACOUMENTA S; BURRIN JM; GHATEI MA; BLOOM SR. (Sep 1987). DIFFERENTIAL INVITRO RELEASE OF VASOPRESSIN AND 7B2 BY CHOLINERGIC AND OSMOTIC STIMULATION. REGUL PEPTIDES. 18:360-360.
• STEEL JH; HAMID Q; CHANDRACHUD L; JONES P; DENNY P; MAURER R; ROBERTS JL; MCNICOL AM; et alLEGON S; BLOOM SR; POLAK JM. (Sep 1987). DYNAMIC ENDOCRINOLOGY OF THE PITUITARY - COMBINED USE OF INSITU HYBRIDIZATION AND IMMUNOCYTOCHEMISTRY FOR THE STUDY OF PROLACTIN AND PROOPIOMELANOCORTIN GENE-EXPRESSION, SYNTHESIS AND SECRETION. REGUL PEPTIDES. 18:375-375.
• BALL JA; MELEAGROS L; DOMIN J; BURRIN JM; BLOOM SR. (Sep 1987). EFFECT OF PEPTIDE YY ON PROLACTIN AND ON FSH AND LH-RELEASE IN MAN. REGUL PEPTIDES. 18:361-361.
• CALAM J; MEHTA A; PAUL G; YIANGOU Y; BLOOM SR. (Sep 1987). EFFECTS OF PEPTIDE HISTIDINE METHIONINE (PHM) INFUSIONS ON ILEOSTOMY OUTPUT. REGUL PEPTIDES. 18:343-343.
• SPOKES RA; KANSE S; MULDERRY PK; BLOOM SR. (Sep 1987). MEMBRANE-BINDING AND BIOLOGICAL-ACTIVITY OF RAT ALPHA-CGRP AND BETA-CGRP - EVIDENCE FOR ONE CLASS OF HIGH-AFFINITY RECEPTOR. REGUL PEPTIDES. 18:365-365.
• DOMIN J; GHATEI MA; CHOHAN P; BLOOM SR. (Sep 1987). NEUROMEDIN-U - A STUDY OF ITS DISTRIBUTION IN THE RAT. PEPTIDES. 8:779-784.
• DOMIN J; GHATEI MA; ADOLPHUS N; BLOOM SR. (Sep 1987). NEUROMEDIN-U LIKE IMMUNOREACTIVITY IN THE RAT - DISTRIBUTION AND MOLECULAR CHARACTERIZATION. REGUL PEPTIDES. 18:362-362.
• GIBSON SJ; KAR S; BALLESTA J; STEEL J; BRETHERTONWATT DG; GHATEI MA; VALENTINO KL; TATEMOTO K; et alBLOOM SR; POLAK JM. (Sep 1987). PANCREASTATIN, A NOVEL NEUROPEPTIDE, IS WIDELY DISTRIBUTED THROUGHOUT PORCINE BRAIN, PITUITARY, SPINAL-CORD AND DORSAL-ROOT GANGLIA. REGUL PEPTIDES. 18:376-376.
• BRETHERTONWATT DG; GHATEI MA; BISHOP AE; FACER P; FAHEY M; VALENTINO KL; TATEMOTO K; ROTH K; et alPOLAK JM; BLOOM SR. (Sep 1987). PANCREASTATIN-LIKE IMMUNOREACTIVITY IN PORCINE PERIPHERAL-TISSUES. REGUL PEPTIDES. 18:364-364.
• SPOKES RA; YIANGOU Y; BLOOM SR. (Sep 1987). PEPTIDE HISTIDINE VALINE-42, A NOVEL PREPRO-VIP DERIVED PEPTIDE, IS A POTENT INHIBITOR OF SPONTANEOUS CONTRACTIONS OF RAT UTERUS. REGUL PEPTIDES. 18:366-366.
• CALAM J; GUPTA S; MYSZOR M; TAIT C; GHATEI MA; ADRIAN TE; DOMIN J; BLOOM SR. (Sep 1987). REGIONAL DIFFERENCES IN REGULATORY PEPTIDE CONCENTRATIONS IN THE HUMAN-COLON. REGUL PEPTIDES. 18:344-344.
• SEKIYA K; GHATEI MA; BURNET PWJ; BLOOM SR. (Sep 1987). THE DISTRIBUTION OF MELANIN-CONCENTRATING HORMONE-LIKE IMMUNOREACTIVITY IN THE CENTRAL-NERVOUS-SYSTEM OF RAT, GUINEA-PIG AND MAN. REGUL PEPTIDES. 18:360-360.
• KENNY MJ; GHATEI MA; WILLIAMS G; LEONHARDT U; BURRIN JM; BLOOM SR. (Sep 1987). THYROID STATUS AFFECTS PANCREATIC SOMATOSTATIN AND GLUCAGON CONCENTRATIONS. REGUL PEPTIDES. 18:361-361.
• BALL JA; BURNET PWJ; GHATEI MA; MULDERRY PK; BLOOM SR. (22 Aug 1987). FLUMAZENIL AND BENZODIAZEPINE WITHDRAWAL. LANCET. 2:463-463.
• LEE YC; BALL JA; REECE D; BLOOM SR. (10 Aug 1987). NEUROMEDIN-N - PRESENCE AND CHROMATOGRAPHIC CHARACTERIZATION IN THE RAT. FEBS LETT. 220:243-246.
• ANDERSSON PO; BJORNBERG J; BLOOM SR; MELLANDER S. (Aug 1987). VASOACTIVE INTESTINAL POLYPEPTIDE IN RELATION TO PENILE ERECTION IN THE CAT EVOKED BY PELVIC AND BY HYPOGASTRIC NERVE-STIMULATION. J UROLOGY. 138:419-422.
• BURRIN JM; UTTENTHAL LO; MCGREGOR GP; BLOOM SR. (15 Jul 1987). ASPECTS OF MEASUREMENT AND ANALYSIS OF REGULATORY PEPTIDES. EXPERIENTIA. 43:734-741.
• POLAK JM; BLOOM SR. (15 Jul 1987). REGULATORY PEPTIDES - A MULTIAUTHOR REVIEW - INTRODUCTION. EXPERIENTIA. 43:723-724.
• GRAFFNER H; BLOOM SR; FARNEBO LO; JARHULT J. (Jul 1987). EFFECTS OF PHYSIOLOGICAL INCREASES OF PLASMA NORADRENALINE ON GASTRIC-ACID SECRETION AND GASTROINTESTINAL HORMONES. DIGEST DIS SCI. 32:715-719.
• WILLIAMS G; BLOOM SR. (27 Jun 1987). THE SEARCH FOR A HORMONAL SWITCH FOR OBESITY. BRIT MED J. 294:1686-1687.
• GYR K; BEGLINGER C; KOHLER E; TRAUTZL U; KELLER U; BLOOM SR. (Jun 1987). CIRCULATING SOMATOSTATIN - PHYSIOLOGICAL REGULATOR OF PANCREATIC FUNCTION. J CLIN INVEST. 79:1595-1600.
• LACOUMENTA S; YEO TH; BURRIN JM; BLOOM SR; PATERSON JL; HALL GM. (Jun 1987). FENTANYL AND THE BETA-ENDORPHIN, ACTH AND GLUCOREGULATORY HORMONAL RESPONSE TO SURGERY. BRIT J ANAESTH. 59:713-720.
• POLAK JM; STEEL JH; VANNOORDEN S; GIBSON SJ; BLOOM SR. (Jun 1987). NOVEL PEPTIDES IN THE HYPOTHALAMUS PITUITARY AXIS AND THEIR RELEVANCE IN NEUROENDOCRINOLOGY. NEUROENDOCRINOL LETT. 9:141-141.
• APPLETON GVN; BRISTOL JB; GHATEI MA; BLOOM SR. (Jun 1987). POST-RESECTIONAL CHANGES IN PLASMA ENTEROGLUCAGON MIRROR CRYPT CELL PRODUCTION-RATES IN DEFUNCTIONED SMALL-BOWEL. BRIT J SURG. 74:542-542.
• ADRIAN TE; SAVAGE AP; FUESSL HS; WOLFE K; BESTERMAN HS; BLOOM SR. (Jun 1987). RELEASE OF PEPTIDE YY (PYY) AFTER RESECTION OF SMALL-BOWEL, COLON, OR PANCREAS IN MAN. SURGERY. 101:715-719.
• FELLOWS IW; EVANS DF; BENNETT T; MACDONALD IA; CLARK AG; BLOOM SR. (Jun 1987). THE EFFECT OF INSULIN-INDUCED HYPOGLYCEMIA ON GASTROINTESTINAL MOTILITY IN MAN. CLIN SCI. 72:743-748.
• BLOOM SR. (29 May 1987). ACROMEGALY. AM J MED. 82:88-91.
• BLOOM SR; POLAK JM. (29 May 1987). GLUCAGONOMA SYNDROME. AM J MED. 82:25-36.
• CLARKE JG; KERWIN R; LARKIN S; LEE Y; YACOUB M; DAVIES GJ; HACKETT D; DAWBARN D; et alBLOOM SR; MASERI A. (9 May 1987). CORONARY-ARTERY INFUSION OF NEUROPEPTIDE-Y IN PATIENTS WITH ANGINA-PECTORIS. LANCET. 1:1057-1059.
• ANDERSON JV; COUPE MO; MORRIS JA; HODGSON HJF; BLOOM SR. (2 May 1987). REMISSION OF SYMPTOMS IN CARCINOID-SYNDROME WITH A NEW 5-HYDROXYTRYPTAMINE M-RECEPTOR ANTAGONIST. BRIT MED J. 294:1129-1129.
• PALMER JBD; CUSS FMC; MULDERRY PK; GHATEI MA; SPRINGALL DR; CADIEUX A; BLOOM SR; POLAK JM; et alBARNES PJ. (May 1987). CALCITONIN GENE-RELATED PEPTIDE IS LOCALIZED TO HUMAN AIRWAY NERVES AND POTENTLY CONSTRICTS HUMAN AIRWAY SMOOTH-MUSCLE. BRIT J PHARMACOL. 91:95-101.
• ISAACS PET; LADAS S; FORGACS IC; DOWLING RH; ELLAM SV; ADRIAN TE; BLOOM SR. (May 1987). COMPARISON OF EFFECTS OF INGESTED MEDIUM-CHAIN AND LONG-CHAIN TRIGLYCERIDE ON GALLBLADDER VOLUME AND RELEASE OF CHOLECYSTOKININ AND OTHER GUT PEPTIDES. DIGEST DIS SCI. 32:481-486.
• SCHON F; THOMAS DT; JEWKES DA; GHATEI MA; MULDERRY PK; BLOOM SR. (May 1987). FAILURE TO DETECT PLASMA NEUROPEPTIDE RELEASE DURING TRIGEMINAL THERMOCOAGULATION. J NEUROL NEUROSUR PS. 50:642-643.
• FRIED M; BLOOM SR; TAYLOR IL; MAYER EA; MEYER JH. (May 1987). GASTRIC-EMPTYING OF FOOD IN RELATION TO GIP AND INSULIN RELEASE. GASTROENTEROLOGY. 92:1396-1396.
• ADRIAN TE; WOOD SM; GHATEI MA; BLOOM SR. (May 1987). MAMMALIAN BOMBESIN RELEASES PEPTIDE-YY (PYY) IN MAN. GASTROENTEROLOGY. 92:1289-1289.
• ALLEN JM; HUGHES J; BLOOM SR. (May 1987). PRESENCE, DISTRIBUTION, AND PHARMACOLOGICAL EFFECTS OF NEUROPEPTIDE-Y IN MAMMALIAN GASTROINTESTINAL-TRACT. DIGEST DIS SCI. 32:506-512.
• ANDERSON JV; BLOOM SR. (May 1987). WHAT IS THE ROLE OF ATRIAL-NATRIURETIC-PEPTIDE IN MAN. SAUDI MED J. 8:213-227.
• MULDERRY PK; GHATEI MA; BLOOM SR. (29 Apr 1987). INVITRO PRODUCTION AND CHARACTERIZATION OF LOW-MOLECULAR-WEIGHT FORMS OF CALCITONIN GENE-RELATED PEPTIDE IMMUNOREACTIVITY FROM RAT-THYROID. BIOCHEM BIOPH RES CO. 144:883-890.
• RUTHERFORD AJ; ANDERSON JV; ELDER MG; BLOOM SR. (18 Apr 1987). RELEASE OF ATRIAL-NATRIURETIC-PEPTIDE DURING PREGNANCY AND IMMEDIATE PUERPERIUM. LANCET. 1:928-929.
• ADRIAN TE; BACARESEHAMILTON AJ; SMITH HA; CHOHAN P; MANOLAS KJ; BLOOM SR. (Apr 1987). DISTRIBUTION AND POSTPRANDIAL RELEASE OF PORCINE PEPTIDE-YY. J ENDOCRINOL. 113:11-14.
• SAVAGE AP; MATTHEWS JL; ADRIAN TE; GHATEI MA; COOKE T; BLOOM SR. (Apr 1987). EFFECT OF A LONG-ACTING ANALOG OF SOMATOSTATIN, SMS 201-995, ON THE DEVELOPMENT OF INTESTINAL TUMORS IN AZOXYMETHANE-TREATED RATS. CARCINOGENESIS. 8:561-563.
• SHARPE GR; REES WDW; ADRIAN TE; CHRISTOFIDES ND; BLOOM SR. (Apr 1987). EFFECT OF NALOXONE ON THE ANTRAL MOTOR RESPONSE TO SOLID FOOD IN MAN. EUR J CLIN INVEST. 17:95-99.
• GUPTA S; GHATEI MA; MITCHELL CJ; BLOOM SR; CALAM J. (Apr 1987). ELEVATED PLASMA-GLUCAGON CAUSED BY DANAZOL. J OBSTET GYNAECOL. 7:291-296.
• FERRI GL; ADRIAN TE; GHATEI MA; SOIMERO L; REBECCHI L; BILIOTTI G; POLAK JM; BLOOM SR. (Apr 1987). INTRAMURAL DISTRIBUTION OF REGULATORY PEPTIDES IN THE HUMAN STOMACH AND DUODENUM. HEPATO-GASTROENTEROL. 34:81-85.
• KIELY EA; BLANK MA; BLOOM SR; WILLIAMS G. (Apr 1987). STUDIES ON INTRACAVERNOSAL VIP LEVELS DURING PHARMACOLOGICALLY INDUCED PENILE ERECTIONS. BRIT J UROL. 59:334-339.
• ANDERSON JV; DONCKIER J; PAYNE NN; BEACHAM J; SLATER JDH; BLOOM SR. (Mar 1987). ATRIAL-NATRIURETIC-PEPTIDE - EVIDENCE OF ACTION AS A NATRIURETIC HORMONE AT PHYSIOLOGICAL PLASMA-CONCENTRATIONS IN MAN. CLIN SCI. 72:305-312.
• FRATER J; HASSALL CJS; ANDERSON JV; WHARTON J; POLAK JM; BLOOM SR; BURNSTOCK G. (Mar 1987). DEMONSTRATION OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) SECRETION FROM CULTURED ATRIAL CELLS - MOLECULAR-FORMS OF THE SECRETED PEPTIDE. J ENDOCRINOL. 112:250-250.
• BRISTOL JB; GHATEI MA; SMITH JHF; BLOOM SR; WILLIAMSON RCN. (Mar 1987). ELEVATED PLASMA ENTEROGLUCAGON ALONE FAILS TO ALTER DISTAL COLONIC CARCINOGENESIS IN RATS. GASTROENTEROLOGY. 92:617-624.
• ANDERSON JV; DONCKIER J; PAYNE NN; BRECKWOLDT J; SLATER JDH; BLOOM SR. (Mar 1987). RENAL AND HORMONAL RESPONSE TO RAISING PLASMA ATRIAL-NATRIURETIC-PEPTIDE (ANP) CONCENTRATIONS WITHIN THE NORMAL RANGE - EVIDENCE FOR A PHYSIOLOGICAL HORMONAL ROLE FOR ANP. J ENDOCRINOL. 112:203-203.
• BLOOM SR; EDWARDS AV; JONES CT. (Mar 1987). THE RELEASE OF CERTAIN NEUROPEPTIDES IN RESPONSE TO SPLANCHNIC NERVE-STIMULATION IN CONSCIOUS CALVES. J PHYSIOL-LONDON. 384:P29-P29.
• SPILLER RC; FROST PF; STEWART JS; BLOOM SR; SILK DBA. (Feb 1987). DELAYED POSTPRANDIAL PLASMA BILE-ACID RESPONSE IN CELIAC PATIENTS WITH SLOW MOUTH CECUM TRANSIT. CLIN SCI. 72:217-223.
• GOODLAD RA; LENTON W; GHATEI MA; ADRIAN TE; BLOOM SR; WRIGHT NA. (Feb 1987). EFFECTS OF AN ELEMENTAL DIET, INERT BULK AND DIFFERENT TYPES OF DIETARY FIBER ON THE RESPONSE OF THE INTESTINAL EPITHELIUM TO REFEEDING IN THE RAT AND RELATIONSHIP TO PLASMA GASTRIN, ENTEROGLUCAGON, AND PYY CONCENTRATIONS. GUT. 28:171-180.
• SAVAGE AP; ADRIAN TE; CAROLAN G; CHATTERJEE VK; BLOOM SR. (Feb 1987). EFFECTS OF PEPTIDE YY (PYY) ON MOUTH TO CECUM INTESTINAL TRANSIT-TIME AND ON THE RATE OF GASTRIC-EMPTYING IN HEALTHY-VOLUNTEERS. GUT. 28:166-170.
• KOELZ A; KRAENZLIN M; GYR K; MEIER V; BLOOM SR; HEITZ P; STALDER H. (Feb 1987). ESCAPE OF THE RESPONSE TO A LONG-ACTING SOMATOSTATIN ANALOG (SMS 201-995) IN PATIENTS WITH VIPOMA. GASTROENTEROLOGY. 92:527-531.
• FERRI GL; ADRIAN TE; BLANK M; REBECCHI L; SOIMERO L; MORREALE RA; POLAK JM; BLOOM SR. (Feb 1987). INTRAMURAL DISTRIBUTION OF VIP, SUBSTANCE-P, MAMMALIAN BOMBESIN AND SOMATOSTATIN IN THE HUMAN OESOPHAGO-CARDIAC AND PYLORIC REGIONS. ITAL J GASTROENTEROL. 19:55-55.
• FUESSL HS; DOMIN J; BLOOM SR. (Feb 1987). ORAL ABSORPTION OF THE SOMATOSTATIN ANALOG SMS 201-995 - THEORETICAL AND PRACTICAL IMPLICATIONS. CLIN SCI. 72:255-257.
• CARROLL DG; DELAHUNT JW; TEAGUE CA; COOKE RR; ADAMS EF; CHRISTOFIDES ND; BLOOM SR; TERENGHI G; et alPOLAK JM. (Feb 1987). RESOLUTION OF ACROMEGALY AFTER REMOVAL OF A BRONCHIAL CARCINOID SHOWN TO SECRETE GROWTH-HORMONE RELEASING-FACTOR. AUST NZ J MED. 17:63-67.
• PETTERSSON K; ANDERSON J; SJOLANDER M; BLOOM SR. (1987). ATRIAL-NATRIURETIC-PEPTIDE AND THE NATRIURESIS DUE TO ACUTE BETA-BLOCKADE IN CONSCIOUS HYPERTENSIVE RATS. CLIN EXP HYPERTENS A. 9:95-107.
• WILLIAMS G; ANDERSON JV; WILLIAMS SJ; BLOOM SR. (1987). CLINICAL-EVALUATION OF SMS 201-995 - LONG-TERM TREATMENT IN GUT NEURO-ENDOCRINE TUMORS, EFFICACY OF ORAL-ADMINISTRATION, AND POSSIBLE USE IN NON-TUMORAL INAPPROPRIATE TSH HYPERSECRETION. ACTA ENDOCRINOL-COP. 116:26-36.
• SANDLER LM; BURRIN JM; WILLIAMS G; JOPLIN GF; CARR DH; BLOOM SR. (Jan 1987). EFFECTIVE LONG-TERM TREATMENT OF ACROMEGALY WITH A LONG-ACTING SOMATOSTATIN ANALOG (SMS-201-995). CLIN ENDOCRINOL. 26:85-95.
• SAVAGE AP; MATTHEWS JL; GHATEI MA; COOKE T; BLOOM SR. (Jan 1987). ENTEROGLUCAGON AND EXPERIMENTAL INTESTINAL CARCINOGENESIS IN THE RAT. GUT. 28:33-39.
• HAMID QA; ADDIS BJ; SPRINGALL DR; IBRAHIM NBN; GHATEI MA; BLOOM SR; POLAK JM. (1987). EXPRESSION OF THE C-TERMINAL PEPTIDE OF HUMAN PRO-BOMBESIN IN 361 LUNG ENDOCRINE TUMORS, A RELIABLE MARKER AND POSSIBLE PROGNOSTIC INDICATOR FOR SMALL CELL-CARCINOMA. VIRCHOWS ARCH A. 411:185-192.
• BLOOM SR. (1987). GUT HORMONES IN ADAPTATION. GUT. 28:31-35.
• ADDIS BJ; HAMID Q; IBRAHIM N; SPRINGALL D; FAHEY M; BLOOM SR; POLAK J. (Jan 1987). IMMUNOHISTOCHEMICAL MARKERS OF SMALL CELL-CARCINOMA AND RELATED TUMORS OF THE LUNG. J PATHOL. 151:A58-A59.
• GHIGLIONE M; UTTENTHAL LO; GEORGE SK; BLOOM SR. (1987). INTESTINAL GLUCAGON-LIKE PEPTIDES IN MAN AND PIG. FRONT HORM RES. 16:121-126.
• RAYNER V; CHRISTOFIDES ND; GREGORY P; GOODALL ED; BLOOM SR. (Jan 1987). MOTILIN SECRETION AND THE MIGRATING MYOELECTRIC COMPLEX IN THE PIG. Q J EXP PHYSIOL CMS. 72:51-60.
• YIANGOU Y; WILLIAMS SJ; BISHOP AE; POLAK JM; BLOOM SR. (Jan 1987). PEPTIDE HISTIDINE-METHIONINE IMMUNOREACTIVITY IN PLASMA AND TISSUE FROM PATIENTS WITH VASOACTIVE INTESTINAL PEPTIDE-SECRETING TUMORS AND WATERY DIARRHEA SYNDROME. J CLIN ENDOCR METAB. 64:131-139.
• GOODLAD RA; LENTON W; GHATEI MA; ADRIAN TE; BLOOM SR; WRIGHT NA. (1987). PROLIFERATIVE EFFECTS OF FIBER ON THE INTESTINAL EPITHELIUM - RELATIONSHIP TO GASTRIN, ENTEROGLUCAGON AND PYY. GUT. 28:221-226.
• FERRI GL; ADRIAN TE; SOIMERO L; MCGREGOR GP; GHATEI MA; MORREALE RA; REBECCHI L; TONELLI L; et alPOLAK JM; BLOOM SR. (1987). REGULATORY PEPTIDE DISTRIBUTION IN SEPARATED LAYERS OF THE HUMAN JEJUNUM. DIGESTION. 37:15-21.
• SAVAGE AP; CHATTERJEE VK; GREGORY H; BLOOM SR. (30 Dec 1986). EPIDERMAL GROWTH-FACTOR IN BLOOD. REGUL PEPTIDES. 16:199-206.
• BLANK MA; BROWN JR; HUNTER JC; BLOOM SR; TYERS MB. (16 Dec 1986). EFFECTS OF VIP AND RELATED PEPTIDES AND GILA MONSTER VENOM ON GENITOURINARY SMOOTH-MUSCLE. EUR J PHARMACOL. 132:155-161.
• BALL JA; BURNET PWJ; FOUNTAIN BA; GHATEI MA; BLOOM SR. (12 Dec 1986). OCTADECANEUROPEPTIDE, BENZODIAZEPINE LIGAND, LIKE IMMUNOREACTIVITY IN RAT CENTRAL-NERVOUS-SYSTEM, PLASMA AND PERIPHERAL-TISSUES. NEUROSCI LETT. 72:183-188.
• SOMERS VK; ANDERSON JV; CONWAY J; SLEIGHT P; BLOOM SR. (Dec 1986). ATRIAL-NATRIURETIC-PEPTIDE IS RELEASED BY DYNAMIC EXERCISE IN MAN. HORM METAB RES. 18:871-872.
• ALLEN JM; SCHON F; YEATS JC; KELLY JS; BLOOM SR. (Dec 1986). EFFECT OF RESERPINE, PHENOXYBENZAMINE AND COLD STRESS ON THE NEUROPEPTIDE-Y CONTENT OF THE RAT PERIPHERAL NERVOUS-SYSTEM. NEUROSCIENCE. 19:1251-1254.
• ADRIAN TE; SMITH HA; CALVERT SA; AYNSLEYGREEN A; BLOOM SR. (Dec 1986). ELEVATED PLASMA PEPTIDE YY IN HUMAN NEONATES AND INFANTS. PEDIATR RES. 20:1225-1227.
• SCHON F; ALLEN JM; YEATS JC; KENT A; KELLY JS; BLOOM SR. (Dec 1986). THE EFFECT OF 6-HYDROXYDOPAMINE, RESERPINE AND COLD STRESS ON THE NEUROPEPTIDE-Y CONTENT OF THE RAT CENTRAL-NERVOUS-SYSTEM. NEUROSCIENCE. 19:1247-1250.
• ANDERSON JV; BHOOLA KD; BLOOM SR; FARRELL S; MACKENZIE JC; MILLAR ND. (Dec 1986). THE INFLUENCE OF PHYSIOLOGICAL-CHANGES IN CIRCULATING ATRIAL-NATRIURETIC-PEPTIDE (ANP) ON THE EXCRETION OF URINARY TISSUE KALLIKREIN IN MAN. J PHYSIOL-LONDON. 381:P25-P25.
• DOMIN J; GHATEI MA; CHOHAN P; BLOOM SR. (14 Nov 1986). CHARACTERIZATION OF NEUROMEDIN-U LIKE IMMUNOREACTIVITY IN RAT, PORCINE GUINEA-PIG AND HUMAN-TISSUE EXTRACTS USING A SPECIFIC RADIOIMMUNOASSAY. BIOCHEM BIOPH RES CO. 140:1127-1134.
• ANDERSON JV; PETTERSSON K; SJOLANDER M; BLOOM SR. (Nov 1986). ATRIAL-NATRIURETIC-PEPTIDE (ANP) RELEASE DURING THE NATRIURETIC RESPONSE TO ACUTE BETA-ADRENOCEPTOR BLOCKADE - FURTHER EVIDENCE OF A HORMONAL ROLE FOR ANP. J ENDOCRINOL. 111:101-101.
• BLOOM SR. (Nov 1986). CARDIAC PEPTIDES OTHER THAN ANP. J ENDOCRINOL. 111:18-18.
• SPRINGALL DR; IBRAHIM NBN; RODE J; SHARPE MS; BLOOM SR; POLAK JM. (Nov 1986). ENDOCRINE DIFFERENTIATION OF EXTRAPULMONARY SMALL CELL-CARCINOMA DEMONSTRATED BY IMMUNOHISTOCHEMISTRY USING ANTIBODIES TO PGP-9.5, NEURON-SPECIFIC ENOLASE AND THE C-FLANKING PEPTIDE OF HUMAN PRO-BOMBESIN. J PATHOL. 150:151-162.
• ANDERSON JV; DONCKIER J; BLOOM SR. (Nov 1986). EVIDENCE SUPPORTING THE HYPOTHESIS THAT ATRIAL-NATRIURETIC-PEPTIDE (ANP) IS A NATRIURETIC HORMONE IN NORMAL MAN. J PHYSIOL-LONDON. 380:P46-P46.
• BLOOM SR. (Nov 1986). GUT HORMONES. CURR OPIN GASTROEN. 2:816-821.
• BORGES F; ANDERSON JV; VOLTA C; PERRY L; DRURY P; BLOOM SR; BESSER GM; GROSSMAN A. (Nov 1986). THE EFFECTS OF OPIOID AGONISTS AND ANTAGONISTS ON ATRIAL-NATRIURETIC-PEPTIDE (ANP) RELEASE IN MAN. J ENDOCRINOL. 111:102-102.
• SENAPATI A; ANAND P; MCGREGOR GP; GHATEI MA; THOMPSON RPH; BLOOM SR. (30 Oct 1986). DEPLETION OF NEUROPEPTIDES DURING WOUND-HEALING IN RAT SKIN. NEUROSCI LETT. 71:101-105.
• WILLIAMS G; BALL J; BLOOM S; JOPLIN GF. (30 Oct 1986). IMPROVEMENT IN HEADACHE ASSOCIATED WITH PROLACTINOMA DURING TREATMENT WITH A SOMATOSTATIN ANALOG - AN N OF 1 STUDY. NEW ENGL J MED. 315:1166-1167.
• SOLT J; KADAS I; POLAK JM; NEMETH A; BLOOM SR; HORVATH L. (Oct 1986). A PANCREATIC-POLYPEPTIDE-PRODUCING TUMOR OF THE STOMACH. DIGEST DIS SCI. 31:S427-S427.
• BAUER FE; ADRIAN TE; CHRISTOFIDES ND; FERRI GL; YANAIHARA N; POLAK JM; BLOOM SR. (Oct 1986). DISTRIBUTION AND MOLECULAR HETEROGENEITY OF GALANIN IN HUMAN, PIG, GUINEA-PIG, AND RAT GASTROINTESTINAL TRACTS. GASTROENTEROLOGY. 91:877-883.
• GOODLAD RA; LENTON W; GHATEI MA; ADRIAN TE; BLOOM SR; WRIGHT NA. (Oct 1986). EFFECTS OF AN ELEMENTAL DIET AND DIFFERENT TYPES OF DIETARY FIBER ON INTESTINAL CRYPT CELL PRODUCTION - AND ITS CORRELATION WITH PLASMA ENTEROGLUCAGON AND PYY LEVELS. GUT. 27:1252-1252.
• GRAFFNER H; BLOOM SR; FARNEBO LO; JARHULT J. (Oct 1986). EFFECTS OF PHYSIOLOGICAL INCREASES OF PLASMA NORADRENALINE ON GASTRIC-ACID SECRETION AND GASTROINTESTINAL HORMONES. DIGEST DIS SCI. 31:S490-S490.
• ADRIAN TE; SAGOR GR; SAVAGE AP; BACARESEHAMILTON AJ; HALL GM; BLOOM SR. (Oct 1986). PEPTIDE YY KINETICS AND EFFECTS ON BLOOD-PRESSURE AND CIRCULATING PANCREATIC AND GASTROINTESTINAL HORMONES AND METABOLITES IN MAN. J CLIN ENDOCR METAB. 63:803-807.
• YIANGOU Y; REQUEJO F; POLAK JM; BLOOM SR. (30 Sep 1986). CHARACTERIZATION OF A NOVEL PREPRO VIP DERIVED PEPTIDE. BIOCHEM BIOPH RES CO. 139:1142-1149.
• DONCKIER J; ANDERSON JV; YEO T; BLOOM SR. (11 Sep 1986). DIURNAL RHYTHM IN THE PLASMA-CONCENTRATION OF ATRIAL-NATRIURETIC-PEPTIDE. NEW ENGL J MED. 315:710-711.
• ANDERSON JV; MILLAR ND; OHARE JP; MACKENZIE JC; CORRALL RJM; BLOOM SR. (Sep 1986). ATRIAL-NATRIURETIC-PEPTIDE - PHYSIOLOGICAL RELEASE ASSOCIATED WITH NATRIURESIS DURING WATER IMMERSION IN MAN. CLIN SCI. 71:319-322.
• GHATINEH S; ANDERSON JV; WHARTON J; WYSE R; ELLIOTT MJ; POLAK JM; BLOOM SR. (Sep 1986). ATRIAL-NATRIURETIC-PEPTIDE (ANP) IS STORED ONLY AS THE PROHORMONE IN HUMAN-HEART. REGUL PEPTIDES. 15:177-177.
• MELEAGROS L; GHATEI MA; ANDERSON JV; WHARTON J; POLAK JM; BLOOM SR. (Sep 1986). CARDIODILATIN-LIKE IMMUNOREACTIVITY IN CARDIAC TISSUES AND PLASMA. REGUL PEPTIDES. 15:186-186.
• BURNET PWJ; BRETHERTONWATT D; FOUNTAIN BA; GHATEI MA; BLOOM SR. (Sep 1986). CEREBELLIN-LIKE PEPTIDE - A NOVEL NEUROTRANSMITTER. REGUL PEPTIDES. 15:169-169.
• HARA M; VARNDELL IM; BISHOP AE; RODE J; BLOOM SR; POLAK JM. (Sep 1986). C-TERMINAL FLANKING PEPTIDE OF HUMAN PROGASTRIN IS EXPRESSED IN NORMAL HUMAN GASTRODUODENAL MUCOSA, ANTRA WITH G-CELL HYPERPLASIA AND ISLET CELL TUMORS PRODUCING GASTRIN. REGUL PEPTIDES. 15:180-180.
• CHOHAN P; ADRIAN TE; BLOOM SR. (Sep 1986). DISTRIBUTION AND POSTPRANDIAL RELEASE OF PORCINE PEPTIDE YY (PYY). REGUL PEPTIDES. 15:170-170.
• PALMER JBD; CUSS FMC; WARREN JB; BLANK M; BLOOM SR; BARNES PJ. (Sep 1986). EFFECT OF INFUSED VASOACTIVE-INTESTINAL-PEPTIDE ON AIRWAY FUNCTION IN NORMAL SUBJECTS. THORAX. 41:663-666.
• FUESSL HS; BURRIN J; WILLIAMS G; BLOOM SR. (Sep 1986). EFFECT OF THE SOMATOSTATIN ANALOG SMS-201-995 ON CARBOHYDRATE INTERMEDIARY METABOLITES. REGUL PEPTIDES. 15:177-177.
• WEBB SC; KRIKLER DM; HENDRY WG; ADRIAN TE; BLOOM SR. (Sep 1986). ELECTROPHYSIOLOGICAL ACTIONS OF SOMATOSTATIN ON THE ATRIOVENTRICULAR JUNCTION IN SINUS RHYTHM AND REENTRY TACHYCARDIA. BRIT HEART J. 56:236-241.
• HAMID Q; SPRINGALL DR; GHATEI MA; FOUNTAIN BA; ADDIS B; IBRAHIM BN; BLOOM SR; POLAK JM. (Sep 1986). EXPRESSION OF C-FLANKING PEPTIDE OF HUMAN PRO-BOMBESIN IN PULMONARY AND EXTRA-PULMONARY SMALL CELL-CARCINOMA. REGUL PEPTIDES. 15:180-180.
• BAUER FE; VENETIKOU M; MACKAY D; GINSBERG L; BURRIN J; BLOOM SR. (Sep 1986). GALANIN - A NOVEL MODULATOR OF PITUITARY AND PANCREATIC HORMONE-SECRETION IN MAN. REGUL PEPTIDES. 15:166-166.
• BAUER FE; VENETIKOU M; GINSBERG L; BURRIN J; BLOOM SR. (Sep 1986). GALANIN INFUSION IN MAN - METABOLIC, PANCREATIC AND PITUITARY ACTIONS OF A NOVEL GASTROINTESTINAL PEPTIDE. Z GASTROENTEROL. 24:486-486.
• LUCAS A; BLOOM SR; AYNSLEYGREEN A. (Sep 1986). GUT HORMONES AND MINIMAL ENTERAL FEEDING. ACTA PAEDIATR SCAND. 75:719-723.
• DOMIN J; ADRIAN TE; BLOOM SR. (Sep 1986). HYPERSECRETION AND MOLECULAR HETEROGENEITY OF PEPTIDE YY-LIKE IMMUNOREACTIVITY IN HUMAN NEONATAL PLASMA. REGUL PEPTIDES. 15:173-173.
• WILLIAMS G; KRAENZLIN M; SANDLER L; BURRIN J; LAW A; BLOOM S; JOPLIN GF. (Sep 1986). HYPERTHYROIDISM DUE TO NONTUMORAL INAPPROPRIATE TSH SECRETION - EFFECT OF A LONG-ACTING SOMATOSTATIN ANALOG (SMS201-995). ACTA ENDOCRINOL-COP. 113:42-46.
• LEONHARDT U; STEVENSON JC; GHATEI MA; LISCHKA A; MACDONALD DWR; WHITEHEAD MI; BLOOM SR. (Sep 1986). INCREASED 7B2 LEVELS THROUGHOUT PREGNANCY. REGUL PEPTIDES. 15:184-184.
• LEONHARDT U; GHATEI MA; BLOOM SR. (Sep 1986). INFLUENCE OF LHRH, FOOD UPTAKE, GLUCOSE AND SMS 201-995 ON 7B2 PLASMA-LEVELS. REGUL PEPTIDES. 15:183-183.
• DOMIN J; ADRIAN TE; BLOOM SR. (Sep 1986). IS HUMAN PEPTIDE SERINE SERINE (PSS) THE C-TERMINAL FLANKING PEPTIDE OF CHOLECYSTOKININ DOUBLY SULFATED. REGUL PEPTIDES. 15:172-172.
• ANAND P; MCGREGOR GP; GHATEI MA; MULDERRY PK; BANNISTER R; BLOOM SR. (Sep 1986). MARKED DEPLETION OF DORSAL SPINAL-CORD TACHYKININS AND CGRP WITH INTACT SKIN FLARES IN PATIENTS WITH THE SHY-DRAGER SYNDROME. REGUL PEPTIDES. 15:165-165.
• MULDERRY PK; SUZUKI H; BURNET PWJ; GHATEI MA; BLOOM SR. (Sep 1986). PEPTIDE IMMUNOREACTIVITIES IN THE DEVELOPING RAT-BRAIN. REGUL PEPTIDES. 15:187-187.
• SUZUKI H; GHATEI MA; WILLIAMS SJ; UTTENTHAL LO; FACER P; BISHOP AE; POLAK JM; BLOOM SR. (Sep 1986). PRODUCTION OF PITUITARY PROTEIN-7B2 IMMUNOREACTIVITY BY ENDOCRINE TUMORS AND ITS POSSIBLE DIAGNOSTIC-VALUE. J CLIN ENDOCR METAB. 63:758-765.
• YIANGOU Y; DIMARZO V; PANICO M; MORRIS H; BLOOM SR. (Sep 1986). PURIFICATION AND SEQUENCE-ANALYSIS OF A NOVEL 42-AMINO ACID PEPTIDE (PHV-42) THAT IS CONTAINED IN PREPRO-VIP. REGUL PEPTIDES. 15:199-199.
• STEEL JH; POLAK JM; VANNOORDEN S; GIBSON SJ; GHATEI MA; LEONHARDT U; BLOOM SR. (Sep 1986). THE NOVEL NEUROPEPTIDES 7B2 AND NEUROMEDIN-B ARE LOCALIZED TO THE MAMMALIAN NEUROHYPOPHYSEAL SYSTEM AND ARE EXPRESSED IN SPECIFIC CELL-TYPES OF THE ANTERIOR-PITUITARY. REGUL PEPTIDES. 15:193-193.
• LEONHARDT U; GHATEI MA; SUZUKI H; WILLIAMS SJ; BLOOM SR. (Sep 1986). THE NOVEL PROTEIN 7B2 IS AN ADDITIONAL MARKER FOR ENDOCRINE TUMORS. Z GASTROENTEROL. 24:494-494.
• ANDERSON JV; RAINE AEG; PROUDLER A; BLOOM SR. (Aug 1986). EFFECT OF HEMODIALYSIS ON PLASMA-CONCENTRATIONS OF ATRIAL-NATRIURETIC-PEPTIDE IN ADULT PATIENTS WITH CHRONIC-RENAL-FAILURE. J ENDOCRINOL. 110:193-196.
• NICHOLL CG; CAROLAN G; SEVELIUS H; BLOOM SR. (Aug 1986). ENPROSTIL REDUCES THE POSTPRANDIAL RISES IN INSULIN AND GLUCOSE-DEPENDENT INSULINOTROPIC PEPTIDE AND DELAYS SMALL INTESTINAL TRANSIT-TIME. DIABETOLOGIA. 29:A575-A575.
• TISCHLER AS; LEE YC; COSTOPOULOS D; NUNNEMACHER G; DELELLIS RA; VANZWIETEN MJ; WOLFE HJ; BLOOM SR. (Aug 1986). ESTABLISHMENT OF A CONTINUOUS SOMATOSTATIN-PRODUCING LINE OF MEDULLARY-THYROID CARCINOMA-CELLS FROM BALB/C MICE. J ENDOCRINOL. 110:309-&.
• ANDERSON JV; DONCKIER J; MCKENNA WJ; BLOOM SR. (Aug 1986). THE PLASMA RELEASE OF ATRIAL-NATRIURETIC-PEPTIDE IN MAN. CLIN SCI. 71:151-155.
• ADRIAN TE; UTTENTHAL LO; WILLIAMS SJ; BLOOM SR. (31 Jul 1986). SECRETION OF PANCREATIC-POLYPEPTIDE IN PATIENTS WITH PANCREATIC ENDOCRINE TUMORS. NEW ENGL J MED. 315:287-391.
• BAUER FE; VENETIKOU M; BURRIN JM; GINSBERG L; MACKAY DJ; BLOOM SR. (26 Jul 1986). GROWTH-HORMONE RELEASE IN MAN INDUCED BY GALANIN, A NEW HYPOTHALAMIC PEPTIDE. LANCET. 2:192-194.
• ANDERSON JV; BLOOM SR; SOMERS VK; CONWAY J; SLEIGHT P. (11 Jul 1986). HYPONATREMIA AND ULTRAMARATHONS. JAMA-J AM MED ASSOC. 256:213-214.
• ANDERSON JV; BLOOM SR. (Jul 1986). ATRIAL-NATRIURETIC-PEPTIDE - WHAT IS THE EXCITEMENT ALL ABOUT. J ENDOCRINOL. 110:7-17.
• BISHOP AE; POLAK JM; BAUER FE; CHRISTOFIDES ND; CARLEI F; BLOOM SR. (Jul 1986). OCCURRENCE AND DISTRIBUTION OF A NEWLY DISCOVERED PEPTIDE, GALANIN, IN THE MAMMALIAN ENTERIC NERVOUS-SYSTEM. GUT. 27:849-857.
• EDWARDS AV; JONES CT; BLOOM SR. (Jul 1986). REDUCED ADRENAL-CORTICAL SENSITIVITY TO ACTH IN LAMBS WITH CUT SPLANCHNIC NERVES. J ENDOCRINOL. 110:81-85.
• WILLIAMS G; GHATEI M; BURRIN J; BLOOM S. (21 Jun 1986). SEVERE HYPERGLUCAGONEMIA DURING TREATMENT WITH OXYMETHOLONE. BRIT MED J. 292:1637-1638.
• BAUER FE; ADRIAN TE; YANAIHARA N; POLAK JM; BLOOM SR. (9 Jun 1986). CHROMATOGRAPHIC EVIDENCE FOR HIGH-MOLECULAR-MASS GALANIN IMMUNOREACTIVITY IN PIG AND CAT ADRENAL-GLANDS. FEBS LETT. 201:327-331.
• SUZUKI H; GHATEI MA; REYNOLDS GP; ANAND P; BLOOM SR. (6 Jun 1986). REGIONAL DISTRIBUTION OF A NOVEL PEPTIDE (P7 OF 1B236) IMMUNOREACTIVITY IN THE HUMAN CENTRAL-NERVOUS-SYSTEM. NEUROSCI LETT. 67:58-62.
• TISCHLER AS; LEE YC; COSTOPOULOS D; SLAYTON VW; JASON WJ; BLOOM SR. (Jun 1986). COOPERATIVE REGULATION OF NEUROTENSIN CONTENT IN PC12 PHEOCHROMOCYTOMA CELL-CULTURES - EFFECTS OF NERVE GROWTH-FACTOR, DEXAMETHASONE, AND ACTIVATORS OF ADENYLATE-CYCLASE. J NEUROSCI. 6:1719-1725.
• BLOOM SR. (Jun 1986). SOMATOSTATIN ANALOG TREATMENT OF APUDOMAS AND PANCREATIC TUMORS. EUR J CANCER CLIN ON. 22:727-727.
• ANDERSON JV; GIBBS JSR; WOODRUFF PWR; GRECO C; ROWLAND E; BLOOM SR. (Jun 1986). THE PLASMA ATRIAL-NATRIURETIC-PEPTIDE RESPONSE TO TREATMENT OF ACUTE CARDIAC-FAILURE, SPONTANEOUS SUPRAVENTRICULAR TACHYCARDIA AND INDUCED REENTRANT TACHYCARDIA IN MAN. J HYPERTENS. 4:S137-S141.
• SANDLER LM; BURRIN JM; JOPLIN GF; BLOOM S. (10 May 1986). COMBINED USE OF VASOPRESSIN AND SYNTHETIC HYPOTHALAMIC RELEASING FACTORS AS TEST OF ANTERIOR-PITUITARY FUNCTION - REPLY. BRIT MED J. 292:1272-1272.
• ANDERSON JV; STRUTHERS AD; PAYNE NN; SLATER JDH; BLOOM SR. (May 1986). ATRIAL-NATRIURETIC-PEPTIDE INHIBITS THE ALDOSTERONE RESPONSE TO ANGIOTENSIN-II IN MAN. CLIN SCI. 70:507-512.
• ADRIAN TE; BACARESEHAMILTON AJ; MALLINSON CN; FUESSL HS; BLOOM SR. (May 1986). CHOLECYSTOKININ AND SECRETIN RELEASE IN CHRONIC-PANCREATITIS. GASTROENTEROLOGY. 90:1320-1320.
• LEE YC; UTTENTHAL LO; SMITH HA; BLOOM SR. (May 1986). INVITRO DEGRADATION OF NEUROTENSIN IN HUMAN-PLASMA. PEPTIDES. 7:383-387.
• ALLEN JM; GODFREY NP; YEATS JC; BING RF; BLOOM SR. (May 1986). NEUROPEPTIDE-Y IN RENOVASCULAR MODELS OF HYPERTENSION IN THE RAT. CLIN SCI. 70:485-488.
• BAUER FE; GINSBERG L; VENETIKOU M; ADRIAN TE; BLOOM SR. (May 1986). PHARMACOKINETICS OF GALANIN IN MAN AND ITS EFFECT ON GLUCOSE-HOMEOSTASIS. GUT. 27:A606-A606.
• KIELY EA; WILLIAMS G; BLOOM SR. (26 Apr 1986). VASOACTIVE INTESTINAL POLYPEPTIDE DURING PENILE ERECTION. LANCET. 1:973-973.
• CHNG JLC; ANDERSON JV; WILLIAMS SJ; CARR DH; BLOOM SR. (12 Apr 1986). REMISSION OF SYMPTOMS DURING LONG-TERM TREATMENT OF METASTATIC PANCREATIC ENDOCRINE TUMORS WITH LONG-ACTING SOMATOSTATIN ANALOG. BRIT MED J. 292:981-982.
• ANDERSON J; STRUTHERS A; CHRISTOFIDES N; BLOOM S. (Apr 1986). ATRIAL-NATRIURETIC-PEPTIDE - AN ENDOGENOUS FACTOR ENHANCING SODIUM-EXCRETION IN MAN. CLIN SCI. 70:327-331.
• SOREIDE O; CZERNIAK A; BRADPIECE H; BLOOM S; BLUMGART L. (Apr 1986). CHARACTERISTICS OF FIBROLAMELLAR HEPATOCELLULAR-CARCINOMA - A STUDY OF 9 CASES AND A REVIEW OF THE LITERATURE. AM J SURG. 151:518-523.
• ANDERSON JV; CHRISTOFIDES ND; BLOOM SR. (Apr 1986). PLASMA RELEASE OF ATRIAL-NATRIURETIC-PEPTIDE IN RESPONSE TO BLOOD-VOLUME EXPANSION. J ENDOCRINOL. 109:9-13.
• LAMEY PJ; FISHER BM; FRIER BM; BLOOM SR; SAVAGE AP; BEELEY JA. (Apr 1986). SALIVARY-GLAND STUDIES IN DIABETIC AUTONOMIC NEUROPATHY. J DENT RES. 65:503-503.
• BENNETT T; BLOOM SR; CLARK AG; EVANS DF; FELLOWS IW; MACDONALD IA. (Apr 1986). THE EFFECT OF INSULIN-INDUCED HYPOGLYCEMIA ON GASTROINTESTINAL MOTILITY IN MAN. J PHYSIOL-LONDON. 373:P33-P33.
• PHILLIPS RE; LOOAREESUWAN S; BLOOM SR; WARRELL DA; TURNER RC; QUANTRILL D; MOORE AR. (29 Mar 1986). EFFECTIVENESS OF SMS 201-995, A SYNTHETIC, LONG-ACTING SOMATOSTATIN ANALOG, IN TREATMENT OF QUININE-INDUCED HYPERINSULINEMIA. LANCET. 1:713-716.
• ANDERSON JV; DONCKIER J; YEO T; BLOOM SR. (Mar 1986). DIURNAL AND POSTURAL CHANGE OF PLASMA ATRIAL-NATRIURETIC-PEPTIDE (ANP) CONCENTRATIONS. J ENDOCRINOL. 108:155-155.
• UTTENTHAL LO; UKPONMWAN OO; WOOD SM; GHIGLIONE M; GHATEI MA; TRAYNER IM; BLOOM SR. (Mar 1986). LONG-TERM EFFECTS OF INTESTINAL ALPHA-GLUCOSIDASE INHIBITION ON POSTPRANDIAL GLUCOSE, PANCREATIC AND GUT HORMONE RESPONSES AND FASTING SERUM-LIPIDS IN DIABETICS ON SULFONYLUREAS. DIABETIC MED. 3:155-160.
• MILLAR ND; WILLIAMS AC; OHARE JP; ANDERSON JV; BHOOLA KD; BLOOM SR; CORRALL RJM. (Mar 1986). URINARY CYCLIC-NUCLEOTIDES AND ATRIAL-NATRIURETIC-PEPTIDE DURING WATER IMMERSION. J ENDOCRINOL. 108:156-156.
• SANDLER LM; BURRIN JM; JOPLIN GF; BLOOM SR. (22 Feb 1986). COMBINED USE OF VASOPRESSIN AND SYNTHETIC HYPOTHALAMIC RELEASING FACTORS AS A NEW TEST OF ANTERIOR-PITUITARY FUNCTION. BRIT MED J. 292:511-514.
• EDWARDS AV; BLOOM SR. (15 Feb 1986). THE ROLE OF THE AUTONOMIC NERVOUS-SYSTEM IN MEDIATING PANCREATIC ENDOCRINE RESPONSES TO ARGININE IN THE CALF. EXPERIENTIA. 42:158-160.
• TERENGHI G; POLAK JM; RODRIGO J; MULDERRY PK; BLOOM SR. (12 Feb 1986). CALCITONIN GENE-RELATED PEPTIDE-IMMUNOREACTIVE NERVES IN THE TONGUE, EPIGLOTTIS AND PHARYNX OF THE RAT - OCCURRENCE, DISTRIBUTION AND ORIGIN. BRAIN RES. 365:1-14.
• ADRIAN TE; DOMIN J; BACARESEHAMILTON AJ; BLOOM SR. (3 Feb 1986). IS THE C-TERMINAL FLANKING PEPTIDE OF RAT CHOLECYSTOKININ DOUBLE SULFATED. FEBS LETT. 196:5-8.
• CIVALLERI D; BLOOM SR; SARSON DL; TRAVERSO E; REPETTO M; BELTRANDI D; VITALE B; SEMINO G; et alBALLETTO N; SCOPINARO N. (Feb 1986). EFFECT OF PARTIAL AND TOTAL BILIOPANCREATIC BYPASS (BPB) WITH EITHER GASTROJEJUNOSTOMY OR GASTRO-ILEOSTOMY ON INSULIN AND GIP RESPONSE TO FOOD. ITAL J GASTROENTEROL. 18:60-60.
• HAMID QA; BISHOP AE; SIKRI KL; VARNDELL IM; BLOOM SR; POLAK JM. (Feb 1986). IMMUNOCYTOCHEMICAL CHARACTERIZATION OF 10 PANCREATIC TUMORS, ASSOCIATED WITH THE GLUCAGONOMA SYNDROME, USING ANTIBODIES TO SEPARATE REGIONS OF THE PRO-GLUCAGON MOLECULE AND OTHER NEUROENDOCRINE MARKERS. HISTOPATHOLOGY. 10:119-133.
• KERLE DJ; WILLIAMS G; SMITH C; YEO T; BLOOM SR. (Feb 1986). LONG-TERM EXPERIENCE OF AN LHRH ANALOG, ZOLADEX, IN ADVANCED PROSTATIC-CARCINOMA. BRIT J UROL. 58:87-87.
• WILLIAMS G; KERLE DJ; WARE H; DOBLE A; DUNLOP H; SMITH C; ALLEN J; YEO T; et alBLOOM SR. (Feb 1986). OBJECTIVE RESPONSES TO KETOCONAZOLE THERAPY IN PATIENTS WITH RELAPSED PROGRESSIVE PROSTATIC-CANCER. BRIT J UROL. 58:45-51.
• KERLE DJ; WILLIAMS G; SMITH C; YEO T; BLOOM SR. (Feb 1986). OBJECTIVE TUMOR RESPONSES TO KETOCONAZOLE THERAPY WITH RELAPSED PROSTATIC-CANCER. BRIT J UROL. 58:86-87.
• ADRIAN TE; SAVAGE AP; BACARESEHAMILTON AJ; WOLFE K; BESTERMAN HS; BLOOM SR. (Feb 1986). PEPTIDE-YY ABNORMALITIES IN GASTROINTESTINAL-DISEASES. GASTROENTEROLOGY. 90:379-384.
• ANDERSON JV; CHRISTOFIDES ND; VINAS P; WHARTON J; VARNDELL IM; POLAK JM; BLOOM SR. (Feb 1986). RADIOIMMUNOASSAY OF ALPHA-RAT ATRIAL-NATRIURETIC-PEPTIDE. NEUROPEPTIDES. 7:159-173.
• SUZUKI H; TISCHLER AS; CHRISTOFIDES ND; CHRETIEN M; SEIDAH NG; POLAK JM; BLOOM SR. (Jan 1986). A NOVEL PITUITARY PROTEIN (7B2)-LIKE IMMUNOREACTIVITY IS SECRETED BY A RAT PHEOCHROMOCYTOMA CELL-LINE (PC12). J ENDOCRINOL. 108:151-155.
• GIBSON SJ; POLAK JM; ANAND P; BLANK MA; YIANGOU Y; SU HC; TERENGHI G; KATAGIRI T; et alMORRISON JFB; LUMB BM; INYAMA C; BLOOM SR. (1986). A VIP/PHI-CONTAINING PATHWAY LINKS URINARY-BLADDER AND SACRAL SPINAL-CORD. PEPTIDES. 7:205-219.
• BAUER FE; CHRISTOFIDES ND; HACKER GW; BLANK MA; POLAK JM; BLOOM SR. (Jan 1986). DISTRIBUTION OF GALANIN IMMUNOREACTIVITY IN THE GENITOURINARY TRACT OF MAN AND RAT. PEPTIDES. 7:5-10.
• BURRIN JM; YEO TH; ASHBY MJ; BLOOM SR. (Jan 1986). EFFECT OF KETOCONAZOLE ON ADRENOCORTICOTROPIC HORMONE-SECRETION INVITRO AND INVIVO. J ENDOCRINOL. 108:37-41.
• JANSEN JBMJ; ENGELS LGJB; ADRIAN TE; BLOOM SR; LAMERS CBHW. (1986). GASTROINTESTINAL HORMONE PROFILE AFTER EXTENSIVE SMALL-BOWEL RESECTION. NETH J MED. 29:32-32.
• ANDERSON JV; MILLAR ND; OHARE JP; CORRALL RJM; BLOOM SR. (1986). NATRIURESIS OF HEAD-OUT WATER IMMERSION IS ASSOCIATED WITH ANP RELEASE IN MAN. J CARDIOVASC PHARM. 8:1325-1325.
• ANDERSON JV; BLOOM SR. (1986). NEUROENDOCRINE TUMORS OF THE GUT - LONG-TERM THERAPY WITH THE SOMATOSTATIN ANALOG SMS-201-995. SCAND J GASTROENTERO. 21:115-128.
• ALLEN JM; BLOOM SR. (1986). NEUROPEPTIDE-Y - A PUTATIVE NEUROTRANSMITTER. NEUROCHEM INT. 8:1-8.
• SILVER M; FOWDEN AL; COMLINE RS; BLOOM SR. (Jan 1986). PANCREATIC ALPHA-CELL FUNCTION IN THE FETAL AND NEWBORN PIG. J ENDOCRINOL. 108:137-142.
• WILLIAMS G; FUESSL H; KRAENZLIN M; BLOOM SR. (1986). POSTPRANDIAL EFFECTS OF SMS-201-995 ON GUT HORMONES AND GLUCOSE-TOLERANCE. SCAND J GASTROENTERO. 21:73-83.
• BROOKS DJ; GIBBS JSR; SHARP P; HEROLD S; TURTON DR; LUTHRA SK; KOHNER EM; BLOOM SR; et alJONES T. (1986). REGIONAL CEREBRAL GLUCOSE-TRANSPORT IN INSULIN-DEPENDENT DIABETIC-PATIENTS STUDIED USING [C-11] 3-O-METHYL-D-GLUCOSE AND POSITRON EMISSION TOMOGRAPHY. J CEREBR BLOOD F MET. 6:240-244.
• POLAK JM; BLOOM SR. (1986). SOMATOSTATIN LOCALIZATION IN TISSUES. SCAND J GASTROENTERO. 21:11-21.
• SANDLER LM; JOPLIN GF; BLOOM SR. (1986). SYMPTOMATIC IMPROVEMENT WITH SMS-201-995 IN ACROMEGALY. SCAND J GASTROENTERO. 21:249-250.
• ANDERSON JV; GIBBS JSR; ROWLAND E; PAYNE NN; SLATER JDH; BLOOM SR. (1986). TACHYCARDIA-INDUCED NATRIURESIS AND ANP. J CARDIOVASC PHARM. 8:1302-1302.
• BLANK MA; GU J; ALLEN JM; HUANG WM; YIANGOU Y; CHNG J; LEWIS G; ELDER MG; et alPOLAK JM; BLOOM SR. (1986). THE REGIONAL DISTRIBUTION OF NPY-CONTAINING, PHM-CONTAINING, AND VIP-CONTAINING NERVES IN THE HUMAN FEMALE GENITAL-TRACT. INT J FERTIL. 31:218-222.
• MULDERRY PK; GHATEI MA; POLAK JM; BLOOM SR. (Dec 1985). CHARACTERIZATION OF CALCITONIN GENE-RELATED PEPTIDE-LIKE IMMUNOREACTIVITY (CGRP-LI) IN TISSUES OF THE RAT. REGUL PEPTIDES. 13:84-84.
• YIANGOU Y; REQUEJO F; BLANK MA; SITARA D; BLOOM SR. (Dec 1985). CHARACTERIZATION OF PHI-PHM-VIP - LIKE PEPTIDES USING REGIONAL SPECIFIC ANTISERA DIRECTED TOWARDS DIFFERENT PORTIONS OF THEIR PRECURSOR. REGUL PEPTIDES. 13:74-74.
• FRANCIS RH; GHATEI MA; FOUNTAIN BA; BURNET PWJ; POLAK JM; BLOOM SR. (Dec 1985). DISTRIBUTION OF CEREBELLIN-LIKE PEPTIDE IMMUNOREACTIVITY IN THE RAT CENTRAL-NERVOUS-SYSTEM (CNS) AND PERIPHERAL-TISSUES. REGUL PEPTIDES. 13:100-100.
• ANDERSON JV; MILLER N; OHARE JP; MCKENZIE JC; CORRALL RJC; BLOOM SR. (1985). DO CIRCULATING LEVELS OF ATRIAL NATRIURETIC PEPTIDE (ANP) MEDIATE THE NATRIURETIC RESPONSE TO WATER IMMERSION IN MAN. CLIN SCI. 69:P39-P39.
• GOODLAD RA; LENTON W; GHATEI MA; BLOOM SR; WRIGHT NA. (Dec 1985). EFFECTS OF AN ELEMENTAL DIET, INERT BULK AND DIFFERENT TYPES OF DIETARY FIBER ON THE INTESTINAL EPITHELIUM OF THE REFED RAT - RELATIONSHIP TO PLASMA ENTEROGLUCAGON LEVELS. REGUL PEPTIDES. 13:102-102.
• GHIGLIONE M; BLAZQUEZ E; UTTENTHAL LO; DEDIEGO JG; ALVAREZ E; GEORGE SK; BLOOM SR. (Dec 1985). GLUCAGONLIKE PEPTIDE-1 DOES NOT HAVE A ROLE IN HEPATIC CARBOHYDRATE-METABOLISM. DIABETOLOGIA. 28:920-921.
• BAUER FE; HACKER GW; ADRIAN TE; TERENGHI G; POLAK JM; BLOOM SR. (Dec 1985). LOCALIZATION AND CHARACTERIZATION OF GALANIN IMMUNOREACTIVITY IN THE HUMAN, PIG AND CAT ADRENAL - MOLECULAR HETEROGENEITY DUE TO N-TERMINAL AND C-TERMINAL EXTENSION OF THE GALANIN MOLECULE. REGUL PEPTIDES. 13:91-91.
• ALLEN JM; YEATS JC; BROWN J; BLOOM SR. (Dec 1985). NEUROPEPTIDE-Y INFUSION ELEVATES BLOOD-PRESSURE. REGUL PEPTIDES. 13:89-89.
• ALLEN JM; SANGHERA JS; FRANCIS RH; BLOOM SR. (Dec 1985). NPY-IMMUNOREACTIVITY IN RAT-BRAIN EXTRACTS DIFFERS FROM PORCINE AND HUMAN NPY. REGUL PEPTIDES. 13:88-88.
• ALLEN JM; BLOOM SR. (Dec 1985). PHARMACOLOGICAL STUDIES ON C-FLANKING PEPTIDE OF NEUROPEPTIDE-Y (CPON). REGUL PEPTIDES. 13:87-87.
• YIANGOU Y; SITARA D; BLOOM SR. (Dec 1985). PHM IMMUNOREACTIVITY IN PLASMA AND TISSUE IN PATIENTS WITH VIP PRODUCING TUMORS AND WATERY DIARRHEA SYNDROME. REGUL PEPTIDES. 13:74-74.
• SUZUKI H; GHATEI MA; WILLIAMS SJ; POLAK JM; BLOOM SR. (1985). PRODUCTION OF A NOVEL PITUITARY PROTEIN BY TUMORS AND ITS DIAGNOSTIC-VALUE. CLIN SCI. 69:P72-P72.
• DONCKIER J; ANDERSON JV; STRUTHERS AD; BLOOM SR. (Dec 1985). REDUCTION OF ELEVATED PLASMA-CONCENTRATIONS OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) AFTER SUCCESSFUL CARDIOVERSION FOR ATRIAL TACHYARRYTHMIAS. REGUL PEPTIDES. 13:97-97.
• MCGREGOR GP; WHARTON J; WOOD HE; POLAK JM; BLOOM SR. (Dec 1985). SUBSTANCE-P-IMMUNOREACTIVITY AND NEUROKININ-IMMUNOREACTIVITY (IR) IN RAT SALIVARY-GLANDS - RADIOIMMUNOLOGICAL EVIDENCE FOR DIFFERENT PERIPHERAL TACHYKININ SYSTEMS. REGUL PEPTIDES. 13:83-83.
• ANDERSON JV; DONCKIER J; BLOOM SR. (Dec 1985). THE PHYSIOLOGICAL VARIATION OF CIRCULATING CONCENTRATIONS OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) IN MAN. REGUL PEPTIDES. 13:89-89.
• DOMIN J; ADRIAN TE; BLOOM SR. (Dec 1985). THE RADIOIMMUNOASSAY OF RAT CHOLECYSTOKININ C-TERMINAL FLANKING PEPTIDE. REGUL PEPTIDES. 13:97-97.
• SUZUKI H; CHRISTOFIDES ND; ADRIAN TE; CHRETIEN M; SEIDAH NG; POLAK JM; BLOOM SR. (28 Nov 1985). ONTOGENY OF A NOVEL PITUITARY PROTEIN (7B2) IN THE HUMAN-FETAL INTESTINE. REGUL PEPTIDES. 12:289-296.
• GULBENKIAN S; WHARTON J; HACKER GW; VARNDELL IM; BLOOM SR; POLAK JM. (Nov 1985). COLOCALIZATION OF NEUROPEPTIDE TYROSINE (NPY) AND ITS C-TERMINAL FLANKING PEPTIDE (C-PON). PEPTIDES. 6:1237-1243.
• ALLEN JM; YEATS JC; BLANK MA; MCGREGOR GP; GU J; POLAK JM; BLOOM SR. (Nov 1985). EFFECT OF 6-HYDROXYDOPAMINE ON NEUROPEPTIDES IN THE RAT FEMALE GENITOURINARY TRACT. PEPTIDES. 6:1213-1217.
• ANAND P; MCGREGOR GP; BANNISTER R; REYNOLDS G; BLOOM SR. (1985). MARKED DEPLETION OF SPINAL-CORD SUBSTANCE-P AND OTHER NEUROPEPTIDES IN THE SHY-DRAGER SYNDROME. CLIN SCI. 68:P43-P43.
• CIMINI V; VANNOORDEN S; GIORDANOLANZA G; NARDINI V; MCGREGOR GP; BLOOM SR; POLAK JM. (1985). NEUROPEPTIDES AND 5-HT IMMUNOREACTIVITY IN THE GASTRIC NERVES OF THE DOGFISH (SCYLIORHINUS-STELLARIS). PEPTIDES. 6:373-377.
• NAMBA M; GHATEI MA; BISHOP AE; GIBSON SJ; MANN DJ; POLAK JM; BLOOM SR. (1985). PRESENCE OF NEUROMEDIN B-LIKE IMMUNOREACTIVITY IN THE BRAIN AND GUT OF RAT AND GUINEA-PIG. PEPTIDES. 6:257-263.
• ADRIAN TE; BACARESEHAMILTON AJ; BLOOM SR. (1985). A NEW SPECIFIC ASSAY FOR CHOLECYSTOKININ OCTAPEPTIDE. ANN NY ACAD SCI. 448:566-567.
• SUZUKI H; CHRISTOFIDES ND; CHRETIEN M; SEIDAH NG; POLAK JM; BLOOM SR. (1985). A NOVEL PITUITARY PROTEIN (7B2) IN THE RAT UROGENITAL TRACT. BIOMED RES-TOKYO. 6:139-143.
• DONCKIER J; ANDERSON JV; BLOOM SR. (1985). ALPHA-ATRIAL NATRIURETIC PEPTIDE CONCENTRATIONS IN PLASMA IN CHILDREN WITH CONGENITAL HEART AND PULMONARY-DISEASES. BRIT MED J. 291:1648-1649.
• HAGEL J; RUPPIN H; PICHL J; FEUERBACH W; BLOOM S; DOMSCHKE W. (1985). ALPHA-GLUCOSIDASE INHIBITOR ACARBOSE - FATE AND EFFECTS IN MAN. GASTROENTEROLOGY. 88:1410-1410.
• ANAND P; POLAK JM; BLOOM SR. (1985). ASPECTS OF NEURO-HORMONAL PEPTIDES. CLIN PHYSIOL. 5:111-120.
• ANDERSON JV; STRUTHERS AD; PAYNE NN; SLATER JDH; BLOOM SR. (1985). ATRIAL NATRIURETIC PEPTIDE (ANP) INHIBITS STIMULATED ALDOSTERONE RELEASE IN MAN. J ENDOCRINOL. 107:39-39.
• DAVIES HA; WHEELER MH; PSAILA J; RHODES J; NEWCOMBE RG; JONES JM; PROCTER D; ADRIAN TE; et alBLOOM SR. (1985). BILE EXCLUSION FROM THE DUODENUM - ITS EFFECT ON GASTRIC AND PANCREATIC FUNCTION IN THE DOG. DIGEST DIS SCI. 30:954-960.
• GHATEI MA; GU J; ALLEN JM; POLAK JM; BLOOM SR. (1985). BOMBESIN-LIKE IMMUNOREACTIVITY IN FEMALE RAT GENITOURINARY TRACT. NEUROSCI LETT. 54:13-19.
• PALMER JBD; CUSS FMC; MULDERRY PK; GHATEI MA; BLOOM SR; BARNES PJ. (1985). CALCITONIN GENE RELATED PEPTIDE IS A POTENT CONSTRICTOR OF HUMAN AIRWAY SMOOTH-MUSCLE. THORAX. 40:713-713.
• GHATEI MA; GU J; MULDERRY PK; BLANK MA; ALLEN JM; MORRISON JFB; POLAK JM; BLOOM SR. (1985). CALCITONIN GENE-RELATED PEPTIDE (CGRP) IN THE FEMALE RAT UROGENITAL TRACT. PEPTIDES. 6:809-815.
• RODRIGO J; POLAK JM; FERNANDEZ L; GHATEI MA; MULDERRY P; BLOOM SR. (1985). CALCITONIN GENE-RELATED PEPTIDE IMMUNOREACTIVE SENSORY AND MOTOR NERVES OF THE RAT, CAT, AND MONKEY ESOPHAGUS. GASTROENTEROLOGY. 88:444-451.
• ANAND KJS; BROWN MJ; CAUSON RC; CHRISTOFIDES ND; BLOOM SR; AYNSLEYGREEN A. (1985). CAN THE HUMAN NEONATE MOUNT AN ENDOCRINE AND METABOLIC RESPONSE TO SURGERY. J PEDIATR SURG. 20:41-48.
• SAVAGE AP; SIAN MS; MATTHEWS JL; BLOOM SR; COOKE T. (1985). CHANGES IN FECAL BILE-ACID EXCRETION FOLLOWING PROMOTION OF COLONIC-CANCER BY SMALL BOWEL RESECTION IN THE RAT. GUT. 26:A564-A564.
• ANDERSSON PO; BLOOM SR; MATTIASSON A; UVELIUS B. (1985). CHANGES IN VASCULAR-RESISTANCE IN THE FELINE URINARY-BLADDER IN RESPONSE TO BLADDER FILLING. J UROLOGY. 134:1041-1046.
• LEE YC; BACARESEHAMILTON AJ; WOOD SM; BLUMGART LH; BLOOM SR. (1985). CHROMATOGRAPHIC CHARACTERIZATION OF NEUROTENSIN-LIKE IMMUNOREACTIVITY IN PLASMA AND TISSUE-EXTRACTS FROM HEPATOMA PATIENTS. CLIN CHIM ACTA. 149:29-36.
• JONES IR; OWENS DR; SARSONS DL; BLOOM SR. (1985). DAY PROFILES OF GLUCOSE DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP) IN NORMAL SUBJECTS. HORM METAB RES. 17:660-662.
• ALLEN JM; CROSS AJ; CROW TJ; JAVOYAGID F; AGID Y; BLOOM SR. (1985). DISSOCIATION OF NEUROPEPTIDE-Y AND SOMATOSTATIN IN PARKINSONS-DISEASE. BRAIN RES. 337:197-200.
• MULDERRY PK; GHATEI MA; BISHOP AE; ALLEN YS; POLAK JM; BLOOM SR. (1985). DISTRIBUTION AND CHROMATOGRAPHIC CHARACTERIZATION OF CGRP-LIKE IMMUNOREACTIVITY IN THE BRAIN AND GUT OF THE RAT. REGUL PEPTIDES. 12:133-143.
• NAMBA M; GHATEI MA; ANAND P; BLOOM SR. (1985). DISTRIBUTION AND CHROMATOGRAPHIC CHARACTERIZATION OF NEUROMEDIN B-LIKE IMMUNOREACTIVITY IN THE HUMAN SPINAL-CORD. BRAIN RES. 342:183-186.
• NAMBA M; GHATEI MA; GIBSON SJ; POLAK JM; BLOOM SR. (1985). DISTRIBUTION AND LOCALIZATION OF NEUROMEDIN B-LIKE IMMUNOREACTIVITY IN PIG, CAT AND RAT SPINAL-CORD. NEUROSCIENCE. 15:1217-&.
• TERENGHI G; POLAK JM; GHATEI MA; MULDERRY PK; BUTLER JM; UNGER WG; BLOOM SR. (1985). DISTRIBUTION AND ORIGIN OF CALCITONIN GENE-RELATED PEPTIDE (CGRP) IMMUNOREACTIVITY IN THE SENSORY INNERVATION OF THE MAMMALIAN EYE. J COMP NEUROL. 233:506-516.
• STEVENSON JC; ADRIAN TE; CHRISTOFIDES ND; BLOOM SR. (1985). EFFECT OF CALCITONIN ON GASTROINTESTINAL REGULATORY PEPTIDES IN MAN. CLIN ENDOCRINOL. 22:655-660.
• MANOLAS KJ; ADRIAN TE; DUNLOP HM; KAMILARIS TC; BACARESEHAMILTON AJ; BLOOM SR; WELBOURN RB. (1985). EFFECT OF FOOD ON PORCINE GUT REGULATORY PEPTIDES IN ARTERIAL AND PORTAL VENOUS-BLOOD. HORM RES. 22:284-290.
• KRAENZLIN ME; WOOD SM; NEUFELD M; ADRIAN TE; BLOOM SR. (1985). EFFECT OF LONG-ACTING SOMATOSTATIN-ANALOGUE, SMS 201995, ON GUT HORMONE-SECRETION IN NORMAL SUBJECTS. EXPERIENTIA. 41:738-740.
• ADRIAN TE; SAVAGE AP; SAGOR GR; ALLEN JM; BACARESEHAMILTON AJ; TATEMOTO K; POLAK JM; BLOOM SR. (1985). EFFECT OF PEPTIDE-YY ON GASTRIC, PANCREATIC, AND BILIARY FUNCTION IN HUMANS. GASTROENTEROLOGY. 89:494-499.
• GHIGLIONE M; UTTENTHAL LO; GEORGE SK; BLOOM SR. (1985). EFFECT OF THE NEUROPEPTIDE HPGRF ON EXOCRINE PANCREATIC-SECRETION IN THE RAT. BIOMED RES-TOKYO. 6:107-109.
• TRISCARI J; BLOOM SR; GAGINELLA T; ODORISIO T; SULLIVAN AC. (1985). EFFECTS OF AN ANORECTIC AGENT (RO 21-7716) ON MEAL-STIMULATED HORMONE LEVELS. INT J OBESITY. 9:A101-A101.
• BLOOM SR; EDWARDS AV. (1985). EFFECTS OF CERTAIN METABOLITES ON PANCREATIC ENDOCRINE RESPONSES TO STIMULATION OF THE VAGUS NERVES IN CONSCIOUS CALVES. J PHYSIOL-LONDON. 362:303-310.
• KRAL JG; NAUSSKAROL C; BLOOM SR; HESHKA S. (1985). EFFECTS OF CHLOROCITRATE ON HORMONE-RELEASE, GASTRIC-EMPTYING, FOOD-INTAKE AND BODY-WEIGHT IN MAN. INT J OBESITY. 9:A130-A130.
• DIANI AR; PETERSON T; SAWADA GA; WYSE BM; BLANKS MC; GERRITSEN GC; TERENGHI G; VARNDELL IM; et alPOLAK JM; BLANK MA; BLOOM SR. (1985). ELEVATED LEVELS OF VASOACTIVE INTESTINAL PEPTIDE IN THE EYE AND URINARY-BLADDER OF DIABETIC AND PREDIABETIC CHINESE HAMSTERS. DIABETOLOGIA. 28:302-307.
• BAUER FE; ADRIAN TE; POLAK JM; BLOOM SR. (1985). EVIDENCE OF HIGH MOLECULAR-WEIGHT GALANIN IMMUNOREACTIVITY IN THE PIG AND CAT ADRENAL. J ENDOCRINOL. 107:40-40.
• CALVERT SA; SOLTESZ G; JENKINS PA; HARRIS D; NEWMAN C; ADRIAN TE; BLOOM SR; AYNSLEYGREEN A. (1985). FEEDING PREMATURE-INFANTS WITH HUMAN-MILK OR PRETERM MILK FORMULA - EFFECTS ON POSTNATAL-GROWTH AND ON CIRCULATING CONCENTRATIONS OF INTERMEDIARY METABOLITES, AMINO-ACIDS, AND REGULATORY PEPTIDES. BIOL NEONATE. 47:189-198.
• GHATEI MA; SPRINGALL DR; NICHOLL CG; POLAK JM; BLOOM SR. (1985). GASTRIN-RELEASING PEPTIDE-LIKE IMMUNOREACTIVITY IN MEDULLARY-THYROID CARCINOMA. AM J CLIN PATHOL. 84:581-586.
• LUCAS A; BLOOM SR; GREEN AA. (1985). GASTROINTESTINAL PEPTIDES AND THE ADAPTATION TO EXTRAUTERINE NUTRITION. CAN J PHYSIOL PHARM. 63:527-537.
• WOODHAMS PL; ALLEN YS; MCGOVERN J; ALLEN JM; BLOOM SR; BALAZS R; POLAK JM. (1985). IMMUNOHISTOCHEMICAL ANALYSIS OF THE EARLY ONTOGENY OF THE NEUROPEPTIDE-Y SYSTEM IN RAT-BRAIN. NEUROSCIENCE. 15:173-&.
• TISCHLER AS; ALLEN JM; COSTOPOULOS D; BLOOM SR. (1985). INCREASED CONTENT OF NEUROPEPTIDE-Y IN HUMAN PHEOCHROMOCYTOMA CELL-CULTURES. J CLIN ENDOCR METAB. 61:303-305.
• MORIARTY KJ; HIGGS NB; WOODFORD M; ALLEN JM; BLOOM SR; TURNBERG LA. (1985). INFLUENCE OF NEUROPEPTIDE-Y ON RABBIT ILEAL MUCOSA. GUT. 26:1137-1138.
• KRAENZLIN ME; CHNG JLC; MULDERRY PK; GHATEI MA; BLOOM SR. (1985). INFUSION OF A NOVEL PEPTIDE, CALCITONIN GENE-RELATED PEPTIDE (CGRP) IN MAN - PHARMACOKINETICS AND EFFECTS ON GASTRIC-ACID SECRETION AND ON GASTROINTESTINAL HORMONES. REGUL PEPTIDES. 10:189-197.
• MAXWELL DL; CHAHAL P; BLOOM SR; HUGHES JMB. (1985). INHIBITION OF VENTILATORY RESPONSE TO HYPOXIA BY SOMATOSTATIN. Q J MED. 57:800-800.
• SAVAGE AP; GORNACZ GE; ADRIAN TE; GHATEI MA; GOODLAD RA; WRIGHT NA; BLOOM SR. (1985). IS RAISED PLASMA PEPTIDE YY AFTER INTESTINAL RESECTION IN THE RAT RESPONSIBLE FOR THE TROPHIC RESPONSE. GUT. 26:1353-1358.
• RENNIE JA; BENNETT A; CHRISTOFIDES NH; BLOOM SR. (1985). IS VASOACTIVE INTESTINAL PEPTIDE AN INHIBITORY TRANSMITTER IN THE COLON. BRIT J SURG. 72:S140-S140.
• TATEMOTO K; SIIMESMAA S; JORNVALL H; ALLEN JM; POLAK JM; BLOOM SR; MUTT V. (1985). ISOLATION AND CHARACTERIZATION OF NEUROPEPTIDE-Y FROM PORCINE INTESTINE. FEBS LETT. 179:181-184.
• VARNDELL IM; BISHOP AE; SIKRI KL; UTTENTHAL LO; BLOOM SR; POLAK JM. (1985). LOCALIZATION OF GLUCAGON-LIKE PEPTIDE (GLP) IMMUNOREACTANTS IN HUMAN GUT AND PANCREAS USING LIGHT AND ELECTRON-MICROSCOPIC IMMUNOCYTOCHEMISTRY. J HISTOCHEM CYTOCHEM. 33:1080-1086.
• ALLEN JM; POLAK JM; RODRIGO J; DARCY K; BLOOM SR. (1985). LOCALIZATION OF NEUROPEPTIDE-Y IN NERVES OF THE RAT CARDIOVASCULAR-SYSTEM AND THE EFFECT OF 6-HYDROXYDOPAMINE. CARDIOVASC RES. 19:570-577.
• KRAENZLIN ME; CHNG JLC; WOOD SM; CARR DH; BLOOM SR. (1985). LONG-TERM TREATMENT OF A VIPOMA WITH SOMATOSTATIN ANALOG RESULTING IN REMISSION OF SYMPTOMS AND POSSIBLE SHRINKAGE OF METASTASES. GASTROENTEROLOGY. 88:185-187.
• CHNG LJC; SANDLER LM; KRAENZLIN ME; BURRIN JM; JOPLIN GF; BLOOM SR. (1985). LONG-TERM TREATMENT OF ACROMEGALY WITH A LONG-ACTING ANALOG OF SOMATOSTATIN. BRIT MED J. 290:284-285.
• SIKRI KL; VARNDELL IM; HAMID QA; WILSON BS; KAMEYA T; PONDER BAJ; LLOYD RV; BLOOM SR; et alPOLAK JM. (1985). MEDULLARY CARCINOMA OF THE THYROID - AN IMMUNOCYTOCHEMICAL AND HISTOCHEMICAL-STUDY OF 25 CASES USING 8 SEPARATE MARKERS. CANCER. 56:2481-2491.
• UTTENTHAL LO; GHIGLIONE M; GEORGE SK; BISHOP AE; POLAK JM; BLOOM SR. (1985). MOLECULAR-FORMS OF GLUCAGON-LIKE PEPTIDE-1 IN HUMAN-PANCREAS AND GLUCAGONOMAS. J CLIN ENDOCR METAB. 61:472-479.
• YIANGOU Y; CHRISTOFIDES ND; BLANK MA; YANAIHARA N; TATEMOTO K; BISHOP AE; POLAK JM; BLOOM SR. (1985). MOLECULAR-FORMS OF PEPTIDE HISTIDINE ISOLEUCINE-LIKE IMMUNOREACTIVITY IN THE GASTROINTESTINAL-TRACT - NONEQUIMOLAR LEVELS OF PEPTIDE HISTIDINE ISOLEUCINE AND VASOACTIVE INTESTINAL PEPTIDE IN THE STOMACH EXPLAINED BY THE PRESENCE OF A BIG PEPTIDE HISTIDINE ISOLEUCINE-LIKE MOLECULEM. GASTROENTEROLOGY. 89:516-524.
• RENNIE JA; CHRISTOFIDES NH; BLOOM SR. (1985). MOTILIN - AN INHIBITOR OF COLONIC MOTILITY IN POSTOPERATIVE ILEUS. BRIT J SURG. 72:S126-S127.
• ALLEN JM; HOYLE NR; YEATS JC; GHATEI MA; THOMAS DGT; BLOOM SR. (1985). NEUROPEPTIDES IN NEUROLOGICAL TUMORS. J NEURO-ONCOL. 3:197-202.
• ALLEN JM; RAINE AEG; LEDINGHAM JGG; BLOOM SR. (1985). NEUROPEPTIDE-Y - A NOVEL RENAL PEPTIDE WITH VASOCONSTRICTOR AND NATRIURETIC ACTIVITY. CLIN SCI. 68:373-377.
• OSBORNE NN; PATEL S; TERENGHI G; ALLEN JM; POLAK JM; BLOOM SR. (1985). NEUROPEPTIDE-Y (NPY)-LIKE IMMUNOREACTIVE AMACRINE CELLS IN RETINAS OF FROG AND GOLDFISH. CELL TISSUE RES. 241:651-656.
• SCHON F; ALLEN JM; YEATS JC; ALLEN YS; BALLESTA J; POLAK JM; KELLY JS; BLOOM SR. (1985). NEUROPEPTIDE-Y INNERVATION OF THE RODENT PINEAL-GLAND AND CEREBRAL BLOOD-VESSELS. NEUROSCI LETT. 57:65-71.
• POLAK JM; BLOOM SR. (1985). OCCURRENCE AND DISTRIBUTION OF REGULATORY PEPTIDES IN THE RESPIRATORY-TRACT. RECENT RES CANCER. 99:1-16.
• BLOOM SR; EDWARDS AV. (1985). PANCREATIC NEURO-ENDOCRINE RESPONSES TO BUTYRATE IN CONSCIOUS SHEEP. J PHYSIOL-LONDON. 364:281-288.
• POLAK JM; BLOOM SR. (1985). PATHOLOGY OF PEPTIDE-PRODUCING NEURO-ENDOCRINE TUMORS. BRIT J HOSP MED. 33:78-&.
• HALL GA; PARSONS KR; BRIDGER JC; GHATEI MA; YING YC; BLOOM SR. (1985). PLASMA ENTEROGLUCAGON AND NEUROTENSIN LEVELS IN GNOTOBIOTIC CALVES INFECTED WITH ENTEROPATHOGENIC AND NON-ENTEROPATHOGENIC VIRUSES. RES VET SCI. 38:99-103.
• ADRIAN TE; LONG RG; FUESSL HS; BLOOM SR. (1985). PLASMA PEPTIDE YY (PYY) IN DUMPING SYNDROME. DIGEST DIS SCI. 30:1145-1148.
• SIKRI KL; VARNDELL IM; BLOOM SR; POLAK JM. (1985). PREPROGLUCAGON COMPONENT PEPTIDES IN NORMAL HUMAN-PANCREAS AND IN GLUCAGONOMAS - LOCALIZATION USING ULTRASTRUCTURAL IMMUNOCYTOCHEMISTRY. J PATHOL. 145:A82-A83.
• BACARESEHAMILTON AJ; ADRIAN TE; BLOOM SR. (1985). PREVENTION OF CHOLECYSTOKININ OXIDATION DURING TISSUE EXTRACTION - A MAJOR PROBLEM SOLVED. ANN NY ACAD SCI. 448:571-572.
• TISCHLER AS; LEE YC; PERLMAN RL; COSTOPOULOS D; BLOOM SR. (1985). PRODUCTION OF ECTOPIC VASOACTIVE INTESTINAL PEPTIDE-LIKE IMMUNOREACTIVITY IN NORMAL HUMAN CHROMAFFIN CELL-CULTURES. LIFE SCI. 37:1881-1886.
• LEE YC; ALLEN JM; UTTENTHAL LO; ROBERTS PM; GILL SS; BLOOM SR. (1985). QUANTITATION AND CHARACTERIZATION OF HUMAN-PLASMA NEUROTENSIN-LIKE IMMUNOREACTIVITY IN RESPONSE TO A MEAL. DIGEST DIS SCI. 30:129-133.
• BACARESEHAMILTON AJ; ADRIAN TE; CHOHAN P; BLOOM SR. (1985). RAT IMMUNOREACTIVE CHOLECYSTOKININ (CCK) - CHARACTERIZATION USING 2 CHROMATOGRAPHIC TECHNIQUES. REGUL PEPTIDES. 11:149-158.
• SUZUKI H; CHRISTOFIDES ND; ANAND P; CHRETIEN M; SEIDAH NG; POLAK JM; BLOOM SR. (1985). REGIONAL DISTRIBUTION OF A NOVEL PITUITARY PROTEIN-(7B2) IN THE RAT SPINAL-CORD - EFFECT OF NEONATAL CAPSAICIN TREATMENT AND THORACIC CORD TRANSECTION. NEUROSCI LETT. 55:151-156.
• SABATE MI; STOLARSKY LS; POLAK JM; BLOOM SR; VARNDELL IM; GHATEI MA; EVANS RM; ROSENFELD MG. (1985). REGULATION OF NEURO-ENDOCRINE GENE-EXPRESSION BY ALTERNATIVE RNA PROCESSING - COLOCALIZATION OF CALCITONIN AND CALCITONIN GENE-RELATED PEPTIDE IN THYROID C-CELLS. J BIOL CHEM. 260:2589-2592.
• WOODRUFF PWR; ANDERSON JV; BLOOM SR. (1985). RESPONSE OF PLASMA ATRIAL NATRIURETIC PEPTIDE (ANP) CONCENTRATIONS TO TREATMENT OF CARDIAC-FAILURE IN MAN. J ENDOCRINOL. 107:85-85.
• SANDLER LM; BURRIN JM; CARR DH; JOPLIN GF; BLOOM SR. (1985). SOMATOSTATIN ANALOG IS EFFECTIVE LONG-TERM TREATMENT IN ACROMEGALY. J ENDOCRINOL. 107:76-76.
• TISCHLER AS; DELELLIS RA; PERLMAN RL; ALLEN JM; COSTOPOULOS D; LEE YC; NUNNEMACHER G; WOLFE HJ; et alBLOOM SR. (1985). SPONTANEOUS PROLIFERATIVE LESIONS OF THE ADRENAL-MEDULLA IN AGING LONG-EVANS RATS - COMPARISON TO PC12-CELLS, SMALL GRANULE-CONTAINING CELLS, AND HUMAN ADRENAL-MEDULLARY HYPERPLASIA. LAB INVEST. 53:486-498.
• ANAND KJS; BROWN MJ; BLOOM SR; AYNSLEYGREEN A. (1985). STUDIES ON THE HORMONAL-REGULATION OF FUEL METABOLISM IN THE HUMAN NEWBORN-INFANT UNDERGOING ANESTHESIA AND SURGERY. HORM RES. 22:115-128.
• SCHON F; GHATEI M; ALLEN JM; MULDERRY PK; KELLY JS; BLOOM SR. (1985). THE EFFECT OF SYMPATHECTOMY ON CALCITONIN GENE-RELATED PEPTIDE LEVELS IN THE RAT TRIGEMINOVASCULAR SYSTEM. BRAIN RES. 348:197-200.
• NICHOLL CG; POLAK JM; BLOOM SR. (1985). THE HORMONAL-REGULATION OF FOOD-INTAKE, DIGESTION, AND ABSORPTION. ANNU REV NUTR. 5:213-239.
• BLOOM SR; EDWARDS AV. (1985). THE ROLE OF THE SYMPATHETIC SYSTEM IN THE CONTROL OF INSULIN RELEASE IN RESPONSE TO HYPERGLYCEMIA IN CONSCIOUS CALVES. J PHYSIOL-LONDON. 362:311-317.
• WOOD SM; KRAENZLIN ME; ADRIAN TE; BLOOM SR. (1985). TREATMENT OF PATIENTS WITH PANCREATIC ENDOCRINE TUMORS USING A NEW LONG-ACTING SOMATOSTATIN ANALOG SYMPTOMATIC AND PEPTIDE RESPONSES. GUT. 26:438-444.
• WILLIAMS G; LOFTS F; FUESSL H; BLOOM S. (1985). TREATMENT WITH DANAZOL AND PLASMA-GLUCAGON CONCENTRATION. BRIT MED J. 291:1155-1156.
• HAMID Q; BISHOP AE; BLOOM SR; POLAK JM. (1985). USE OF MULTIPLE MARKERS IN HISTOPATHOLOGICAL DIAGNOSIS OF ENDOCRINE TUMORS. J PATHOL. 145:A83-A83.
• DELAMARTER JF; BUELL GN; KAWASHIMA E; POLAK JM; BLOOM SR. (1985). VASOACTIVE INTESTINAL PEPTIDE - EXPRESSION OF THE PROHORMONE IN BACTERIAL-CELLS. PEPTIDES. 6:95-102.
• MORRISON JFB; ANAND P; BLANK MA; GIBSON SJ; GU J; TERENGHI G; POLAK JM; BLOOM SR. (1985). VIP-CONTAINING NERVES IN THE BLADDER AND SACRAL CORD. PHILOS T ROY SOC B. 308:411-411.
• TERENGHI G; BLANK MA; DIANI AR; BLOOM SR; POLAK JM. (1985). VIP-IMMUNOREACTIVE NERVE CHANGES IN EYE AND URINARY-BLADDER OF DIABETIC CHINESE HAMSTERS. J PATHOL. 145:A102-A103.
• ZACH GA; GYR KE; VONALVENSLEBEN E; MILLS JG; STALDER GA; DUNN SL; BLOOM S. (1984). A DOUBLE-BLIND RANDOMIZED, CONTROLLED-STUDY TO INVESTIGATE THE EFFICACY OF CIMETIDINE GIVEN IN ADDITION TO CONVENTIONAL THERAPY IN THE PREVENTION OF STRESS ULCERATION AND HEMORRHAGE IN PATIENTS WITH ACUTE SPINAL-INJURY. DIGESTION. 29:214-222.
• GIBSON SJ; BLOOM SR; POLAK JM. (1984). A NOVEL SUBSTANCE-P PATHWAY LINKING THE DORSAL AND VENTRAL HORN IN THE UPPER LUMBAR SEGMENTS OF THE RAT SPINAL-CORD. BRAIN RES. 301:243-251.
• SOLT J; KADAS I; POLAK JM; NEMETH A; BLOOM SR; RAUTH J; HORVATH L. (1984). A PANCREATIC-POLYPEPTIDE-PRODUCING TUMOR OF THE STOMACH. CANCER. 54:1101-1104.
• BLOOM SR. (1984). ALIMENTARY-TRACT TUMORS SECRETING REGULATORY PEPTIDES. BRIT J CANCER. 49:380-380.
• BACARESEHAMILTON AJ; ADRIAN TE; BLOOM SR. (1984). ANOMALOUS ELUTION OF CCK-8 FROM GEL CHROMATOGRAPHIC COLUMNS. REGUL PEPTIDES. 9:322-322.
• SUZUKI H; TISCHLER AS; CHRISTOFIDES ND; CHRETIEN M; POLAK JM; BLOOM SR. (1984). APPG SECRETION IN A RAT PHEOCHROMOCYTOMA CELL-LINE (PC12). REGUL PEPTIDES. 9:348-348.
• SUZUKI H; CHRISTOFIDES ND; ANAND P; CHRETIEN M; POLAK JM; BLOOM SR. (1984). APPG-DISTRIBUTION IN RAT SPINAL-CORD - EVIDENCE OF AN APPG-CONTAINING ASCENDING PATHWAY. REGUL PEPTIDES. 9:347-347.
• WILLIAMS G; KERLE D; GRIFFIN S; DUNLOP H; BLOOM SR. (1984). BIODEGRADABLE POLYMER LUTEINIZING-HORMONE RELEASING HORMONE ANALOG FOR PROSTATIC-CANCER - USE OF A NEW PEPTIDE DELIVERY SYSTEM. BRIT MED J. 289:1580-1581.
• SABATE MI; CARPANI M; VARNDELL IM; GHATEI MA; ROSENFELD MG; BLOOM SR; POLAK JM. (1984). CALCITONIN GENE-RELATED PEPTIDE IN NORMAL THYROID AND MEDULLARY CARCINOMA OF THYROID. J PATHOL. 142:A29-A29.
• BLOOM SR; EDWARDS AV. (1984). CHARACTERISTICS OF THE NEUROENDOCRINE RESPONSES TO STIMULATION OF THE SPLANCHNIC NERVES IN BURSTS IN THE CONSCIOUS CALF. J PHYSIOL-LONDON. 346:533-545.
• CHRISTOFIDES ND; YIANGOU Y; TATEMOTO K; BLOOM SR. (1984). CHARACTERIZATION OF PEPTIDE HISTIDINE ISOLEUCINE-LIKE IMMUNOREACTIVITY IN THE RAT, HUMAN, GUINEA-PIG AND CAT GASTROINTESTINAL TRACTS - EVIDENCE OF SPECIES-DIFFERENCES. DIGESTION. 30:165-170.
• SPILLER RC; TROTMAN IF; LEE YC; GHATEI MA; BLOOM SR; MISIEWICZ JJ; SILK DBA. (1984). CHARACTERIZATION OF THE STIMULUS INITIATING THE ILEAL BRAKE IN MAN. GUT. 25:A545-A545.
• HESHKA S; BLOOM S; NAUSSKAROL C; NYMAN A; PORIKOS K; KRAL J. (1984). CHLOROCITRATE AFFECTS BODY-WEIGHT INDEPENDENT OF CALORIC-INTAKE IN MAN. PHARMACOL BIOCHEM BE. 20:985-985.
• CHNG JLC; POLAK JM; BLOOM SR. (1984). CLINICAL AND PATHOLOGICAL MANIFESTATIONS OF PANCREATIC ENDOCRINE TUMORS. FRONT HORM RES. 12:136-147.
• MINTH CD; BLOOM SR; POLAK JM; DIXON JE. (1984). CLONING, CHARACTERIZATION, AND DNA-SEQUENCE OF A HUMAN CDNA-ENCODING NEUROPEPTIDE TYROSINE. P NATL ACAD SCI-BIOL. 81:4577-4581.
• KERLE D; WARE H; SMITH CB; YEO T; ALLEN J; BLOOM SR; WILLIAMS G. (1984). COMBINED KETOCONAZOLE AND LHRH PRODUCING OBJECTIVE RESPONSES IN PATIENTS WITH PROSTATIC-CANCER WHO HAVE FAILED CONVENTIONAL TREATMENT. J STEROID BIOCHEM. 20:1395-1395.
• MCGREGOR GP; BISHOP AE; BLANK MA; CHRISTOFIDES ND; YIANGOU Y; POLAK JM; BLOOM SR. (1984). COMPARATIVE DISTRIBUTION OF VASOACTIVE INTESTINAL POLYPEPTIDE (VIP), SUBSTANCE-P AND SUBSTANCE-PHI IN THE ENTERIC SPHINCTERS OF THE CAT. EXPERIENTIA. 40:469-471.
• ANDERSSON PO; BLOOM SR; MATTIASSON A; UVELIUS B. (1984). DECREASE IN BLADDER VASCULAR-RESISTANCE IN RESPONSE TO FILLING IN CAT URINARY-BLADDER. J PHYSIOL-LONDON. 346:P108-P108.
• GU J; LAZARIDES M; PRYOR JP; BLANK MA; POLAK JM; MORGAN R; MARANGOS PJ; BLOOM SR. (1984). DECREASE OF VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) IN THE PENISES FROM IMPOTENT MEN. LANCET. 2:315-318.
• POLAK JM; GU J; MORGAN R; PRYOR JP; MARANGOS PJ; BLANK MA; BLOOM SR. (1984). DECREASE OF VIPERGIC NERVES IN DIABETIC IMPOTENCE IN MAN. DIABETOLOGIA. 27:A320-A321.
• GU J; POLAK JM; SU HC; BLANK MA; MORRISON JFB; BLOOM SR. (1984). DEMONSTRATION OF PARACERVICAL GANGLION ORIGIN FOR THE VASOACTIVE INTESTINAL PEPTIDE-CONTAINING NERVES OF THE RAT UTERUS USING RETROGRADE TRACING TECHNIQUES COMBINED WITH IMMUNOCYTOCHEMISTRY AND DENERVATION PROCEDURES. NEUROSCI LETT. 51:377-382.
• BACARESEHAMILTON AJ; ADRIAN TE; BLOOM SR. (1984). DISTRIBUTION AND HETEROGENEITY OF IMMUNOREACTIVE CHOLECYSTOKININ (CCK) IN THE MUCOSA OF THE PORCINE GASTROINTESTINAL-TRACT. REGUL PEPTIDES. 9:289-298.
• CHRISTOFIDES ND; STEPHANOU A; SUZUKI H; YIANGOU Y; BLOOM SR. (1984). DISTRIBUTION OF IMMUNOREACTIVE GROWTH HORMONE-RELEASING HORMONE IN THE HUMAN-BRAIN AND INTESTINE AND ITS PRODUCTION BY TUMORS. J CLIN ENDOCR METAB. 59:747-751.
• FERRI GL; MARANGOS PJ; BLOOM SR; POLAK JM. (1984). DISTRIBUTION OF NEURON-SPECIFIC ENOLASE IN SEPARATED LAYERS OF THE HUMAN GUT. FRONT HORM RES. 12:78-80.
• CHRISTOFIDES ND; YIANGOU Y; PIPER PJ; GHATEI MA; SHEPPARD MN; TATEMOTO K; POLAK JM; BLOOM SR. (1984). DISTRIBUTION OF PEPTIDE HISTIDINE ISOLEUCINE IN THE MAMMALIAN RESPIRATORY-TRACT AND SOME ASPECTS OF ITS PHARMACOLOGY. ENDOCRINOLOGY. 115:1958-1963.
• POLAK JM; BLOOM SR. (1984). DISTRIBUTION OF REGULATORY PEPTIDE-CONTAINING NERVES. FRONT HORM RES. 12:95-107.
• ROBERT A; BLOOM SR. (1984). EFFECT OF 16,16-DIMETHYL PROSTAGLANDIN-E2 ON GUT PEPTIDE LEVELS OF PLASMA, STOMACH, INTESTINE AND PANCREAS. GASTROENTEROLOGY. 86:1220-1220.
• NICHOLSON SA; ADRIAN TE; GILLHAM B; JONES MT; BLOOM SR. (1984). EFFECT OF HYPOTHALAMIC NEUROPEPTIDES ON CORTICOTROPIN RELEASE FROM QUARTERS OF RAT ANTERIOR-PITUITARY GLAND INVITRO. J ENDOCRINOL. 100:219-226.
• READ NW; MCFARLANE A; KINSMAN RI; BATES TE; BLACKHALL NW; FARRAR GBJ; HALL JC; MOSS G; et alMORRIS AP; ONEILL B; WELCH I; LEE Y; BLOOM SR. (1984). EFFECT OF INFUSION OF NUTRIENT SOLUTIONS INTO THE ILEUM ON GASTROINTESTINAL TRANSIT AND PLASMA-LEVELS OF NEUROTENSIN AND ENTEROGLUCAGON. GASTROENTEROLOGY. 86:274-280.
• NAMBA M; GHATEI MA; ADRIAN TE; BACARESEHAMILTON AJ; MULDERRY PK; BLOOM SR. (1984). EFFECT OF NEUROMEDIN-B ON GUT HORMONE-SECRETION IN THE RAT. BIOMED RES-TOKYO. 5:229-233.
• MORIARTY KJ; HEGARTY JE; TATEMOTO K; MUTT V; CHRISTOFIDES ND; BLOOM SR; WOOD JR. (1984). EFFECT OF PEPTIDE HISTIDINE ISOLEUCINE ON WATER AND ELECTROLYTE TRANSPORT IN THE HUMAN JEJUNUM. GUT. 25:624-628.
• MCGREGOR GP; GIBSON SJ; SABATE IM; BLANK MA; CHRISTOFIDES ND; WALL PD; POLAK JM; BLOOM SR. (1984). EFFECT OF PERIPHERAL-NERVE SECTION AND NERVE CRUSH ON SPINAL-CORD NEUROPEPTIDES IN THE RAT - INCREASED VIP AND PHI IN THE DORSAL HORN. NEUROSCIENCE. 13:207-216.
• ALLEN JM; ADRIAN TE; WEBSTER J; HOWE A; BLOOM SR. (1984). EFFECT OF SINGLE DOSE OF OMEPRAZOLE ON THE GASTROINTESTINAL PEPTIDE RESPONSE TO FOOD. HEPATO-GASTROENTEROL. 31:44-46.
• BLOOM SR; EDWARDS AV; GHATEI MA. (1984). EFFECTS OF CERTAIN METABOLITES ON PANCREATIC ENDOCRINE RESPONSES TO GASTRIN-RELEASING PEPTIDE IN CONSCIOUS CALVES. J PHYSIOL-LONDON. 346:547-555.
• ALLEN JM; FITZPATRICK ML; YEATS JC; DARCY K; ADRIAN TE; BLOOM SR. (1984). EFFECTS OF PEPTIDE-YY AND NEUROPEPTIDE-Y ON GASTRIC-EMPTYING IN MAN. DIGESTION. 30:255-262.
• DIXSON AF; KENDRICK KM; BLANK MA; BLOOM SR. (1984). EFFECTS OF TACTILE AND ELECTRICAL STIMULI UPON RELEASE OF VASOACTIVE INTESTINAL POLYPEPTIDE IN THE MAMMALIAN PENIS. J ENDOCRINOL. 100:249-252.
• ANAND P; BLANK MA; THOMAS PK; BLOOM SR. (1984). ELEVATED VASOACTIVE INTESTINAL POLYPEPTIDE CONTENT OF THE SCIATIC-NERVE IN DIABETIC RATS AND INCREASED VIP ACCUMULATION AFTER NERVE TRANSECTION. DIABETOLOGIA. 27:A252-A252.
• ALLEN JM; FERRIER IN; ROBERTS GW; CROSS AJ; ADRIAN TE; CROW TJ; BLOOM SR. (1984). ELEVATION OF NEUROPEPTIDE-Y (NPY) IN SUBSTANTIA INNOMINATA IN ALZHEIMERS TYPE DEMENTIA. J NEUROL SCI. 64:325-331.
• SAGOR GR; GHATEI MA; ALMUKHTAR MYT; WRIGHT NA; BLOOM SR. (1984). ENTEROGLUCAGON AND INTESTINAL ADAPTATION AFTER COLECTOMY. BRIT J SURG. 71:994-994.
• TISCHLER AS; LEE YC; PERLMAN RL; JUMBLATT JE; BLOOM SR. (1984). ENVIRONMENTAL MODULATION OF NEUROENDOCRINE FUNCTION IN HUMAN PHEOCHROMOCYTOMA-CELL CULTURES. LAB INVEST. 50:A60-A60.
• KERLE D; WILLIAMS G; WARE H; DOBLE A; ALLEN J; BLOOM SR. (1984). EXPERIENCE WITH AN LHRH ANALOG IN THE MANAGEMENT OF RELAPSED PROGRESSIVE PROSTATIC-CANCER. BRIT J UROL. 56:495-498.
• KERLE D; WILLIAMS G; WARE H; BLOOM SR. (1984). FAILURE OF LONG-TERM LUTEINIZING-HORMONE RELEASING HORMONE-TREATMENT FOR PROSTATIC-CANCER TO SUPPRESS SERUM LUTEINIZING-HORMONE AND TESTOSTERONE. BRIT MED J. 289:468-469.
• SPILLER RC; LEE YC; EDGE C; RALPHS DNL; BLOOM SR; STEWART JS; SILK DBA. (1984). FUNCTIONAL-SIGNIFICANCE OF THE ILEAL BRAKE IN CELIAC-DISEASE. GUT. 25:A545-A545.
• GHIGLIONE M; UTTENTHAL LO; GEORGE SK; BLOOM SR. (1984). GLUCAGON-LIKE PEPTIDE-1 HAS NO GLUCAGON-LIKE EFFECT ON PLASMA-GLUCOSE AND INSULIN. DIABETOLOGIA. 27:A278-A279.
• TOMKINS AM; PATEL H; BLOOM SR. (1984). GUT HORMONES IN MALNOURISHED CHILDREN WITH PROTRACTED DIARRHEA. P NUTR SOC. 43:A83-A83.
• ANDERSSON PO; BLOOM SR; MELLANDER S. (1984). HEMODYNAMICS OF PELVIC NERVE INDUCED PENILE ERECTION IN THE DOG - POSSIBLE MEDIATION BY VASOACTIVE INTESTINAL POLYPEPTIDE. J PHYSIOL-LONDON. 350:209-224.
• MELLANDER S; ANDERSSON PO; BLOOM SR. (1984). HEMODYNAMICS OF PENILE ERECTION - ROLE OF VIP-ERGIC AND CHOLINERGIC NEUROTRANSMITTER MECHANISMS. ACTA PHYSIOL SCAND. 120:A17-A17.
• GU J; POLAK JM; ALLEN JM; HUANG WM; SHEPPARD MN; TATEMOTO K; BLOOM SR. (1984). HIGH-CONCENTRATIONS OF A NOVEL PEPTIDE, NEUROPEPTIDE-Y, IN THE INNERVATION OF MOUSE AND RAT-HEART. J HISTOCHEM CYTOCHEM. 32:467-472.
• GHIGLIONE M; UTTENTHAL LO; GEORGE SK; BLOOM SR. (1984). HOW GLUCAGON-LIKE IS GLUCAGON-LIKE PEPTIDE-1. DIABETOLOGIA. 27:599-600.
• BACARESEHAMILTON AJ; ADRIAN TE; BLOOM SR. (1984). HUMAN AND PORCINE IMMUNOREACTIVE GASTRIC-INHIBITORY POLYPEPTIDES (IR-GIP) ARE NOT IDENTICAL. FEBS LETT. 168:125-128.
• VARNDELL IM; SIKRI KL; BLOOM SR; POLAK JM. (1984). HUMAN PREPROGLUCAGON COMPONENT PEPTIDES ARE TOPOGRAPHICALLY SEGREGATED WITHIN THE PANCREATIC ALPHA-GRANULE. REGUL PEPTIDES. 9:352-352.
• SHEPPARD MN; CORRIN B; BENNETT MH; MARANGOS PJ; BLOOM SR; POLAK JM. (1984). IMMUNOCYTOCHEMICAL LOCALIZATION OF NEURON SPECIFIC ENOLASE IN SMALL CELL CARCINOMAS AND CARCINOID-TUMORS OF THE LUNG. HISTOPATHOLOGY. 8:171-181.
• FERRI GL; ALIRACHEDI A; TATEMOTO K; BLOOM SR; POLAK JM. (1984). IMMUNOCYTOCHEMICAL LOCALIZATION OF NEUROPEPTIDE Y-LIKE IMMUNOREACTIVITY IN EXTRINSIC NORADRENERGIC AND INTRINSIC GUT NEURONS. FRONT HORM RES. 12:81-84.
• FERRI GL; ALIRACHEDI A; ALLEN JA; TATEMOTO K; VEZZADINI P; LABO G; BLOOM SR; POLAK JM. (1984). IMMUNOCYTOCHEMICAL LOCALIZATION OF NEUROPEPTIDE-Y (NPY)-IMMUNOREACTIVITY IN EXTRINSIC NORADRENERGIC AND INTRINSIC NEURONS OF THE ENTERIC NERVOUS-SYSTEM. ITAL J GASTROENTEROL. 16:71-71.
• RICHARDS NT; WOOD SM; CHRISTOFIDES ND; BHUTTACHARJI SC; BLOOM SR. (1984). IMPAIRED GROWTH-HORMONE RESPONSE TO HUMAN PANCREATIC GROWTH-HORMONE RELEASING-FACTOR [GRF(1-44)] IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES. DIABETOLOGIA. 27:529-534.
• FERRI GL; MARANGOS PJ; BLOOM SR; VEZZADINI P; LABO G; POLAK JM. (1984). INTRAMURAL DISTRIBUTION OF NEURON-SPECIFIC ENOLASE (NSE) IN THE HUMAN GASTROINTESTINAL-TRACT. ITAL J GASTROENTEROL. 16:72-73.
• SAVAGE AP; MATTHEWS JL; COOKE T; BLOOM SR. (1984). IS A CIRCULATING FACTOR RESPONSIBLE FOR THE PROMOTION OF INTESTINAL CARCINOGENESIS AFTER JEJUNAL RESECTION IN THE RAT. GUT. 25:1191-1192.
• POLAK JM; BLOOM SR. (1984). LOCALIZATION AND MEASUREMENT OF VIP IN THE GENITOURINARY SYSTEM OF MAN AND ANIMALS. PEPTIDES. 5:225-230.
• WILLIAMS G; KERLE D; WARE H; ALLEN J; BLOOM SR. (1984). LONG-TERM EXPERIENCE OF LHRH ANALOG ICI-118630 IN ADVANCED PROSTATIC-CANCER. J STEROID BIOCHEM. 20:1412-1412.
• ANAND P; MCGREGOR GP; BLANK MA; BLOOM SR. (1984). LOSS OF AXONAL FLOW OF SUBSTANCE-P BUT NOT VIP IN RAT SCIATIC-NERVES AFTER INJURY. REGUL PEPTIDES. 9:321-321.
• BLOOM SR; EDWARDS AV; GHATEI MA. (1984). NEUROENDOCRINE RESPONSES TO STIMULATION OF THE SPLANCHNIC NERVES IN BURSTS IN THE CONSCIOUS ADRENALECTOMIZED CALF. J PHYSIOL-LONDON. 346:519-531.
• SHEPPARD MN; MARANGOS PJ; BLOOM SR; POLAK JM. (1984). NEURON SPECIFIC ENOLASE - A MARKER FOR THE EARLY DEVELOPMENT OF NERVES AND ENDOCRINE-CELLS IN THE HUMAN-LUNG. LIFE SCI. 34:265-271.
• SHEPPARD MN; POLAK JM; ALLEN JM; BLOOM SR. (1984). NEUROPEPTIDE TYROSINE (NPY) - A NEWLY DISCOVERED PEPTIDE IS PRESENT IN THE MAMMALIAN RESPIRATORY-TRACT. THORAX. 39:326-330.
• VARNDELL IM; POLAK JM; ALLEN JM; TERENGHI G; BLOOM SR. (1984). NEUROPEPTIDE TYROSINE (NPY) IMMUNOREACTIVITY IN NOREPINEPHRINE-CONTAINING CELLS AND NERVES OF THE MAMMALIAN ADRENAL-GLAND. ENDOCRINOLOGY. 114:1460-1462.
• POLAK JM; BLOOM SR. (1984). NEUROPEPTIDE TYROSINE (NPY) IN THE PERIPHERAL AUTONOMIC NERVOUS-SYSTEM. J ANAT. 138:567-567.
• ALIRACHEDI A; ALLEN YS; ALLEN JM; BLOOM SR; POLAK JM. (1984). NEUROPEPTIDE Y IN NEUROHYPOPHYSIS AND MEDIAN-EMINENCE - IMMUNOCYTOCHEMICAL AND BIOCHEMICAL-EVIDENCE FOR ITS PRESENCE AND ORIGIN IN THESE STRUCTURES. J PATHOL. 143:A300-A300.
• ANAND P; BLOOM SR. (1984). NEUROPEPTIDES ARE SELECTIVE MARKERS OF SPINAL-CORD AUTONOMIC PATHWAYS. TRENDS NEUROSCI. 7:267-268.
• ALLEN JM; GIBSON SJ; ADRIAN TE; POLAK JM; BLOOM SR. (1984). NEUROPEPTIDE-Y IN HUMAN SPINAL-CORD. BRAIN RES. 308:145-148.
• ALLEN JM; GU J; ADRIAN TE; POLAK JM; BLOOM SR. (1984). NEUROPEPTIDE-Y IN THE GUINEA-PIG BILIARY-TRACT. EXPERIENTIA. 40:765-767.
• ALLEN YS; ROBERTS GW; BLOOM SR; CROW TJ; POLAK JM. (1984). NEUROPEPTIDE-Y IN THE STRIA TERMINALIS - EVIDENCE FOR AN AMYGDALOFUGAL PROJECTION. BRAIN RES. 321:357-362.
• WOOD JR; MELIA WM; WOOD SM; WILKINSON ML; LEE YC; PORTMANN B; BLOOM SR; WILLIAMS R. (1984). NEUROTENSIN AND HEPATOCELLULAR-CARCINOMA. LANCET. 1:687-687.
• COLLIER NA; WEINBREN K; BLOOM SR; LEE YC; HODGSON HJF; BLUMGART LH. (1984). NEUROTENSIN SECRETION BY FIBROLAMELLAR CARCINOMA OF THE LIVER. LANCET. 1:538-540.
• TROTMAN IF; SPILLER RC; LEE YC; BLOOM SR; SILK DBA; MISIEWICZ JJ. (1984). NO PHYSIOLOGICAL-ROLE FOR NEUROTENSIN (NT) IN THE GASTRO-COLIC REFLEX. GASTROENTEROLOGY. 86:1284-1284.
• ALLEN JM; MCGREGOR GP; WOODHAMS PL; POLAK JM; BLOOM SR. (1984). ONTOGENY OF A NOVEL PEPTIDE, NEUROPEPTIDE-Y (NPY) IN RAT-BRAIN. BRAIN RES. 303:197-200.
• SPILLER RC; EDGE C; RALPHS DNL; BLOOM SR; STEWART JS; SILK DBA; LEE YC. (1984). OPERATION OF THE ILEAL BRAKE IN CELIAC-DISEASE. GASTROENTEROLOGY. 86:1264-1264.
• ANAGNOSTIDES AA; COX TM; ADRIAN TE; CHRISTOFIDES ND; MATON PN; BLOOM SR; CHADWICK VS. (1984). PANCREATIC EXOCRINE AND ENDOCRINE RESPONSES IN CHRONIC-PANCREATITIS. AM J GASTROENTEROL. 79:206-212.
• ANAGNOSTIDES AA; CHRISTOFIDES ND; TATEMOTO K; CHADWICK VS; BLOOM SR. (1984). PEPTIDE HISTIDINE ISOLEUCINE - A SECRETAGOGUE IN HUMAN JEJUNUM. GUT. 25:381-385.
• MORIARTY KJ; HEGARTY JE; TATEMOTO K; MUTT V; CHRISTOLIDES ND; BLOOM SR; WOOD JR. (1984). PEPTIDE HISTIDINE ISOLEUCINE (PHI) INHIBITS WATER AND ION ABSORPTION IN THE HUMAN JEJUNUM. GASTROENTEROLOGY. 86:1188-1188.
• ALIRACHEDI A; VARNDELL IM; GAPP DA; ADRIAN TE; VANNOORDEN S; BLOOM SR; POLAK JM. (1984). PEPTIDE TYROSINE (PYY) IS CO-LOCALIZED WITH GLUCAGON-RELATED IMMUNOREACTANTS IN ENDOCRINE-CELLS OF GUT AND PANCREAS. J PATHOL. 143:A298-A298.
• ALIRACHEDI A; VARNDELL IM; ADRIAN TE; GAPP DA; VANNOORDEN S; BLOOM SR; POLAK JM. (1984). PEPTIDE YY (PYY) IMMUNOREACTIVITY IS CO-STORED WITH GLUCAGON-RELATED IMMUNOREACTANTS IN ENDOCRINE-CELLS OF THE GUT AND PANCREAS. HISTOCHEMISTRY. 80:487-491.
• GU J; BLANK MA; HUANG WM; ISLAM KN; MCGREGOR GP; CHRISTOFIDES N; ALLEN JM; BLOOM SR; et alPOLAK JM. (1984). PEPTIDE-CONTAINING NERVES IN HUMAN URINARY-BLADDER. UROLOGY. 24:353-357.
• HUANG WM; GU J; BLANK MA; ALLEN JM; BLOOM SR; POLAK JM. (1984). PEPTIDE-IMMUNOREACTIVE NERVES IN THE MAMMALIAN FEMALE GENITAL-TRACT. HISTOCHEM J. 16:1297-1310.
• VARNDELL IM; TERENGHI G; BLOOM SR; POLAK JM. (1984). PEPTIDES IN THE ADRENAL-MEDULLA AND CAROTID-BODY. J ANAT. 138:592-592.
• ANAND P; GIBSON SJ; YIANGOU Y; CHRISTOFIDES ND; POLAK JM; BLOOM SR. (1984). PHI-LIKE IMMUNOREACTIVITY CO-LOCATES WITH THE VIP-CONTAINING SYSTEM IN HUMAN LUMBOSACRAL SPINAL-CORD. NEUROSCI LETT. 46:191-196.
• YIANGOU Y; CHRISTOFIDES ND; GU J; PIPER PJ; POLAK JM; BLOOM SR. (1984). PHI-LIKE IMMUNOREACTIVITY IN THE GALLBLADDER AND INVITRO EFFECT OF PORCINE PHI ON SMOOTH-MUSCLE OF THE GALLBLADDER. FEBS LETT. 175:307-312.
• BACARESEHAMILTON AJ; ADRIAN TE; BLOOM SR. (1984). PLASMA CHOLECYSTOKININ RESPONSE TO FOOD IN HEALTHY-SUBJECTS. REGUL PEPTIDES. 9:322-322.
• SAVAGE AP; GORNACZ GE; ADRIAN TE; GOODLAD RA; WRIGHT NA; BLOOM SR. (1984). PLASMA PYY IS RAISED AFTER SMALL BOWEL RESECTION IN THE RAT BUT DOES NOT MEDIATE THE TROPHIC RESPONSE. GUT. 25:1156-1156.
• UTTENTHAL LO; GHIGLIONE M; GEORGE SK; BLOOM SR. (1984). POST TRANSLATIONAL PROCESSING OF PROGLUCAGON IN MAN. REGUL PEPTIDES. 9:351-351.
• ALLEN JM; TODD N; CROCKARD HA; SCHON F; YEATS JC; BLOOM SR. (1984). PRESENCE OF NEUROPEPTIDE-Y IN HUMAN CIRCLE OF WILLIS AND ITS POSSIBLE ROLE IN CEREBRAL VASOSPASM. LANCET. 2:550-552.
• TISCHLER AS; LEE YC; PERLMAN RL; COSTOPOULOS D; SLAYTON VW; BLOOM SR. (1984). PRODUCTION OF ECTOPIC VASOACTIVE INTESTINAL PEPTIDE-LIKE AND NEUROTENSIN-LIKE IMMUNOREACTIVITY IN HUMAN PHEOCHROMOCYTOMA CELL-CULTURES. J NEUROSCI. 4:1398-1404.
• ADRIAN TE; SAVAGE AP; BACARESEHAMILTON AJ; WOLFE KD; BESTERMAN HS; BLOOM SR. (1984). PYY, A NEW COLONIC HORMONE - CHANGES IN GASTROINTESTINAL-DISEASES. GUT. 25:1160-1160.
• UTTENTHAL LO; GHIGLIONE M; GEORGE SK; BLOOM SR. (1984). RADIOIMMUNOASSAY FOR GLUCAGON-LIKE-PEPTIDE-1 - PRESENCE IN HUMAN-PANCREAS AND GLUCAGONOMAS. DIABETOLOGIA. 27:A341-A341.
• ALLEN JM; YEATS JC; ADRIAN TE; BLOOM SR. (1984). RADIOIMMUNOASSAY OF NEUROPEPTIDE-Y. REGUL PEPTIDES. 8:61-70.
• GHATEI MA; BLOOM SR; LANGEVIN H; MCGREGOR GP; LEE YC; ADRIAN TE; OSHAUGHNESSY DJ; BLANK MA; et alUTTENTHAL LO. (1984). REGIONAL DISTRIBUTION OF BOMBESIN AND 7 OTHER REGULATORY PEPTIDES IN THE HUMAN-BRAIN. BRAIN RES. 293:101-109.
• POLAK JM; BLOOM SR. (1984). REGULATORY PEPTIDES - THE DISTRIBUTION OF 2 NEWLY DISCOVERED PEPTIDES - PHI AND NPY. PEPTIDES. 5:79-89.
• CROSS AJ; CROW TJ; FERRIER IN; JOHNSON JA; BLOOM SR; CORSELLIS JAN. (1984). SEROTONIN RECEPTOR CHANGES IN DEMENTIA OF THE ALZHEIMER TYPE. J NEUROCHEM. 43:1574-1581.
• EDWARDS AV; ANDERSSON PO; JARHULT J; BLOOM SR. (1984). STUDIES OF THE IMPORTANCE OF THE PATTERN OF AUTONOMIC STIMULATION IN RELATION TO ALIMENTARY EFFECTORS. Q J EXP PHYSIOL CMS. 69:607-614.
• DIXSON AF; KENDRICKS KM; BLANK M; BLOOM SR. (1984). TACTILE STIMULI CAUSE VIP RELEASE IN THE MAMMALIAN PENIS. GEN COMP ENDOCR. 53:465-466.
• GIBSON SJ; POLAK JM; ALLEN JM; ADRIAN TE; KELLY JS; BLOOM SR. (1984). THE DISTRIBUTION AND ORIGIN OF A NOVEL BRAIN PEPTIDE, NEUROPEPTIDE-Y, IN THE SPINAL-CORD OF SEVERAL MAMMALS. J COMP NEUROL. 227:78-91.
• GIBSON SJ; POLAK JM; ANAND P; BLANK MA; MORRISON JFB; KELLY JS; BLOOM SR. (1984). THE DISTRIBUTION AND ORIGIN OF VIP IN THE SPINAL-CORD OF 6 MAMMALIAN-SPECIES. PEPTIDES. 5:201-207.
• BISHOP AE; POLAK JM; YIANGOU Y; CHRISTOFIDES ND; BLOOM SR. (1984). THE DISTRIBUTIONS OF PHI AND VIP IN PORCINE GUT AND THEIR CO-LOCALIZATION TO A PROPORTION OF INTRINSIC GANGLION-CELLS. PEPTIDES. 5:255-259.
• ALLEN JM; WILLIAMS G; OSHEA JP; SMITH C; YEO T; KERLE D; BLOOM SR. (1984). THE EFFECT OF PREVIOUS ENDOCRINE THERAPY ON RESPONSES TO A SINGLE DOSE OF AN LHRH ANALOG. UROL RES. 12:249-251.
• KOOPMANS HS; FERRI GL; SARSON DL; POLAK JM; BLOOM SR. (1984). THE EFFECTS OF ILEAL TRANSPOSITION AND JEJUNOILEAL BYPASS ON FOOD-INTAKE AND GI HORMONE LEVELS IN RATS. PHYSIOL BEHAV. 33:601-609.
• SPILLER RC; TROTMAN IF; LEE YC; GHATEI MA; BLOOM SR; MISIEWICZ JJ; SILK DBA. (1984). THE ILEAL BRAKE - DEFINITION OF THE IMPORTANCE OF INTRALUMINAL LIPOLYSIS. GASTROENTEROLOGY. 86:1264-1264.
• SPILLER RC; TROTMAN IF; HIGGINS BE; GHATEI MA; GRIMBLE GK; LEE YC; BLOOM SR; MISIEWICZ JJ; et alSILK DBA. (1984). THE ILEAL BRAKE - INHIBITION OF JEJUNAL MOTILITY AFTER ILEAL FAT PERFUSION IN MAN. GUT. 25:365-374.
• FRIER BM; CORRALL RJM; ADRIAN TE; BLOOM SR; STRACHAN RK; HEADING RC. (1984). THE INFLUENCE OF ADRENERGIC DENERVATION ON THE RESPONSE TO FEEDING OF THE GASTROENTEROPANCREATIC SYSTEM IN MAN. CLIN ENDOCRINOL. 21:639-647.
• JARHULT J; GRAFFNER H; BLOOM SR. (1984). THE INFLUENCE OF MODIFIED SHAM FEEDING ON PLASMA POLYPEPTIDE (CCK, GASTRIN, MOTILIN, NEUROTENSIN AND SOMATOSTATIN) CONCENTRATIONS IN DUODENAL-ULCER DISEASE. ACTA CHIR SCAND. 150:141-144.
• AYNSLEYGREEN A; SOLTESZ G; JENKINS PA; MACKENZIE IZ; ADRIAN IE; BLOOM SR. (1984). THE METABOLIC AND ENDOCRINE MILIEU OF THE HUMAN-FETUS AT 16-20 WEEKS GESTATION. PEDIATR RES. 18:94-94.
• ANAND KJS; BROWN M; BLOOM SR; AYNSLEYGREEN A. (1984). THE METABOLIC AND ENDOCRINE RESPONSES OF NEONATES TO SURGICAL STRESS. PEDIATR RES. 18:1207-1207.
• LEE YC; ALLEN JM; UTTENTHAL LO; WALKER MC; SHEMILT J; GILL SS; BLOOM SR. (1984). THE METABOLISM OF INTRAVENOUSLY INFUSED NEUROTENSIN IN MAN AND ITS CHROMATOGRAPHIC CHARACTERIZATION IN HUMAN-PLASMA. J CLIN ENDOCR METAB. 59:45-50.
• BALLESTA J; POLAK JM; ALLEN JM; BLOOM SR. (1984). THE NERVES OF THE JUXTAGLOMERULAR APPARATUS OF MAN AND OTHER MAMMALS CONTAIN THE POTENT PEPTIDE NPY. HISTOCHEMISTRY. 80:483-485.
• BISHOP AE; HODSON NP; MAJOR JH; PROBERT L; YEATS J; EDWARDS GB; WRIGHT JA; BLOOM SR; et alPOLAK JM. (1984). THE REGULATORY PEPTIDE SYSTEM OF THE LARGE BOWEL IN EQUINE GRASS SICKNESS. EXPERIENTIA. 40:801-806.
• KATAGIRI T; SU HC; GIBSON SJ; BLOOM SR; POLAK JM. (1984). THE TOPOGRAPHIC DISTRIBUTION OF PUDENDAL MOTOR NUCLEI AND THEIR PEPTIDERGIC CONNECTIONS IN THE RAT USING RETROGRADE UPTAKE COMBINED WITH IMMUNOCYTOCHEMISTRY. REGUL PEPTIDES. 9:336-336.
• WILLIAMS G; BLOOM SR. (1984). TREATMENT OF ADVANCED-CARCINOMA OF THE PROSTATE. BRIT MED J. 289:571-572.
• ALLEN JM; RODRIGO J; YEATS JC; SAVAGE AP; POLAK JM; BLOOM SR. (1984). VASCULAR DISTRIBUTION OF NEUROPEPTIDE-Y (NPY) AND EFFECT ON BLOOD-PRESSURE. CLIN EXP HYPERTENS A. 6:1879-1882.
• OMORAIN C; BISHOP AE; MCGREGOR GP; LEVI AJ; BLOOM SR; POLAK JM; PETERS TJ. (1984). VASOACTIVE INTESTINAL PEPTIDE CONCENTRATIONS AND IMMUNOCYTOCHEMICAL STUDIES IN RECTAL BIOPSIES FROM PATIENTS WITH INFLAMMATORY BOWEL-DISEASE. GUT. 25:57-61.
• FERRI GL; BOTTI PL; REBECCHI L; BILIOTTI G; LELI G; BLOOM SR; TONELLI L; LABO G; et alPOLAK JM. (1984). VASOACTIVE INTESTINAL POLYPEPTIDE-ENKEPHALIN-IMMUNOREACTIVE, SUBSTANCE P-ENKEPHALIN-IMMUNOREACTIVE AND MET-ENKEPHALIN-IMMUNOREACTIVE INNERVATION OF THE HUMAN GASTROINTESTINAL MUCOSA. FRONT HORM RES. 12:74-77.
• DEBUITLEIR M; CHRISTOFIDES N; BLOOM SR; KRIKLER DM. (1984). VERAPAMIL AND CONSTIPATION. BRIT J CLIN PHARMACO. 18:P297-P297.
• BARNES PJ; BLOOM SR; DIXON CMS. (1984). VIP AND ASTHMA. LANCET. 1:112-112.
• FERRI GL; BOTTI P; BILIOTTI G; REBECCHI L; BLOOM SR; TONELLI L; LABO G; POLAK JM. (1984). VIP-ENKEPHALIN-IMMUNOREACTIVE, SUBSTANCE-P-ENKEPHALIN-IMMUNOREACTIVE AND MET-ENKEPHALIN-IMMUNOREACTIVE INNERVATION OF THE HUMAN GASTRODUODENAL MUCOSA AND BRUNNERS GLANDS. GUT. 25:948-952.
• ANAND P; SPRINGALL DR; BLANK MA; CHU T; SELLU D; POLAK JM; BLOOM SR. (1984). VIP-ERGIC INNERVATION OF HUMAN ECCRINE SWEAT GLANDS - STUDIES IN AXILLARY HYPERHIDROSIS. CLIN SCI. 66:P18-P18.
• VARNDELL IM; POLAK JM; SIKRI KL; MINTH CD; BLOOM SR; DIXON JE. (1984). VISUALIZATION OF MESSENGER-RNA DIRECTING PEPTIDE-SYNTHESIS BY INSITU HYBRIDIZATION USING A NOVEL SINGLE-STRANDED CDNA PROBE - POTENTIAL FOR THE INVESTIGATION OF GENE-EXPRESSION AND ENDOCRINE CELL-ACTIVITY. HISTOCHEMISTRY. 81:597-601.
• SHEPPARD MN; CHRISTOFIDES ND; ALLEN JM; TATEMOTO K; BLOOM SR; POLAK JM. (1983). 2 NEWLY DISCOVERED ACTIVE PEPTIDES, PHI AND NPY, ARE FOUND IN THE MAMMALIAN LUNG. J PATHOL. 141:522-523.
• BLOOM SR; LEE YC; LACROUTE JM; ABBASS A; SONDAG D; BAUMANN R; WEILL JP. (1983). 2 PATIENTS WITH PANCREATIC APUDOMAS SECRETING NEUROTENSIN AND VIP. GUT. 24:448-452.
• NICHOLSON SA; ADRIAN TE; BACARESEHAMILTON AJ; GILLHAM B; JONES MT; BLOOM SR. (1983). 24-HOUR VARIATION IN CONTENT AND RELEASE OF HYPOTHALAMIC NEUROPEPTIDES IN THE RAT. REGUL PEPTIDES. 7:385-397.
• BLOOM SR; GU J; ADRIAN TE; ALLEN JM; TATEMOTO K; POLAK JM. (1983). A MAJOR NEW NEURAL SYSTEM IN HUMAN-HEART. Q J MED. 52:546-547.
• GIBSON SJ; ANAND P; MCGREGOR GP; POLAK JM; BLOOM SR. (1983). A RAPID DISSECTION TECHNIQUE FOR IMPROVED RECOVERY OF SUBSTANCE-P IN THE RAT SPINAL-CORD. J PATHOL. 140:173-174.
• ANAND P; GIBSON SJ; MCGREGOR GP; BLANK MA; GHATEI MA; BACARESEHAMILTON AJ; POLAK JM; BLOOM SR. (1983). A VIP-CONTAINING SYSTEM CONCENTRATED IN THE LUMBOSACRAL REGION OF HUMAN SPINAL-CORD. NATURE. 305:143-145.
• WOOD SM; CHNG JLC; ADAMS EF; WEBSTER JD; JOPLIN GF; MASHITER K; BLOOM SR. (1983). ABNORMALITIES OF GROWTH-HORMONE RELEASE IN RESPONSE TO HUMAN PANCREATIC GROWTH-HORMONE RELEASING-FACTOR (GRF (1-44)) IN ACROMEGALY AND HYPOPITUITARISM. BRIT MED J. 286:1687-1691.
• UTTENTHAL LO; UKPONMWAN OO; GHATEI MA; BLOOM SR. (1983). ACUTE AND SHORT-TERM EFFECTS OF INTESTINAL ALPHA-GLUCOSIDASE INHIBITION ON GUT HORMONE RESPONSES IN MAN. GUT. 24:A461-A462.
• ALLEN JM; PENKETH ARL; ADRIAN TE; LEE YC; SARSON DL; HODSON ME; BATTEN JC; BLOOM SR. (1983). ADULT CYSTIC-FIBROSIS - POSTPRANDIAL RESPONSE OF GUT REGULATORY PEPTIDES. GASTROENTEROLOGY. 85:1379-1383.
• ALLEN JM; OSHEA JP; MASHITER K; WILLIAMS G; BLOOM SR. (1983). ADVANCED-CARCINOMA OF THE PROSTATE - TREATMENT WITH A GONADOTROPIN-RELEASING HORMONE AGONIST. BRIT MED J. 286:1607-1609.
• BLOOM SR; CHRISTOFIDES ND; TATEMOTO K; POLAK JM. (1983). ALL VIPOMAS PRODUCE PHI. REGUL PEPTIDES. 6:290-290.
• DRURY MI; CREGAN D; DRURY R; KURTZ AB; BLOOM SR; GERLIN LS. (1983). ANTIBODY-RESPONSES FOLLOWING CHANGE-OVER TO MIXED SPECIES (PORCINE BOVINE) INSULINS. DIABETOLOGIA. 25:151-152.
• DRURY MI; CREGAN D; DRURY RM; KURTZ AB; BLOOM SR; GERLIS LS. (1983). ANTIBODY-RESPONSES FOLLOWING CHANGE-OVER TO MIXED SPECIES (PORCINE BOVINE) INSULINS. IRISH J MED SCI. 152:325-328.
• GHATEI MA; SHEPPARD MN; HENZENLOGMAN S; BLANK MA; POLAK JM; BLOOM SR. (1983). BOMBESIN AND VASOACTIVE INTESTINAL POLYPEPTIDE IN THE DEVELOPING LUNG - MARKED CHANGES IN ACUTE RESPIRATORY-DISTRESS SYNDROME. J CLIN ENDOCR METAB. 57:1226-1232.
• MAJOR J; GHATEI MA; BLOOM SR. (1983). BOMBESIN-LIKE IMMUNOREACTIVITY IN THE PITUITARY-GLAND. EXPERIENTIA. 39:1158-1159.
• ANAND P; MCGREGOR GP; BLOOM SR. (1983). CAPSAICIN PRETREATMENT INHIBITS AXON REFLEX VASODILATATION CAUSED BY SOMATOSTATIN AND VIP IN HUMAN-SKIN. CLIN SCI. 64:P21-P21.
• GOODLAD RA; ALMUKHTAR MYT; GHATEI MA; BLOOM SR; WRIGHT NA. (1983). CELL-PROLIFERATION, PLASMA ENTEROGLUCAGON AND PLASMA GASTRIN-LEVELS IN STARVED AND REFED RATS. VIRCHOWS ARCH B. 43:55-62.
• FERRI GL; KOOPMANS HS; VEZZADINI P; BLOOM SR; POLAK JM. (1983). CHANGES IN THE EXOCRINE AND ENDOCRINE PANCREAS AND IN THE ILEUM AFTER ILEAL-DUODENAL TRANSPOSITION IN THE RAT. ITAL J GASTROENTEROL. 15:219-219.
• ANDERSSON PO; BLOOM SR; JARHULT J. (1983). COLONIC MOTOR AND VASCULAR-RESPONSES TO PELVIC NERVE-STIMULATION AND THEIR RELATION TO LOCAL PEPTIDE RELEASE IN THE CAT. J PHYSIOL-LONDON. 334:293-307.
• ALLEN JM; KERLE DJ; WARE H; DOBLE A; WILLIAMS G; BLOOM SR. (1983). COMBINED TREATMENT WITH KETOCONAZOLE AND LUTEINIZING-HORMONE RELEASING HORMONE ANALOG - A NOVEL-APPROACH TO RESISTANT PROGRESSIVE PROSTATIC-CANCER. BRIT MED J. 287:1766-1766.
• SPILLER RC; TROTMAN IF; SILK DBA; LEE YC; GHATEI MA; BLOOM SR; MISIEWICZ JJ. (1983). CONTROL OF JEJUNAL MOTILITY BY ILEAL CONTENTS AND HORMONES IN MAN. GASTROENTEROLOGY. 84:1319-1319.
• SHEPPARD MN; JOHNSON NF; COLE GA; MARANGOS PJ; BLOOM SR; POLAK JM. (1983). DETECTION OF PULMONARY CELL HYPERPLASIA INDUCED BY ASBESTOS, USING ANTIBODIES TO NEURON SPECIFIC ENOLASE (NSE) AND ELECTRON-MICROSCOPY. IRISH J MED SCI. 152:257-258.
• BLOOM SR; DELAMARTER J; KAWASHIMA E; CHRISTOFIDES ND; BUELL G; POLAK JM. (1983). DIARRHEA IN VIPOMA PATIENTS ASSOCIATED WITH COSECRETION OF A 2ND ACTIVE PEPTIDE (PEPTIDE HISTIDINE ISOLEUCINE) EXPLAINED BY SINGLE CODING GENE. LANCET. 2:1163-1165.
• JENKINS DJA; WOLEVER TMS; TAYLOR RH; KANNAN W; SARSON D; BLOOM SR. (1983). DIETARY CARBOHYDRATE AND 2ND MEAL GLYCEMIC RESPONSE - REPLY. AM J CLIN NUTR. 37:153-154.
• OSHAUGHNESSY DJ; MCGREGOR GP; GHATEI MA; BLANK MA; SPRINGALL DR; GU J; POLAK JM; BLOOM SR. (1983). DISTRIBUTION OF BOMBESIN, SOMATOSTATIN, SUBSTANCE-P AND VASOACTIVE INTESTINAL POLYPEPTIDE IN FELINE AND PORCINE SKIN. LIFE SCI. 32:2827-2836.
• BACARESEHAMILTON AJ; ADRIAN TE; BLOOM SR. (1983). DISTRIBUTION OF CHOLECYSTOKININ OCTAPEPTIDE CCK-8 IN PORCINE SMALL-INTESTINE MEASUREMENT BY SPECIFIC RADIOIMMUNOASSAY. REGUL PEPTIDES. 7:275-275.
• POLAK JM; BLOOM SR. (1983). DISTRIBUTION OF NEWLY DISCOVERED REGULATORY PEPTIDES. BIOMED RES-TOKYO. 4:7-23.
• BLOOM SR; CHRISTOFIDES ND; TATEMOTO K; POLAK JM. (1983). DISTRIBUTION OF PHI IN MAN AND OTHER ANIMALS. REGUL PEPTIDES. 6:289-289.
• ANAND P; GIBSON SJ; BLANK MA; MCGREGOR GP; WEBSTER JD; POLAK JM; BLOOM SR. (1983). DISTRIBUTION OF SOMATOSTATIN, MET-ENKEPHALIN IN AND VIP IN SPINAL CORDS OF 3 SPECIES - EVIDENCE OF A SPECIFIC VIP-ERGIC SYSTEM IN HUMAN SACRAL CORD. CLIN SCI. 64:P21-P21.
• MCDONALD TJ; GHATEI MA; BLOOM SR; ADRIAN TE; MOCHIZUKI T; YANAIHARA C; YANAIHARA N. (1983). DOSE-RESPONSE COMPARISONS OF CANINE PLASMA GASTROENTEROPANCREATIC HORMONE RESPONSES TO BOMBESIN AND THE PORCINE GASTRIN-RELEASING PEPTIDE (GRP). REGUL PEPTIDES. 5:125-137.
• VARNDELL IM; TAPIA FJ; DEMEY J; BLOOM SR; POLAK JM. (1983). DOUBLE IMMUNOGOLD STAINING PROCEDURE FOR THE SIMULTANEOUS ULTRASTRUCTURAL-LOCALIZATION OF REGULATORY PEPTIDE ANTIGENS IN ISLET CELL TUMORS. J PATHOL. 139:500-500.
• ALLEN JM; SARSON DL; ADRIAN TE; WOOD C; THOMPSON GR; BLOOM SR. (1983). EFFECT OF PARTIAL ILEAL BYPASS ON THE GUT HORMONE RESPONSES TO FOOD IN MAN. DIGESTION. 28:191-196.
• ADAMS EF; BLOOM SR; CHNG JLC; JOPLIN GF; MASHITER K; WEBSTER JD; WOOD SM. (1983). EFFECTS OF A HUMAN PANCREATIC GROWTH-HORMONE RELEASING-FACTOR ON GROWTH-HORMONE SECRETION IN MAN. J PHYSIOL-LONDON. 341:P84-P84.
• ANAND P; MCGREGOR GP; CHRISTOFIDES ND; BLANK MA; MORRISON JFB; BLOOM SR. (1983). ELEVATED PHI AND VIP LEVELS AFTER THORACIC TRANSECTION AND AFTER NEONATAL CAPSAICIN TREATMENT IN THE ADULT-RAT LUMBOSACRAL SPINAL-CORD. REGUL PEPTIDES. 6:290-290.
• BLOOM SR; EDWARDS AV; GHATEI MA. (1983). ENDOCRINE RESPONSES TO EXOGENOUS BOMBESIN AND GASTRIN RELEASING PEPTIDES IN CONSCIOUS CALVES. J PHYSIOL-LONDON. 344:37-48.
• TISCHLER AS; LEE YC; PERLMAN RL; COSTOPOULOS D; SLAYTON VW; BLOOM SR. (1983). ENHANCED PRODUCTION OF ECTOPIC VIP-LIKE IMMUNOREACTIVITY IN HUMAN PHEOCHROMOCYTOMA CELL-CULTURES. REGUL PEPTIDES. 6:291-291.
• HARRIS A; GHATEI MA; FERRI GL; BLOOM SR; POLAK JM. (1983). ENTEROGLUCAGON (EG) CELLS IN FASTING AND REFED RATS. J PATHOL. 140:171-171.
• CASSAR J; GHATEI MA; SARSON DL; JOPLIN GF; MASHITER K; BLOOM SR. (1983). ENTEROGLUCAGON AND GIP AFTER ORAL GLUCOSE IN PATIENTS WITH PROLACTINOMA AND ACROMEGALY. CLIN ENDOCRINOL. 18:95-102.
• BISHOP AE; PRESTON DM; MCGREGOR GP; BLOOM SR; LENNARDJONES J; POLAK JM. (1983). ENTEROGLUCAGON IN FAMILIAL POLYPOSIS COLI. J PATHOL. 141:543-543.
• SAGOR GR; GHATEI MA; ALMUKHTAR MYT; WRIGHT NA; BLOOM SR. (1983). EVIDENCE FOR A HUMORAL MECHANISM AFTER SMALL INTESTINAL RESECTION - EXCLUSION OF GASTRIN BUT NOT ENTEROGLUCAGON. GASTROENTEROLOGY. 84:902-906.
• BRUNZELL JD; MILLER NE; ALAUPOVIC P; STHILAIRE RJ; WANG CS; SARSON DL; BLOOM SR; LEWIS B. (1983). FAMILIAL CHYLOMICRONEMIA DUE TO A CIRCULATING INHIBITOR OF LIPOPROTEIN-LIPASE ACTIVITY. J LIPID RES. 24:12-19.
• ALIRACHEDI A; VANNOORDEN S; ALLEN Y; FERRI GL; BLOOM SR; CROW T; POLAK JM. (1983). FMRFAMIDE, A PEPTIDE CHEMICALLY RELATED TO GASTRIN-CHOLECYSTOKININ AND PROOPIOCORTIN FAMILIES CO-EXISTS WITH ACTH IN HUMAN AND MAMMALIAN BRAIN AND PITUITARY. J PATHOL. 139:497-498.
• ALIRACHEDI A; FERRI GL; VARNDELL IM; BLOOM SR; POLAK JM. (1983). FMRFAMIDE, A PEPTIDE CHEMICALLY RELATED TO THE GASTRIN-CHOLECYSTOKININ AND TO THE PROOPIOCORTIN FAMILIES, CO-EXISTS WITH GASTRIN IN HUMAN AND MAMMALIAN G-CELLS. J PATHOL. 139:483-483.
• ANAGNOSTIDES AA; MATON PN; ADRIAN TE; CHRISTOFIDES ND; BLOOM SR; CHADWICK VS. (1983). GASTROINTESTINAL HORMONE RESPONSE TO SHAM FEEDING. CLIN SCI. 65:P56-P56.
• FERRI GL; KOOPMANS HS; GHATEI MA; VEZZADINI P; LABO G; BLOOM SR; POLAK JM. (1983). ILEAL ENTEROGLUCAGON CELLS AFTER ILEAL-DUODENAL TRANSPOSITION IN THE RAT. DIGESTION. 26:10-16.
• ALIRACHEDI A; FERRI GL; VARNDELL IM; VANNOORDEN S; SCHOT LPC; LING N; BLOOM SR; POLAK JM. (1983). IMMUNOCYTOCHEMICAL EVIDENCE FOR THE PRESENCE OF GAMMA-1-MSH-LIKE IMMUNOREACTIVITY IN PITUITARY CORTICOTROPHS AND ACTH-PRODUCING TUMORS. NEUROENDOCRINOLOGY. 37:427-433.
• ROBERTS GW; CROW TJ; BLOOM SR; POLAK JM. (1983). IMMUNOCYTOCHEMICAL LOCALIZATION OF PEPTIDES IN THE HUMAN TEMPORAL-LOBE. J PATHOL. 139:482-483.
• HUANG WM; GU J; LEWIS G; ELDER MG; BLANK M; BLOOM SR; POLAK JM. (1983). IMMUNOCYTOCHEMICAL LOCALIZATION OF REGULATORY PEPTIDES IN THE HUMAN FEMALE GENITALIA. J PATHOL. 141:544-545.
• GIBSON SJ; FITZGERALD M; BLOOM SR; POLAK JM. (1983). IMMUNOCYTOCHEMICAL LOCALIZATION OF SUBSTANCE-P IN THE SPINAL-CORD, DORSAL ROOT-GANGLIA, SCIATIC-NERVE AND ASSOCIATED SKIN OF THE NEONATAL RAT. J PATHOL. 141:541-542.
• SABATE IM; GIBSON SJ; BLOOM SR; POLAK JM. (1983). IMMUNOCYTOCHEMICAL LOCALIZATION OF SUBSTANCE-P, NEUROPEPTIDE Y (NPY), M-ENKEPHALIN (M-ENK) AND VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) IN THE GUINEA-PIG SPINAL-CORD. J PATHOL. 141:540-540.
• FERRI GL; ALIRACHEDI A; BLOOM SR; TATEMOTO K; POLAK JM. (1983). IMMUNOCYTOCHEMICAL LOCALIZATION OF THE NEWLY DISCOVERED NEUROPEPTIDE-Y (NPY) IN EXTRINSIC (NOR-ADRENERGIC) AND INTRINSIC GUT NEURONS. GUT. 24:A489-A489.
• PRESTON DM; ADRIAN TE; LENNARDJONES JE; BLOOM SR. (1983). IMPAIRED GASTRIN-RELEASE IN CHRONIC CONSTIPATION. GUT. 24:A481-A481.
• KURIAN SS; SHEPPARD MN; STANLEY P; COLE P; MACKAY I; BLANK M; BLOOM SR; POLAK JM. (1983). INCREASE IN VIP NERVES IN THE NASAL MUCOSAE OF PATIENTS SUFFERING FROM VASOMOTOR RHINITIS. J PATHOL. 139:468-468.
• FINK RS; ADRIAN TE; MARGOT DH; BLOOM SR. (1983). INCREASED PLASMA PANCREATIC-POLYPEPTIDE IN CHRONIC ALCOHOL-ABUSE. CLIN ENDOCRINOL. 18:417-421.
• ALLEN JM; CHRISTOFIDES ND; GORNACZ G; TATEMOTO K; BARON JH; BLOOM SR. (1983). INFUSION OF A NOVEL PEPTIDE, PHI, IN MAN - PHARMACOKINETICS AND EFFECT ON GASTRIC-SECRETION. EXPERIENTIA. 39:1129-1131.
• VARNDELL IM; HARRIS A; TAPIA FJ; YANAIHARA N; DEMEY J; BLOOM SR; POLAK JM. (1983). INTRACELLULAR TOPOGRAPHY OF IMMUNOREACTIVE GASTRIN DEMONSTRATED USING ELECTRON IMMUNOCYTOCHEMISTRY. EXPERIENTIA. 39:713-717.
• FERRI GL; MARANGOS PJ; BLOOM SR; POLAK JM. (1983). INTRAMURAL DISTRIBUTION OF NEURON SPECIFIC ENOLASE (NSE) IN THE HUMAN GASTROINTESTINAL-TRACT. GUT. 24:A485-A485.
• FERRI GL; MARANGOS PJ; BLOOM SR; POLAK JM. (1983). INTRAMURAL DISTRIBUTION OF NEURON SPECIFIC ENOLASE (NSE) IN THE HUMAN GASTROINTESTINAL-TRACT. EXPERIENTIA. 39:622-623.
• FERRI GL; MARANGOS PJ; BLOOM SR; POLAK JM. (1983). INTRAMURAL DISTRIBUTION OF NEURON SPECIFIC ENOLASE (NSE) IN THE HUMAN GUT. J PATHOL. 140:172-172.
• CHAPPLE M; FRANCIS J; KOHNER EM; JUNG RT; WEBSTER J; BLOOM SR. (1983). JOINT CONTRACTURES AND DIABETIC-RETINOPATHY. POSTGRAD MED J. 59:291-294.
• ALLEN JM; OSHEA JP; WILLIAMS G; BLOOM SR. (1983). LHRH ANALOG TREATMENT FOR ADENOCARCINOMA OF PROSTATE. BRIT J CANCER. 48:117-117.
• TERENGHI G; COCCHIA D; MICHETTI F; DIANI AR; PETERSON T; COLE DF; BLOOM SR; POLAK JM. (1983). LOCALIZATION OF S-100 PROTEIN IN MULLER CELLS OF THE RETINA .1. LIGHT MICROSCOPICAL IMMUNOCYTOCHEMISTRY. INVEST OPHTH VIS SCI. 24:976-980.
• WILLIAMS G; ALLEN JM; SMITH C; BLOOM SR. (1983). LONG-ACTING LHRH ANALOG IN PATIENTS WITH ADENOCARCINOMA OF THE PROSTATE. PROSTATE. 4:424-424.
• ADRIAN TE; SAGOR GR; SAVAGE AP; ALLEN JM; BACARESEHAMILTON AJ; TATEMOTO K; POLAK JM; BLOOM SR. (1983). LOW-DOSE PYY INHIBITS GASTRIC-SECRETION IN MAN. GUT. 24:A479-A479.
• BRYANT MG; BLOOM SR; POLAK JM; HOBBS S; DOMSCHKE W; DOMSCHKE S; MITZNEGG P; RUPPIN H; et alDEMLING L. (1983). MEASUREMENT OF GUT HORMONAL PEPTIDES IN BIOPSIES FROM HUMAN STOMACH AND PROXIMAL SMALL-INTESTINE. GUT. 24:114-119.
• GU J; HUANG WM; BLANK M; MORRISON JFB; BLOOM SR; POLAK JM. (1983). MEASUREMENT OF VIP AND ORIGIN OF ITS INNERVATION IN THE RAT URINARY-BLADDER. REGUL PEPTIDES. 6:305-305.
• LUCAS A; BLOOM SR; AYNSLEYGREEN A. (1983). METABOLIC AND ENDOCRINE CONSEQUENCES OF DEPRIVING PRETERM INFANTS OF ENTERAL NUTRITION. ACTA PAEDIATR SCAND. 72:245-249.
• SORENSON GD; PETTENGILL OS; CATE CC; GHATEI MA; BLOOM SR. (1983). MODULATION OF HORMONE-SECRETION IN SMALL CELL-CARCINOMA OF THE LUNG. LAB INVEST. 48:A80-A80.
• DELAMARTER J; BUELL G; KAWASHIMA E; POLAK J; BLOOM S. (1983). MOLECULAR CHARACTERIZATION OF THE HUMAN VIP PROHORMONE. REGUL PEPTIDES. 7:283-283.
• GHATEI MA; UTTENTHAL LO; CHRISTOFIDES ND; BRYANT MG; BLOOM SR. (1983). MOLECULAR-FORMS OF HUMAN ENTEROGLUCAGON IN TISSUE AND PLASMA - PLASMA RESPONSES TO NUTRIENT STIMULI IN HEALTH AND IN DISORDERS OF THE UPPER GASTROINTESTINAL-TRACT. J CLIN ENDOCR METAB. 57:488-495.
• CAPELLA C; POLAK JM; BUFFA R; TAPIA FJ; HEITZ P; USELLINI L; BLOOM SR; SOLCIA E. (1983). MORPHOLOGIC PATTERNS AND DIAGNOSTIC-CRITERIA OF VIP-PRODUCING ENDOCRINE TUMORS - A HISTOLOGIC, HISTOCHEMICAL, ULTRASTRUCTURAL, AND BIOCHEMICAL-STUDY OF 32 CASES. CANCER. 52:1860-1874.
• TAPIA FJ; VARNDELL IM; DEMEY J; YANAIHARA N; BLOOM SR; POLAK JM. (1983). MORPHOLOGICAL DEMONSTRATION OF INSULIN-BIOSYNTHESIS USING IMMUNOGOLD PROCEDURES. J PATHOL. 139:500-500.
• FERRI GL; BOTTI PL; BILIOTTI G; VEZZADINI P; BLOOM SR; LABO G; TONELLI L; POLAK JM. (1983). MUCOSAL DISTRIBUTION OF VIP-CONTAINING, SUBSTANCE-P-CONTAINING, AND MET-ENKEPHALIN-CONTAINING NERVES IN THE HUMAN STOMACH AND DUODENUM. GUT. 24:A489-A489.
• PRINZ RA; ELSABBAGH H; ADRIAN TE; BLOOM SR; GARDNER I; POLAK JM; INOKUCHI H; BISHOP AE; et alWELBOURN RB. (1983). NEURAL REGULATION OF PANCREATIC-POLYPEPTIDE RELEASE. SURGERY. 94:1011-1018.
• ANDERSSON PO; BLOOM SR; EDWARDS AV; JARHULT J; MELLANDER S. (1983). NEURAL VASODILATOR CONTROL IN THE RECTUM OF THE CAT AND ITS POSSIBLE MEDIATION BY VASOACTIVE INTESTINAL POLYPEPTIDE. J PHYSIOL-LONDON. 344:49-67.
• ADRIAN TE; BLOOM SR; EDWARDS AV. (1983). NEUROENDOCRINE RESPONSES TO STIMULATION OF THE VAGUS NERVES IN BURSTS IN CONSCIOUS CALVES. J PHYSIOL-LONDON. 344:25-35.
• SHEPPARD MN; MARANGOS PJ; BLOOM SR; POLAK JM. (1983). NEURON SPECIFIC ENOLASE (NSE) - A MARKER FOR THE EARLY DEVELOPMENT OF THE NERVOUS-SYSTEM AND ENDOCRINE-CELLS IN THE HUMAN-LUNG. J PATHOL. 141:522-522.
• SHEPPARD MN; KURIAN SS; HENZENLOGMANS SC; MICHETTI F; COCCHIA D; COLE P; RUSH RA; MARANGOS PJ; et alBLOOM SR; POLAK JM. (1983). NEURON-SPECIFIC ENOLASE AND S-100 - NEW MARKERS FOR DELINEATING THE INNERVATION OF THE RESPIRATORY-TRACT IN MAN AND OTHER MAMMALS. THORAX. 38:333-340.
• GU J; ADRIAN TE; TATEMOTO K; POLAK JM; ALLEN JM; BLOOM SR. (1983). NEUROPEPTIDE TYROSINE (NPY) - A MAJOR CARDIAC NEUROPEPTIDE. LANCET. 1:1008-1010.
• VARNDELL IM; POLAK JM; ALLEN JM; TERENGHI G; BLOOM SR. (1983). NEUROPEPTIDE TYROSINE (NPY) IS CO-STORED WITH NORADRENALINE IN THE MAMMALIAN ADRENAL-GLAND. REGUL PEPTIDES. 7:305-305.
• ALLEN JM; BIRCHAM PMM; EDWARDS AV; TATEMOTO K; BLOOM SR. (1983). NEUROPEPTIDE Y (NPY) REDUCES MYOCARDIAL PERFUSION AND INHIBITS THE FORCE OF CONTRACTION OF THE ISOLATED PERFUSED RABBIT HEART. REGUL PEPTIDES. 6:247-253.
• TERENGHI G; POLAK JM; ALLEN JM; ZHANG SQ; UNGER WG; BLOOM SR. (1983). NEUROPEPTIDE Y-IMMUNOREACTIVE NERVES IN THE UVEA OF GUINEA-PIG AND RAT. NEUROSCI LETT. 42:33-38.
• FERRI GL; ALIRACHEDI A; TATEMOTO K; BLOOM SR; POLAK JM. (1983). NEUROPEPTIDE-Y (NPY) IMMUNOREACTIVE INNERVATION OF THE MAMMALIAN GASTROINTESTINAL-TRACT. J PATHOL. 140:173-173.
• ALLEN JM; ADRIAN TE; POLAK JM; BLOOM SR. (1983). NEUROPEPTIDE-Y (NPY) IN THE ADRENAL-GLAND. J AUTONOM NERV SYST. 9:559-563.
• CARLEI F; POLAK JM; BLOOM SR; TATEMOTO K; LEZOCHE E; SPERANZA V. (1983). NEUROPEPTIDE-Y (NPY) LOCALIZATION IN RAT PANCREAS. J PATHOL. 141:511-511.
• HOKFELT T; LUNDBERG JM; TATEMOTO K; MUTT V; TERENIUS L; POLAK J; BLOOM S; SASEK C; et alELDE R; GOLDSTEIN M. (1983). NEUROPEPTIDE-Y (NPY)-LIKE AND FMRFAMIDE NEUROPEPTIDE-LIKE IMMUNOREACTIVITIES IN CATECHOLAMINE NEURONS OF THE RAT MEDULLA-OBLONGATA. ACTA PHYSIOL SCAND. 117:315-318.
• ADRIAN TE; ALLEN JM; BLOOM SR; GHATEI MA; ROSSOR MN; ROBERTS GW; CROW TJ; TATEMOTO K; et alPOLAK JM. (1983). NEUROPEPTIDE-Y DISTRIBUTION IN HUMAN-BRAIN. NATURE. 306:584-586.
• ALLEN YS; ADRIAN TE; ALLEN JM; TATEMOTO K; CROW TJ; BLOOM SR; POLAK JM. (1983). NEUROPEPTIDE-Y DISTRIBUTION IN THE RAT-BRAIN. SCIENCE. 221:877-879.
• YEATS JC; ALLEN JM; BLOOM SR; LEIGH PJ; MACDERMOT J. (1983). NEUROPEPTIDE-Y IN NEURO-BLASTOMA X GLIOMA HYBRID-CELLS - RESPONSE TO DEXAMETHASONE AND NERVE GROWTH-FACTOR. FEBS LETT. 163:57-61.
• ALLEN YS; ROBERTS GW; TATEMOTO K; CROW TJ; BLOOM SR; POLAK JM. (1983). NEUROPEPTIDE-Y IN THE STRIA TERMINALIS - EVIDENCE FOR AN AMYGDALOFUGAL PROJECTION. J PATHOL. 141:545-545.
• ALLEN YS; ADRIAN TE; ALLEN J; ROBERTS GW; CROW TJ; TATEMOTO K; BLOOM SR; POLAK JM. (1983). NEUROPEPTIDE-Y IS THE ENDOGENOUS PP-LIKE PEPTIDE WIDELY DISTRIBUTED IN THE BRAIN OF MAN AND OTHER MAMMALS. J PATHOL. 140:129-130.
• TERENGHI G; POLAK JM; VARNDELL IM; LEE YC; WHARTON J; BLOOM SR. (1983). NEUROTENSIN-LIKE IMMUNOREACTIVITY IN A SUBPOPULATION OF NORADRENALINE-CONTAINING CELLS OF THE CAT ADRENAL-GLAND. ENDOCRINOLOGY. 112:226-233.
• ROBERTS GW; CROSS AJ; FERRIER IN; LEE Y; JOHNSON J; CROW TJ; CORSELLIS JAN; ADRIAN TE; et alMCGREGOR G; BACARESEHAMILTON AJ; POLAK JM; BLOOM SR. (1983). NEUROTRANSMITTERS IN SENILE DEMENTIA OF THE ALZHEIMER TYPE. NEUROPATH APPL NEURO. 9:335-335.
• WOOD SM; KRAENZLIN ME; BLOOM SR. (1983). NEW SOMATOSTATIN ANALOG FOR HOME TREATMENT OF ENDOCRINE TUMORS. GUT. 24:A984-A985.
• BALLESTA J; POLAK JM; HERNANDEZ J; BLOOM SR. (1983). NPY LOCALIZATION AND DISTRIBUTION IN THE JUXTAGLOMERULAR APPARATUS. REGUL PEPTIDES. 7:276-276.
• TERENGHI G; UNGER WG; TATEMOTO K; BLOOM SR; POLAK JM. (1983). NPY-IMMUNOREACTIVE FIBERS IN THE UVEA OF GUINEA-PIG AND RAT. J PATHOL. 141:541-541.
• CHRISTOFIDES ND; MCGREGOR GP; WOODHAMS PL; YIANGOU Y; AARONS E; TATEMOTO K; BLOOM SR. (1983). ONTOGENY OF PHI IN THE RAT-BRAIN. BRAIN RES. 264:359-361.
• ANAGNOSTIDES AA; COX TM; ADRIAN TE; CHRISTOFIDES ND; MATON PN; BLOOM SR; CHADWICK VS. (1983). PANCREATIC EXOCRINE AND ENDOCRINE RESPONSES IN CHRONIC-PANCREATITIS. GUT. 24:A502-A502.
• ADRIAN TE; YEATS J; WOOD SM; POLAK JM; BLOOM SR. (1983). PANCREATIC-POLYPEPTIDE SECRETION BY PANCREATIC APUDOMAS AND ITS LACK OF SUPPRESSION BY CHOLINERGIC BLOCKADE. GUT. 24:A596-A596.
• SABATE IM; STEPHENSON C; BISHOP AE; PROBERT L; COLE GA; HODSON NP; EDWARDS GB; YEATS J; et alBLOOM SR; POLAK JM. (1983). PATHOLOGICAL-CHANGES IN THE REGULATORY PEPTIDES OF THE GUT IN EQUINE GRASS SICKNESS. J PATHOL. 139:484-484.
• ANAGNOSTIDES AA; CHRISTOFIDES ND; BLOOM SR; CHADWICK VS. (1983). PEPTIDE HISTIDINE ISOLEUCINE - A SECRETAGOGUE IN HUMAN INTESTINE. GUT. 24:A472-A472.
• ANAGNOSTIDES AA; MANOLAS K; CHRISTOFIDES ND; YIANGOU Y; WELBOURN RB; BLOOM SR; CHADWICK VS. (1983). PEPTIDE HISTIDINE ISOLEUCINE (PHI) - A SECRETAGOGUE IN PORCINE INTESTINE. DIGEST DIS SCI. 28:893-896.
• BLOOM SR; CHRISTOFIDES ND; YIANGOU Y; BLANK MA; TATEMOTO K; POLAK JM. (1983). PEPTIDE HISTIDINE ISOLEUCINE (PHI) AND THE VERNER-MORRISON SYNDROME. GUT. 24:A473-A473.
• ANAGNOSTIDES AA; CHRISTOFIDES ND; BLOOM SR; CHADWICK VS. (1983). PEPTIDE HISTIDINE ISOLEUCINE INHIBITS BILIARY BUT NOT PANCREATIC-SECRETION IN MAN. CLIN SCI. 65:P40-P41.
• CAI W; GU J; HUANG W; MCGREGOR GP; GHATEI MA; BLOOM SR; POLAK JM. (1983). PEPTIDE IMMUNOREACTIVE NERVES AND CELLS OF THE GUINEA-PIG GALLBLADDER AND BILIARY PATHWAYS. GUT. 24:1186-1193.
• ALIRACHEDI A; VARNDELL IM; GAPP DA; VANNOORDEN S; ADRIAN TE; BLOOM SR; POLAK JM. (1983). PEPTIDE TYROSINE (PYY) IS CO-STORED WITH GLUCAGON-RELATED IMMUNOREACTANTS IN ENDOCRINE-CELLS OF THE GUT AND PANCREAS. REGUL PEPTIDES. 7:272-272.
• GU J; CAI W; HUANG W; MCGREGOR GP; GHATEI MA; BLOOM SR; POLAK JM. (1983). PEPTIDE-CONTAINING SYSTEM IN THE GUINEA-PIG GALLBLADDER AND BILIARY PATHWAYS. J PATHOL. 140:169-169.
• GU J; POLAK JM; PROBERT L; ISLAM KN; MARANGOS PJ; MINA S; ADRIAN TE; MCGREGOR GP; et alOSHAUGHNESSY DJ; BLOOM SR. (1983). PEPTIDERGIC INNERVATION OF THE HUMAN MALE GENITAL-TRACT. J UROLOGY. 130:386-391.
• ROBERTS GW; FERRIER IN; LEE Y; CROW TJ; JOHNSTONE EC; OWENS DGC; BACARESEHAMILTON AJ; MCGREGOR G; et alOSHAUGHNESSEY D; POLAK JM; BLOOM SR. (1983). PEPTIDES, THE LIMBIC LOBE AND SCHIZOPHRENIA. BRAIN RES. 288:199-211.
• ROBERTS GW; LEE YC; FERRIER IN; BACARESEHAMILTON AJ; POLAK JM; CROW TJ; BLOOM SR. (1983). PEPTIDES, THE TEMPORAL-LOBE AND SCHIZOPHRENIC SYMPTOMS. J PATHOL. 139:496-496.
• ANAND P; GIBSON SJ; MCGREGOR GP; BLANK MA; YIANGOU Y; BACARESEHAMILTON AJ; POLAK JM; BLOOM SR. (1983). PERIPHERAL NEURONAL SYSTEMS SHOW MARKED INCREASES IN VIP/PHI AND CCK CONTENT FOLLOWING INJURY. REGUL PEPTIDES. 7:273-273.
• SHEPPARD MN; POLAK JM; CHRISTOFIDES ND; ALLEN JM; BLOOM SR. (1983). PHI AND NPY IN THE LUNG INNERVATION. REGUL PEPTIDES. 7:300-300.
• CHRISTOFIDES ND; MALLET E; GHATEI MA; LEE Y; BLOOM SR. (1983). PLASMA ENTEROGLUCAGON AND NEUROTENSIN IN INFANTILE PYLORIC-STENOSIS. ARCH DIS CHILD. 58:52-55.
• WILLIAMS G; ALLEN JM; OSHEA JP; MASHITER K; DOBLE A; BLOOM SR. (1983). PROSTATIC-CANCER - TREATMENT WITH LONG-ACTING LHRH ANALOG. BRIT J UROL. 55:743-746.
• FERRI GL; ADRIAN TE; GHATEI MA; LEE YC; OSHAUGHNESSY D; VEZZADINI P; POLAK JM; BLOOM SR. (1983). QUANTITATIVE DISTRIBUTION OF PEPTIDE-HORMONES AND NEUROPEPTIDES IN THE HUMAN INTESTINAL WALL. ITAL J GASTROENTEROL. 15:217-217.
• CHRISTOFIDES ND; YIANGOU Y; AARONS E; FERRI GL; TATEMOTO K; POLAK JM; BLOOM SR. (1983). RADIOIMMUNOASSAY AND INTRAMURAL DISTRIBUTION OF PHI-IR IN HUMAN INTESTINE. DIGEST DIS SCI. 28:507-512.
• MCGREGOR GP; BLOOM SR. (1983). RADIOIMMUNOASSAY OF SUBSTANCE-P AND ITS STABILITY IN TISSUE. LIFE SCI. 32:655-662.
• BLOOM SR; POLAK JM. (1983). REGULATORY PEPTIDES AND THE SKIN. CLIN EXP DERMATOL. 8:2-18.
• SHEPPARD MN; CORRIN B; BENNETT M; MARANGOS PJ; BLOOM SR; POLAK JM. (1983). REGULATORY PEPTIDES IN BRONCHIAL CARCINOIDS. J PATHOL. 140:170-170.
• HALL GA; GHATEI MS; PARSONS KR; LEE YC; BLOOM SR; BRIDGER JC. (1983). REGULATORY PEPTIDES IN GNOTOBIOTIC CALVES EXPERIMENTALLY INFECTED WITH ENTEROPATHOGENIC AND NON-ENTEROPATHOGENIC VIRUSES. J MED MICROBIOL. 16:R3-R4.
• HALL GA; GHATEI MS; PARSONS KR; LEE YC; BLOOM SR; BRIDGER JC. (1983). REGULATORY PEPTIDES IN GNOTOBIOTIC CALVES EXPERIMENTALLY INFECTED WITH ENTEROPATHOGENIC AND NON-ENTEROPATHOGENIC VIRUSES. J PATHOL. 141:511-512.
• POLAK JM; BLOOM SR. (1983). REGULATORY PEPTIDES OF THE RESPIRATORY-TRACT - A NEWLY DISCOVERED CONTROL-SYSTEM. FRONT NEUROENDOCRIN. 8:199-221.
• NAGORNEY DM; BLOOM SR; POLAK JM; BLUMGART LH. (1983). RESOLUTION OF RECURRENT VERNER-MORRISON SYNDROME BY RESECTION OF METASTATIC VIPOMA. SURGERY. 93:348-353.
• SHARPE GR; REES WDW; BLOOM SR; TURNBERG LA. (1983). ROLE OF ENDOGENOUS OPIATES IN MEDIATING THE ANTRAL MOTOR RESPONSE TO SOLID FOOD IN MAN. GUT. 24:A476-A476.
• PASQUALI C; ADRIAN TE; PESCOSTA F; BACCARESEHAMILTON AJ; PEDRAZZOLI S; BLOOM SR. (1983). SOYA INDUCED PANCREATIC HYPERTROPHY AND THE CCK. ITAL J GASTROENTEROL. 15:208-209.
• GIBSON SJ; BLOOM SR; POLAK JM. (1983). SUBSTANCE-P INTERCONNECTIONS IN THE VENTRAL SPINAL-CORD OF THE UPPER LUMBAR SEGMENTS OF THE RAT. J PATHOL. 140:170-171.
• TERENGHI G; MCGREGOR GP; HUANG WM; GU J; ISLAM KN; MORRISON JFB; BLOOM SR; POLAK JM. (1983). SUBSTANCE-P-IMMUNOREACTIVE NERVES IN THE BLADDER ORIGINATE FROM PELVIC AND HYPOGASTRIC NERVES. J PATHOL. 140:168-168.
• TERENGHI G; BHUTTACHARJI S; GHATEI M; BLOOM SR; POLAK JM. (1983). SUBSTANCE-P-IMMUNOREACTIVE NERVES OF THE LUNG ORIGINATE FROM PRIMARY SENSORY NEURONS OF THE NODOSE GANGLION. J PATHOL. 139:498-499.
• SHEPPARD MN; KURIAN SS; HAYES AG; TYERS MB; GHATEI MA; BLOOM SR; POLAK JM. (1983). SYSTEMIC ADMINISTRATION OF CAPSAICIN TO NEONATAL RATS INDUCES A DRAMATIC DEPLETION OF SUBSTANCE P-CONTAINING NERVES FROM THE LUNG. J PATHOL. 139:498-498.
• WOODHAMS PL; ALLEN YS; ALLEN JM; BLOOM SR; BALAZS R; POLAK JM. (1983). THE DEVELOPMENT OF NEUROPEPTIDE-Y IMMUNOREACTIVITY IN THE RAT-BRAIN. REGUL PEPTIDES. 7:309-309.
• GIBSON SJ; HUANG W; ADRIAN T; ALLEN J; MCGREGOR GP; ANAND P; KELLY JS; TATEMOTO K; et alBLOOM SR; POLAK JM. (1983). THE DISTRIBUTION OF A NEWLY DISCOVERED BRAIN PEPTIDE, NEUROPEPTIDE-Y, IN THE SPINAL-CORD OF THE RAT, CAT, MONKEY AND HORSE. J PATHOL. 140:172-173.
• BATES TE; BLACKHALL NW; BLOOM SR; FARRAR GBJ; HALL JC; KINSMAN R; LEE Y; MACFARLANE A; et alMORRIS AP; MOSS G; ONEILL B; READ NW; WELCH I. (1983). THE EFFECT OF INFUSION OF NUTRIENT SOLUTIONS INTO THE ILEUM ON GASTROINTESTINAL TRANSIT AND PLASMA-LEVELS OF NEUROTENSIN AND ENTEROGLUCAGON. J PHYSIOL-LONDON. 342:P27-P28.
• WOOD SM; JUNG RT; WEBSTER JD; GHATEI MA; ADRIAN TE; YANAIHARA N; YANAIHARA C; BLOOM SR. (1983). THE EFFECT OF THE MAMMALIAN NEUROPEPTIDE, GASTRIN-RELEASING PEPTIDE (GRP), ON GASTROINTESTINAL AND PANCREATIC HORMONE-SECRETION IN MAN. CLIN SCI. 65:365-371.
• ADRIAN TE; BLOOM SR; GILLHAM B; JONES MT; NICHOLSON SA. (1983). THE EFFECT OF VARIOUS HYPOTHALAMIC NEUROPEPTIDES ON ADRENOCORTICOTROPIN (ACTH) RELEASE FROM THE RAT ANTERIOR-PITUITARY INVITRO. J PHYSIOL-LONDON. 339:P50-P51.
• REES WDW; SHARPE GR; CHRISTOFIDES ND; BLOOM SR; TURNBERG LA. (1983). THE EFFECTS OF AN OPIATE AGONIST AND ANTAGONIST ON THE HUMAN UPPER GASTROINTESTINAL-TRACT. EUR J CLIN INVEST. 13:221-225.
• HALL GM; ADRIAN TE; BLOOM SR; MASHITER K. (1983). THE EFFECTS OF NALOXONE ON CIRCULATING METABOLITES, GLYCOREGULATORY HORMONES AND GUT PEPTIDES DURING PELVIC-SURGERY. CLIN PHYSIOL. 3:49-58.
• SPILLER RC; HIGGINS BE; LEE YC; GHATEI MA; BLOOM SR; SILK DBA. (1983). THE ILEAL BRAKE - JEJUNAL AND HORMONAL RESPONSES TO ILEAL FAT INFUSION IN MAN. GASTROENTEROLOGY. 84:1319-1319.
• WOOD SM; MATHIAS CJ; WEBSTER JD; FRANKEL HL; BLOOM SR. (1983). THE INFLUENCE OF SYMPATHETIC DENERVATION ON GLUCOSE-HOMEOSTASIS IN MAN. CLIN SCI. 64:P63-P63.
• SOLTESZ G; MACKENZIE IZ; JENKINS PA; BLOOM SR; AYNSLEYGREEN A. (1983). THE METABOLIC AND ENDOCRINE MILIEU OF THE HUMAN-FETUS AT 18-21 WEEKS OF GESTATION. BIOL NEONATE. 44:323-323.
• ALMUKHTAR MYT; SAGOR GR; GHATEI MA; BLOOM SR; WRIGHT NA. (1983). THE ROLE OF PANCREATICO-BILIARY SECRETIONS IN INTESTINAL ADAPTATION AFTER RESECTION, AND ITS RELATIONSHIP TO PLASMA ENTEROGLUCAGON. BRIT J SURG. 70:398-400.
• SHEPPARD MN; CORRIN B; BENNETT M; MARANGOS PJ; BLOOM SR; POLAK JM. (1983). THE USE OF NEURON SPECIFIC ENOLASE (NSE) IMMUNOSTAINING AS AN INDICATOR OF NEUROENDOCRINE DIFFERENTIATION IN SMALL CELL CARCINOMAS AND CARCINOID-TUMORS OF THE LUNG. J PATHOL. 140:149-150.
• SPRINGALL DR; GU J; COCCHIA D; MICHETTI F; LEVENE A; LEVENE MM; MARANGOS PJ; BLOOM SR; et alPOLAK JM. (1983). THE VALUE OF S-100 IMMUNOSTAINING AS A DIAGNOSTIC-TOOL IN HUMAN-MALIGNANT MELANOMAS - A COMPARATIVE-STUDY USING S-100 AND NEURON-SPECIFIC ENOLASE ANTIBODIES. VIRCHOWS ARCH A. 400:331-343.
• FERRI GL; ADRIAN TE; GHATEI MA; OSHAUGHNESSY DJ; PROBERT L; LEE YC; BUCHAN AMJ; POLAK JM; et alBLOOM SR. (1983). TISSUE LOCALIZATION AND RELATIVE DISTRIBUTION OF REGULATORY PEPTIDES IN SEPARATED LAYERS FROM THE HUMAN BOWEL. GASTROENTEROLOGY. 84:777-786.
• ANAND P; BLOOM SR; MCGREGOR GP. (1983). TOPICAL CAPSAICIN PRETREATMENT INHIBITS AXON REFLEX VASODILATATION CAUSED BY SOMATOSTATIN AND VASOACTIVE INTESTINAL POLYPEPTIDE IN HUMAN-SKIN. BRIT J PHARMACOL. 78:665-669.
• WOODS SM; YEATS J; ADRIAN TE; BLOOM SR. (1983). TREATMENT OF PANCREATIC-ISLET CELL-CARCINOMA WITH STREPTOZOTOCIN - EXPERIENCE IN 15 PATIENTS. GUT. 24:A596-A596.
• PROBERT L; DEMEY J; BLOOM SR; POLAK JM. (1983). ULTRASTRUCTURAL-LOCALIZATION OF NEUROPEPTIDE-Y (NPY)-IMMUNOREACTIVITY WITHIN THE GUT AND ITS ASSOCIATION WITH SYMPATHETIC-NERVES. J PATHOL. 141:510-511.
• GIBSON SJ; MCGREGOR GP; SABATE IM; BLANK MA; BLOOM SR; POLAK JM; WALL PD. (1983). UNILATERAL SCIATIC-NERVE SECTION INDUCES A SIGNIFICANT INCREASE OF VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) IN NERVES OF THE IPSILATERAL DORSAL HORN OF THE RAT. REGUL PEPTIDES. 6:304-304.
• TERENGHI G; MCGREGOR GP; BHUTTACHARJI S; WHARTON J; BLOOM SR; POLAK JM. (1983). VAGAL ORIGIN OF SUBSTANCE P-CONTAINING NERVES IN THE GUINEA-PIG LUNG. NEUROSCI LETT. 36:229-236.
• CLARK AJL; ADRIAN TE; MCMICHAEL HB; BLOOM SR. (1983). VASOACTIVE INTESTINAL PEPTIDE IN SHOCK AND HEART-FAILURE. LANCET. 1:539-539.
• GRANOT E; DECKELBAUM RJ; SCHILLER M; OKON E; GODER K; LANDAU H; BLOOM SR. (1983). VASOACTIVE INTESTINAL PEPTIDE SECRETING TUMOR APPEARING AS GROWTH FAILURE. AM J DIS CHILD. 137:1203-1204.
• GIBSON SJ; POLAK JM; SABATE IM; MCGREGOR GP; ANAND P; BLANK M; BLOOM SR; SCADDING JW. (1983). VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) IN THE MAMMALIAN SPINAL-CORD, NORMAL-DISTRIBUTION AND CHANGES FOLLOWING PERIPHERAL-NERVE INJURY. J PATHOL. 141:544-544.
• KURIAN SS; BLANK MA; SHEPPARD MN; STANLEY PJ; MACKAY IS; COLE PJ; BLOOM SR; POLAK JM. (1983). VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) IN VASOMOTOR RHINITIS. IRCS MED SCI-BIOCHEM. 11:425-426.
• MCGREGOR GP; BISHOP AE; BLANK MA; CHRISTOFIDES ND; YIANGOU Y; POLAK JM; BLOOM SR. (1983). VASOACTIVE INTESTINAL POLYPEPTIDE (VIP), SUBSTANCE-P (SP), SOMATOSTATIN (SOM), AND PHI IN THE ENTERIC SPHINCTERS OF THE CAT. GUT. 24:A485-A485.
• GU J; RESTORICK JM; BLANK MA; HUANG WM; POLAK JM; BLOOM SR; MUNDY AR. (1983). VASOACTIVE INTESTINAL POLYPEPTIDE IN THE NORMAL AND UNSTABLE BLADDER. BRIT J UROL. 55:645-647.
• POLAK JM; BLOOM SR. (1983). VIP AND THE GENITOURINARY SYSTEM OF MAN AND ANIMALS. REGUL PEPTIDES. 6:322-322.
• BLANK MA; GHATEI MA; SHEPPARD MN; MAJOR JH; POLAK JM; BLOOM SR. (1983). VIP IN THE DEVELOPING AND ADULT HUMAN-LUNG. REGUL PEPTIDES. 6:288-288.
• BLANK MA; ANAND P; SPRINGALL DR; POLAK JM; BLOOM SR. (1983). VIP-CONTAINING NERVES IN HUMAN AXILLARY SKIN SUPPLY ECCRINE SWEAT GLANDS. REGUL PEPTIDES. 6:288-288.
• FERRI GL; REBECCHI L; MASSARENTI L; BILIOTTI G; BLOOM SR; LABO G; POLAK JM. (1983). VIP-IMMUNOREACTIVE, SUBSTANCE P-IMMUNOREACTIVE AND ENKEPHALIN-IMMUNOREACTIVE INNERVATION OF THE HUMAN GASTROINTESTINAL MUCOSA. REGUL PEPTIDES. 7:285-285.
• ALLEN JM; ADRIAN TE; TATEMOTO K; POLAK JM; HUGHES J; BLOOM SR. (1982). 2-NOVEL RELATED PEPTIDES, NEUROPEPTIDE-Y (NPY) AND PEPTIDE-YY (PYY) INHIBIT THE CONTRACTION OF THE ELECTRICALLY STIMULATED MOUSE VAS-DEFERENS. NEUROPEPTIDES. 3:71-77.
• POLAK JM; BISHOP AE; FACER P; MARANGOS PJ; BLOOM SR. (1982). A NEW HISTOLOGIC TOOL FOR THE VISUALIZATION OF ALL ENDOCRINE-CELLS AND NEUROENDOCRINE COMPLEXES OF THE BOWEL. GASTROENTEROLOGY. 82:1150-1150.
• POLAK JM; FERRI GL; WRIGHT NA; BLOOM SR. (1982). A NEW METHOD FOR THE QUANTIFICATION OF ENDOCRINE-CELLS USING WHOLE INTESTINAL CRYPTS AND VILLI. GASTROENTEROLOGY. 82:1150-1150.
• GORCHEIN A; VALORI RM; WINGATE DL; BLOOM SR. (1982). ABNORMAL PROXIMAL GUT MOTILITY IN ACUTE INTERMITTENT PORPHYRIA (AIP) - A NEUROPATHIC MODEL. GASTROENTEROLOGY. 82:1070-1070.
• UTTENTHAL LO; HARRIS A; YEATS JC; GHATEI MA; SAGOR GR; POLAK JM; BLOOM SR. (1982). ACARBOSE AND GUAR HAVE DIFFERENT EFFECTS ON APPETITE AND REGULATORY PEPTIDES IN THE RAT. DIABETOLOGIA. 22:397-397.
• ALLEN JM; ADRIAN TE; CRAMER P; STEINERT J; BLOOM SR. (1982). ACUTE RISE OF PANCREATIC-POLYPEPTIDE AFTER ELECTROCONVULSIVE-THERAPY. BRIT J PSYCHIAT. 141:24-26.
• CHRISTOFIDES ND; YIANGOU Y; BLANK MA; TATEMOTO K; POLAK JM; BLOOM SR. (1982). ARE PEPTIDE HISTIDINE ISOLEUCINE AND VASOACTIVE INTESTINAL PEPTIDE CO-SYNTHESIZED IN THE SAME PRO-HORMONE. LANCET. 2:1398-1398.
• BLOOM SR; POLAK JM. (1982). ASPECTS OF NEUROTENSIN PHYSIOLOGY AND PATHOLOGY. ANN NY ACAD SCI. 400:105-116.
• BJORNSSON OG; CHRISTOFIDES ND; SVENBERG T; BLOOM SR; CHADWICK VS. (1982). BILIARY-SECRETION AND PLASMA MOTILIN ARE MARKEDLY SUPPRESSED DURING DUODENAL PERFUSION WITH SODIUM TAUROCHOLATE (STC) IN MAN. EUR J CLIN INVEST. 12:3-3.
• GHATEI MA; JUNG RT; STEVENSON JC; HILLYARD CJ; ADRIAN TE; LEE YC; CHRISTOFIDES ND; SARSON DL; et alMASHITER K; MACINTYRE I; BLOOM SR. (1982). BOMBESIN - ACTION ON GUT HORMONES AND CALCIUM IN MAN. J CLIN ENDOCR METAB. 54:980-985.
• BLOOM SR; EDWARDS AV; GHATEI MA. (1982). BOMBESIN - AN IMPORTANT COMPONENT IN NEURAL CONTROL OF INSULIN RELEASE. DIABETOLOGIA. 23:464-465.
• BLOOM SR; GHATEI MA; CATE CC; PETTENGILL OS; SORENSON GD. (1982). BOMBESIN PRODUCTION BY HUMAN SMALL CELL-CARCINOMA OF THE LUNG. REGUL PEPTIDES. 3:66-66.
• POLAK JM; FERRI GL; PROBERT L; BISHOP AE; COCCHIA D; MICHETTI F; MARANGOS PJ; BLOOM SR. (1982). DELINEATION OF THE ENTIRE ENTERIC NERVOUS-SYSTEM BY THE USE OF ANTIBODIES TO BRAIN PROTEINS. GASTROENTEROLOGY. 82:1150-1150.
• TAPIA FJ; VARNDELL IM; DEMEY J; HEDING L; YANAIHARA N; BLOOM SR; POLAK JM. (1982). DEMONSTRATION OF IMMUNOREACTIVE SITES OF INSULIN-BIOSYNTHESIS USING IMMUNOGOLD PROCEDURES. GUT. 23:A883-A883.
• BRYANT MG; BUCHAN AMJ; GREGOR M; GHATEI MA; POLAK JM; BLOOM SR. (1982). DEVELOPMENT OF INTESTINAL REGULATORY PEPTIDES IN THE HUMAN-FETUS. GASTROENTEROLOGY. 83:47-54.
• POLAK JM; STEIN BA; BUCHAN AMJ; BRYANT MG; GREGOR M; MORRIS J; BLOOM SR. (1982). DEVELOPMENTAL PATTERN OF REGULATORY PEPTIDES IN THE HUMAN STOMACH. GASTROENTEROLOGY. 82:1151-1151.
• MCGREGOR GP; WOODHAMS PL; OSHAUGHNESSY DJ; GHATEI MA; POLAK JM; BLOOM SR. (1982). DEVELOPMENTAL-CHANGES IN BOMBESIN, SUBSTANCE-P, SOMATOSTATIN AND VASOACTIVE INTESTINAL POLYPEPTIDE IN THE RAT-BRAIN. NEUROSCI LETT. 28:21-27.
• FERRI GL; BLOOM SR; POLAK JM. (1982). DIFFERENTIAL DISTRIBUTION OF THE MUCOSAL PEPTIDERGIC INNERVATION IN THE HUMAN SMALL AND LARGE-INTESTINE. REGUL PEPTIDES. 4:360-360.
• FERRI GL; BLOOM SR; POLAK JM. (1982). DIFFERENTIAL DISTRIBUTION OF THE PEPTIDERGIC INNERVATION IN THE HUMAN INTESTINAL-MUCOSA. GUT. 23:A883-A883.
• CHRISTOFIDES ND; YIANGOU Y; PIPER PJ; GHATEI MA; TATEMOTO K; POLAK JM; BLOOM SR. (1982). DISTRIBUTION OF PHI IN THE MAMMALIAN RESPIRATORY-TRACT AND SOME ASPECTS OF ITS PHARMACOLOGY. REGUL PEPTIDES. 4:359-359.
• GHIGLIONE M; CHRISTOFIDES ND; YIANGOU Y; UTTENTHAL LO; BLOOM SR. (1982). DOSE-DEPENDENT EFFECT OF PHI ON NET FLUID TRANSPORT IN THE RAT SMALL-INTESTINE. REGUL PEPTIDES. 4:362-362.
• BJORNSSON OG; FLETCHER DR; CHRISTOFIDES ND; BLOOM SR; CHADWICK VS. (1982). DUODENAL PERFUSION WITH SODIUM TAUROCHOLATE INHIBITS BILIARY BUT NOT PANCREATIC-SECRETION IN MAN. CLIN SCI. 62:651-659.
• WOOD SM; JUNG RT; WEBSTER JD; GHATEI MA; BLOOM SR. (1982). EFFECT OF GASTRIN RELEASING PEPTIDE (GRP) ON THE RELEASE OF PANCREATIC AND GUT HORMONES. CLIN SCI. 63:P64-P64.
• FLETCHER DR; BLACKBURN AM; BLOOM SR; ADRIAN TE; BARON JH. (1982). EFFECT OF NEUROTENSIN ON PANCREATIC BILIARY-SECRETION IN MAN. AUST NZ J MED. 12:114-114.
• ADRIAN TE; MITCHENERE P; SAGOR G; BLOOM SR. (1982). EFFECT OF PANCREATIC-POLYPEPTIDE ON GALLBLADDER PRESSURE AND HEPATIC BILE SECRETION. AM J PHYSIOL. 243:G204-G207.
• LONG RG; OSHAUGHNESSY DJ; ADRIAN TE; GHATEI MA; BLOOM SR. (1982). EFFECT OF SOMATOSTATIN ON POSTPRANDIAL HORMONE-RELEASE. GASTROENTEROLOGY. 82:1120-1120.
• LONG RG; CHRISTOFIDES ND; FITZPATRICK ML; OSHAUGHNESSY DJ; BLOOM SR. (1982). EFFECTS OF INTRAVENOUS SOMATOSTATIN AND MOTILIN ON THE BLOOD-GLUCOSE AND HORMONAL RESPONSE TO ORAL GLUCOSE. EUR J CLIN INVEST. 12:331-336.
• ANDERSSON PO; BLOOM SR; EDWARDS AV; JARHULT J. (1982). EFFECTS OF STIMULATION OF THE CHORDA TYMPANI IN BURSTS ON SUB-MAXILLARY RESPONSES IN THE CAT. J PHYSIOL-LONDON. 322:469-483.
• BLOOM SR; EDWARDS AV. (1982). EFFECTS OF THE AUTONOMIC SYSTEM ON INSULIN RELEASE IN RESPONSE TO EXOGENOUS GLUCOSE IN WEANED LAMBS. J PHYSIOL-LONDON. 327:421-429.
• VARNDELL IM; TAPIA FJ; DEMEY J; RUSH RA; BLOOM SR; POLAK JM. (1982). ELECTRON IMMUNO-CYTOCHEMICAL LOCALIZATION OF ENKEPHALIN-LIKE MATERIAL IN CATECHOLAMINE-CONTAINING CELLS OF THE CAROTID-BODY, THE ADRENAL-MEDULLA, AND IN PHEOCHROMOCYTOMAS OF MAN AND OTHER MAMMALS. J HISTOCHEM CYTOCHEM. 30:682-690.
• ALLEN JM; CHRISTOFIDES ND; CRAMER PA; STEINERT J; BLOOM SR. (1982). ELEVATED MOTILIN LEVELS IN PATIENTS TREATED WITH ANTI-DEPRESSANT AND NEUROLEPTIC DRUGS. BRIT J PSYCHIAT. 141:27-29.
• FERRI GL; HARRIS A; BLOOM SR; WRIGHT NA; POLAK JM. (1982). ENDOCRINE CELL COUNT IN WHOLE COLONIC CRYPTS. J PATHOL. 138:87-87.
• FERRI GL; BLOOM SR; WRIGHT NA; POLAK JM. (1982). ENDOCRINE CELL QUANTIFICATION IN THE HUMAN INTESTINE - A NEW APPROACH. GUT. 23:A434-A434.
• AYNSLEYGREEN A; ADRIAN TE; BLOOM SR. (1982). FEEDING AND THE DEVELOPMENT OF ENTEROINSULAR HORMONE-SECRETION IN THE PRETERM INFANT - EFFECTS OF CONTINUOUS GASTRIC INFUSIONS OF HUMAN-MILK COMPARED WITH INTERMITTENT BOLUSES. ACTA PAEDIATR SCAND. 71:379-383.
• ALIRACHEDI A; FERRI GL; VARNDELL I; YATES J; VANNOORDEN S; SCHOT LPC; BLOOM SR; POLAK JM. (1982). FMRF-NH2-IMMUNOREACTIVE PEPTIDE IN GUT AND PITUITARY OF MAN AND MAMMALS. GUT. 23:A885-A885.
• ALIRACHEDI A; FERRI GL; VARNDELL IM; BLOOM SR; POLAK JM. (1982). GAMMA-1-MSH IMMUNOREACTIVITY IN CORTICOTROPHS AND ACTH-PRODUCING TUMORS. REGUL PEPTIDES. 4:355-355.
• WOOD SM; BLOOM SR. (1982). GLUCAGON AND GASTRIN-SECRETION BY A PANCREATIC TUMOR AND ITS METASTASES. J ROY SOC MED. 75:42-44.
• HODSON N; EDWARDS GB; BARNETT SW; BISHOP AE; COLE GA; PROBERT L; BLOOM SR; POLAK JM. (1982). GRASS SICKNESS OF HORSES - CHANGES IN THE REGULATORY PEPTIDE SYSTEM OF THE BOWEL. VET REC. 110:276-276.
• FERRI GL; KOOPMANS HS; GHATEI MA; BLOOM SR; POLAK JM. (1982). GUT ENDOCRINE-CELLS IN INTESTINAL ADAPTATION - THE ENTEROGLUCAGON CELLS AFTER ILEAL-DUODENAL TRANSPOSITION. J PATHOL. 137:75-75.
• KENNEDY HJ; SARSON DL; BLOOM SR; TRUELOVE SC. (1982). GUT HORMONE RESPONSES IN SUBJECTS WITH A PERMANENT ILEOSTOMY. DIGESTION. 24:133-136.
• BESTERMAN HS; ADRIAN TE; MALLINSON CN; CHRISTOFIDES ND; SARSON DL; PERA A; LOMBARDO L; MODIGLIANI R; et alBLOOM SR. (1982). GUT HORMONE-RELEASE AFTER INTESTINAL RESECTION. GUT. 23:854-861.
• VARNDELL IM; TAPIA FJ; PROBERT L; BUCHAN AMJ; GU J; DEMEY J; BLOOM SR; POLAK JM. (1982). IMMUNOGOLD STAINING PROCEDURE FOR THE LOCALIZATION OF REGULATORY PEPTIDES. PEPTIDES. 3:259-272.
• POLAK JM; VARNDELL I; PROBERT L; TAPIA F; DEMEY J; BLOOM SR. (1982). IMMUNOGOLD STAINING PROCEDURE FOR THE ULTRASTRUCTURAL-LOCALIZATION OF REGULATORY PEPTIDES IN THE GUT. GASTROENTEROLOGY. 82:1151-1151.
• BISHOP AE; OMORAINE C; LEVI AJ; PETERS TJ; BLOOM SR; POLAK JM. (1982). IMMUNOSTAINING OF VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) CONTAINING NERVES AS A DIFFERENTIAL TOOL IN THE DIAGNOSIS OF INFLAMMATORY BOWEL DISEASES. J PATHOL. 137:67-68.
• SARSON DL; WOOD SM; KANSAL P; BLOOM SR. (1982). INSULINOTROPIC PROPERTIES OF GIP - A NON-PHYSIOLOGICAL PHENOMENON. DIABETOLOGIA. 23:197-197.
• REES WDW; LEIGH RJ; CHRISTOFIDES ND; BLOOM SR; TURNBERG LA. (1982). INTERDIGESTIVE MOTOR-ACTIVITY IN PATIENTS WITH SYSTEMIC-SCLEROSIS. GASTROENTEROLOGY. 83:575-580.
• WOOD SM; WOOD JR; GHATEI MA; SORENSON GD; BLOOM SR. (1982). IS BOMBESIN A TUMOR-MARKER FOR SMALL-CELL CARCINOMA. LANCET. 1:690-691.
• CHAPPLE M; FRANCIS J; WEBSTER J; BLOOM SR; KOHNER E; JUNG RT. (1982). JOINT CONTRACTURES ARE NOT AN EARLY INDICATOR OF THE DEVELOPMENT OF RETINOPATHY. DIABETOLOGIA. 22:384-384.
• GHATEI MA; SHEPPARD MN; HENZENLOGMANS S; BLANK MA; POLAK JM; BLOOM SR. (1982). LARGE CHANGES IN HUMAN-FETAL PULMONARY BOMBESIN DURING DEVELOPMENT AND ACUTE RESPIRATORY-DISTRESS SYNDROME. REGUL PEPTIDES. 4:362-362.
• FERRI GL; POLAK JM; ADRIAN TE; BUCHAN AMJ; PROBERT L; GHATEI MA; LEE YC; BLOOM SR. (1982). LAYER SEPARATION OF THE HUMAN BOWEL FOR THE STUDY OF REGULATORY PEPTIDES. REGUL PEPTIDES. 3:70-70.
• GIBSON SJ; POLAK JM; MCGREGOR G; BLOOM SR; WALL PD. (1982). LOCAL APPLICATION OF CAPSAICIN TO ONE SCIATIC-NERVE INDUCES PROFOUND CHANGES IN PEPTIDE-CONTAINING AFFERENT-FIBERS IN THE IPSILATERAL LUMBAR DORSAL HORN OF THE ADULT-RAT. REGUL PEPTIDES. 3:71-71.
• GIBSON SJ; POLAK JM; MCGREGOR G; BLOOM SR; WALL PD. (1982). LOCAL APPLICATION OF CAPSAICIN TO ONE SCIATIC-NERVE INDUCES SIGNIFICANT, DOSE-DEPENDENT, DECREASES OF PEPTIDE-CONTAINING-C FIBERS IN THE LUMBAR SPINAL-CORD AND SKIN INNERVATED BY THE SCIATIC-NERVE OF THE ADULT-RAT. J PATHOL. 138:88-88.
• GIBSON SJ; MCGREGOR G; BLOOM SR; POLAK JM; WALL PD. (1982). LOCAL APPLICATION OF CAPSAICIN TO ONE SCIATIC-NERVE OF THE ADULT-RAT INDUCES A MARKED DEPLETION IN THE PEPTIDE CONTENT OF THE LUMBAR DORSAL HORN. NEUROSCIENCE. 7:3153-3162.
• VARNDELL IM; TAPIA FJ; DEMEY J; YANAIHARA N; BLOOM SR; POLAK JM. (1982). LOCALIZATION OF DISTINCT SUB-POPULATIONS OF GASTRIN-CONTAINING SECRETORY GRANULES IN THE MAMMALIAN GASTROINTESTINAL-TRACT USING A NEW DOUBLE IMMUNOGOLD STAINING METHOD. GUT. 23:A880-A880.
• HILLEBRAND I; AUBELL R; BOEHME K; UTTENTHAL LO; BLOOM SR; BERCHTOLD P. (1982). LONG-TERM TREATMENT OF DIABETES WITH ACARBOSE, A GLUCOSIDASE INHIBITOR - EFFICACY, TOLERABILITY AND EFFECT ON GASTROINTESTINAL HORMONES. DIABETOLOGIA. 23:468-468.
• TERENGHI G; POLAK JM; MCGREGOR GP; PROBERT L; BUTLER JM; COLE DF; BLOOM SR. (1982). MAPPING AND QUANTIFICATION OF SUBSTANCE-P AND VIP IMMUNOREACTIVITY IN THE UVEA. J PATHOL. 138:94-94.
• TERENGHI G; POLAK JM; PROBERT L; MCGREGOR GP; FERRI GL; BLANK MA; BUTLER JM; UNGER WG; et alZHANG SQ; COLE DF; BLOOM SR. (1982). MAPPING, QUANTITATIVE DISTRIBUTION AND ORIGIN OF SUBSTANCE-P-CONTAINING AND VIP-CONTAINING NERVES IN THE UVEA OF GUINEA-PIG EYE. HISTOCHEMISTRY. 75:399-417.
• HILLEBRAND I; BLOOM SR; UTTENTHAL LO; BERCHTOLD P. (1982). MARGINAL, NON-PROGRESSIVE AND REVERSIBLE EFFECTS OF 5 YEARS ACARBOSE THERAPY ON GASTROINTESTINAL HORMONES IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES. DIABETOLOGIA. 23:174-174.
• BISHOP AE; COLE GA; PROBERT L; HODSON NP; BLOOM SR; POLAK JM. (1982). MARKED CHANGES IN THE REGULATORY PEPTIDE SYSTEM OF THE BOWEL IN EQUINE GRASS SICKNESS. REGUL PEPTIDES. 3:65-65.
• MANESCHI F; FOLEY K; MASHITEL K; BLOOM SR; ALBERTI KGMM; KOHNER EM. (1982). METABOLIC AND HORMONAL FACTORS IN THE PATHOGENESIS OF RETINOPATHY IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES - INSULIN RESISTANCE, RESIDUAL INSULIN-SECRETION, INTERMEDIATE METABOLITES, GROWTH-HORMONE, PROLACTIN, GASTROINTESTINAL HORMONES. DIABETOLOGIA. 23:185-185.
• TAPIA FJ; POLAK JM; CAPELLA C; BUFFA R; HEITZ P; SOLCIA E; BLOOM SR. (1982). MORPHOLOGICAL PATTERNS AND DIAGNOSTIC-CRITERIA OF VIP-PRODUCING ENDOCRINE TUMORS OF THE PANCREAS - A HISTOLOGICAL, HISTOCHEMICAL, ULTRASTRUCTURAL, AND BIOCHEMICAL-STUDY OF 28 CASES. J PATHOL. 138:88-89.
• BLOOM SR; CHRISTOFIDES ND; GOODALL ED; RAYNER V. (1982). MOTILIN AND THE MIGRATING MYOELECTRIC COMPLEX IN PIGS. J PHYSIOL-LONDON. 322:P54-P54.
• BLOOM SR; EDWARDS AV. (1982). NEUROENDOCRINE RESPONSES TO STIMULATION OF THE PERIPHERAL ENDS OF THE SPLANCHNIC NERVES IN BURSTS IN THE CONSCIOUS ADRENALECTOMIZED CALF. J PHYSIOL-LONDON. 332:P84-P85.
• SHEPPARD MN; JOHNSON NF; COLE GA; BLOOM SR; MARANGOS PJ; POLAK JM. (1982). NEURON SPECIFIC ENOLASE (NSE) IMMUNOSTAINING A USEFUL TOOL FOR THE LIGHT MICROSCOPICAL DETECTION OF ENDOCRINE CELL HYPERPLASIA IN ADULT-RATS EXPOSED TO ASBESTOS. HISTOCHEMISTRY. 74:505-513.
• SHEPPARD MN; WHARTON J; MARANGOS PJ; BLOOM SR; POLAK JM. (1982). NEURON-SPECIFIC ENOLASE (NSE) DISTRIBUTION IN THE RESPIRATORY-TRACT OF MAN AND OTHER MAMMALS. J PATHOL. 138:90-90.
• ALLEN YS; CROW TJ; BLOOM SR; POLAK JM. (1982). NEUROPEPTIDE-Y - A NEWLY DISCOVERED PEPTIDE OF THE PANCREATIC-POLYPEPTIDE FAMILY IS PRESENT IN THE RAT-BRAIN. REGUL PEPTIDES. 4:356-356.
• LUNDBERG JM; TERENIUS L; HOKFELT T; MARTLING CR; TATEMOTO K; MUTT V; POLAK J; BLOOM S; et alGOLDSTEIN M. (1982). NEUROPEPTIDE-Y (NPY)-LIKE IMMUNOREACTIVITY IN PERIPHERAL NORADRENERGIC NEURONS AND EFFECTS OF NPY ON SYMPATHETIC FUNCTION. ACTA PHYSIOL SCAND. 116:477-480.
• BLOOM SR; PEART WS; UNWIN RJ. (1982). NEUROTENSIN AND RENAL-FUNCTION IN THE CONSCIOUS RABBIT. J PHYSIOL-LONDON. 332:P95-P96.
• TERENGHI G; VARNDELL IM; WHARTON J; LEE YC; BLOOM SR; POLAK JM. (1982). NEUROTENSIN-LIKE IMMUNOREACTIVITY IN ADRENAL-MEDULLA. J PATHOL. 137:82-83.
• GIBSON SJ; BLOOM SR; POLAK JM. (1982). NOVEL SUBSTANCE-P NEURAL CIRCUITS IN THE VENTRAL SPINAL-CORD OF THE UPPER LUMBAR LEVEL OF THE RAT. REGUL PEPTIDES. 4:363-363.
• TERENGHI G; MCGREGOR GP; HUANG WM; GU J; ISLAM KN; MORRISON JFB; BLOOM SR; POLAK JM. (1982). ORIGIN OF SP-IMMUNOREACTIVE NERVES IN THE RAT BLADDER. REGUL PEPTIDES. 4:381-381.
• BESTERMAN HS; ADRIAN TE; BLOOM SR; CHRISTOFIDES ND; MALLINSON CN; PONTI V; LOMBARDO L; MODIGLIANI R; et alGUERIN S; SOUTH M. (1982). PANCREATIC AND GASTROINTESTINAL HORMONES IN CHRONIC-PANCREATITIS. DIGESTION. 24:195-208.
• BUCHAN AMJ; BRYANT MG; STEIN BA; GREGOR M; GHATEI MA; MORRIS JF; BLOOM SR; POLAK JM. (1982). PANCREATIC GLUCAGON IN HUMAN-FETAL STOMACH. HISTOCHEMISTRY. 74:515-520.
• WOOD SM; WEBSTER JD; MATHIAS CJ; FRANKEL HL; BLOOM SR. (1982). PANCREATIC HORMONE RESPONSES TO HYPOGLYCEMIA ARE UNAFFECTED BY ADRENERGIC DENERVATION IN MAN. REGUL PEPTIDES. 4:384-384.
• JANSSENS J; HELLEMANS J; ADRIAN TE; BLOOM SR; PEETERS TL; CHRISTOFIDES N; VANTRAPPEN GR. (1982). PANCREATIC-POLYPEPTIDE IS NOT INVOLVED IN THE REGULATION OF THE MIGRATING MOTOR COMPLEX IN MAN. REGUL PEPTIDES. 3:41-49.
• ANDERSSON PO; BLOOM SR; EDWARDS AV. (1982). PAROTID RESPONSES TO STIMULATION OF THE PARASYMPATHETIC INNERVATION IN BURSTS IN WEANED LAMBS. J PHYSIOL-LONDON. 330:163-174.
• FERRI GL; BOTTI PL; VEZZADINI P; BILIOTTI G; BLOOM SR; POLAK JM. (1982). PEPTIDE-CONTAINING INNERVATION OF THE HUMAN INTESTINAL-MUCOSA - AN IMMUNOCYTOCHEMICAL STUDY ON WHOLE-MOUNT PREPARATIONS. HISTOCHEMISTRY. 76:413-420.
• BISHOP AE; MCGREGOR GP; LAKE BD; PRESTON DM; BLOOM SR; POLAK JM. (1982). PEPTIDE-CONTAINING NERVOUS-SYSTEM OF THE GUT IN 3 FORMS OF MEGACOLON. GUT. 23:A880-A880.
• GU J; ISLAM KN; RESTORICK JM; MCGREGOR GP; ADRIAN TE; BLOOM SR; POLAK JM. (1982). PEPTIDERGIC INNERVATION OF THE HUMAN URINARY-TRACT. J PATHOL. 138:89-90.
• ANAGNOSTIDES AA; MANOLAS K; CHRISTOFIDES ND; YIANGOS Y; WELBOURN RB; BLOOM SR; CHADWICK VS. (1982). PORCINE HISTIDINE ISOLEUCINE (PHI) INDUCES SECRETION IN THE PIG SMALL-INTESTINE. GUT. 23:A914-A914.
• LUCAS A; BLOOM SR; AYNSLEYGREEN A. (1982). POSTNATAL SURGES IN PLASMA GUT HORMONES IN TERM AND PRETERM INFANTS. BIOL NEONATE. 41:63-67.
• FERRI GL; HARRIS A; WRIGHT NA; BLOOM SR; POLAK JM. (1982). QUANTIFICATION OF ENDOCRINE-CELLS IN WHOLE INTESTINAL CRYPTS AND VILLI. HISTOCHEM J. 14:692-695.
• BLANK MA; GU J; MCGREGOR GP; YIANGOU Y; BACARESEHAMILTON AJ; POLAK JM; BLOOM SR. (1982). REGIONAL DISTRIBUTION OF PHI, CCK, VIP AND SUBSTANCE-P IN THE FELINE URINARY SYSTEM. REGUL PEPTIDES. 4:357-357.
• ANAND P; GIBSON SJ; BLANK MA; MCGREGOR GP; GHATEI MA; POLAK JM; BLOOM SR. (1982). REGIONAL DISTRIBUTION OF REGULATORY PEPTIDES IN SPINAL-CORD OF 3 SPECIES - EVIDENCE OF A SPECIFIC VIP-ERGIC SYSTEM IN NORMAL HUMAN SACRAL CORD. REGUL PEPTIDES. 4:356-356.
• POLAK JM; BLOOM SR. (1982). REGULATORY PEPTIDES AND NEURON-SPECIFIC ENOLASE IN THE RESPIRATORY-TRACT OF MAN AND OTHER MAMMALS. EXP LUNG RES. 3:313-328.
• GHATEI MA; SHEPPARD MN; OSHAUGHNESSY DJ; ADRIAN TE; MCGREGOR GP; POLAK JM; BLOOM SR. (1982). REGULATORY PEPTIDES IN THE MAMMALIAN RESPIRATORY-TRACT. ENDOCRINOLOGY. 111:1248-1254.
• WOOD SM; WEBSTER J; BLOOM SR. (1982). REGULATORY PEPTIDES IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES. DIABETOLOGIA. 22:398-398.
• ROBERTS GW; FERRIER IN; LEE YC; BACARESEHAMILTON AJ; MCGREGOR G; GHATEI M; POLAK JM; BLOOM SR; et alCROW TJ. (1982). SCHIZOPHRENIA - ALTERATIONS IN THE PEPTIDE CONTENT OF THE LATERAL THALAMUS. J PATHOL. 138:90-91.
• ROBERTS GW; FERRIER IN; LEE YC; ADRIAN TE; OSHAUGHNESSEY DJ; CROW TJ; POLAK JM; BLOOM SR. (1982). SCHIZOPHRENIA - PEPTIDERGIC DEFICITS IN THE LIMBIC SYSTEM. REGUL PEPTIDES. 3:81-81.
• JENKINS DJA; WOLEVER TMS; TAYLOR RH; GRIFFITHS C; KRZEMINSKA K; LAWRIE JA; BENNETT CM; GOFF DV; et alSARSON DL; BLOOM SR. (1982). SLOW RELEASE DIETARY CARBOHYDRATE IMPROVES 2ND-MEAL TOLERANCE. AM J CLIN NUTR. 35:1339-1346.
• GILL SS; LEE YC; UTTENTHAL LO; BLOOM SR. (1982). SOME INVESTIGATIONS OF THE MECHANISM OF NEUROTENSIN RELEASE. DIABETOLOGIA. 22:387-387.
• BRISTOL JB; GHATEI MA; BLOOM SR; WILLIAMSON RNC. (1982). THE ATROPHY AND IMPAIRED CARCINOGENESIS OF DEFUNCTIONED COLON ARE UNAFFECTED BY POSTOPERATIVE ELEVATIONS OF PLASMA ENTEROGLUCAGON. BRIT J SURG. 69:677-677.
• POLAK JM; BLOOM SR. (1982). THE CENTRAL AND PERIPHERAL DISTRIBUTION OF NEUROTENSIN. ANN NY ACAD SCI. 400:75-93.
• FRIER BM; CORRALL RJM; ADRIAN TE; BLOOM SR. (1982). THE EFFECT OF ADRENERGIC AND CHOLINERGIC MECHANISMS ON THE SECRETION OF PANCREATIC-POLYPEPTIDE AND GASTRIN FOLLOWING HYPOGLYCEMIA IN MAN. CLIN ENDOCRINOL. 17:433-439.
• MITCHENERE P; ADRIAN TE; HOBBS KEF; BLOOM SR. (1982). THE EFFECT OF THE REGULATORY PEPTIDES ON GALLBLADDER PRESSURE AND BILE OUTPUT. GASTROEN CLIN BIOL. 6:815-816.
• EDWARDS AV; BLOOM SR. (1982). THE GLUCOSE DEPENDENCE OF PANCREATIC ENDOCRINE RESPONSES TO 2-DEOXYGLUCOSE IN THE CALF. EXPERIENTIA. 38:815-816.
• SHEPPARD MN; GHATEI MA; OSHAUGHNESSY DJ; ADRIAN TE; MCGREGOR GP; BLOOM SR; POLAK JM. (1982). THE LOCALIZATION OF REGULATORY PEPTIDES IN THE RESPIRATORY-TRACT. J PATHOL. 137:57-57.
• BISHOP AE; MCGREGOR G; PRESTON DM; LAKE BD; BLOOM SR; POLAK JM. (1982). THE PEPTIDE-CONTAINING ENTERIC NERVOUS-SYSTEM IN 3 FORMS OF MEGACOLON. J PATHOL. 138:68-68.
• MITCHELL SJ; MODLIN IM; BARROS AAJD; BLOOM SR. (1982). THE PHARMACOKINETICS OF VIP IN DOG AND PIG. EXPERIENTIA. 38:1091-1093.
• LUCAS A; BLOOM SR; AYNSLEYGREEN A. (1982). VASOACTIVE INTESTINAL PEPTIDE (VIP) IN PRETERM AND TERM NEONATES. ACTA PAEDIATR SCAND. 71:71-74.
• POLAK JM; TAPIA FJ; CAPELLA C; BUFFA R; HEITZ P; SOLCIA E; BLOOM SR. (1982). VIPOMAS - MORPHOLOGY AND DIAGNOSTIC-CRITERIA OF 29 NONNEURONAL TUMORS. GASTROENTEROLOGY. 82:1151-1151.
• POLAK JM; BLOOM SR. (1981). THE PERIPHERAL SUBSTANCE P-ERGIC SYSTEM. PEPTIDES. 2:133-148.
• BISHOP AE; POLAK JM; LAKE BD; BRYANT MG; BLOOM SR. (1981). ABNORMALITIES OF THE COLONIC REGULATORY PEPTIDES IN HIRSCHSPRUNGS-DISEASE. HISTOPATHOLOGY. 5:679-688.
• SVENBERG T; CHRISTOFIDES ND; FITZPATRICK ML; BLOOM SR; WELBOURN RB. (1981). BILIARY OUTPUT IN MAN IS ASSOCIATED WITH A RISE IN PLASMA MOTILIN. GUT. 22:A870-A870.
• JUNG RT; GHATEI MA; SARSON DL; BLOOM SR. (1981). BOMBESIN AND THE ENTEROINSULAR AXIS. DIABETOLOGIA. 21:509-509.
• WOOD SM; WOOD JR; GHATEI MA; LEE YC; OSHAUGHNESSY D; BLOOM SR. (1981). BOMBESIN, SOMATOSTATIN AND NEUROTENSIN-LIKE IMMUNOREACTIVITY IN BRONCHIAL-CARCINOMA. J CLIN ENDOCR METAB. 53:1310-1313.
• POLAK JM; BLOOM SR. (1981). CENTRAL AND PERIPHERAL REGULATORY PEPTIDES. P NUTR SOC. 40:363-363.
• LONG RG; BRYANT MG; MITCHELL SJ; ADRIAN TE; POLAK JM; BLOOM SR. (1981). CLINICOPATHOLOGICAL STUDY OF PANCREATIC AND GANGLIONEUROBLASTOMA TUMORS SECRETING VASOACTIVE INTESTINAL POLYPEPTIDE (VIPOMAS). BRIT MED J. 282:1767-1771.
• JIAN R; BESTERMAN HS; SARSON DL; AYMES C; HOSTEIN J; BLOOM SR; RAMBAUD JC. (1981). COLONIC INHIBITION OF GASTRIC-SECRETION IN MAN. DIGEST DIS SCI. 26:195-201.
• BISHOP AE; POLAK JM; CHESA PG; TIMSON CM; BRYANT MG; BLOOM SR. (1981). DECREASE OF PANCREATIC SOMATOSTATIN IN NEONATAL NESIDIOBLASTOSIS. DIABETES. 30:122-126.
• BLOOM SR; EDWARDS AV. (1981). DEVELOPMENTAL-CHANGES IN PANCREATIC ENDOCRINE FUNCTION IN THE YOUNG CALF. J PHYSIOL-LONDON. 314:23-35.
• BARNES AJ; LONG RG; ADRIAN TE; VALE W; BROWN MR; RIVIER JE; HANLEY J; GHATEI MA; et alSARSON DL; BLOOM SR. (1981). EFFECT OF A LONG-ACTING OCTAPEPTIDE ANALOG OF SOMATOSTATIN ON GROWTH-HORMONE AND PANCREATIC AND GASTROINTESTINAL HORMONES IN MAN. CLIN SCI. 61:653-656.
• BLOOM SR; SARSON DL; SCOPINARO N; CIVALLERI D; GIANETTA E. (1981). EFFECT OF BILIOPANCREATIC BYPASS-SURGERY FOR MORBID-OBESITY ON THE HORMONAL RESPONSE TO FOOD. GASTROENTEROLOGY. 80:1114-1114.
• LEZOCHE E; CARLEI F; MCCROSSAN M; BLOOM SR; SPERANZA V; POLAK J. (1981). EFFECT OF CHRONIC TREATMENT OF CIMETIDINE ON THE STOMACH AND DUODENUM ENDOCRINE-CELLS. GASTROENTEROLOGY. 80:1211-1211.
• MITCHENERE P; ADRIAN TE; KIRK RM; BLOOM SR. (1981). EFFECT OF GUT REGULATORY PEPTIDES ON INTESTINAL LUMINAL FLUID IN THE RAT. LIFE SCI. 29:1563-1570.
• CHRISTOFIDES ND; LONG RG; FITZPATRICK ML; MCGREGOR GP; BLOOM SR. (1981). EFFECT OF MOTILIN ON THE GASTRIC-EMPTYING OF GLUCOSE AND FAT IN HUMANS. GASTROENTEROLOGY. 80:456-460.
• BLOOM SR; ANDERSON PO; EDWARDS AV; JARHULT J. (1981). EFFECT OF PATTERN OF STIMULATION ON VIP AND VASCULAR-RESISTANCE IN THE SUB-MAXILLARY GLAND OF THE CAT. GASTROENTEROLOGY. 80:1113-1113.
• AYNSLEYGREEN A; BARNES ND; ADRIAN TE; KINGSTON J; BOYES S; BLOOM SR. (1981). EFFECT OF SOMATOSTATIN INFUSION ON INTERMEDIARY METABOLISM AND ENTERO-INSULAR HORMONE-RELEASE IN INFANTS WITH HYPERINSULINEMIC HYPOGLYCEMIA. ACTA PAEDIATR SCAND. 70:889-895.
• CAMILLERI M; COOPER BT; ADRIAN TE; BLOOM SR; CHADWICK VS. (1981). EFFECTS OF VASOACTIVE INTESTINAL PEPTIDE AND PANCREATIC-POLYPEPTIDE IN RABBIT INTESTINE. GUT. 22:14-18.
• COOPER BT; WALSH CH; HOLMES GKT; WRIGHT AD; COOKE WT; BLOOM SR. (1981). GIP AND INSULIN RESPONSES TO ORAL GLUCOSE IN CELIAC PATIENTS BEFORE AND AFTER TREATMENT. SCAND J GASTROENTERO. 16:411-415.
• JONES HW; LENDRUM R; SARSON DL; BOTTAZZO GF; BLOOM SR. (1981). GIP CELL AUTOIMMUNITY - A NEW MODEL FOR THE STUDY OF THE ENTEROINSULAR AXIS. DIABETOLOGIA. 21:509-509.
• SARSON DL; SCOPINARO N; BLOOM SR. (1981). GUT HORMONE CHANGES AFTER JEJUNOILEAL (JIB) OR BILIOPANCREATIC (BPB) BYPASS-SURGERY FOR MORBID-OBESITY. INT J OBESITY. 5:471-480.
• BESTERMAN HS; SARSON DL; RAMBAUD JC; STEWART JS; GUERIN S; BLOOM SR. (1981). GUT HORMONE RESPONSES IN THE IRRITABLE BOWEL SYNDROME. DIGESTION. 21:219-224.
• LUCAS A; AYNSLEYGREEN A; BLOOM SR. (1981). GUT HORMONES AND THE 1ST MEALS. CLIN SCI. 60:349-353.
• AYNSLEYGREEN A; LUCAS A; BLOOM SR. (1981). GUT HORMONES IN NEONATAL NESIDIOBLASTOSIS OF THE PANCREAS. LANCET. 1:1006-1007.
• DAMMANN HG; BESTERMAN HS; BLOOM SR; SCHREIBER HW. (1981). GUT-HORMONE PROFILE IN TOTALLY PANCREATECTOMIZED PATIENTS. GUT. 22:103-107.
• GHATEI MA; SHEPPARD MN; OSHAUGHNESSY DJ; ADRIAN TF; MCGREGOR GP; POLAK JM; BLOOM SR. (1981). HORMONAL PEPTIDES IN THE RESPIRATORY-TRACT. ACTA ENDOCRINOL-COP. 97:79-79.
• LUX G; LEDERER PC; FEMPPEL J; BLOOM SR; ROSCH W; DOMSCHKE W. (1981). HOW BASAL ARE GASTROINTESTINAL FUNCTIONS DURING THE EMPTY PHASE. Z GASTROENTEROL. 19:536-536.
• BLOOM SR; BLACKBURN AM; EDWARDS AV. (1981). INSULIN-RESPONSE TO PHYSIOLOGICAL-CHANGES IN PLASMA NEUROTENSIN CONCENTRATION IN THE CONSCIOUS CALF. DIABETOLOGIA. 20:665-666.
• TIEDEMANN K; PRITCHARD J; LONG R; BLOOM SR. (1981). INTRACTABLE DIARRHEA IN A PATIENT WITH VASOACTIVE INTESTINAL PEPTIDE-SECRETING NEURO-BLASTOMA - ATTEMPTED CONTROL BY SOMATOSTATIN. EUR J PEDIATR. 137:217-219.
• ADRIAN TE; GREENBERG GR; FITZPATRICK ML; BLOOM SR. (1981). LACK OF EFFECT OF PANCREATIC-POLYPEPTIDE IN THE RATE OF GASTRIC-EMPTYING AND GUT HORMONE-RELEASE DURING BREAKFAST. DIGESTION. 21:214-218.
• LUCAS A; BOYES S; BLOOM SR; AYNSLEYGREEN A. (1981). METABOLIC AND ENDOCRINE RESPONSES TO A MILK FEED IN 6-DAY-OLD TERM INFANTS - DIFFERENCES BETWEEN BREAST AND COWS MILK FORMULA FEEDING. ACTA PAEDIATR SCAND. 70:195-200.
• KOLANOWSKI J; SARSON DL; BLOOM SR. (1981). METABOLIC AND HORMONAL EFFECTS OF GALACTOSE IN NORMAL AND OBESE SUBJECTS. EUR J CLIN INVEST. 11:18-18.
• LONG RG; BRYANT MG; YUILLE PM; POLAK JM; BLOOM SR. (1981). MIXED PANCREATIC APUDOMA WITH SYMPTOMS OF EXCESS VASOACTIVE INTESTINAL POLYPEPTIDE AND INSULIN - IMPROVEMENT OF DIARRHEA WITH METOCLOPRAMIDE. GUT. 22:505-511.
• CHRISTOFIDES ND; BRYANT MG; GHATEI MA; KISHIMOTO S; BUCHAN AMJ; POLAK JM; BLOOM SR. (1981). MOLECULAR-FORMS OF MOTILIN IN THE MAMMALIAN AND HUMAN GUT AND HUMAN-PLASMA. GASTROENTEROLOGY. 80:292-300.
• KISHIMOTO S; POLAK JM; BUCHAN AMJ; VERHOFSTAD AAJ; STEINBUSCH HWM; YANAIHARA N; BLOOM SR; PEARSE AGE. (1981). MOTILIN CELLS INVESTIGATED BY THE USE OF REGION-SPECIFIC ANTISERA. VIRCHOWS ARCH B. 36:207-218.
• AYNSLEYGREEN A; POLAK JM; BLOOM SR; GOUGH MH; KEELING J; ASHCROFT SJH; TURNER RC; BAUM JD. (1981). NESIDIOBLASTOSIS OF THE PANCREAS - DEFINITION OF THE SYNDROME AND THE MANAGEMENT OF THE SEVERE NEONATAL HYPERINSULINEMIC HYPOGLYCEMIA. ARCH DIS CHILD. 56:496-508.
• TAPIA FJ; BARBOSA AJA; MARANGOS PJ; POLAK JM; BLOOM SR; DERMODY C. (1981). NEURON-SPECIFIC ENOLASE IS PRODUCED BY NEUROENDOCRINE TUMORS. LANCET. 1:808-811.
• LEE YC; TERENGHI G; POLAK JM; BLOOM SR. (1981). NEUROTENSIN IN ADRENAL-MEDULLA OF THE CAT. ACTA ENDOCRINOL-COP. 97:84-84.
• BLOOM SR; EDWARDS AV; FIELDING AS. (1981). PANCREATIC ENDOCRINE FUNCTION IN CORTISOL-TREATED THYROIDECTOMIZED CALVES. J PHYSIOL-LONDON. 318:395-406.
• BLACKBURN AM; BLOOM SR; EDWARDS AV. (1981). PANCREATIC ENDOCRINE RESPONSES TO EXOGENOUS NEUROTENSIN IN THE CONSCIOUS CALF. J PHYSIOL-LONDON. 314:11-21.
• BLACKBURN AM; BLOOM SR; EDWARDS AV. (1981). PANCREATIC ENDOCRINE RESPONSES TO PHYSIOLOGICAL-CHANGES IN PLASMA NEUROTENSIN CONCENTRATION IN THE CALF. J PHYSIOL-LONDON. 318:407-412.
• BLOOM SR; EDWARDS AV. (1981). PANCREATIC ENDOCRINE RESPONSES TO STIMULATION OF THE PERIPHERAL ENDS OF THE VAGUS NERVES IN CONSCIOUS CALVES. J PHYSIOL-LONDON. 315:31-41.
• BLOOM SR; EDWARDS AV; FIELDING AS. (1981). PANCREATIC HORMONE CHANGES IN EXPERIMENTAL DIABETES IN THE CALF. DIABETOLOGIA. 20:666-666.
• LUCAS A; AYNSLEYGREEN A; BLACKBURN AM; ADRIAN TE; BLOOM SR. (1981). PLASMA NEUROTENSIN IN TERM AND PRETERM NEONATES. ACTA PAEDIATR SCAND. 70:201-206.
• LONG RG; TIEDEMANN K; PRITCHARD J; BLOOM SR. (1981). PLASMA VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) AND OTHER PEPTIDES IN CHILDREN WITH NEUROGENIC TUMORS. GASTROENTEROLOGY. 80:1217-1217.
• TIEDEMANN K; LONG RG; PRITCHARD J; BLOOM SR. (1981). PLASMA VASOACTIVE INTESTINAL POLYPEPTIDE AND OTHER REGULATORY PEPTIDES IN CHILDREN WITH NEUROGENIC TUMORS. EUR J PEDIATR. 137:147-150.
• STEIN BA; BUCHAN AMJ; BRYANT MG; GREGOR M; MORRIS J; BLOOM SR; POLAK JM. (1981). REGULATORY PEPTIDES IN THE HUMAN-FETAL STOMACH. GUT. 22:A883-A884.
• ANDERSON PO; BLOOM SR; EDWARDS AV; JARHULT J. (1981). RELEASE OF VASOACTIVE INTESTINAL PEPTIDE (VIP) FROM THE SUB-MAXILLARY GLAND OF THE CAT. J PHYSIOL-LONDON. 313:P20-P21.
• JENKINS DJA; TAYLOR RH; GOFF DV; FIELDEN H; MISIEWICZ JJ; SARSON DL; BLOOM SR; ALBERTI KGMM. (1981). SCOPE AND SPECIFICITY OF ACARBOSE IN SLOWING CARBOHYDRATE-ABSORPTION IN MAN. DIABETES. 30:951-954.
• WRIGHT NA; ALMUKHTAR M; SAGOR G; BLOOM S. (1981). SEARCH FOR AN APPROPRIATE MEASUREMENT OF PROLIFERATIVE STATUS IN EXPERIMENTAL WORK IN INTESTINAL ADAPTATION. GUT. 22:A439-A439.
• LONG RG; PETERS JR; BLOOM SR; BROWN MR; VALE W; RIVIER JE; GRAHAMESMITH DG. (1981). SOMATOSTATIN, GASTROINTESTINAL PEPTIDES, AND THE CARCINOID-SYNDROME. GUT. 22:549-553.
• GIBSON SJ; POLAK JM; BLOOM SR; WALL PD. (1981). THE DISTRIBUTION OF 9 PEPTIDES IN RAT SPINAL-CORD WITH SPECIAL EMPHASIS ON THE SUBSTANTIA GELATINOSA AND ON THE AREA AROUND THE CENTRAL CANAL (LAMINA-XBAR). J COMP NEUROL. 201:65-79.
• FRIER BM; ASHBY JP; ADRIAN TE; BLOOM SR; STRACHAN RK; CORRALL RJM. (1981). THE EFFECT OF ADRENERGIC DENERVATION ON THE ENTEROPANCREATIC SYSTEM FOLLOWING A MEAL IN MAN. DIABETOLOGIA. 21:271-272.
• ADRIAN TE; BARNES AJ; LONG RG; OSHAUGHNESSY DJ; BROWN MR; RIVIER J; VALE W; BLACKBURN AM; et alBLOOM SR. (1981). THE EFFECT OF SOMATOSTATIN ANALOGS ON SECRETION OF GROWTH, PANCREATIC, AND GASTROINTESTINAL HORMONES IN MAN. J CLIN ENDOCR METAB. 53:675-681.
• MITCHENERE P; ADRIAN TE; HOBBS KEF; BLOOM SR. (1981). THE EFFECTS OF CERULEIN AND A MEAL STIMULUS ON GALLBLADDER INTRALUMINAL PRESSURE AND BILE-FLOW IN THE PIG. BRIT J SURG. 68:154-157.
• FRIER BM; CORRALL RJM; ASHBY JP; ADRIAN TE; BLOOM SR. (1981). THE MECHANISM OF ABNORMAL PANCREATIC BETA-CELL RESPONSE TO FOOD FOLLOWING ACUTE HYPOGLYCEMIA IN MAN. HORM METAB RES. 13:191-195.
• BLOOM SR; EDWARDS AV. (1981). THE ROLE OF THE PARASYMPATHETIC SYSTEM IN THE CONTROL OF INSULIN RELEASE IN THE CONSCIOUS CALF. J PHYSIOL-LONDON. 314:37-46.
• BLOOM SR. (1981). TREATMENT OF DUMPING. LANCET. 1:1209-1209.
• BUCHAN AMJ; POLAK JM; BRYANT MG; BLOOM SR; PEARSE AGE. (1981). VASOACTIVE INTESTINAL POLYPEPTIDE (VIP)-LIKE IMMUNOREACTIVITY IN ANURAN INTESTINE. CELL TISSUE RES. 216:413-422.
• OMORAIN C; BISHOP AE; LEVI AJ; PETERS TJ; BLOOM SR; POLAK JM. (1981). VIP NERVES IN ENDOSCOPIC RECTAL BIOPSIES FROM PATIENTS WITH INFLAMMATORY BOWEL-DISEASE - A DOUBLE-BLIND-STUDY. GASTROENTEROLOGY. 80:1234-1234.
• OMORAIN C; BISHOP AE; POLAK JM; BLOOM SR; LEVI AJ; PETERS TJ. (1981). VIP NERVES IN ENDOSCOPIC RECTAL BIOPSIES FROM PATIENTS WITH INFLAMMATORY BOWEL-DISEASE - A DOUBLE-BLIND-STUDY. GUT. 22:A440-A440.
• POLAK JM; MINA S; GU J; BLOOM SR. (1981). VIPERGIC NERVES IN THE PENIS. LANCET. 2:217-219.
• LONG RG; BRYANT MG; POLAK JM; BLOOM SR. (1981). VIPOMA PRODUCING MULTIPLE MOLECULAR-FORMS - STUDIES WITH METOCLOPRAMIDE. GASTROENTEROLOGY. 80:1216-1216.
• RENNIE JA; CHRISTOFIDES ND; ELLIS MR; MICHENER P; BLOOM SR; JOHNSON AG. (1980). A COMPARISON OF ENDOGENOUS AND EXOGENOUS MOTILIN ON COLONIC MOTILITY. BRIT J SURG. 67:369-369.
• SARSON DL; BRYANT MG; BLOOM SR. (1980). A RADIOIMMUNOASSAY OF GASTRIC-INHIBITORY POLYPEPTIDE IN HUMAN-PLASMA. J ENDOCRINOL. 85:487-496.
• BISHOP AE; POLAK JM; LAKE B; BRYANT MG; BLOOM SR. (1980). ABNORMALITIES OF NEURAL AND HORMONAL PEPTIDES IN HIRSCHSPRUNGS-DISEASE. GUT. 21:A460-A460.
• POLAK JM; BISHOP AE; LAKE B; BRYANT MG; BLOOM SR. (1980). ABNORMALITIES OF THE PEPTIDERGIC NERVOUS-SYSTEM IN HIRSCHSPRUNGS-DISEASE. LAB INVEST. 42:143-144.
• BISHOP AE; POLAK JM; BRYANT MG; BLOOM SR; HAMILTON S. (1980). ABNORMALITIES OF VASOACTIVE INTESTINAL POLYPEPTIDE-CONTAINING NERVES IN CROHNS-DISEASE. GASTROENTEROLOGY. 79:853-860.
• VIBERTI GC; KEEN H; BLOOM SR. (1980). BETA-BLOCKADE AND DIABETES-MELLITUS - EFFECT OF OXPRENOLOL AND METOPROLOL ON THE METABOLIC, CARDIOVASCULAR, AND HORMONAL RESPONSE TO INSULIN-INDUCED HYPOGLYCEMIA IN INSULIN-DEPENDENT DIABETICS. METABOLISM. 29:873-879.
• VIBERTI GC; KEEN H; BLOOM SR. (1980). BETA-BLOCKADE AND DIABETES-MELLITUS - EFFECT OF OXPRENOLOL AND METOPROLOL ON THE METABOLIC, CARDIOVASCULAR, AND HORMONAL RESPONSE TO INSULIN-INDUCED HYPOGLYCEMIA IN NORMAL SUBJECTS. METABOLISM. 29:866-872.
• JUNG RT; WOOD SM; CHALMERS RA; CANNON JA; BLOOM SR. (1980). BLOOD-GLUCOSE MONITORING. LANCET. 2:1203-1203.
• LUCAS A; BLACKBURN AM; AYNSLEYGREEN A; SARSON DL; ADRIAN TE; BLOOM SR. (1980). BREAST VS BOTTLE - ENDOCRINE RESPONSES ARE DIFFERENT WITH FORMULA FEEDING. LANCET. 1:1267-1269.
• MCDONALD TJ; TRACK N; BLOOM SR; GHATEI M; MUTT V; DUPRE J. (1980). CANINE PLASMA-INSULIN, GLUCAGON AND GIP RESPONSES TO BOMBESIN AND A STRUCTURALLY RELATED PORCINE GI PEPTIDE. CLIN RES. 28:A692-A692.
• MCDONALD TJ; TRACK N; BLOOM SR; GHATEI M; MUTT V. (1980). CANINE PLASMA-LEVELS OF GI HORMONES AFTER ADMINISTRATION OF BOMBESIN AND A STRUCTURALLY RELATED PORCINE GI PEPTIDE. CLIN RES. 28:A679-A679.
• SCOPINARO N; SARSON DL; CIVALLERI D; GIANETTA E; BONALUMI U; FRIEDMAN D; BLOOM SR. (1980). CHANGES IN PLASMA GUT HORMONES AFTER BILIOPANCREATIC BYPASS FOR OBESITY - A PRELIMINARY-REPORT. ITAL J GASTROENTEROL. 12:93-96.
• BLOOM SR; LONG RG; BRYANT MG; MITCHELL SJ; POLAK JM. (1980). CLINICAL BIOCHEMICAL AND PATHOLOGICAL-STUDIES ON 62 VIPOMAS. GASTROENTEROLOGY. 78:1143-1143.
• LONG RG; CHRISTOFFIDES ND; FITZPATRICK ML; BLOOM SR. (1980). CONTRARY EFFECTS OF EXOGENOUS INFUSION OF SOMATOSTATIN AND MOTILIN ON GLUCOSE-TOLERANCE. DIABETOLOGIA. 19:295-295.
• LUCAS A; BLOOM SR; AYNSLEYGREEN A. (1980). DEVELOPMENT OF GUT HORMONE RESPONSES TO FEEDING IN NEONATES. ARCH DIS CHILD. 55:678-682.
• LUCAS A; SARSON DL; BLOOM SR; AYNSLEYGREEN A. (1980). DEVELOPMENTAL ASPECTS OF GASTRIC-INHIBITORY POLYPEPTIDE (GIP) AND ITS POSSIBLE ROLE IN THE ENTERO-INSULAR AXIS IN NEONATES. ACTA PAEDIATR SCAND. 69:321-325.
• BLOOM SR; EDWARDS AV. (1980). DEVELOPMENTAL-CHANGES IN THE PANCREATIC NEUROENDOCRINE RESPONSES TO 2-DEOXYGLUCOSE IN THE YOUNG CALF. J PHYSIOL-LONDON. 302:P24-P25.
• LUCAS A; ADRIAN TE; BLOOM SR; AYNSLEYGREEN A. (1980). DIFFERENCES IN ALIMENTARY HORMONE RESPONSES BETWEEN BREAST AND BOTTLE-FED INFANTS. PEDIATR RES. 14:179-179.
• BUCHAN AMJ; CHRISTOFIDES N; KISHIMOTO S; POLAK JM; BLOOM SR. (1980). DOES CO-STORAGE OF AMINE AND PEPTIDE IN A SINGLE CELL AFFECT ANTIBODY-BINDING. J PATHOL. 131:260-260.
• BUCHAN AMJ; CHRISTOFIDES N; KISHIMOTO S; POLAK JM; BLOOM SR. (1980). DOES CO-STORAGE OF AMINE AND PEPTIDE IN A SINGLE CELL AFFECT ANTIBODY-BINDING. J MED MICROBIOL. 13:PR14-PR14.
• BLACKBURN AM; EDWARDS AV; MCGREGOR GP; BLOOM SR. (1980). DOES NEUROTENSIN CONTROL INSULIN RELEASE. DIABETOLOGIA. 19:558-558.
• BARNES AJ; LONG RG; BANNISTER R; BROWN M; ADRIAN TE; BLOOM SR. (1980). EFFECT OF AUTONOMIC NEUROPATHY ON HORMONE-RELEASE AND BLOOD-GLUCOSE - STUDIES OF PATIENTS WITH SHY-DRAGER AND CHAGAS DISEASES. DIABETOLOGIA. 19:255-256.
• RENNIE JA; CHRISTOFIDES ND; ELLIS MR; MICHENER P; JOHNSON AG; BLOOM SR. (1980). EFFECT OF MOTILIN ON HUMAN COLONIC ACTIVITY. CLIN SCI. 58:P12-P12.
• BLOOM SR; EDWARDS AV. (1980). EFFECTS OF AUTONOMIC STIMULATION ON THE RELEASE OF VASOACTIVE INTESTINAL PEPTIDE FROM THE GASTROINTESTINAL-TRACT IN THE CALF. J PHYSIOL-LONDON. 299:437-452.
• LONG RG; CHRISTOFIDES ND; FITZPATRICK ML; MCGREGOR GP; BLOOM SR. (1980). EFFECTS OF MOTILIN AND SOMATOSTATIN ON GASTRIC-EMPTYING AND GLUCOSE-TOLERANCE. GASTROENTEROLOGY. 78:1210-1210.
• ADRIAN TE; GREENBERG GR; BARNES AJ; CHRISTOFIDES ND; ALBERTI KGMM; BLOOM SR. (1980). EFFECTS OF PANCREATIC-POLYPEPTIDE ON MOTILIN AND CIRCULATING METABOLITES IN MAN. EUR J CLIN INVEST. 10:235-240.
• LONG RG; PETERS JR; GRAHAMESMITH DG; OSHAUGHNESSY DJ; VALE W; RIVIER JE; BROWN MR; BLOOM SR. (1980). EFFECTS OF SOMATOSTATIN ON FLUSHING AND PLASMA GASTROINTESTINAL PEPTIDES IN THE CARCINOID-SYNDROME. CLIN SCI. 59:P9-P9.
• LONG RG; PETERS JR; GRAHAMESMITH DG; BLOOM SR. (1980). EFFECTS OF SOMATOSTATIN ON PROVOKED FLUSHING AND PLASMA GUT HORMONES IN THE CARCINOID-SYNDROME. GUT. 21:A464-A464.
• BLACKBURN AM; CHRISTOFIDES ND; GHATEI MA; SARSON DL; EBEID FH; RALPHS DNL; BLOOM SR. (1980). ELEVATION OF PLASMA NEUROTENSIN IN THE DUMPING SYNDROME. CLIN SCI. 59:237-243.
• LUCAS A; BLOOM SR; AYNSLEYGREEN A. (1980). ENDOCRINE AND METABOLIC EFFECTS OF DEPRIVATION OF ENTERAL FEEDING IN SICK PRE-TERM INFANTS. PEDIATR RES. 14:1421-1421.
• LONG RG; BARNES AJ; ALBUQUERQUE RH; BANNISTER R; ADRIAN TE; BLOOM SR. (1980). EVIDENCE FOR FUNCTIONAL PANCREATIC ENDOCRINE DENERVATION IN CHAGAS-DISEASE AND THE SHY-DRAGER SYNDROME. EUR J CLIN INVEST. 10:23-23.
• BARNES AJ; BROWN PM; LOWY C; SONKSEN PH; BLOOM SR. (1980). GASTROINTESTINAL MEDIATOR OF INSULIN ACTION. LANCET. 1:661-662.
• BLOOM SR; POLAK JM. (1980). GLUCAGONOMAS, VIPOMAS AND SOMATOSTATINOMAS. CLIN ENDOCRINOL META. 9:285-297.
• LUCAS A; ADRIAN TE; BLOOM SR; AYNSLEYGREEN A. (1980). GUT HORMONES IN THE NEONATE. PEDIATR RES. 14:177-177.
• JOHNSTON DG; ALBERTI KGMM; NATTRASS M; BARNES AJ; BLOOM SR; JOPLIN GF. (1980). HORMONAL AND METABOLIC RHYTHMS IN CUSHINGS-SYNDROME. METABOLISM. 29:1046-1052.
• BARNES AJ; BOTTAZZO GF; DONIACH D; CHRISTOFIDES ND; BLOOM SR. (1980). HORMONAL AND METABOLIC STUDIES IN PATIENTS WITH CIRCULATING GLUCAGON-CELL AND SOMATOSTATIN-CELL ANTIBODIES. CLIN SCI. 58:P21-P21.
• POLAK JM; BISHOP AE; HAMILTON S; BRYANT MG; BLOOM SR. (1980). HYPERPLASIA OF VIP CONTAINING NERVES OF THE GUT IN CROHNS-DISEASE AS A DIFFERENTIAL DIAGNOSTIC-TOOL. J HISTOCHEM CYTOCHEM. 28:618-619.
• LUCAS A; ADRIAN TE; AYNSLEYGREEN A; BLOOM SR. (1980). IATROGENIC HYPERINSULINISM AT BIRTH. LANCET. 1:144-145.
• BUCHAN AMJ; POLAK JM; BRYANT MG; BLOOM SR. (1980). IMMUNO-CYTOCHEMICAL LOCALIZATION OF GUT HORMONES IN HUMAN-FETAL INTESTINE. GUT. 21:A907-A907.
• JENKINS DJA; WOLEVER TMS; NINEHAM R; SARSON DL; BLOOM SR; AHERN J; ALBERTI KGMM; HOCKADAY TDR. (1980). IMPROVED GLUCOSE-TOLERANCE 4 HOURS AFTER TAKING GUAR WITH GLUCOSE. DIABETOLOGIA. 19:21-24.
• BLOOM SR; EDWARDS AV; JARHULT J. (1980). INHIBITORY EFFECT OF SOMATOSTATIN ON CERTAIN PANCREATIC NEUROENDOCRINE RESPONSES. J PHYSIOL-LONDON. 300:P52-P52.
• MONSON JP; BORTHWICK LJ; SPATHIS GS; BLOOM SR. (1980). INSULINOPENIA IN IMPAIRED GLUCOSE-TOLERANCE PRESERVATION OF INSULIN-RESPONSE TO IV ARGININE AND TOLBUTAMIDE. ACTA DIABETOL LAT. 17:1-7.
• BISHOP AE; POLAK JM; GREEN IC; BRYANT MG; BLOOM SR. (1980). LOCATION OF VIP IN THE PANCREAS OF MAN AND RAT. DIABETOLOGIA. 18:73-78.
• MITCHENERE P; ADRIAN TE; BLOOM SR; HOBBS KEF. (1980). MEASUREMENT OF GALLBLADDER PRESSURE BY RADIOTELEMETRY. GASTROENTEROLOGY. 78:1224-1224.
• PICKUP JC; VIBERTI GC; BILOUS RW; DALTON N; BINDER C; BLOOM SR; ALBERTI KGMM; KEEN H. (1980). METABOLIC AND HORMONAL DECOMPENSATION AFTER DELIBERATE WITHDRAWAL OF PROLONGED SUBCUTANEOUS INSULIN INFUSION. DIABETOLOGIA. 19:563-563.
• RENNIE JA; CHRISTOFIDES ND; MITCHENERE P; JOHNSON AG; BLOOM SR. (1980). MOTILIN AND HUMAN COLONIC ACTIVITY. GASTROENTEROLOGY. 78:1243-1243.
• LONG RG; BARNES AJ; OSHAUGHNESSY DJ; BANNISTER R; BISHOP AE; ALBUQUERQUE RH; MCGREGOR GP; POLAK JM; et alBLOOM SR. (1980). NEURAL AND HORMONAL PEPTIDES IN RECTAL BIOPSY SPECIMENS FROM PATIENTS WITH CHAGAS-DISEASE AND CHRONIC AUTONOMIC FAILURE. LANCET. 1:559-562.
• RENNIE JA; CHRISTOFIDES ND; MITCHENERE P; FLETCHER D; STOCKLEYLEATHARD HL; BLOOM SR; JOHNSON AG; HARDINGRAINS AJ. (1980). NEURAL AND HUMORAL-FACTORS IN POSTOPERATIVE ILEUS. BRIT J SURG. 67:694-698.
• BLOOM SR; BLOOM FE. (1980). OF NEURO-HYPOTHESIS AND ENTERO-HARMONY. REGUL PEPTIDES. 1:R5-R6.
• BLOOM SR; EDWARDS AV. (1980). PANCREATIC ENDOCRINE RESPONSES TO SPLANCHNIC NERVE-STIMULATION IN CONSCIOUS ADRENALECTOMIZED CALVES. J PHYSIOL-LONDON. 301:P88-P89.
• BLOOM SR; EDWARDS AV. (1980). PANCREATIC ENDOCRINE RESPONSES TO STIMULATION OF THE PERIPHERAL ENDS OF THE SPLANCHNIC NERVES IN THE CONSCIOUS ADRENALECTOMIZED CALF. J PHYSIOL-LONDON. 308:39-48.
• BLOOM SR; ADRIAN TE; POLAK JM. (1980). PANCREATIC-POLYPEPTIDE FROM PANCREATIC ENDOCRINE TUMORS. LANCET. 2:1026-1026.
• LUX G; FEMPPEL J; LEDERER P; ADRIAN T; ROSCH W; BLOOM SR; DOMSCHKE W. (1980). PANCREATIC-POLYPEPTIDE, MOTILIN AND SOMATOSTATIN LEVELS DURING INTERDIGESTIVE MOTILITY IN MAN. GASTROENTEROLOGY. 78:1212-1212.
• JESSEN KR; POLAK JM; VANNOORDEN S; BLOOM SR; BURNSTOCK G. (1980). PEPTIDE-CONTAINING NEURONS CONNECT THE 2 GANGLIONATED PLEXUSES OF THE ENTERIC NERVOUS-SYSTEM. NATURE. 283:391-393.
• BISHOP AE; POLAK JM; ALBUQUERQUE RH; MACGREGOR GP; BLOOM SR. (1980). PEPTIDERGIC INNERVATION IN EXPERIMENTAL CHAGAS-DISEASE. J MED MICROBIOL. 13:PR2-PR2.
• BISHOP AE; POLAK JM; ALBUQUERQUE RH; MACGREGOR GP; BLOOM SR. (1980). PEPTIDERGIC INNERVATION IN EXPERIMENTAL CHAGAS-DISEASE. J PATHOL. 131:255-256.
• LUCAS A; ADRIAN TE; CHRISTOFIDES N; BLOOM SR; AYNSLEYGREEN A. (1980). PLASMA MOTILIN, GASTRIN, AND ENTEROGLUCAGON AND FEEDING IN THE HUMAN NEWBORN. ARCH DIS CHILD. 55:673-677.
• LUCAS A; ADRIAN TE; BLOOM SR; AYNSLEYGREEN A. (1980). PLASMA PANCREATIC-POLYPEPTIDE IN THE HUMAN NEONATE. ACTA PAEDIATR SCAND. 69:211-214.
• LUCAS A; ADRIAN TE; BLOOM SR; AYNSLEYGREEN A. (1980). PLASMA SECRETIN IN NEONATES. ACTA PAEDIATR SCAND. 69:205-210.
• BLOOM SR; POLAK JM. (1980). PLASMA-HORMONE CONCENTRATIONS IN GASTROINTESTINAL-DISEASE. CLIN GASTROENTEROL. 9:785-798.
• SAGOR GR; BRYANT MG; GHATEI MA; KIRK RM; BLOOM SR. (1980). RELEASE OF VIP (VASOACTIVE INTESTINAL PEPTIDE) IN DUMPING PROVOCATION. GUT. 21:A931-A931.
• LONG RG; ALBUQUERQUE RH; PRATA A; BARNES AJ; ADRIAN TE; CHRISTOFIDES ND; BLOOM SR. (1980). RESPONSE OF PLASMA PANCREATIC AND GASTROINTESTINAL HORMONES AND GROWTH-HORMONE TO ORAL AND INTRAVENOUS GLUCOSE AND INSULIN HYPOGLYCEMIA IN CHAGAS-DISEASE. GUT. 21:772-777.
• FRIER BM; ADRIAN TE; SAUNDERS JHB; BLOOM SR. (1980). SERUM TRYPSIN CONCENTRATION AND PANCREATIC TRYPSIN SECRETION IN INSULIN-DEPENDENT DIABETES-MELLITUS. CLIN CHIM ACTA. 105:297-300.
• LONG RG; PETERS JR; OSHAUGHNESSY DJ; GRAHAMESMITH DG; VALE W; RIVIER JE; BROWN MR; BLOOM SR. (1980). SOMATOSTATIN ADMINISTRATION IN THE CARCINOID-SYNDROME. GASTROENTEROLOGY. 78:1211-1211.
• LONG RG; CHRISTOFIDES ND; FITZPATRICK ML; MITCHENERE P; BLOOM SR. (1980). SOMATOSTATIN AND MOTILIN INCREASE THE RATE OF GASTRIC-EMPTYING OF GLUCOSE. EUR J CLIN INVEST. 10:23-23.
• POLAK JM; WHARTON J; BISHOP AE; MCGREGOR GP; BLOOM SR. (1980). SUBSTANCE P-LIKE IMMUNOREACTIVE NERVES IN THE HEART. J HISTOCHEM CYTOCHEM. 28:618-618.
• BJORNSSON OG; CHRISTOFIDES ND; FLETCHER D; BLOOM SR; CHADWICK VS. (1980). SUPPRESSION OF PLASMA-LEVELS OF MOTILIN DURING DUODENAL PERFUSION OF SODIUM TAUROCHOLATE IN MAN. GASTROENTEROLOGY. 78:1142-1142.
• POLAK JM; BLOOM SR. (1980). THE DISTRIBUTION AND SIGNIFICANCE OF THE VIPERGIC SYSTEM IN MAN AND OTHER MAMMALS. ENDOCRINOL JAPON. 27:11-21.
• SCHOON IM; BLOOM SR; OLBE L. (1980). THE EFFECT OF ANTRAL DISTENSION IN HEALTHY-SUBJECTS ON BETAZOLE-STIMULATED GASTRIC-ACID SECRETION AND THE PLASMA-CONCENTRATION OF IMMUNOREACTIVE NEUROTENSIN. SCAND J GASTROENTERO. 15:277-282.
• BLOOM SR; EDWARDS AV; JARHULT J. (1980). THE EFFECT OF SOMATOSTATIN ON PANCREATIC ENDOCRINE RESPONSES MEDIATED VIA THE PARASYMPATHETIC INNERVATION IN THE CONSCIOUS CALF. J PHYSIOL-LONDON. 308:29-38.
• BLOOM SR; EDWARDS AV. (1980). THE ROLE OF THE PARASYMPATHETIC SYSTEM IN THE CONTROL OF INSULIN RELEASE. DIABETOLOGIA. 19:258-259.
• BLOOM SR; EDWARDS AV. (1980). VASOACTIVE INTESTINAL PEPTIDE IN RELATION TO ATROPINE RESISTANT VASODILATATION IN THE SUB-MAXILLARY GLAND OF THE CAT. J PHYSIOL-LONDON. 300:41-53.
• ROBERTS GW; WOODHAMS PL; BRYANT MG; CROW TJ; BLOOM SR; POLAK JM. (1980). VIP IN THE RAT-BRAIN - EVIDENCE FOR A MAJOR PATHWAY LINKING THE AMYGDALA AND HYPOTHALAMUS VIA THE STRIA TERMINALIS. HISTOCHEMISTRY. 65:103-119.
• BLOOM SR. (1980). WHATS WRONG WITH FREEDOM. DIABETOLOGIA. 18:427-427.
• BLOOM SR; ADRIAN TE; BARNES AJ; POLAK JM. (1979). AUTO-IMMUNITY IN DIABETICS INDUCED BY HORMONAL CONTAMINANTS OF INSULIN. LANCET. 2:14-17.
• TIMSON CM; POLAK JM; WHARTON J; GHATEI MA; BLOOM SR; USELLINI L; CAPELLA C; SOLCIA E; et alBROWN MR; PEARSE AGE. (1979). BOMBESIN-LIKE IMMUNOREACTIVITY IN THE AVIAN GUT AND ITS LOCALIZATION TO A DISTINCT CELL TYPE. HISTOCHEMISTRY. 61:213-221.
• LONG RG; MITCHELL SJ; BRYANT MG; POLAK JM; BLOOM SR. (1979). CLINICO-PATHOLOGICAL STUDY OF PANCREATIC AND NEURAL VIPOMAS. GUT. 20:A934-A934.
• BLOOM SR; LUCAS A; ADRIAN TE; AYNSLEYGREEN A. (1979). DIFFERENCES IN ALIMENTARY HORMONE RESPONSES BETWEEN BREAST AND BOTTLE-FED INFANTS. GASTROENTEROLOGY. 76:1103-1103.
• POLAK JM; BLOOM SR. (1979). DIFFUSE NEURO-ENDOCRINE SYSTEM - STUDIES OF THIS NEWLY DISCOVERED CONTROLLING SYSTEM IN HEALTH AND DISEASE. J HISTOCHEM CYTOCHEM. 27:1398-1400.
• BRYANT MG; BLOOM SR. (1979). DISTRIBUTION OF THE GUT HORMONES IN THE PRIMATE INTESTINAL-TRACT. GUT. 20:653-659.
• AYNSLEYGREEN A; LUCAS A; BLOOM SR. (1979). EFFECT OF FEEDS OF DIFFERING COMPOSITION ON ENTERO-INSULAR HORMONE-SECRETION IN THE 1ST HOURS OF LIFE IN HUMAN NEONATES. ACTA PAEDIATR SCAND. 68:265-270.
• CHRISTOFIDES ND; MODLIN IM; FITZPATRICK ML; BLOOM SR. (1979). EFFECT OF MOTILIN ON THE RATE OF GASTRIC-EMPTYING AND GUT HORMONE-RELEASE DURING BREAKFAST. GASTROENTEROLOGY. 76:903-907.
• CHALMERS RJ; BLOOM SR; DUNCAN G; JOHNSON RH; SULAIMAN WR. (1979). EFFECT OF SOMATOSTATIN ON METABOLIC AND HORMONAL CHANGES DURING AND AFTER EXERCISE. CLIN ENDOCRINOL. 10:451-458.
• BJORNSSON OG; CHRISTOFIDES ND; ADRIAN TE; RUMP S; FLETCHER D; BLOOM SR; CHADWICK VS. (1979). EFFECTS OF DUODENAL PERFUSION OF SODIUM TAUROCHOLATE ON BILIARY AND PANCREATIC OUTPUT AND GUT HORMONE-RELEASE IN MAN. CLIN SCI. 57:P28-P29.
• BJORNSSON OG; ADRIAN TE; DAWSON J; MCCLOY RF; GREENBERG GR; BLOOM SR; CHADWICK VS. (1979). EFFECTS OF GASTRO-INTESTINAL HORMONES ON FASTING GALLBLADDER STORAGE PATTERNS IN MAN. EUR J CLIN INVEST. 9:293-300.
• BLOOM SR; ADRIAN TE; LUCAS A; AYNSLEYGREEN A. (1979). ELEVATED ENTEROGLUCAGON IN NEONATES DEPENDS ON ENTERAL FEEDING. GASTROENTEROLOGY. 76:1101-1101.
• LUCAS A; CHRISTOFIDES ND; ADRIAN TE; BLOOM SR; AYNSLEYGREEN A. (1979). FETAL DISTRESS, MECONIUM, AND MOTILIN. LANCET. 1:718-718.
• DAMMANN HG; BESTERMAN HS; BLOOM SR; SCHREIBER HW. (1979). GASTRO-INTESTINAL HORMONES AND TOTAL DUODENOPANCREATECTOMY. Z GASTROENTEROL. 17:567-567.
• LUCAS A; ADRIAN TE; AYNSLEYGREEN A; BLOOM SR. (1979). GUT HORMONES IN FETAL DISTRESS. LANCET. 2:968-968.
• ADRIAN TE; AYNSLEYGREEN A; BLOOM SR; LUCAS A. (1979). GUT HORMONES IN THE NEONATE. ARCH DIS CHILD. 54:979-979.
• BESTERMAN HS; COOK GC; SARSON DL; CHRISTOFIDES ND; BRYANT MG; GREGOR M; BLOOM SR. (1979). GUT HORMONES IN TROPICAL MALABSORPTION. BRIT MED J. 2:1252-1255.
• BLOOM SR. (1979). HORMONAL PEPTIDES OF THE GASTRO-INTESTINAL TRACT. EUR J CLIN INVEST. 9:111-113.
• ADRIAN TE; BARNES AJ; BLOOM SR. (1979). HYPOTRYPSINEMIA IN DIABETES-MELLITUS. CLIN CHIM ACTA. 97:213-216.
• POLAK JM; BUCHAN AMJ; BRYANT MG; TIMSON CM; BLOOM SR. (1979). INTESTINAL GASTRIN - CELLULAR-ORIGIN, ONTOGENY AND TUMOR DISTRIBUTION. GASTROENTEROLOGY. 76:1219-1219.
• BUCHAN AMJ; BRYANT MG; TIMSON CM; POLAK JM; BLOOM SR. (1979). INTESTINAL GASTRIN - ONTOGENY AND TUMOR DISTRIBUTION. GUT. 20:A454-A454.
• LUCAS A; BLOOM SR; AYNSLEYGREEN A. (1979). METABOLIC AND ENDOCRINE EVENTS AT THE TIME OF THE 1ST FEED OF HUMAN MILK IN PRETERM AND TERM INFANTS. PEDIATR RES. 13:80-80.
• BLOOM SR; POLAK JM. (1979). MOTILIN AND NEUROTENSIN. CLIN ENDOCRINOL META. 8:401-411.
• VANTRAPPEN G; JANSSENS J; PEETERS TL; BLOOM SR; CHRISTOFIDES ND; HELLEMANS J. (1979). MOTILIN AND THE INTERDIGESTIVE MIGRATING MOTOR COMPLEX IN MAN. DIGEST DIS SCI. 24:497-500.
• CHRISTOFIDES ND; LONG RG; FITZPATRICK ML; BLOOM SR. (1979). MOTILIN INCREASES THE RATE OF GASTRIC-EMPTYING OF GLUCOSE. GUT. 20:A924-A924.
• BLOOM SR; LUCAS A; CHRISTOFIDES ND; ADRIAN TE; AYNSLEYGREEN A. (1979). MOTILIN, ASPECTS OF ITS DEVELOPMENTAL PHYSIOLOGY. GASTROENTEROLOGY. 76:1103-1103.
• REVERDIN N; HUTTON M; LING A; WINGATE DL; RITCHIE HD; CHRISTOFIDES N; ADRIAN TE; BLOOM SR. (1979). MOTOR RESPONSE TO FOOD - VAGUS-DEPENDENT OR INDEPENDENT. GASTROENTEROLOGY. 76:1225-1225.
• POLAK JM; BLOOM SR. (1979). NEURO-ENDOCRINE DESIGN OF THE GUT. CLIN ENDOCRINOL META. 8:313-330.
• BLOOM SR; LUCAS A; BLACKBURN AM; ADRIAN TE; AYNSLEYGREEN A. (1979). NEUROTENSIN IN THE NEWBORN. GASTROENTEROLOGY. 76:1103-1103.
• POLAK JM; BLOOM SR. (1979). PEPTIDERGIC INNERVATION - OLD ENIGMA SOLVED. ANN ROY COLL SURG. 61:154-154.
• ADRIAN TE; BESTERMAN HS; MALLINSON CN; PERA A; REDSHAW MR; WOOD TP; BLOOM SR. (1979). PLASMA TRYPSIN IN CHRONIC-PANCREATITIS AND PANCREATIC ADENOCARCINOMA. CLIN CHIM ACTA. 97:205-212.
• SARSON DL; BESTERMAN HS; BLOOM SR. (1979). RADIOIMMUNOASSAY OF GASTRIC-INHIBITORY POLYPEPTIDE AND ITS RELEASE IN MORBID OBESITY AND AFTER JEJUNO-ILEAL BYPASS. J ENDOCRINOL. 81:P155-P156.
• BLOOM SR; EDWARDS AV. (1979). RELATIONSHIP BETWEEN RELEASE OF VASOACTIVE INTESTINAL PEPTIDE IN THE SALIVARY-GLAND OF THE CAT IN RESPONSE TO PARASYMPATHETIC STIMULATION AND THE ATROPINE RESISTANT VASODILATATION. J PHYSIOL-LONDON. 295:P35-P36.
• CHRISTOFIDES ND; BLOOM SR; BESTERMAN HS; ADRIAN TE; GHATEI MA. (1979). RELEASE OF MOTILIN BY ORAL AND INTRAVENOUS NUTRIENTS IN MAN. GUT. 20:102-106.
• BLOOM SR; EDWARDS AV; MITCHELL SJ. (1979). RELEASE OF VASOACTIVE INTESTINAL PEPTIDE FROM THE GASTRO-INTESTINAL TRACT IN RESPONSE TO AUTONOMIC STIMULATION IN THE CALF. J PHYSIOL-LONDON. 289:P47-P47.
• RENNIE JA; CHRISTOFIDES ND; BLOOM SR; JOHNSON AG. (1979). STIMULATION OF HUMAN COLONIC ACTIVITY BY MOTILIN. GUT. 20:A912-A912.
• WHARTON J; POLAK JM; BLOOM SR; WILL JA; BROWN MR; PEARSE AGE. (1979). SUBSTANCE P-LIKE IMMUNOREACTIVE NERVES IN MAMMALIAN LUNG. INVEST CELL PATHOL. 2:3-10.
• LONG RG; ADRIAN TE; BROWN MR; RIVIER JE; BARNES AJ; MALLINSON CN; VALE W; CHRISTOFIDES ND; et alBLOOM SR. (1979). SUPPRESSION OF PANCREATIC ENDOCRINE TUMOR SECRETION BY LONG-ACTING SOMATOSTATIN ANALOG. LANCET. 2:764-767.
• MODLIN IM; BLOOM SR; MITCHELL S. (1979). VIP AND THE WDHA SYNDROME. GASTROENTEROLOGY. 76:1078-1079.
• BARRACLOUGH MA; BLOOM SR. (1979). VIPOMA OF THE PANCREAS - OBSERVATIONS ON THE DIARRHEA AND CIRCULATORY DISTURBANCES. ARCH INTERN MED. 139:467-471.
• POLAK JM; WHARTON J; BLOOM SR; GHATEI MA; SOLCIA E; BROWN MR. (1978). BOMBESIN, POSSIBLE ROLE OF A NEW GUT AND BRAIN PEPTIDE. GASTROENTEROLOGY. 74:1078-1078.
• WHARTON J; POLAK JM; BLOOM SR; GHATEI MA; SOLCIA E; BROWN MR; PEARSE AGE. (1978). BOMBESIN-LIKE IMMUNOREACTIVITY IN LUNG. NATURE. 273:769-770.
• BESTERMAN HS; SARSON DL; STEWART J; GUERIN S; MODIGLIANI R; MALLINSON CN; BLOOM SR. (1978). CELIAC-DISEASE - DIAGNOSTIC HORMONE PROFILE. CLIN SCI MOL MED. 54:P24-P24.
• BLOOM SR; EDWARDS AV. (1978). CERTAIN PHARMACOLOGICAL CHARACTERISTICS OF RELEASE OF PANCREATIC GLUCAGON IN RESPONSE TO STIMULATION OF SPLANCHNIC NERVES. J PHYSIOL-LONDON. 280:25-35.
• EDWARDS AV; BIRCHAM PMM; MITCHELL SJ; BLOOM SR. (1978). CHANGES IN CONCENTRATION OF VASOACTIVE INTESTINAL PEPTIDE IN INTESTINAL LYMPH IN RESPONSE TO VAGAL-STIMULATION IN CALF. EXPERIENTIA. 34:1186-1187.
• BLOOM SR; BRYANT MG; ADRIAN TE; MALLINSON CN. (1978). CHROMATOGRAPHIC ANALYSIS OF TUMOR-PRODUCED HORMONES. GASTROENTEROLOGY. 74:1011-1011.
• MODLIN IM; BLOOM SR; BARNES A; WELBOURN RB. (1978). CURE OF INTRACTABLE WATERY DIARRHEA BY EXCISION OF A VIPOMA. BRIT J SURG. 65:234-236.
• POLAK JM; BLOOM SR; BISHOP AE; MCCROSSAN MV. (1978). D-CELL PATHOLOGY IN DUODENAL ULCERS AND ACHLORHYDRIA. METABOLISM. 27:1239-1242.
• WALSH CH; MALINS JM; BLOOM SR. (1978). DIABETES-MELLITUS IN IDIOPATHIC HEMOCHROMATOSIS. BRIT MED J. 2:1267-1268.
• VANTRAPPEN G; JANSSENS J; PEETERS TL; BLOOM S; VANTONGEREN J; HELLEMANS J. (1978). DOES MOTILIN HAVE A ROLE IN ELICITING INTERDIGESTIVE MIGRATING MOTOR COMPLEX(MMC) IN MAN. GASTROENTEROLOGY. 74:1149-1149.
• HACKI WH; BLOOM SR. (1978). EFFECT OF FASTING ON SECRETIN, MOTILIN, PANCREATIC POLYPEPTIDE AND ENTEROGLUCAGON IN MAN. SCHWEIZ MED WSCHR. 108:1095-1095.
• BLOOM S; IVERSEN LL; QUIK M. (1978). EFFECT OF VASOACTIVE INTESTINAL PEPTIDE (VIP) AND OTHER NEUROPEPTIDES ON CAMP ACCUMULATION IN BRAIN-SLICES. BRIT J PHARMACOL. 62:P435-P435.
• QUIK M; IVERSEN LL; BLOOM SR. (1978). EFFECT OF VASOACTIVE INTESTINAL PEPTIDE (VIP) AND OTHER PEPTIDES ON CAMP ACCUMULATION IN RAT-BRAIN. BIOCHEM PHARMACOL. 27:2209-2213.
• BLOOM SR; ADRIAN TE; GREENBERG GR; BESTERMAN HS; MCCLOY RF; CHADWICK VS; BARON JH; MALLINSON CN; et alBARNES AJ; ALBERTI KGMM. (1978). EFFECTS OF PANCREATIC POLYPEPTIDE INFUSION IN MAN. GASTROENTEROLOGY. 74:1012-1012.
• DOMSCHKE W; LUX G; DOMSCHKE S; STRUNZ U; BLOOM SR; WUNSCH E. (1978). EFFECTS OF VASOACTIVE INTESTINAL PEPTIDE ON RESTING AND PENTAGASTRIN-STIMULATED LOWER ESOPHAGEAL SPHINCTER PRESSURE. GASTROENTEROLOGY. 75:9-12.
• STRUNZ U; REISS M; BLOOM SR; GREENBERG GR; DOMSCHKE W. (1978). ELIMINATION OF SECRETIN IN DOG. GASTROENTEROLOGY. 74:1146-1146.
• SULLIVAN SN; BLOOM SR; POLAK JM. (1978). ENKEPHALIN IN PERIPHERAL NEUROENDOCRINE TUMORS. LANCET. 1:986-987.
• MODLIN IM; BLOOM SR; MITCHELL SJ. (1978). EXPERIMENTAL-EVIDENCE FOR VASOACTIVE INTESTINAL PEPTIDE AS CAUSE OF WATERY DIARRHEA SYNDROME. GASTROENTEROLOGY. 75:1051-1054.
• MALLINSON CN; BLOOM SR; ADRIAN TE; BRYANT M. (1978). GLUCAGONOMA NEWS. ANN ROY COLL SURG. 60:142-143.
• ADRIAN TE; BARNES AJ; BLOOM SR. (1978). GROSS REDUCTION OF PLASMA TRYPSIN IN DIABETES, CORRELATION WITH PP ANTIBODIES. DIABETOLOGIA. 15:213-213.
• BLOOM SR; BESTERMAN HS; ADRIAN TE; CHRISTOFIDES ND; SARSON DL; MALLINSON CN; PERA A; SOUTH M; et alMODIGLIANI R; GUERIN S. (1978). GUT HORMONE PROFILE IN PANCREATIC DISEASE. GASTROENTEROLOGY. 74:1012-1012.
• BLOOM SR; BESTERMAN HS; COOK GC; SARSON DL; CHRISTOFIDES ND. (1978). GUT HORMONE PROFILE IN POST-INFECTIVE TROPICAL MALABSORPTION (ACUTE TROPICAL-SPRUE). GASTROENTEROLOGY. 74:1011-1011.
• BLOOM SR; POLAK JM. (1978). GUT HORMONES. P NUTR SOC. 37:259-271.
• BLOOM SR; BESTERMAN HS. (1978). GUT-HORMONE PROFILE. LANCET. 1:1264-1265.
• STUBBS WA; JONES A; EDWARDS CRW; DELITALA G; JEFFCOATE WJ; RATTER SJ; BESSER GM; BLOOM SR; et alALBERTI KGMM. (1978). HORMONAL AND METABOLIC RESPONSES TO AN ENKEPHALIN ANALOG IN NORMAL MAN. LANCET. 2:1225-1227.
• BLOOM SR; LUCAS A; AYNSLEYGREEN A. (1978). HORMONAL RESPONSE TO 1ST FEEDING IN NEONATES. J PEDIATR. 93:900-901.
• BLOOM SR; BESTERMAN HS; SARSON DI; STEWART J; GUERIN S; MODIGLIANI R; MALLINSON CN. (1978). HORMONE PROFILE OF CELIAC-DISEASE. GASTROENTEROLOGY. 74:1011-1011.
• LUCAS A; BLOOM SR; AYNSLEYGREEN A. (1978). HORMONES FROM GUT AND PANCREAS IN TERM NEONATES - RESPONSE TO FETAL DISTRESS AND DIFFERENT ALIMENTARY STIMULI. PEDIATR RES. 12:1088-1088.
• POLAK JM; BUCHAN AMJ; DRYBURGH JR; CHRISTOFIDES N; BLOOM SR; YANAIHARA N. (1978). IMMUNOREACTIVE MOTILINS. LANCET. 1:1364-1365.
• BRETHOLZ A; LEVESQUE D; VOIROL M; TISCORNIA OM; BLOOM SR; SARLES H. (1978). IMPAIRED SECRETIN RELEASE IN CHRONIC-ALCOHOLIC DOGS. DIGESTION. 17:437-440.
• ADRIAN TE; BESTERMAN HS; BLOOM SR. (1978). IMPORTANCE OF CHOLINERGIC TONE ON PANCREATIC POLYPEPTIDE RELEASE. J ENDOCRINOL. 79:P26-P27.
• BARNES AJ; KOHNER EM; BLOOM SR; JOHNSTON DG; ALBERTI KGMM; SMYTHE P. (1978). IMPORTANCE OF PITUITARY HORMONES IN ETIOLOGY OF DIABETIC KETOACIDOSIS. LANCET. 1:1171-1174.
• DSA AAJB; BLOOM SR; BARON JH. (1978). INHIBITION BY SOMATOSTATIN (GROWTH-HORMONE RELEASE-INHIBITING HORMONE, GH-RIH) OF GASTRIC-ACID AND PEPSIN AND G-CELL RELEASE OF GASTRIN. GUT. 19:315-320.
• LUX G; STRUNZ U; FEMPPEL J; BLOOM SR; ROSCH W; DOMSCHKE W. (1978). INHIBITION OF LOWER ESOPHAGEAL SPHINCTER PRESSURE BY VASOACTIVE INTESTINAL PEPTIDE - MODE OF ACTION. GASTROENTEROLOGY. 74:1058-1058.
• BUCHAN AMJ; POLAK JM; BLOOM SR; HOBBS S; SULLIVAN SN; PEARSE AGE. (1978). LOCALIZATION AND DISTRIBUTION OF NEUROTENSIN IN HUMAN INTESTINE. J ENDOCRINOL. 77:P41-P42.
• MITCHELL SJ; BLOOM SR. (1978). MEASUREMENT OF FASTING AND POSTPRANDIAL PLASMA VIP IN MAN. GUT. 19:1043-1048.
• BLOOM SR; BLACKBURN AM; BESTERMAN HS; SARSON DL; POLAK JM. (1978). MEASUREMENT OF NEUROTENSIN IN MAN - NEW CIRCULATING PEPTIDE HORMONE AFFECTING INSULIN RELEASE AND CARBOHYDRATE-METABOLISM. DIABETOLOGIA. 15:220-220.
• LUCAS A; BLOOM SR; AYNSLEYGREEN A. (1978). METABOLIC AND ENDOCRINE EVENTS AT TIME OF 1ST FEED OF HUMAN MILK IN PRETERM AND TERM INFANTS. ARCH DIS CHILD. 53:731-736.
• MODLIN IM; MITZNEGG P; BLOOM SR. (1978). MOTILIN RELEASE IN PIG. GUT. 19:399-402.
• BLACKBURN AM; POLAK JM; BLOOM SR. (1978). NEUROTENSIN - NEW PEPTIDE HORMONE IN CIRCULATION OF MAN. J ENDOCRINOL. 79:P26-P26.
• BLACKBURN AM; BLOOM SR; EBEID FH; RALPHS DNL. (1978). NEUROTENSIN AND DUMPING SYNDROME. GUT. 19:A447-A447.
• BLOOM SR; BLACKBURN AM; EBEID FH; RALPHS DNL. (1978). NEUROTENSIN AND DUMPING SYNDROME. GASTROENTEROLOGY. 74:1011-1011.
• POLAK JM; HOBBS SE; BLOOM SR; BESTERMAN HS; GREENBERG GR; PEARSE AGE; CLEARY J; GAZET JC; et alMONSON J; PILKINGTON TRE. (1978). NEUROTENSIN AND ENTEROGLUCAGON IN OBESITY. GASTROENTEROLOGY. 74:1078-1078.
• HOBBS SE; POLAK JM; PEARSE AGE; BESTERMAN HS; BLOOM SR; GREENBERG GR; CLEARY J; GAZET JC; et alMONSON J; PILKINGTON TL. (1978). NEUROTENSIN AND ENTEROGLUCAGON IN OBESITY. GUT. 19:A456-A456.
• BLOOM SR; POLAK JM. (1978). NEW PEPTIDE HORMONES OF GUT AND THEIR CLINICAL SIGNIFICANCE. ACTA GASTRO-ENT BELG. 41:371-393.
• BARNES AJ; BLOOM SR; LONG RG; ADRIAN TE; HANLEY J; MALLINSON CN; VALE W; RIVIER JE; et alBROWN MR. (1978). NEW SPECIFIC LONG-ACTING SOMATOSTATIN ANALOGS IN TREATMENT OF PANCREATIC ENDOCRINE TUMORS. DIABETOLOGIA. 15:217-217.
• BLOOM SR; ADRIAN TE; BARNES AJ; LONG RG; HANLEY J; MALLINSON CN; RIVIER JE; BROWN MR. (1978). NEW SPECIFIC LONG-ACTING SOMATOSTATIN ANALOGS IN TREATMENT OF PANCREATIC ENDOCRINE TUMORS. GUT. 19:A446-A447.
• BLOOM SR; ADRIAN TE; BARNES AJ; LONG RG; HANLEY J; MALLINSON CN; RIVIER JE; BROWN MR. (1978). NEW SPECIFIC LONG-ACTING SOMATOSTATIN ANALOGS IN TREATMENT OF PANCREATIC ENDOCRINE TUMORS. GASTROENTEROLOGY. 74:1013-1013.
• BLOOM SR; ADRIAN TE; BRYANT MG; POLAK JM. (1978). PANCREATIC POLYPEPTIDE - MARKER FOR ZOLLINGER-ELLISON SYNDROME. LANCET. 1:1155-1155.
• ADRIAN TE; BLOOM SR; HERMANSEN K; IVERSEN J. (1978). PANCREATIC POLYPEPTIDE, GLUCAGON AND INSULIN-SECRETION FROM ISOLATED PERFUSED CANINE PANCREAS. DIABETOLOGIA. 14:413-417.
• POLAK JM; BLOOM SR. (1978). PEPTIDE HORMONES OF ALIMENTARY-TRACT. REV ESP ENFERM APAR. 53:11-40.
• POLAK JM; BLOOM SR. (1978). PEPTIDERGIC NERVES OF THE GASTROINTESTINAL-TRACT. INVEST CELL PATHOL. 1:301-326.
• POLAK JM; BISHOP AE; BLOOM SR. (1978). PEPTIDERGIC NEURONS AS MAIN AUTONOMIC INNERVATION OF GUT. GASTROENTEROLOGY. 74:1080-1080.
• BLOOM SR; POLAK JM. (1978). PEPTIDERGIC VERSUS PURINERGIC. LANCET. 1:93-93.
• ADRIAN TE; GREENBERG GR; BESTERMAN HS; BLOOM SR. (1978). PHARMACOKINETICS OF PANCREATIC POLYPEPTIDE IN MAN. GUT. 19:907-909.
• CHRISTOFIDES ND; BLOOM SR. (1978). PLASMA MOTILIN LEVELS IN DUODENAL-ULCER AND EFFECT OF A TRUNCAL VAGOTOMY AND HYPOGLYCEMIA. EXPERIENTIA. 34:809-811.
• MODLIN IM; BLOOM SR; MITCHELL S. (1978). PLASMA VASOACTIVE INTESTINAL POLYPEPTIDE (VIP) LEVELS AND INTESTINAL ISCHEMIA. EXPERIENTIA. 34:535-536.
• GREENBERG GR; BLOOM SR. (1978). PLASMA-SECRETIN DURING FASTING. LANCET. 1:273-273.
• BLOOM SR; ADRIAN TE; PERA A; POLAK JM; BESTERMAN HS; MODIGLIANI R; BRYANT MG; MODLIN IM; et alBARNADO DE; GRAHAMESMITH DG. (1978). PP IN PATIENTS WITH CARCINOID-SYNDROME, PANCREATIC ENDOCRINE TUMORS AND ADENOCARCINOMAS. GASTROENTEROLOGY. 74:1012-1012.
• CHRISTOFIDES ND; MODLIN I; SARSON DL; ALBUQUERQUE RH; GHATEI MA; ADRIAN TE; BLOOM SR. (1978). RELEASE OF GASTRIN, PP, VIP AND MOTILIN AFTER AN ORAL WATER LOAD AND ATROPINE IN MAN. CLIN SCI MOL MED. 54:P12-P13.
• MODLIN I; BLOOM SR; CHRISTOFIDES N; SARSON DL; ALBUQUERQUE RH; GHATEI MA; ADRIAN TE. (1978). RELEASE OF GASTRIN, PP, VIP AND MOTILIN FOLLOWING AN ORAL WATER LOAD AND ATROPINE IN MAN. FED PROC. 37:374-374.
• BLOOM SR; SARSON DL; CHRISTOFIDES ND; ALBUQUERQUE RH; ADRIAN TE; GHATEI MA; MODLIN IM. (1978). RELEASE OF GASTROINTESTINAL HORMONES FOLLOWING AN ORAL WATER LOAD AND ATROPINE IN MAN. GASTROENTEROLOGY. 74:1010-1010.
• BLOOM SR; CHRISTOFIDES ND; BESTERMAN HS; ADRIAN TE; GHATEI MA. (1978). RELEASE OF MOTILIN IN MAN BY ORAL AND INTRAVENOUS NUTRIMENTS. GASTROENTEROLOGY. 74:1010-1010.
• BLOOM SR; MITCHELL SJ; GREENBERG GR; CHRISTOFIDES N; DOMSCHKE W; DOMSCHKE S; MITZNEGG P; DEMLING L. (1978). RELEASE OF VIP, SECRETIN AND MOTILIN AFTER DUODENAL ACIDIFICATION IN MAN. ACTA HEPATO-GASTRO. 25:365-368.
• BLOOM SR; EDWARDS AV; HARDY RN. (1978). ROLE OF AUTONOMIC NERVOUS-SYSTEM IN CONTROL OF GLUCAGON, INSULIN AND PANCREATIC POLYPEPTIDE RELEASE FROM PANCREAS. J PHYSIOL-LONDON. 280:9-23.
• BLOOM SR; EDWARDS AV; HARDY RN. (1978). ROLE OF AUTONOMIC NERVOUS-SYSTEM IN CONTROL OF PANCREATIC ENDOCRINE RESPONSES TO MILK INGESTION IN CALF. J PHYSIOL-LONDON. 280:37-53.
• JOHNSTON DI; PATEL H; BLOOM SR. (1978). SECRETIN RELEASE IN CHILDREN WITH CELIAC-DISEASE. PEDIATR RES. 12:149-149.
• BLOOM SR. (1978). SOMATOSTATIN AND GUT. GASTROENTEROLOGY. 75:145-147.
• BLOOM SR; POLAK JM; WEST AM. (1978). SOMATOSTATIN CONTENT OF PANCREATIC ENDOCRINE TUMORS. METABOLISM. 27:1235-1238.
• LENNON J; BLOOM SR; SIRCUS W. (1978). STUDIES ON BLOOD-LEVELS OF VASOACTIVE INHIBITORY PEPTIDE (VIP) AND PANCREATIC POLYPEPTIDE (PP) AND THEIR RELATION TO CLINICAL BEHAVIOR IN A CASE OF WERNER-MORRISON SYNDROME. ITAL J GASTROENTEROL. 10:104-106.
• MALLINSON CN; HANLEY J; ALLISON DJ; ADRIAN TE; BLOOM SR. (1978). TREATMENT OF MALIGNANT PANCREATIC GLUCAGONOMA - EFFECT OF ZINC ON RASH AND HEPATIC ARTERIAL EMBOLIZATION ON LIVER METASTASES. GUT. 19:A448-A448.
• DOMSCHKE S; DOMSCHKE W; BLOOM SR; MITZNEGG P; MITCHELL SJ; LUX G; STRUNZ U. (1978). VASOACTIVE INTESTINAL PEPTIDE IN MAN - PHARMACOKINETICS, METABOLIC AND CIRCULATORY EFFECTS. GUT. 19:1049-1053.
• BLOOM SR. (1978). VASOACTIVE INTESTINAL PEPTIDE, MAJOR MEDIATOR OF WDHA (PANCREATIC CHOLERA) SYNDROME - VALUE OF MEASUREMENT IN DIAGNOSIS AND TREATMENT. AM J DIG DIS. 23:373-376.
• POLAK JM; BISHOP AE; BLOOM SR; TABAQCHALI S. (1978). VIP NERVES IN CROHN DISEASE. GASTROENTEROLOGY. 74:1079-1079.
• KINGHAM JGC; DICK R; BLOOM SR; FRANKEL RJ. (1978). VIPOMA - LOCALIZATION BY PERCUTANEOUS TRANS-HEPATIC PORTAL VENOUS SAMPLING. BRIT MED J. 2:1682-1683.
• MODLIN IM; BLOOM SR. (1978). VIPOMAS AND WATERY DIARRHEA SYNDROME. S AFR MED J. 54:53-56.
• POLAK JM; BUCHAN AMJ; TIMSON CM; BLOOM SR; PEARSE AGE. (1977). 2 NEW CELLS IN HUMAN PANCREATIC-ISLETS. GUT. 18:A414-A415.
• MCCROSSAN VM; BUCHAN AMJ; TIMSON CM; BLOOM SR; PEARSE AGE. (1977). 2 NEW CELLS IN HUMAN PANCREATIC-ISLETS. ACTA ENDOCRINOL-COP. 85:196-196.
• BLOOM SR; EDWARDS AV; HARDY RN. (1977). ADRENAL AND PANCREATIC ENDOCRINE RESPONSES TO HYPOXIA AND HYPERCAPNIA IN CALF. J PHYSIOL-LONDON. 269:131-154.
• BLOOM SR; EDWARDS AV; HARDY RN; MALINOWSKA KW. (1977). ADRENAL RESPONSES TO HYPOXIA AND HYPERCAPNIA IN YOUNG CALF. EXPERIENTIA. 33:362-363.
• BESTERMAN HS; STEWART J; GUERIN S; MODIGLIANI R; MALLINSON CN; BLOOM SR. (1977). CELIAC-DISEASE - DIAGNOSTIC HORMONE PROFILE. GUT. 18:A942-A942.
• IVERSEN J; BLOOM SR; ADRIAN TE; HERMANSEN K. (1977). CONTROL OF GLUCAGON, INSULIN AND PP SECRETION IN ISOLATED PANCREAS. ACTA ENDOCRINOL-COP. 85:8-8.
• SULLIVAN SN; BLOOM SR; POLAK JM. (1977). DISTRIBUTION OF ENKEPHALIN IN GUT AND BRAIN. GUT. 18:A410-A410.
• MCCROSSAN MV; POLAK JM; BLOOM SR; HOBBS S; PEARSE AGE. (1977). DUODENAL BOMBESIN CELL PATHOLOGY. GUT. 18:A407-A407.
• GREENBERG GR; MCCLOY RF; CHADWICK VS; ADRIAN TE; BARON JH; BLOOM SR. (1977). EFFECT OF BOVINE PANCREATIC POLYPEPTIDE (BPP) INFUSIONS ON GASTRIC AND BILIARY FUNCTION IN MAN. GUT. 18:A978-A978.
• ISENBERG JI; CANO R; BLOOM SR. (1977). EFFECT OF GRADED AMOUNTS OF ACID INSTILLED INTO DUODENUM ON PANCREATIC BICARBONATE SECRETION AND PLASMA SECRETIN IN DUODENAL-ULCER PATIENTS AND NORMAL SUBJECTS. GASTROENTEROLOGY. 72:6-8.
• MITZNEGG P; BLOOM SR; DOMSCHKE W; HAECKI WH; DOMSCHKE S; BELOHLAVEK D; WUNSCH E; DEMLING L. (1977). EFFECT OF SECRETIN ON PLASMA MOTILIN IN MAN. GUT. 18:468-471.
• POLAK JM; BLOOM SR; SULLIVAN SN; FACER P; PEARSE AGE. (1977). ENCEPHALIN-LIKE IMMUNOREACTIVITY IN HUMAN GASTROINTESTINAL-TRACT. LANCET. 1:972-974.
• AYNSLEYGREEN A; BLOOM SR; WILLIAMSON DH; TURNER RC. (1977). ENDOCRINE AND METABOLIC RESPONSE IN HUMAN NEWBORN TO FIRST FEED OF BREAST-MILK. ARCH DIS CHILD. 52:291-295.
• DOMSCHKE W; GREENBERG GR; DOMSCHKE S; BLOOM SR; MITZNEGG P; SPRUGEL W; DEMLING L. (1977). ENDOGENOUS ACID RELEASES SECRETIN IN MAN. ACTA HEPATO-GASTRO. 24:362-363.
• BLOOM SR; TURNER RC; WARD AS. (1977). GIP RELEASE, INSULIN RELEASE AND INHIBITION OF GASTRIC-ACID. GASTROENTEROLOGY. 72:813-813.
• BARNES AJ; BLOOM SR; ALBERTI KGMM. (1977). GLUCAGON, PANCREATECTOMY AND KETOACIDOSIS - REPLY. NEW ENGL J MED. 297:559-559.
• BARNES AJ; KOHNER EM; BLOOM SR; JOHNSTON DG; SMYTHE P. (1977). IMPORTANCE OF PITUITARY IN DEVELOPMENT OF DIABETIC KETOACIDOSIS. DIABETOLOGIA. 13:380-380.
• DOMSCHKE W; LUX G; DOMSCHKE S; STRUNZ U; ROSCH W; BLOOM SR; WUNSCH E; DEMLING L. (1977). INHIBITION BY VIP AND SECRETIN OF LOWER ESOPHAGEAL SPHINCTER PRESSURE IN MAN. ACTA HEPATO-GASTRO. 24:484-485.
• CHASE RA; SULLIVAN S; BLOOM SR; SILK DBA; WILLIAMS R. (1977). INSULIN, GLUCAGON, AND AMINO-ACID IMBALANCES IN FULMINANT HEPATIC-FAILURE. GUT. 18:A953-A953.
• BARNES AJ; BLOOM SR; ALBERTI KGMM; SMYTHE P; ALFORD FP; CHISHOLM DJ. (1977). KETOACIDOSIS IN PANCREATECTOMIZED MAN. NEW ENGL J MED. 296:1250-1253.
• MITCHELL SJ; BLOOM SR; MODLIN I. (1977). MASSIVE RELEASE OF VASOACTIVE INTESTINAL PEPTIDE AFTER INTESTINAL ISCHEMIA. J ENDOCRINOL. 73:P14-P14.
• ADRIAN TE; BESTERMAN HS; COOKE TJC; BLOOM SR; BARNES AJ; RUSSELL RCG; FABER RG. (1977). MECHANISM OF PANCREATIC POLYPEPTIDE RELEASE IN MAN. LANCET. 1:161-163.
• MALLINSON CN; ADRIAN TE; HANLEY J; BRYANT M; BLOOM SR. (1977). METABOLIC AND CLINICAL RESPONSES IN PATIENTS WITH PANCREATIC GLUCAGONOMAS. IRISH J MED SCI. 146:37-38.
• JOHNSTON DG; ALBERTI KGMM; HINKS L; SMYTHE P; BARNES AJ; BLOOM SR; JOPLIN GF. (1977). METABOLIC RHYTHMS IN CUSHINGS-SYNDROME. ACTA ENDOCRINOL-COP. 85:89-89.
• BARNES AJ; BLOOM SR; ALBERTI KGM; SMYTHE P. (1977). METABOLIC ROLE OF GLUCAGON IN STABLE AND INSULIN-DEPRIVED DIABETICS. J ENDOCRINOL. 73:P40-P40.
• POLAK JM; BUCHAN AMJ; BLOOM SR; WEST A; PEARSE AGE. (1977). MORPHOLOGICAL INVESTIGATIONS OF PANCREAS AND ITS APPLICATIONS TO ENDOCRINE TUMORS. IRISH J MED SCI. 146:40-40.
• POLAK JM; BLOOM SR; BUCHAN AMJ; PEARSE AGE. (1977). MULTIPLE HORMONAL APUD CELLS. GUT. 18:A410-A410.
• BISHOP AE; POLAK JM; BLOOM SR; BUCHAN AMJ; PEARSE AGE. (1977). MULTIPLE HORMONAL APUD CELLS. ACTA ENDOCRINOL-COP. 85:103-103.
• BLOOM SR. (1977). NEW GUT HORMONES. J IRISH COLL PHYS S. 6:109-109.
• BLOOM SR; WEST AM; POLAK JM; ADRIAN TE. (1977). NEW VIEW OF PANCREATIC ENDOCRINE TUMORS. GUT. 18:A983-A983.
• PEARSE AGE; POLAK JM; BLOOM SR. (1977). NEWER GUT HORMONES - CELLULAR SOURCES, PHYSIOLOGY, PATHOLOGY, AND CLINICAL ASPECTS. GASTROENTEROLOGY. 72:746-761.
• BLOOM SR; IVERSEN J; POLAK JM; HERMANSEN K; ADRIAN TE. (1977). PANCREATIC HORMONE INTERRELATIONSHIPS. DIABETOLOGIA. 13:383-383.
• POLAK JM; BISHOP A; BLOOM SR; PEARSE AGE. (1977). PEPTIDE HORMONES AS MARKERS FOR GASTROINTESTINAL TUMOR PATHOLOGY. GUT. 18:A416-A416.
• BARNES AJ; BLOOM SR; MASHITER K; ALBERTI KGMM; SMYTHE P; TURNELL D. (1977). PERSISTENT METABOLIC ABNORMALITIES IN DIABETES IN ABSENCE OF GLUCAGON. DIABETOLOGIA. 13:71-75.
• MITZNEGG P; BLOOM SR; DOMSCHKE W; DOMSCHKE S; WUENSCH E; DEMLING L. (1977). PHARMACOKINETICS OF MOTILIN IN MAN. GASTROENTEROLOGY. 72:413-416.
• BLOOM SR; GREENBERG GR; ADRIAN TE; BESTERMAN HS; MALLINSON CN; MCCLOY RF; CHADWICK VS; BARON JH. (1977). PHYSIOLOGICAL-ROLE OF PP IN MAN. IRISH J MED SCI. 146:15-15.
• RUSSEL RCG; PARDY BJ; CARRUTHERS ME; BLOOM SR. (1977). PLASMA GLUCAGON LEVELS IN HEMORRHAGIC-SHOCK. BRIT J SURG. 64:285-289.
• CHRISTOFIDES ND; BLOOM SR. (1977). PLASMA MOTILIN LEVELS IN DUODENAL-ULCER AND EFFECT OF TRUNCAL VAGOTOMY AND HYPOGLYCEMIA. GUT. 18:A406-A407.
• HACKI WH; BLOOM SR; MITZNEGG P; DOMSCHKE W; DOMSCHKE S; BELOHLAVEK D; DEMLING L; WUNSCH E. (1977). PLASMA SECRETIN AND PANCREATIC BICARBONATE RESPONSE TO EXOGENOUS SECRETIN IN MAN. GUT. 18:191-195.
• MODLIN IM; BLOOM SR; CHRISTOFIDES N. (1977). PLASMA-MOTILIN IN CARCINOID TUMORS. LANCET. 2:979-979.
• ADRIAN TE; BESTERMAN HS; MALLINSON CN; BLOOM SR. (1977). PP IN ASSESSMENT OF PANCREATIC EXOCRINE FUNCTION. GUT. 18:A982-A982.
• BLOOM SR; BESTERMAN HS; ADRIAN TE; MALLINSON CN. (1977). PP IN DIAGNOSIS OF PANCREATIC INSUFFICIENCY. IRISH J MED SCI. 146:13-13.
• BLOOM SR; MITZNEGG P; DOMSCHKE W; DOMSCHKE S; CHRISTOFIDES ND; WUENSCH E; DEMLING L. (1977). RELEASE OF MOTILIN IN MAN. GASTROENTEROLOGY. 72:812-812.
• MODLIN IM; MITZNEGG P; BLOOM SR; POLAK J; WELBOURN RB. (1977). RELEASE OF MOTILIN IN PIG. BRIT J SURG. 64:17-17.
• BLOOM SR; MITCHELL SJ; GREENBERG GR; CHRISTOFIDES N; DOMSCHKE W; DOMSCHKE S; MITZNEGG P; DEMLING L. (1977). RELEASE OF VIP BY DUODENAL ACIDIFICATION IN MAN. GUT. 18:A963-A963.
• GREENBERG GR; HACKI W; DOMSCHKE W; DOMSCHKE S; MITZNEGG P; DEMLING L; BLOOM SR. (1977). RISE OF SECRETIN AFTER ORAL FEEDING. GUT. 18:A981-A981.
• MODLIN IM; BLOOM SR; MITCHELL SJ. (1977). ROLE OF VIP IN DIARRHEA. GUT. 18:A418-A419.
• POLAK JM; PEARSE AGE; SZELKE M; BLOOM SR; HUDSON D; FACER P; BUCHAN AMJ; BRYANT MG; et alCHRISTOPHODES N; MACINTYRE I. (1977). SPECIFIC IMMUNOSTAINING OF CCK CELLS BY USE OF SYNTHETIC FRAGMENT ANTISERA. EXPERIENTIA. 33:762-763.
• BUCHAN AMJ; POLAK JM; FACER P; BLOOM SR; SZELKE M; HUDSON D; PEARSE AGE. (1977). SYNTHETIC FRAGMENTS FOR SPECIFIC IMMUNOSTAINING OF CCK CELLS. GUT. 18:A406-A406.
• MODLIN IM; MITCHELL S; BLOOM SR; POLAK JM. (1977). VASOACTIVE INTESTINAL PEPTIDE IN BOWEL ISCHEMIA. EUR SURG RES. 9:15-15.
• BLOOM SR; MITCHELL SJ; DOMSCHKE S; DOMSCHKE W; MITZNEGG P; LUX G; STRUNZ U; DEMLING L. (1977). VIP INFUSION IN MAN. GUT. 18:A963-A963.
• MODLIN IM; BLOOM SR; MITCHELL SJ. (1977). VIP RELEASE IN INTESTINAL ISCHEMIA. GUT. 18:A963-A963.
• JOFFE SN; BLOOM SR; POLAK JM; WELBOURN RB. (1976). RELEASE OF SECRETIN FROM S CELLS OF PORCINE DUODENUM + JEJUNUM BY ACID. EUR SURG RES. 8:44-44.
• BLOOM SR; EDWARDS AV; HARDY RN; SILVER M. (1976). ADRENAL AND PANCREATIC ENDOCRINE RESPONSES TO HYPOXIA IN CONSCIOUS CALF. J PHYSIOL-LONDON. 261:271-283.
• HEITZ P; POLAK JM; BLOOM SR; ADRIAN TE; PEARSE AGE. (1976). CELLULAR ORIGIN OF HUMAN PANCREATIC POLYPEPTIDE (HPP) IN ENDOCRINE TUMORS OF PANCREAS. VIRCHOWS ARCH B. 21:259-265.
• GREENBERG GR; BLOOM SR; POLAK JM; BARNES AJ; REID JL; JONES DH; ALLISON D; WELBOURN RB; et alMODLIN I; RAKE M. (1976). CURE OF DIARRHEA BY REMOVAL OF A GANGLIONEUROBLASTOMA. GUT. 17:817-817.
• RUSSELL RCG; BLOOM SR; FIELDING LP; BRYANT MG. (1976). CURRENT PROBLEMS IN MEASUREMENT OF GASTRIN RELEASE - REPRODUCIBLE MEASURE OF PHYSIOLOGICAL GASTRIN RELEASE. POSTGRAD MED J. 52:645-650.
• BARNES AJ; BLOOM SR; ALFORD FP; RUSSELL RCG. (1976). DIABETES WITHOUT GLUCAGON. LANCET. 1:967-967.
• BLOOM SR; JOHNSON RH; PARK DM; RENNIE MJ; SULAIMAN WR. (1976). DIFFERENCES IN METABOLIC AND HORMONAL RESPONSE TO EXERCISE BETWEEN RACING CYCLISTS AND UNTRAINED INDIVIDUALS. J PHYSIOL-LONDON. 258:1-18.
• BLOOM SR; ADRIAN TE; MITCHELL SJ; BARNES AJ; POLAK JM. (1976). DIRTY INSULIN, A STIMULANT TO AUTOIMMUNITY. GUT. 17:817-817.
• BLOOM SR; ADRIAN TE; MITCHELL SJ; BARNES AJ; KOHNER EM. (1976). DIRTY INSULIN, A STIMULANT TO AUTOIMMUNITY. DIABETOLOGIA. 12:381-381.
• MITZNEGG P; BLOOM SR; DOMSCHKE W; DOMSCHKE S; WUNSCH E; DEMLING L. (1976). DISAPPEARANCE HALF TIME OF EXOGENOUS AND ENDOGENOUS MOTILIN IN MAN. N-S ARCH PHARMACOL. 293:R63-R63.
• BLOOM SR; JOFFE SN; POLAK JM. (1976). EFFECT OF SOMATOSTATIN ON PANCREATIC AND BILIARY FUNCTION. BIOL GASTRO-ENTEROL. 9:87-87.
• BLOOM SR; EDWARDS AV; HARDY RN; MALINOWSKA KW; SILVER M. (1976). ENDOCRINE RESPONSES TO HYPOXIA IN CONSCIOUS CALF. J PHYSIOL-LONDON. 254:P29-P30.
• DOMSCHKE W; LUX G; MITZNEGG P; ROSCH W; DOMSCHKE S; BLOOM SR; WUNSCH E; DEMLING L. (1976). ENDOGENOUS MOTILIN AND LOWER ESOPHAGEAL SPHINCTER PRESSURE IN MAN - CLUE TO AN ASSOCIATION. ACTA HEPATO-GASTRO. 23:274-275.
• BLOOM SR; PATEL HR; JOHNSTON DI. (1976). FAILURE OF SECRETIN RELEASE IN CELIAC-DISEASE. GUT. 17:812-812.
• BATSTONE GF; ALBERTI KGMM; LLOYD B; HINKS L; LAING JE; LEVICK P; BLOOM SR. (1976). FUEL MOBILIZATION - ROLE OF CORTISOL IN CATABOLIC RESPONSE FOLLOWING SEVERE BURNS. EUR J CLIN INVEST. 6:317-317.
• BARNES AJ; BLOOM SR; MASHITER K; ALFORD FP; SMYTHE P; TURNELL D. (1976). GLUCAGON AND KETOGENESIS - STUDIES IN PANCREATECTOMIZED MAN. DIABETOLOGIA. 12:379-379.
• POLAK JM; BLOOM SR; PEARSE AGE. (1976). GUT ENDOCRINOLOGY - CORRELATION OF PHYSIOLOGY AND MORPHOLOGY. CLIN ENDOCRINOL. 5:S205-S216.
• BLOOM SR; IVERSEN J. (1976). GUT HORMONES AND ALPHA-CELL. METABOLISM. 25:1457-1458.
• BLOOM SR; NALIN DR; MITCHELL SJ; BRYANT MG. (1976). HIGH LEVELS OF VIP IN CHOLERA STOOL WATER. GUT. 17:817-817.
• BATSTONE GF; HINKS L; WHITEFOOT R; BLOOM S; LAING JE; ALBERTI KGMM. (1976). HORMONAL CHANGES AFTER THERMAL INJURY. J ENDOCRINOL. 68:P38-P39.
• BUCHANAN N; MOODLEY G; EYBERG C; BLOOM SR; HANSEN JDL. (1976). HYPOGLYCEMIA ASSOCIATED WITH SEVERE KWASHIORKOR. S AFR MED J. 50:1442-1446.
• HEITZ P; POLAK JM; BLOOM SR; PEARSE AGE. (1976). IDENTIFICATION OF D1-CELL AS SOURCE OF HUMAN PANCREATIC POLYPEPTIDE (HPP). GUT. 17:755-758.
• POLAK JM; BLOOM SR; MCCROSSAN MV; ARIMURA A; PEARSE AGE. (1976). MORPHOLOGY OF SOMATOSTATIN IN GASTROINTESTINAL HEALTH AND DISEASE. GUT. 17:816-816.
• BARNES AJ; BLOOM SR. (1976). PANCREATECTOMIZED MAN - MODEL FOR DIABETES WITHOUT GLUCAGON. LANCET. 1:219-221.
• POLAK JM; BLOOM SR; ARIMURA A; PEARSE AGE. (1976). PATHOLOGY OF PANCREATIC SOMATOSTATIN. BIOL GASTRO-ENTEROL. 9:85-85.
• THOMSON JPS; BLOOM SR. (1976). PLASMA ENTEROGLUCAGON AND PLASMA-VOLUME CHANGE AFTER GASTRIC SURGERY. CLIN SCI MOL MED. 51:177-183.
• BLOOM SR; BARNES AJ; BRYANT MG; ALBERTI KGMM. (1976). PLASMA GLUCAGON IN DIABETES RESULTING FROM TOTAL PANCREATECTOMY. METABOLISM. 25:1481-1482.
• FAIRCLOUGH PD; BLOOM SR; MITCHELL SJ. (1976). PLASMA-VIP IN ULCERATIVE-COLITIS. LANCET. 1:964-964.
• BRYANT MG; POLAK JM; MODLIN I; BLOOM SR; ALBUQUERQUE RH; PEARSE AGE. (1976). POSSIBLE DUAL ROLE FOR VASOACTIVE INTESTINAL PEPTIDE AS GASTROINTESTINAL HORMONE AND NEUROTRANSMITTER SUBSTANCE. LANCET. 1:991-993.
• ADRIAN TE; BLOOM SR; BRYANT MG; POLAK JM; HEITZ P. (1976). RADIOIMMUNOASSAY OF A NEW GUT HORMONE - HUMAN PANCREATIC POLYPEPTIDE. GUT. 17:393-394.
• BLOOM SR; MITZNEGG P; DOMSCHKE W; DOMSCHKE S; CHRISTOFIDES ND; WUENSCH E; DEMLING L. (1976). RELEASE OF MOTILIN IN MAN. GUT. 17:816-816.
• HAECKI WH; BELOHLAVEK D; BLOOM SR; DEMLING L; DOMSCHKE W; DOMSCHKE S; GALARIOTIS C; MALLINSON C; et alMITZNEGG P; WUENSCH E. (1976). SECRETIN PHARMACOKINETICS AND PLASMA-LEVELS FOR HALF MAXIMUM BICARBONATE RESPONSE IN MAN. GUT. 17:393-393.
• GAGEL RF; COSTANZA ME; DELELLIS RA; NORTON RA; BLOOM SR; MILLER HH; UCCI A; NATHANSON L. (1976). STREPTOZOCIN-TREATED VERNER-MORRISON SYNDROME - PLASMA VASOACTIVE INTESTINAL PEPTIDE AND TUMOR RESPONSES. ARCH INTERN MED. 136:1429-1435.
• VILLAR HV; FENDER HR; RAYFORD PL; BLOOM SR; RAMUS NI; THOMPSON JC. (1976). SUPPRESSION OF GASTRIN RELEASE AND GASTRIC-SECRETION BY GASTRIC INHIBITORY POLYPEPTIDE (GIP) AND VASOACTIVE INTESTINAL POLYPEPTIDE (VIP). ANN SURG. 184:97-102.
• TURNER RC; HARRIS E; BLOOM S. (1975). 2 DISORDERS OF GLUCOSE-INDUCED INSULIN-SECRETION - DECREASED MAXIMAL SECRETORY CAPACITY (LOW-VMAX) IN LATENT-DIABETES, AND DECREASED SENSITIVITY OF B-CELLS (HIGH-KM) IN WOMEN WHO PRODUCED LFD BABIES. CLIN SCI MOL MED. 49:P21-P22.
• BESSER GM; HALL R; SCHALLY AV; COY DH; BLOOM SR. (1975). ACTIONS OF GROWTH-HORMONE RELEASE-INHIBITING HORMONE IN MAN. ACTA ENDOCRINOL-COP. 78:176-177.
• BLOOM SR; EDWARDS AV; HARDY RN; MALINOWSKA K; SILVER M. (1975). CARDIOVASCULAR AND ENDOCRINE RESPONSES TO FEEDING IN YOUNG CALF. J PHYSIOL-LONDON. 253:135-155.
• BRYANT MG; BLOOM SR. (1975). CHARACTERIZATION OF NEW GASTROINTESTINAL HORMONES. GUT. 16:840-840.
• BARROSDSA AAJ; BLOOM SR; BARON JH. (1975). DIRECT INHIBITION OF GASTRIC-ACID BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE IN DOGS. LANCET. 1:886-887.
• BLOOM SR; BRYANT MG; POLAK JM. (1975). DISTRIBUTION OF GUT HORMONES. GUT. 16:821-821.
• BLOOM SR; RALPHS DN; BESSER GM; HALL R; COY DH; KASTIN AJ; SCHALLY AV. (1975). EFFECT OF SOMATOSTATIN ON MOTILIN LEVELS AND GASTRIC-EMPTYING. GUT. 16:834-834.
• BLOOM SR; JOFFE SN; POLAK JM. (1975). EFFECT OF SOMATOSTATIN ON PANCREATIC AND BILIARY FUNCTION. GUT. 16:836-837.
• WARD AS; BLOOM SR. (1975). EFFECT OF VAGOTOMY ON SECRETIN RELEASE IN MAN. GUT. 16:951-956.
• JOFFE SN; GASKIN R; DSA AAJB; POLAK JM; BLOOM SR; BARON JH. (1975). GASTRIN, G-CELLS, AND GASTRIC-ACID IN RATS WITH SECRETAGOGUE-PRODUCED AND ANTI-SECRETAGOGUE-INHIBITED DUODENAL ULCERS. GUT. 16:407-407.
• POLAK JM; PEARSE AGE; GRIMELIUS L; BLOOM SR; MARKS V. (1975). GASTROINTESTINAL APUDOSIS IN OBESE, HYPERGLYCEMIC (OB-OB) MICE. J ENDOCRINOL. 67:P67-P67.
• BLOOM SR. (1975). GASTROINTESTINAL HORMONES. P ROY SOC MED. 68:710-711.
• BLOOM SR. (1975). GIP IN DIABETES. DIABETOLOGIA. 11:334-334.
• RUSSELL RCG; BLOOM SR; DAVIES WA; POLAK JM; REED PI. (1975). HYPERGASTRINEMIA IN A PEPTIC-ULCER PATIENT WITH ANTRAL GASTRIN CELL HYPERPLASIA. BRIT MED J. 4:441-441.
• ORTON CI; SEGAL AW; BLOOM SR; CLARKE J. (1975). HYPERSECRETION OF GLUCAGON AND GASTRIN IN SEVERELY BURNT PATIENTS. BRIT MED J. 2:170-172.
• BARROSDSA AAJ; BLOOM SR; POLAK JM; BARON JH. (1975). INHIBITION OF GASTRIC-ACID SECRETION AND G-CELL RELEASE OF GASTRIN BY GROWTH-HORMONE RELEASE-INHIBITING HORMONE (GH-RIH). CLIN SCI MOL MED. 49:P26-P26.
• LENNON JR; SIRCUS W; BLOOM SR; MITCHELL SJ; POLAK JM; BESSER GM; HALL R; COY DH; et alKASTIN AJ; SCHALLY AV. (1975). INVESTIGATION AND TREATMENT OF A RECURRENT VIPOMA. GUT. 16:821-822.
• POLAK JM; BLOOM SR; JOFFE S; PEARSE AGE. (1975). MORPHOLOGY AND PHYSIOLOGY OF GH-RIH (SOMATOSTATIN) IN GASTROINTESTINAL-TRACT. CLIN SCI MOL MED. 49:P26-P26.
• BLOOM SR; BRYANT MG; COCHRANE JPS. (1975). NORMAL DISTRIBUTION AND POSTPRANDIAL RELEASE OF GUT HORMONES. CLIN SCI MOL MED. 49:P3-P3.
• BLOOM SR; BRYANT MG; POLAK JM; COCHRANE JPS. (1975). NORMAL DISTRIBUTION AND POSTPRANDIAL RELEASE OF GUT HORMONES. BIOL GASTRO-ENTEROL. 8:358-358.
• CANO R; BLOOM SR; ISENBERG JI. (1975). PANCREATIC BICARBONATE SECRETION AND SERUM SECRETIN IN RESPONSE TO GRADED AMOUNTS OF DUODENAL ACIDIFICATION IN DUODENAL-ULCER AND NORMAL SUBJECTS. GASTROENTEROLOGY. 68:870-870.
• POLAK JM; BLOOM SR; ARIMURA A; PEARSE AGE. (1975). PANCREATIC D-CELLS IN NORMAL AND PATHOLOGICAL HUMAN PANCREAS. GUT. 16:837-837.
• POLAK JM; PEARSE AGE; BLOOM SR; JOFFE SN. (1975). QUANTIFICATION OF PHYSIOLOGICAL CHANGES IN GUT ENDOCRINE CELLS - IMMUNOCYTOCHEMICAL AND RADIOIMMUNOASSAYS OF SECRETIN CELL FUNCTION. ACTA HEPATO-GASTRO. 22:186-189.
• POLAK JM; PEARSE AGE; JOFFE S; BLOOM SR. (1975). QUANTIFICATION OF SECRETIN RELEASE BY ACID, USING IMMUNOCYTOCHEMISTRY AND RADIOIMMUNOASSAY. EXPERIENTIA. 31:462-464.
• PALLONE F; POLAK JM; BLOOM SR; JOFFE SN; BARON JH. (1975). QUANTITATIVE IMMUNOCYTOCHEMICAL STUDIES ON RODENT ANTRAL G-CELLS. REND GASTROENTEROL. 7:60-64.
• BLOOM SR; EDWARDS AV; HARDY RN; MALINOWSKA KW; SILVER M. (1975). RESPONSES TO FEEDING IN CONSCIOUS UNWEANED CALF. J PHYSIOL-LONDON. 247:P34-P35.
• BLOOM SR; JOFFE SN; POLAK JM. (1975). SECRETIN RADIOIMMUNOASSAY IN PIG. J ENDOCRINOL. 67:P67-P67.
• POLAK JM; PEARSE AGE; BLOOM SR. (1975). VASOACTIVE INTESTINAL PEPTIDE CHARACTERISTICS IN HUMAN GUT. GUT. 16:840-840.
• ELIAS E; MITCHELL SJ; BLOOM SR. (1975). VASOACTIVE INTESTINAL PEPTIDE IN CIRRHOSIS. LANCET. 2:1312-1312.
• SEIF FJ; SADOWSKI P; HENI F; FISCHER R; BLOOM SR; POLAK JM. (1975). VASOACTIVE INTESTINAL POLYPEPTIDE IN VERNER-MORRISON SYNDROME. DEUT MED WOCHENSCHR. 100:399-&.
• POLAK JM; PEARSE AGE; GARAUD JC; BLOOM SR. (1974). CELLULAR LOCALIZATION OF A VASOACTIVE INTESTINAL PEPTIDE IN MAMMALIAN AND AVIAN GASTROINTESTINAL-TRACT. GUT. 15:720-724.
• PEARSE AGE; POLAK JM; BLOOM SR; ADAMS C; DRYBURGH JR; BROWN JC. (1974). ENTEROCHROMAFFIN CELLS OF MAMMALIAN SMALL-INTESTINE AS SOURCE OF MOTILIN. VIRCHOWS ARCH B. 16:111-120.
• PEARSE AGE; POLAK JM; BLOOM SR; JOFFE S. (1974). STUDIES ON SECRETIN. ACTA HEPATO-GASTRO. 21:477-477.
• POLAK JM; BLOOM SR; KUZIO M; BROWN JC; PEARSE AGE. (1973). CELLULAR LOCALIZATION OF GASTRIC INHIBITORY POLYPEPTIDE IN DUODENUM AND JEJUNUM. GUT. 14:284-288.
• POLAK JM; HOFFBRAN.AV; REED PI; BLOOM S; PEARSE GE. (1973). QUALITATIVE AND QUANTITATIVE STUDIES OF ANTRAL AND FUNDIC G-CELLS IN PERNICIOUS-ANEMIA. SCAND J GASTROENTERO. 8:361-367.
• WINGATE DL; BLOOM SR; GORCHEIN A. (1982). ABSENT NERVES AND ABSENT MOTILIN. SCAND J GASTROENTERO. 17:139-139.
• ANDERSON JV; STRUTHERS AD; PAYNE NN; SLATER JDH; BLOOM SR. (1986). ATRIAL NATUIURETIC PEPTIDE (ANP) INHIBITS PLASMA-RENIN ACTIVITY IN MAN. CLIN SCI. 70:P44-P44.
• ANDERSON JV; RAINE AEG; PROUDLER A; COX K; BLOOM SR. (1986). ATRIAL-NATRIURETIC-PEPTIDE (ANP) AND RENAL-FAILURE. CLIN SCI. 70:P45-P45.
• RHODES J; DAVIES HA; WHEELER MH; PSAILA J; NEWCOMBE RG; JONES JM; BLOOM S. (1984). BILE DIVERSION FROM THE DUODENUM - ITS EFFECT ON GASTRIC AND PANCREATIC FUNCTION. SCAND J GASTROENTERO. 19:221-223.
• BLOOM SR; BRYANT MG; POLAK JM; HOBBS S; DOMSCHKE W; DOMSCHKE S; MITZNEGG P; RUPPIN H; et alDEMLING L. (1978). CLINIC BIOPSIES IN DIAGNOSIS OF GUT ENDOCRINE DISORDERS. SCAND J GASTROENTERO. 13:25-25.
• POLAK JM; BLOOM SR; WRIGHT NA; DALY MJ. (1981). ELECTRON-MICROSCOPY OF THE GASTROINTESTINAL-TRACT - PROCEEDINGS OF THE 1ST SYMPOSIUM IN A SERIES ON BASIC SCIENCE IN GASTROENTEROLOGY - PREFACE. SCAND J GASTROENTERO. 16:U1-U1.
• HELLEMANS J; VANTRAPPEN G; BLOOM SR. (1976). ENDOGENOUS MOTILIN AND LES PRESSURE. SCAND J GASTROENTERO. 11:67-73.
• ANDERSON JV; SOMERS VK; CONWAY J; SLEIGHT P; BLOOM SR. (1987). GRADED DYNAMIC EXERTION PROGRESSIVELY INCREASES PLASMA-CONCENTRATIONS OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) IN NORMAL MAN. CLIN SCI. 72:P42-P42.
• WOOD SM; POLAK JM; BLOOM SR. (1983). GUT HORMONE SECRETING TUMORS. SCAND J GASTROENTERO. 18:165-179.
• BLOOM SR; POLAK JM. (1983). GUT HORMONES IN DISEASE - INTRODUCTION. SCAND J GASTROENTERO. 18:1-5.
• ANDERSON JV; DONCKIER J; PAYNE NN; BRECKWOLDT J; SLATER JDH; BLOOM SR. (1987). INHIBITION OF PLASMA-RENIN ACTIVITY (PRA) BY PHYSIOLOGICAL PLASMA-CONCENTRATIONS OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) IN MAN. CLIN SCI. 72:P63-P63.
• VANTRAPPEN G; JANSSENS J; PEETERS T; BLOOM S; CHRISTOFIDES ND; HELLEMANS J. (1978). INTRA-DUODENAL PH, MOTILIN AND INTERDIGESTIVE MIGRATING MOTOR COMPLEX IN MAN. SCAND J GASTROENTERO. 13:190-190.
• GREENBERG GR; MCCLOY RF; BJORNSSON OG; ADRIAN TE; CHADWICK VS; BARON JH; BLOOM SR. (1978). INVESTIGATION OF A PHYSIOLOGICAL-ROLE FOR PANCREATIC POLYPEPTIDE (PP) IN MAN. SCAND J GASTROENTERO. 13:68-68.
• ANDERSON JV; DONCKIER J; MCKENNA W; BURNS ACR; BLOOM SR. (1986). ISOTONIC SALINE INFUSION STIMULATES PLASMA RELEASE OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) IN MAN. CLIN SCI. 70:P74-P74.
• BLOOM SR; MITZNEGG P; BRYANT MG. (1976). MEASUREMENT OF HUMAN-PLASMA MOTILIN. SCAND J GASTROENTERO. 11:47-52.
• BLOOM SR; BRYANT MG; ADRIAN TE. (1978). MULTIPLE HORMONE FORMS IN PPOMAS, VIPOMAS AND GLUCAGONOMAS. SCAND J GASTROENTERO. 13:24-24.
• BLOOM SR; BLACKBURN AM; EBEID FH; RALPHS DNL; POLAK JM. (1978). NEUROTENSIN AND DUMPING SYNDROME. SCAND J GASTROENTERO. 13:23-23.
• BLOOM SR; ADRIAN TE; BARNES AJ; LONG RG; HANLEY J; MALLINSON CN; RIVIER JE; VALE W; et alBROWN MR. (1978). NEW SPECIFIC LONG-ACTING SOMATOSTATIN ANALOGS IN TREATMENT OF PANCREATIC ENDOCRINE TUMORS. SCAND J GASTROENTERO. 13:22-22.
• PRESTON DM; ADRIAN TE; CHRISTOFIDES ND; LENNARDJONES JE; BLOOM SR. (1983). PANCREATIC-POLYPEPTIDE AND MOTILIN RESPONSE IN DIFFERENT TYPES OF FUNCTIONAL BOWEL-DISEASE. SCAND J GASTROENTERO. 18:199-200.
• BISHOP AE; FERRI GL; PROBERT L; BLOOM SR; POLAK JM. (1982). PEPTIDERGIC NERVES. SCAND J GASTROENTERO. 17:43-59.
• ANDERSON JV; RUTHERFORD AJ; ELDER MG; BLOOM SR. (1987). POST-PARTUM RELEASE OF ATRIAL-NATRIURETIC-PEPTIDE IN HEALTHY PREGNANT-WOMEN. CLIN SCI. 73:P44-P44.
• EDWARDS AV; BLOOM SR. (1982). RECENT PHYSIOLOGICAL-STUDIES OF THE ALIMENTARY AUTONOMIC INNERVATION. SCAND J GASTROENTERO. 17:77-89.
• POLAK JM; BUCHAN AMJ; PROBERT L; TAPIA F; DEMEY J; BLOOM SR. (1981). REGULATORY PEPTIDES IN ENDOCRINE-CELLS AND AUTONOMIC NERVES - ELECTRON IMMUNOCYTOCHEMISTRY. SCAND J GASTROENTERO. 16:11-23.
• DOMSCHKE W; LUX G; MITZNEGG P; ROSCH W; DOMSCHKE S; BLOOM SR; WUNSCH E; DEMLING L. (1976). RELATIONSHIP OF PLASMA MOTILIN RESPONSE TO LOWER ESOPHAGEAL SPHINCTER PRESSURE IN MAN. SCAND J GASTROENTERO. 11:81-84.
• MITZNEGG P; BLOOM SR; CHRISTOFIDES N; BESTERMAN H; DOMSCHKE W; DOMSCHKE S; WUNSCH E; DEMLING L. (1976). RELEASE OF MOTILIN IN MAN. SCAND J GASTROENTERO. 11:53-56.
• BLOOM SR; CHRISTOFIDES ND; BESTERMAN HS; ADRIAN TE; GHATEI MA. (1978). RELEASE OF MOTILIN IN MAN BY ORAL AND INTRAVENOUS NUTRIMENTS. SCAND J GASTROENTERO. 13:26-26.
• BLOOM SR; MITCHELL SJ; GREENBERG GR; CHRISTOFIDES N; DOMSCHKE W; DOMSCHKE S; MITZNEGG P; DEMLING L. (1978). RESPONSE OF VIP, SECRETIN AND MOTILIN TO DUODENAL ACIDIFICATION IN MAN. SCAND J GASTROENTERO. 13:27-27.
• ELSABBAGH HN; BLOOM SR; ADRIAN TE; PRINZ RA; BARON JH; WELBOURNE RB. (1980). THE EFFECT OF PIRENZEPINE ON MEAL-STIMULATED GASTROINTESTINAL HORMONES. SCAND J GASTROENTERO. 15:57-61.
• BLOOM SR; POLAK JM. (1982). THE HORMONAL PATTERN OF INTESTINAL ADAPTATION - A MAJOR ROLE FOR ENTEROGLUCAGON. SCAND J GASTROENTERO. 17:93-103.
• GILL JS; GHATEI MA; BLOOM SR. (1987). VALOSIN IMMUNOREACTIVITY IN CENTRAL AND PERIPHERAL-TISSUES OF 3 MAMMALIAN-SPECIES. CLIN SCI. 73:P12-P12.
• MILLAR ND; OHARE JP; ANDERSON JV; BARNES IC; CORRALL RJM; BLOOM SR; MACKENZIE JC; READ AER. (1987). WATER IMMERSION IN CIRRHOSIS - THE ATRIAL-NATRIURETIC-PEPTIDE RESPONSE. CLIN SCI. 72:P33-P33.

Chapters in books

• Bloom SR; Ghatei MA; Taheri S. Glucagon- and proglucagon-derived peptides. In Wiley Encyclopedia of Molecular Medicine. 1430-1434. (2002).
• Calam J; Taheri S; Bloom SR. Gastrinoma. In Oxford Textbook of Endocrinology and Diabetes. 877-882. (2002).
• Frankton S; Bloom SR. Glucagonoma. In Oxford Textbook of Endocrinology and Diabetes. 889-894. (2002).
• Howard JK; Bloom SR. VIPomas. In Oxford Textbook of Endocrinology and Diabetes. 895-899. (2002).
• Howard JK; Ghatei MA; Bloom SR. Bombesin. In Wiley Encyclopedia of Molecular Medicine. 381-383. (2002).
• Seal LJ; Ghatei MA; Bloom SR. Secretin. In Wiley Encyclopedia of Molecular Medicine. 2871-2874. (2002).
• Stanley SA; Ghatei MA; Bloom SR. Pancreatic polypeptide. In Wiley Encyclopedia of Molecular Medicine. 2381-2384. (2002).
• Taheri S; Ghatei MA; Bloom SR. The orexins/hypocretins - novel hypothalamic neuropeptides with multiple functions. 121-133. (2001).
• Taheri S; Ghatei MA; Bloom SR. Cholecystokinin (CCK). In Wiley Encylopedia of Molecular Medicine. 752-754. (2002).
• Taheri S; Ghatei MA; Bloom SR. Endocrinology of the gastrointestinal tract. In Comprehensive Clinical Endocrinology. 3rd:453-469. (2002).
• Taheri S; Ghatei MA; Bloom SR. Orexins (Hypocretins). In Wiley Encyclopedia of Molecular Medicine. 2328-2331. (2002).
• Todd JF; Bloom SR. Insulinomas and hypoglycaemia. In Oxford Textbook of Endocrinology and Diabetes. 883-888. (2002).
• Barakat MT; Lynn JA; Bloom SR. Endocrine Tumors of the Gastrointestinal Tract. In Endocrine Surgery. 643-658. Schwartz AE (ed); Pertsemlidis D (ed); Gagner M (ed). Marcel Dekker, New York (2003).

Conferences

• Ramachandran R; Bech P; Murphy KG; Dhillo WS; Marelli L; Ghatei MA; Bloom SR; Caplin M; et alMartin NM. Plasma Somatostatin: Gastrin Ratio Improves the Diagnosis of Gastrinoma. 94:9-9. (2011).
• Bech P; Ramachandran R; Martin NM; Murphy K; Dhillo WS; Caplin M; Ghatei MA; Bloom SR. Chromogranin B Is a Prognostic Marker in NETs. 94:1-1. (2011).
• Bueter M; Seyfried F; Fenske WK; Miras AD; Ghatei MA; Bloom SR; le Roux CW. Exogenous Peptide YY 3-36 and Exendin-4 Further Decrease Food Intake, While Octreotide Increases Food Intake in Rats after Roux-En-Y Gastric Bypass. 21:1127-1127. (Aug 2011).
• Bueter M; Miras AD; Chichger H; Fenske W; Ghatei MA; Bloom SR; Unwin RJ; Lutz TA; et alSpector AC; le Roux CW. Alterations of Sucrose Preference after Roux-En-Y Gastric Bypass. 21:1127-1127. (Aug 2011).
• Bueter M; Hankir M; Gsell W; Seyfried F; Khalil M; Smith KL; Bloom SR; Bell JD; et alle Roux CW. Increased Energy Expenditure in Gastric Bypass Rats is Not Caused by Activated Brown Adipose Tissue. 21:1126-1126. (Aug 2011).
• Ashrafian H; Li JV; Bueter M; le Roux CW; Bloom SR; Marchesi JR; Nicholson JK; Holmes E; et alDarzi A; Athanasiou T. Metabolic Surgery Modulates the Systemic Metabolic Profile and Gut Microbial Ecology. 21:1098-1098. (Aug 2011).
• Bueter M; Theis N; Werling M; Ashrafian H; Lowenstein C; Bloom SR; Spector AC; Olbers T; et alLutz TA; le Roux CW. Roux-En-Y Gastric Bypass Affects the Preference for High Fat Food in Rats and Humans. 21:1016-1016. (Aug 2011).
• de Jonge C; Verdam FJ; Rensen SS; Vincent RP; Bloom SR; Ghatei MA; Buurman WA; le Roux CW; et alBouvy ND; Greve JWM. Endobarrier (TM) Gastrointestinal Liner Treatment Rapidly Improves Diabetes Parameters Paralleled by Increased Postprandial GLP-1 and PYY Levels in Obese Type 2 Diabetic Patients. 21:1011-1011. (Aug 2011).
• Ramachandran R; Bech P; Murphy KG; Dhillo WS; Marelli L; Ghatei MA; Bloom SR; Caplin M; et alMartin NM. PLASMA GASTRIN: SOMATOSTATIN RATIO IS DECREASED IN GASTRINOMAS. 60:A117-A117. (Apr 2011). DOI.
• Boughton CK; Patterson M; Tadross JA; Bewick GA; Gardiner JV; Ghatei MA; Bloom SR; Murphy KG. The Novel Neuropeptide Alarin Stimulates Food Intake and the Reproductive Axis in Male Rats. 31. (Jun 2010).
• Hostomska K; Salem V; Field BCT; Murphy KG; Ghatei MA; Bloom SR. Resistance to the Anorectic Effect of PYY3-36 during Continuous Infusion Is Independent from the Stimulation of Appetite Resulting from Weight Loss. 31. (Jun 2010).
• Goldstone AP; de Hernandez CGP; Scholtz S; Durighel G; Deliran SS; Wong T; Ashby D; Frost G; et alBloom SR; Bell JD. Ghrelin Mimics Fasting in Biasing Food Appeal towards High-Calorie Foods. 31:S2537-S2537. (Jun 2010).
• Leavy EM; Gardiner JV; Richardson E; Buckley NW; Martin NM; Bloom SR; Smith KL. The Role of Neuropeptide Y within the Hypothalamic Dorsomedial Nucleus in the Regulation of Energy Homeostasis. 31. (Jun 2010).
• Addison ML; Minnion JS; Shillito JC; Tan T; Murphy KG; Ghatei MG; Bloom SR. Investigating the Metabolic Clearance and Degradation of the Anorexigenic Gut Hormone PYY3-36 as a Tool To Design Long-Acting Analogues of PYY3-36 for the Treatment of Obesity. 31. (Jun 2010).
• Jayasena CN; Nijher GMK; Abbara A; Murphy KG; Lim A; Patel DA; Mehta A; Todd C; et alDonaldson M; Trew G; Ghatei MA; Bloom SR; Dhillo WS. Twice-Weekly Administration of Kisspeptin-54 for Eight Weeks Stimulates Reproductive Hormone Release in Women with Hypothalamic Amenorrhea. 31:S2527-S2527. (Jun 2010).
• Richardson E; Hussain SS; Counsell JR; Leavy E; Bewick GA; Bloom SR; Gardiner JV. The Role of Ventromedial Hypothalamic Glucose-Sensing Neurons during Glucoprivation. 31. (Jun 2010).
• Bloom S. Practical aspect of drug development in the peptide field. 164:24-24. (9 Sep 2010). DOI.
• Bloom S. Control of appetite by gut hormones. 164:22-22. (9 Sep 2010). DOI.
• Ramachandran R; Bech P; Murphy KG; Dhillo WS; Meeran KM; Chapman RC; Caplin M; Ghatei MA; et alBloom SR; Martin NM. Chromogranin A assays: Comparison of diagnostic accuracy. 164:12-12. (9 Sep 2010). DOI.
• Ramachandran R; Bech P; Dhillo W; Ghatei M; Bloom S; Toumpanakis C; Caplin M. Rabbit interference with gut peptide immunoassay. 164:15-16. (9 Sep 2010). DOI.
• Stebbing J; Keun HC; Sidhu J; Patterson M; Bloom SR; Amber V; Coombes C; Marconell H; et alPshezhetskiy D. Serum molecular signatures of weight change during early breast cancer chemotherapy. 27. (20 May 2009).
• Bloom S. Gut hormones and appetite regulation. 43:437-438. (Oct 2009).
• Ashrafian H; Bueter M; Ahmed K; Rao C; Ahmed AR; Bloom SR; Athanasiou T; Darzi A; et alle Roux CW. Food preference after Roux-en-Y gastric bypass surgery. 209:S14-S14. (Sep 2009).
• Kokkinos A; leRoux CW; Alexiadou K; Tentolouris N; Vincent RP; Kyriaki D; Perrea D; Ghatei MA; et alBloom SR; Katsilambros N. The postprandial response of the anorexigenic gut hormones PYY and GLP-1 is affected by eating rate. 52:S227-S227. (Sep 2009).
• Ashrafian H; Bueter M; Ahmed K; Ahmed A; Bloom S; Athanasiou T; Darzi A; Le Roux C. Gastric Bypass Surgery and Taste Sensitivity. 19:997-998. (Aug 2009).
• Bueter M; Ashrafian H; Frankel AH; Tam FWK; Bloom SR; Le Roux CW. Sodium and Water Handling After Roux-En-Y Gastric Bypass in Rats. 19:989-989. (Aug 2009).
• Bueter M; Ashrafian H; Frankel A; Tam F; Unwin R; Bloom S. Energy Expenditure After Roux-En-Y Gastric Bypass in Rats. 19:988-989. (Aug 2009).
• Ashrafian H; Bueter M; Ahmed K; Ahmed A; Bloom S; Athanasiou T; Darzi A; Le Roux C. Gastric Bypass Surgery and Food Choice. 19:969-969. (Aug 2009).
• Bueter M; Ashrafian H; Frankel A; Tam F; Unwin R; Bloom S. Upper Gastrointestinal Investigations Before Gastric Banding. 19:953-953. (Aug 2009).
• Busbridge M; Ashby D; Gale DP; Chapman R; Patrick M; Bloom S. Erythropoietin therapy leads to a reduction in hepcidin in chronic renal disease patients. 55:A169-A169. (Jun 2009).
• McGowan BMC; Stanley SA; Ghatei MA; Bloom SR. Relaxin-3 and Its Role in Neuroendocrine Function. 1160:250-255. (2009). DOI.
• Chaudhri OB; Wynne K; Bloom SR. Can Gut Hormones Control Appetite and Prevent Obesity?. 31:S284-S289. (Feb 2008). DOI.
• Chaudhri OB; Field BCT; Bloom SR. Gastrointestinal satiety signals. 32:S28-S31. (Dec 2008). DOI.
• NELSONPIERCY C; HAMMOND PJ; BLOOM SR. GASTROINTESTINAL ENDOCRINE TUMORS DURING CHILDHOOD. 21:170-181. (1992).
• GOODLAD RA; CHINERY R; LEE CY; GHATEI MA; BLOOM SR; WRIGHT NA. EFFECTS OF SHORT-CHAIN FATTY-ACID INFUSION ON THE GASTROINTESTINAL EPITHELIUM OF INTRAVENOUSLY FED RATS. 280-284. (1993).
• Ashby D; Choi P; Bloom S. Gut hormones and the treatment of disease cachexia. Annual Meeting of the Nutrition-Society/British-Association-for-Parenteral-and-Enteral-Nutrition. 67:263-269. (Aug 2008).
• Pournaras D; Le Roux C; Osborne A; Hawkins S; Bloom S; Ghatei M; Mahon D; Welbourn R. Gut hormone changes in the first 24 months after gastric bypass. 18:933-933. (Aug 2008).
• Pournaras D; Le Roux C; Osborne A; Hawkins S; Bloom S; Ghatel M; Mahon D; Welbourn R. GLP-1, insulin and insulin resistance in the first week after bariatric surgery. 18:928-928. (Aug 2008).
• Venetikou M; Burrin J; Ghatei M; Bloom S. ACTH and 7B2 release by AtT-20 cells in vitro: effect of CRF, VIP, AVP and SRIF during perifusion and static culture. Joint Conference of the 33rd FEBS Congress/11th IUBMB Conference. 275:262-262. (Jun 2008).
• Huda M; Dovey T; Wong S; English P; Halford J; McCulloch P; Cleator J; Martin B; et alCashen J; Hayden K; Ghatei M; Bloom S; Wilding J; Pinkney J. Endocrine adaptations to short term fasting are preserved after gastrectomy but impaired in morbid obesity. 32:S74-S74. (May 2008).
• Bloom SR; Kuhajda FP; Ismail L; Pi-Sunyer X; Ronnett GV; Tan TMM; Weigle DS. The obesity epidemic: Pharmacological challenges. Experimental Biology 2008 Annual Meeting. 8:82-98. (1 Apr 2008).
• Chambers JC; Scott J; Meeran K; Jain P; Bloom S; Kooner JS. Transcription factor 7-like 2, insulin action and risk of type 2 diabetes among Indian Asian and White European men. Annual Scientific Conference of the British-Cardiovascular-Society. 94:A59-A59. (Jul 2008).
• Bloom SR. GEP peptides powerfully influence appetite - An ongoing story. 8th International Symposium on VIP, PACAP and Related Peptides. 33:326-326. (2007).
• Borg CM; Le Roux CW; Ghatei MA; Bloom SR; Aylwin SJB; Patel AG. Roux-en-Y gastric bypass is associated with elevated levels of glucagon-like peptide 2 (GLP-2) and peptide YY (PYY) in human subjects and with proliferation of the intestinal mucosa in a rodent model. 17:1053-1053. (Aug 2007).
• Borg CM; Le Roux CW; Ghatei MA; Bloom SR; Patel AG. Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. 10th World Congress of the International-Federation-for-the-Surgery-of-Obesity/19th International Symposium on Obesity Surgery/4th International Symposium on Allied Health Sciences. 17:1193-1198. (Sep 2007).
• GHATEI MA; TAKAHASHI K; SUZUKI H; GARDINER JV; JONES PM; BLOOM SR. DISTRIBUTION, SYNTHESIS AND MOLECULAR CHARACTERIZATION OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) IN RAT-BRAIN. 5TH INTERNATIONAL SYMP ON VIP ( VASOACTIVE INTESTINAL PEPTIDE ) AND RELATED PEPTIDES. 13:337-342. (Feb 1992).
• KULKARNI RN; GHATEI MA; BYFIELD P; BLOOM SR. THE EFFECT OF GLP-1(7-36)NH2 AND ITS FRAGMENTS ON INSULIN RELEASE. International Symposium on Glucagon-Like Peptide-1. 54:380-382. (Nov 1993).
• BLOOM SR. Paracrine regulation of regulatory peptides. 15th Gut Hormone Conference. 15:1-4. (Feb 1994).
• CHANGANI KK; BARNARD ML; BELL JD; WILLIAMS SCR; BLOOM SR; ILES RA. In vivo hepatic energy pertubations during alanine infusion using P-31-NMR spectroscopy. 653rd Meeting of the Biochemical-Society-of-London. 23:S336-S336. (May 1995).
• HOWARTH PH; REDINGTON AE; SPRINGALL DR; MARTIN U; BLOOM SR; POLAK JM; HOLGATE ST. Epithelially derived endothelin and nitric oxide in asthma. 20th Symposium of the Collegium-Internationale-Allergologicum on Molecular and Clinical Implications for Allergy in the 21st-Century. 107:228-230. (May 1995).
• Wynick D; Small CJ; Bloom SR; Pachnis V. Targeted disruption of the murine galanin gene. Conference on Galanin - Basic Research Discoveries and Therapeutic Implications. 863:22-47. (1998).
• Small CJ; Rossi M; Bloom SR. Glucagon like peptide-1 (GLP-1), Neuropeptide Y (NPY) and Melanin Concentrating Hormone (MCH) in the hypothalamic regulation of food intake. 8th International Congress on Obesity. 279-288. (1999).
• Chaudhary M; FitzGerald AJ; Mandir N; Howard JK; Lord GM; Ghatei MA; Bloom SR; Goodlad RA. Leptin, starvation and the mouse gut. 3rd Conference on Food and Cancer Prevention. 314-319. (2000).
• le Roux CW; Aylwin SJB; Batterham RL; Wynne KJ; Borg CM; Hunt C; Wedlake L; Monteiro M; et alFrost G; Ghatei MA; Bloom SR. PYY deficiency may reinforce obesity. 13th European Congress on Obesity. 28:S219-S219. (May 2004).
• Borg CM; le Roux CW; Ghatei MA; Bloom SR; Patel AG; Aylwin SJB. Prospective changes in gut hormones after Roux-en-Y gastric bypass for morbid obesity. Annual Meeting of the Association-of-Surgeons-of-Great-Britain-and-Ireland. 92:38-38. (Apr 2005).
• Borg CM; Le Roux CW; Ghatei MA; Bloom SR; Patel AG. Changes in gut hormones after sham and bariatric surgery in Wistar rats. 10th World Congress of the International-Federation-for-the-Surgery-of-Obesity/19th International Symposium on Obesity Surgery/4th International Symposium on Allied Health Sciences. 15:937-937. (Aug 2005).
• Le Roux CW; Aylwin SJB; Batterham RL; Coyle F; Borg CM; Prasad V; Shurey S; Ghatei MA; et alPatel AG; Bloom SR. Gut hormone profiles may explain reduced appetite and food intake following bariatric surgery. 10th World Congress of the International-Federation-for-the-Surgery-of-Obesity/19th International Symposium on Obesity Surgery/4th International Symposium on Allied Health Sciences. 15:936-936. (Aug 2005).
• le Roux CW; Aylwin SJB; Batterham RL; Borg CM; Coyle F; Prasad V; Shurey S; Ghateil MA; et alPatel AG; Bloom SR. Gut hormone profiles may explain reduced appetite and food intake following bariatric surgery. 2nd Congress of the IFSO European Chapter/3rd Combined Meeting of Bariatric and Plastic Surgery. 16:402-402. (Apr 2006).
• Werling M; le Roux C; Laurenius A; Bjorklund P; Lonroth H; Fandriks L; Ghatei M; Bloom S; et alOlbers T. Peptide YY responses after food intake correlates with weight reduction following Roux-en-Y Gastric Bypass surgery. 11th World Congress of the International-Federation-for-the-Surgery-of-Obesity. 16:984-985. (Aug 2006).
• Vincent R; le Roux C; Kokkinos A; Ghatei M; Bloom S. Physiological blockade of gut hormones increases food intake. 15th European Congress on Obesity. 31:S21-S21. (May 2007).
• Bloom S. Brain-gut axis and food intake. 31:S6-S6. (May 2007).
• Murphy KG; Thompson EL; Patterson M; Bewick GA; Jethwa PH; Stamp GWH; Todd JF; Ghatei MA; et alBloom SR. Continuous subcutaneous administration of kisspeptin-54 causes testicular degeneration in rats. 27:77-77. (May 2006). DOI.
• Coen CW; Grimshaw SE; Goubillon ML; Strutton PH; Ghatei MA; Bloom SR; Wilson CA. Effects of fasting and refeeding on luteinising hormone pulses and on multiple indices of metabolic state in female rats. 27:70-70. (May 2006). DOI.
• Borg CM; Le Roux CW; Ghatei MA; Bloom SR; Patel AG. A reliable rat model of human Roux-en-Y gastric bypass. 15:938-938. (Aug 2005).
• Gossiel F; Le Roux CW; Batterham RL; Cohen MA; Bloom SR; Blumsohn A. Bone turnover response to feeding and infusion of gut hormones peptide YY3-36, pancreatic polypeptide and oxyntomodulin. 19:S375-S375. (Oct 2004).
• Vincent RP; le Roux C; Patterson M; Ghatei M; Bloom S. Ghrelin levels following increasingly calorific meals in obese and lean individuals. 28:S35-S35. (May 2004).
• Park A; Sileno A; Brandt G; Quay S; Bloom S. Nasal peptide YY3-36: Phase 1 dose ranging and safety study in healthy subjects. 28:S222-S222. (May 2004).
• LAMBERT PD; WILDING JPH; GHATEI MA; BLOOM SR. A ROLE FOR GLP-1(7-36)NH2 IN THE CENTRAL CONTROL OF FEEDING-BEHAVIOR. 54:360-361. (Nov 1993).
• JAMAL H; JONES PM; BYRNE J; SUDA K; GHATEI MA; KANSE SM; BLOOM SR. VASOACTIVE INTESTINAL POLYPEPTIDE AND ITS MESSENGER-RNA IN THE ISOLATED RAT ISLETS OF LANGERHANS - EFFECT OF DEXAMETHASONE TREATMENT. 13:233-238. (1992).
• KANSE SM; TAKAHASHI K; WARREN JB; PERERA T; PORTA M; GHATEI M; BLOOM SR. PRODUCTION OF ENDOTHELIN BY VASCULAR SMOOTH-MUSCLE CELLS. 17:S113-S116. (1991).
• GOODLAD RA; GHATEI MA; DOMIN J; BLOOM SR; WRIGHT NA. IS PEPTIDE-YY TROPHIC TO THE INTESTINAL EPITHELIUM OF PARENTALLY FED RATS. 46:177-181. (1990).

Patents

• 2 patents applied for.